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“Fight on my men”, says Sir Andrew Barton 
“I am hurt, but I am not slain; 
I’ll lay me down and bleed a while 
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Lay Summary 
Several decades ago, a family with an unusually high rate of multiple psychiatric 
disorders was discovered in Scotland. The disorders included schizophrenia, bipolar 
disorder, and recurrent major depressive disorder, which are highly debilitating and 
involve emotional and behavioural problems. It was subsequently found that the 
family also carries a unique genetic mutation, called the t(1:11) translocation, that 
involves the exchange of genetic material between the chromosomes, which carry 
genes. Chromosomes 1 and 11 are affected. The translocation is inherited with very 
high risk of developing the disorders and is a major factor in the family’s risk.  
The exchange of genetic material, DNA, between chromosomes 1 and 11 means that 
large pieces of DNA have broken off at both locations, then exchanged. This now 
means that part of chromosome 1 is on chromosome 11, and vice versa. This has 
disrupted three genes, two which are present and overlap on chromosome 1, and one 
which is on chromosome 11. Of these three, one on chromosome 1 can instruct cells 
to produce a protein, named DISC1. There is a high level of DISC1 protein in cells 
of the brain (neurons) and it increases in presence during the development of neuron 
cell models. The protein is also known to have a role in many cellular processes 
involving the strengthening of connections between neurons in the brain, which is 
known to be important in learning and memory. It also has a role in how the neurons 
organise during brain development, and in how they produce energy. Because of the 
exchange of genetic material between chromosomes 1 and 11, the second half of the 
DISC1 gene is missing and in its place is DNA from chromosome 11. This appears to 
result in lower levels of the DISC1 protein, in addition to changes in movement of 
molecules around the neurons.. 
We now have access to a unique type of neuron which is generated from skin 
samples, donated by members of the family. These neurons are therefore genetically 
matched to the family members that donated them. Members both with and without 
the translocation have made donations, so we can compare the two groups. We also 
have access to a unique mouse model. Mice also have a version of the DISC1 gene. 
Here, this unique mouse model has been artificially altered so that its Disc1 gene is 
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also missing the second half, which has been replaced by human DNA from 
chromosome 11 at the correct breakpoint. We have used mice where either one or 
both of its original Disc1 genes have been altered in this manner.  
This thesis describes the study of these human and mouse models, which have been 
investigated for altered levels of other cellular molecules which could be changed 
due to the mutation. It is shown that these changes are more likely than chance to be 
overlapping with those highlighted by other researchers, and are more likely than 
chance to be involved in various neuron activities relating to strengthening 
connections and moving molecules around the neuron. We also report that there 
appear to be higher levels of DRD2, a protein which antipsychotic drugs block the 
action of. This thesis also describes an investigation to look for different proportions 
of various cell types between the mutant and control samples; little evidence for this 
was found in the human cells. A part of the brain called the cortex shows unusual cell 
type proportion changes in the mouse if both the Disc1 genes are altered. It does also 
appear that some cell types will be worse affected by the mutation than others, in 
activity if not in total number. Overall, this thesis highlights the overlaps between the 
effects of this unique mutation and other more common ones which are known to 
increase risk of schizophrenia. It also highlights some activities of the cells which 
appear to be abnormal and have been previously suspected of being important in 
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Abstract 
The t(1;11) translocation is a mutation unique to a Scottish pedigree, members of 
which have been diagnosed with schizophrenia, bipolar disorder, recurrent major 
depressive disorder and other related disorders. The translocation is significantly 
linked to increased risk of these diagnoses. It disrupts three genes, only one of which, 
DISC1, encodes a protein. A number of experiments have explored the function of 
DISC1 as a molecular scaffold and developmental regulator. DISC1 and its 
interactors have roles in processes of relevance to psychiatric disease. These include 
neuronal precursor proliferation, migration and integration in the developing and 
adult brain, neurite outgrowth, mitochondrial activity, which is particularly important 
in neurons due to their high energy demands, and intracellular trafficking, especially 
critical in neurons due to their highly elongated morphology. Although various 
DISC1 mutations have been investigated in the past, it is only with advances in 
technology that neural cells derived directly from translocation carriers, and therefore 
carrying the translocation plus their genetic background, have been generated and 
analysed. In addition a recently described mouse model mimics the effects of the 
translocation upon DISC1 expression. It does so by removing endogenous Disc1 
exons corresponding to those distal to the breakpoint in translocation carriers, and 
fusing the remaining endogenous 5’ Disc1 genomic sequence to human chromosome 
11 genomic sequence distal to the translocation breakpoint. The result is a chimeric 
gene with 5’ mouse Disc1 joined to a segment of human DISC1FP1, the non-coding 
fusion partner of DISC1 located on chromosome 11. This leads to loss of wild-type 
Disc1 and prediction of chimeric transcripts encoding aberrant C-terminally 
truncated forms of Disc1. 
This thesis builds on the work of previous researchers to characterise the RNA-
sequenced transcriptome of ‘cortical’ neurons derived from induced pluripotent stem 
cells from various members of the pedigree. Both heterozygous and homozygous 
mutant mice have also been utilised to generate RNA-sequencing data from the 
hippocampus and cortex. The thesis not only describes the differential expression of 
genes and exons, but also carries out a series of analyses to examine whether 
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proportions of certain cell types are altered, as well as whether differentially 
expressed genes are highly associated with specific cell types.  
RNA-Seq data have been analysed for differential expression at the gene and 
individual exon level using DESeq2 and DEXSeq, respectively. This has revealed 
over 1,200 differentially expressed genes in human neurons carrying the 
translocation, which predict changes to functions relating to intracellular transport 
and synaptic activity. In addition, a number of genes have been verified by RT-qPCR 
as being differentially expressed in these neurons. These include genes of known 
relevance to schizophrenia such as DRD2, which encodes the D2 dopamine receptor, 
NTRK2, which encodes the BDNF receptor NTRK2, and BBS1 which encodes the 
DISC1 interactor and centrosomal protein BBS1. The human neurons also show 
significant overlap with previously published dysregulated genes in human neurons 
carrying other DISC1 mutations, as well as with genes associated with schizophrenia 
by large-scale genome wide association and copy number variation studies. Human 
neuron RNA-Seq data have also been examined for evidence of local effects of the 
translocation upon gene expression, and no obvious strong effect was found. The 
pattern of gene dysregulation in heterozygous mutant mouse cortex overlaps with 
that of the mutant human neurons. Gene expression changes in the mutant mouse 
cortex have also been verified by RT-qPCR in the genes Arc and Avp, and the list of 
implicated genes also shows overlap with genes associated with schizophrenia by 
large-scale genome wide association and copy number variation studies. 
An RNA-Seq deconvolution analysis was carried out to look for evidence of altered 
proportions of cell types at both the broad and more specific cell type level. This 
compared the observed expression of hundreds of genes in in the RNA-Seq samples 
against their expression in publically available RNA-Seq data of specific cell types. 
There does not appear to be any strong and consistent effect of the t(1;11) or mouse 
mutation on cell proportions. However, the data indicate greater than expected 
dysregulation of genes that are highly enriched in specific cell types. This includes 
certain subtypes of astrocyte. Mutant mouse cortex also shows dysregulation of 
genes associated with several subtypes of interneuron and pyramidal neuron, 
including parvalbumin positive interneurons. This indicates that, while the 
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proportions of cell types appears to be unaffected by the translocation or mouse 
mutation, specialised cellular functions may be perturbed. 
To conclude, this thesis highlights a number of processes which appear to be 
disturbed by the translocation and mouse mutation. In all models, RNA-Seq evidence 
suggests signalling pathways of known relevance to psychiatric disease have been 
affected without significant alteration of cell proportions. This concurs with 
histological analyses of the mouse model by previous researchers. This thesis also 
describes the overlap between genes implicated in the study of this unique mutation 
as well as those implicated by studies seeking common or rare mutations 
predisposing to schizophrenia, supporting the hypothesis that different genomic risk 
variants and mutations converge upon certain molecular pathways that are especially 
important in this illness. The implication that the t(1;11) may alter the activities of 
certain cell types is also notable and future work can elucidate the cell-specific 
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1.1 Psychiatric illness 
Psychiatric illnesses are among the major causes of human misery. The World Health 
Organisation estimates that over 800,000 people die by suicide every year
1
. 
However, a more nuanced measure of the burden of psychiatric illness is given by 
Disability Adjusted Life Years (DALYs). DALYs are a useful, if limited, means of 
quantifying harm in terms of years of life lost (YLLs), and years lived with disability 
(YLDs), which take into account time lived with the condition and the negative 
effects on quality of life during that period. Psychiatric illnesses are highly 
significant DALY contributors, with the three relatively common conditions of 
recurrent major depressive disorder (rMDD) (2.5% world total DALYs), 
schizophrenia (SZ) (0.6%), and bipolar disorder (BP) (0.5%) each contributing 
substantial proportions to the world total of DALYs 
2
. As a group, they are also the 
largest single contributor to the world total of YLDs
3
. The true contribution is higher 
when self-harm and increased mortality due to psychiatric illnesses is included
4
. As 
expected given their prevalence and severity, these illnesses have immense social 
and economic implications
5
, with the three conditions above estimated to have cost 
England a combined 16.7 billion pounds in 2007, with 5.5 billion of this in service 
costs and the rest in lost earnings
6
. Despite their severity and chronic nature, 
psychiatric illnesses receive a disproportionately low level of funding, with the 
global median estimated at just under 3% of expenditure compared to the 10% of 
DALYs they contribute (including self-harm)
4
. Phenotypically, psychiatric illnesses 
are characterised by harmful behaviours or abnormal psychological functions, as well 
as altered cognition. 
Schizophrenia is a chronic condition characterised by a multitude of behavioural and 
psychological symptoms. These can be broadly characterised into positive, negative 
and cognitive
7
. Positive symptoms relate to acquired phenotypes such as 
hallucinations and delusions. Negative symptoms are those which relate to a loss of 
normal function, such as apathy, anhedonia and a “flat/blunt affect” (unemotional 
responsiveness and flattened speech). Deficits in cognitive functioning have been 
more recently identified as being present in schizophrenia. The DSM-V has been 
criticised in some quarters, but the kappa values (measurement of the likelihood of 
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agreement on a diagnosis) for DSM-V schizophrenia are relatively high, indicating a 
reliable diagnosis. The editors of the American Journal of Psychiatry note that the 
0.46 kappa value for schizophrenia equates to two clinicians agreeing on a diagnosis 
85% of the time, if 10% of their patients in the clinic have the illness
8
. DSM-IV 
schizophrenia, which is highly similar to DSM-V schizophrenia, is a diagnosis which 
is reliable with 80-90% of individuals diagnosed retaining it for 1-10 years after 
diagnosis
9
. Schizophrenia is therefore a diagnosis which is long lasting, enjoys broad 
but not absolute agreement among clinicians, and is partially treatable with 
recognised symptoms. Active psychosis can be controlled via use of antipsychotics
7
, 
but functional recovery allowing resumption of employment, independent living, 
etc., is less achievable, with estimates ranging from 30-40% of individuals achieving 
this a few years after their first episode of schizophrenia
10
. Bipolar disorder is 
another severe psychiatric illness characterised by behavioural abnormalities. It has 
previously been distinguished from schizophrenia in that patients do not present with 
psychotic symptoms; this is part of the so called-Kraepelian dichotomy separating 
the affective disorders involving episodes of altered mood and affect from the 
psychotic disorders which tend to present earlier and last longer
7,11
. This dichotomy 
has been challenged by some authors
12
. Bipolar disorder is generally diagnosed by 
the presence of manic episodes characterised by hyper-excitability and altered mood, 
along with the presence of depressive episodes involving anhedonia, apathy, and 
other symptoms. There are different subtypes of the disorder; including cyclothymia 
which appears to involve symptoms of reduced intensity; including hypomania rather 
than full mania and depressive symptoms which do not fit the criteria for a 
depressive episode
11
. Bipolar disorder is relatively common; adding the two major 
subtypes (type I and type II) together gives a lifetime prevalence of 1%
13
. The kappa 
values of type I and type II, 0.56 and 0.4, are similar to that of schizophrenia
8
. The 
exact diagnosis of bipolar disorder is difficult, as major depressive disorder has 
phenotypic overlap with bipolar disorder. This is particularly seen in those subtypes 
which are not characterised by periods of mania. Many individuals diagnosed with 
unipolar depression may actually have a form of bipolar disorder and 20% of these 
individuals experience a manic or hypomanic episode within five years
11
. It appears 
an elevated number of these may be found amongst treatment-resistant depression 




. Major depressive disorder itself is characterised by a number of biological 
changes (loss of appetite, loss of desire, changes in sleep patterns), sadness, suicidal 
thoughts, slowing of speech and action, which persist for weeks and cause significant 
disability. It is surprisingly common, with a lifetime prevalence of 17% according to 
the US National Comorbidity study, although this should be tempered with the 
understanding that the diagnosis is difficult to make
14
. The DSM-V kappa value is 
0.28, described as of “questionable agreement” among clinicians
8
. The disorder tends 
to be lifelong in duration and adolescent or childhood presentation is not rare
14
. 
These three conditions cannot be regarded as entirely separate entities. It is clear that 
there is great phenotypic overlap between the manic/psychotic elements of bipolar 
disorder and schizophrenia, while depression is very hard to distinguish from bipolar 
disorder which has not yet been characterised by a manic phase. It is also difficult to 
describe any symptom which is highly specific and sensitive in the diagnosis of these 
psychiatric diseases. Van Os and Kapur 2009 state (italics mine) “Within the cluster 
of diagnostic categories, the term schizophrenia is applied to a syndrome 
characterised by long duration, bizarre delusions, negative symptoms, and few 
affective symptoms” which they contrast with bipolar disorder, which has less 
negative and more affective symptoms. They also note that many symptoms, even of 
schizophrenia, are present in the healthy population at reasonable prevalence. 
Experience of auditory hallucinations and paranoia are common, at 5-8%
7
. Clearly 
fine lines cannot be drawn around psychiatric conditions. Some authors have 
proposed that psychiatric illnesses should be described more as a spectrum
12
. In 
addition to their phenotypic similarities, the conditions have pharmacological 
overlap. Antipsychotics such as clozapine can be used to treat the positive symptoms 
of schizophrenia as well as the manic phase of bipolar disorder, particularly if the 
patient exhibits psychosis. Selective serotonin reuptake inhibitors are key in treating 
the depressive symptoms of bipolar disorder as they are unlikely to cause mania, but 
are also used in the treatment of major depressive disorder
13
. As I describe below, the 
genetics of these conditions are characterised by a similar overlap.  
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1.2 Genetics of psychiatric disease 
The genetic architecture of schizophrenia and other psychiatric illnesses continues to 
be discussed and is mired in controversy. Psychiatric diseases are surprisingly 
common and heritable, yet were hypothesised to have an extreme effect upon 
reproductive fitness via increased mortality and lower fecundity ratios. Both of these 
observations have been proven to be true. Psychiatric diseases are highly injurious, 
reflecting their contribution towards global DALYs. According to one 
epidemiological review, the median mortality rate of individuals with rMDD is 1.7 
times the norm, while it is 2.6 times the norm for individuals with schizophrenia or 
bipolar disorder
15
. The effect is particularly strong in schizophrenia with 13-15 years 
of life typically being lost according to a recent meta-analysis. The authors 
hypothesised that the effect was due to increased suicide rates, but also due to 
cardiovascular and diabetic complications which are known to be more prevalent in 
schizophrenia
16
. Regarding fecundity, Power et al. 2013 have used a cohort of 
2.3x10
6
 individuals to investigate fecundity rates in individuals with autism or 
schizophrenia compared to the undiagnosed (and presumably largely healthy) 
population. Male individuals with autism or schizophrenia have a fecundity ratio ¼ 
of the norm, while female individuals have fecundity ratios about ½ of the norm. 
Bipolar disorder has a lesser effect, but also results in reduced fecundity, especially 
in males. Similarly, male but not female individuals with depression had reduced 
fecundity
17
. It is notable that schizophrenia has an earlier onset and poorer prognosis 
in males
18
, and the incidence rate is higher
19
. Autism also shows gender differences, 
particularly in prevalence
20
. The body of literature discussing the evolution of 
psychiatric disorders is enormous
21
 and discusses possible fitness effects (especially 
in relatives), “parental war” involving allelic imprinting, disorders as emergent 
consequences of the human mind or extremes of normal variation
22
 , and mutation-
selection balances 
23,24
. The study described by Power et al. was interested in sibling 
effects, so as to explore the possibility that variants predisposing to psychiatric 
disease were maintained by balancing selection. They found slight decreases in male 
sibling fertility and increases in female sibling fertility in autism and a decrease in 
male sibling fertility in schizophrenia, which they proposed might reflect sex specific 
allele affects which help to maintain the risk alleles via balancing selection. However 
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this clear male-deficit female-benefit was not seen in bipolar disorder, only partially 
in schizophrenia, and in any case involved fecundity changes of >3%, far too small 
to mean positive selection is an explanation for why these disorders persist despite 
strong selection
17
. For now, it appears that no positive selection effect of these 
diseases has been discovered. One might ask why it is that these diseases therefore 
exist despite obvious negative effects.  
Of relevance to this persistence of schizophrenia is the debate over the genetic 
architecture of the disease, and its evolutionary history. The consensus among 
researchers is that various psychiatric illnesses have moderate to strong heritability 
(typically >0.6, up to 0.8), with that of schizophrenia and autism greater than bipolar 
disorder, and bipolar disorder greater than rMDD
25
. This consensus rests upon classic 
twin studies
26
, and is buttressed by large population studies confirming that the risks 
of schizophrenia and bipolar disorder run in families
27
. As of yet however, there is no 
known psychiatric illness that has a strictly Mendelian inheritance; therefore no allele 
can give diagnostic certainty. Psychiatric diseases therefore exhibit complex 
inheritance. The primary debate is whether this inheritance is made up of very many 
low risk but common (>5% in the population) variants, the basis for genome wide 
association studies (GWAS) due to their commonality
28,29
, or fewer but more highly 
penetrant variants (<1% in the population, typically undetectable by GWAS)
30,31
. 
These hypotheses are referred to as the “common disease common variants” (CDCV) 
model and the “common disease rare variants” model (CDRV) respectively. The 
CDRV model predicts that rare variants increasing risk of disease are unlikely to be 
inherited due to selection against them, and are therefore likely to be caused by de 
novo mutation. Such mutations could run in families for some generations before 
selection inevitably takes its toll. Evidence now exists suggesting de novo mutation 
is higher in cases of psychiatric disease
32,33
, and affects specific pathways known to 
be of interest in these conditions, namely synaptic processes and 
neurodevelopment
34–36
. In addition there are paternal-age effects on the genesis of 
psychiatric illness
37–39
 and on de novo mutation
40
. The degree to which advanced 
paternal age causes psychiatric disease has been questioned, as the reverse can also 
be true for a behavioural condition and has been shown to only need a small effect to 
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explain the observation that older fathers are more likely to have offspring with these 
conditons
41
. However a de novo origin for variants predisposing to schizophrenia 
would also explain the equal prevalence across populations. We therefore have with 
the CDRV model an explanation for the prevalence of the disease; mutation-selection 
balance. The CDCV model is the basis of GWAS, which associate particular alleles 
with conditions. One of the largest GWAS performed so far (with approximately 
37,000 cases and 113,000 controls) has associated 108 loci with SNPs increasing risk 
of schizophrenia
29
. The SNPs associated with schizophrenia are for the most part 
weakly so; selection would have a very mild effect on these variants as they are only 
infrequently associated with the disease state. The CDCV model therefore too 
explains the prevalence of psychiatric disease. Controversy continues over the utility 
of the candidate gene CDRV-driven approach versus that of the GWAS CDCV-
driven approach, although it has been suggested that both hypotheses have merit to 
them and need not be mutually exclusive
42,43
. GWAS, for example, explain very little 
of the heritability of psychiatric disease, and many rare mutations appear to be 
unique or near unique. Together they might explain the genetics of psychiatric 
disease. There are analogous scenarios; breast cancer has at least 86 variants 
associated with moderately increased risk of the disease (typically <2 times the risk), 
yet several cancers are also familial conditions with rare mutations associated with 
vastly increased rates of the disease, such as those in BRCA1
44
. It is evident that both 
rare familial mutations and common variation are at play here, as is the impact of 
environmental risk factors. In addition, the two models can be reconciled with a 
typical hypothesis of how risk of schizophrenia and other psychiatric illnesses is 
understood
43
. This is called the threshold model and a representation is given in 
Figure 1. Under this model, risk of a psychiatric disease is normally distributed, and 
a few individuals are close to the threshold of disease. In reality the threshold does 
not need to be so binary; it may represent individuals who are at appreciable risk of 
developing illness, or those who require a secondary factor to induce it. A high risk 
red population in Figure 1 has a greater proportion of individuals who have crossed 
the threshold than the general population. 
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Figure 1. Representative image of threshold model for risk of psychiatric disease. A high risk population (red) and an 
ordinary population (grey) both have variation in underling risk, and both have individuals who have crossed the 
threshold for disease emergence. This proportion is far greater for the red population. 
We can see how this can reconcile the two models of psychiatric genetics; the 
underlying population risk (possibly represented by an endophenotype, a genetically 
encoded phenotype which varies in the population and is disease associated) is 
underpinned by common variation, the load of which is likely to be normally 
distributed
43
. Meanwhile, the factor that converts a grey population or family to a red 
one can be a rare mutation. Alternatively, the rare mutation may function as a trigger 
factor for the individuals past the threshold. Environmental risk factors also 
undoubtedly play a role.  
Many environmental risk factors for psychiatric disease act during development. 
Maternal stress during pregnancy increases risk of schizophrenia, bipolar disorder, 
and depression in the offspring
45,46
, as does maternal infection in schizophrenia and 
bipolar disorder. The window for these risk factors appears to coincide with critical 
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periods of foetal brain development. Risks can also be postnatal; a wide variety of 
drugs appear to increase risk of bipolar disorder, for example, and hypoxia at birth 
increases the risk of schizophrenia
46,47
. Traumatic events and stress in childhood also 
increase the risk of psychiatric disease
45
. Exactly how environmental risk factors 
impact upon pathways of relevance to psychiatric disease is still being investigated. 
It has been noted that stress alters the HPA axis, a major neuroendocrinal system 
involved in the production of cortisol, a stress related hormone. Stress decreases 
hippocampal dendrites and hippocampal BDNF levels, which may be linked to 
depressive symptoms. Maternal stress has been linked to some cognitive dysfunction, 
hyperactivity, and diminished PPI in a mouse model, as well as altered GABAergic 
interneuron epigenetic markers
45
. Models for other risk factors show some 
schizophrenia related phenotypes as well; rats which underwent perinatal hypoxia 
showed diminished prepulse inhibition in adulthood, a schizophrenia-related 
phenotype which was treatable by the antipsychotic clozapine. Hypoxia may also 
affect myelination, which is a developmental process
45
. 
As mentioned previously, many psychiatric conditions display phenotypic and 
pharmacological overlap. The genetics of such closely related phenomena are 
characterised by similar overlap. Evidence of this is shown in large familial studies. 
Relatives of individuals with bipolar disorder have an enhanced risk of schizophrenia 
as well as bipolar disorder, even if raised in a different environment
27
. This strongly 
suggests that the same genetic lesions are responsible for risk predisposing towards 
multiple psychiatric disease. Copy Number Variants (CNVs) are one such source of 
genetic risk. An early paper by Guilmatre et al. searched for evidence of CNVs at 
several loci containing candidate genes for schizophrenia, autism, and mental 
retardation. They found CNVs likely to be causative for each disorder, and in many 
cases the CNVs appeared to be capable of predisposing to more than one disorder. 
They even detected comorbidity of schizophrenia and mental retardation in some 
individuals carrying certain rearrangements. Many of the CNVs were de novo, but a 
number had been inherited from an unaffected parent, typically from a mother to a 
son. We can see that this study shows risks run in families (some families found had 
multiple affected siblings), that risk is genetic, and that risk for multiple conditions 
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can be caused by the same mutation
48
. A large GWAS looking at variants 
predisposing to multiple disorders appears to have found SNPs which predispose to 
the five disorders of schizophrenia, bipolar disorder, major depressive disorder, 
autism, and ADHD. Of the four SNPs which predispose to all disorders, two are 
located within calcium channel genes, and one has been significantly associated in 
separate disorder specific GWAS for bipolar disorder, schizophrenia, and major 
depressive disorder
49
. The study described in this thesis is an opportunity to see if a 
rare mutation predisposing to schizophrenia displays any overlap with these common 
sources of risk. The question remains how exactly it is that the same mutation can 
associate with different disorders. Answers to the particular question of overlap for 
some pairs of disorders have been offered. For example, an explanation for the 
neuroanatomical, behavioural and epidemiological similarity between autism and 
schizophrenia has been proposed. This explanation suggests the timing and duration 
of neuroinflammation distinguishes schizophrenia from autism
50
. Blocking IL-6 
mediated inflammation does appear to prevent neurological damage caused by 
prenatal LPS exposure. Similarly, an explanation for the differences between bipolar 
disorder and schizophrenia has been offered. Schizophrenia presents with more 
severe premorbid cognitive functioning, and this is apparent even in childhood. Brain 
abnormalities also appear to be greater in cases of schizophrenia, especially in the 
medial temporal lobe. Murray et al. have proposed that since prenatal and perinatal 
risk factors predispose to schizophrenia but not bipolar disorder, it is possible that 
this severe developmental insult places an individual already at high risk of bipolar 
disorder onto a trajectory towards schizophrenia. In this case, the environmental 
insult combines with the genetic liability to result in an exacerbated phenotype
51
. 
This “two-hit” hypothesis has surfaced elsewhere, in which a single CNV 
predisposed to developmental delay, while a second additional CNV within a 
minority of the cohort appeared to cause a more severe phenotype. This has led one 
reviewer to describe psychiatric disease inheritance as possibly being “omnigenic” in 
character
24
. Craddock and Owen have suggested that the overlap we see between 
many pairs of disorders should be viewed in another way; as an overarching 
spectrum of disorders, characterised by partial phenotypic and genetic overlap. In 
this model, psychiatric diseases are unified by some phenotypic overlap, but 
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distinguished by severity of developmental abnormality. Intellectual disability and 
autism are on one end of the spectrum, characterised by high developmental 
abnormality, high risk mutation (with larger CNVs), and severe pathology. On the 
other end are affective disorders such as bipolar and major depressive disorder. 
Schizophrenia is proposed as being somewhere in between, so mutation predisposing 
to either bipolar disorder or to autism can also predispose to it, but not typically to 
one another. Mutation and environmental risk can be either specific to a disorder or 
general. One of the strengths of this model is that it can incorporate our observations 
of phenotypic overlap, and give an explanation for why both rare and highly 




1.3 Pathways causing psychiatric disease 
The biology of psychiatric disease is still mysterious, although great advances in 
understanding have been made. As mentioned previously, schizophrenia presents 
with anatomical differences including enlarged lateral ventricles and reduced cortical 
grey matter volume which are observable early in life. There are also premorbid 
problems in cognitive functioning. These observations, along with the lack of gliosis 
typically caused by neurodegeneration, have led to the conceptualisation of 
schizophrenia as a neurodevelopmental disorder, rather than a neurodegenerative 
one
52
. As stated earlier, this older conceptualisation fits in perfectly with the newer 
concept of all psychiatric diseases being distinguishable by differing degrees of 
neurodevelopmental pathology. The challenge now is to determine what processes 
are disturbed that might lead to altered development, or altered function in adulthood 
resulting from this altered development. One reasonable approach is genetic; to look 
for what genes carry the rare or common variants discussed earlier. Rare variant 
genes are typically found via investigation of pedigrees with high rates of disease (or 
parent-child trios searching for de novo mutation) while GWAS search for common 
variants. Rare variants often have accompanying mouse models and functional 
studies. A non-exhaustive discussion of genes related to psychiatric disease and the 
pathways they implicate is given below.  
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Given the importance of the synapse in learning, memory, and neuronal activity, we 
might expect that proteins involved in synaptic structure or activity might be 
implicated in psychiatric disease. It has been known for some time that 
neurotransmitters underlie some of the pathology of psychiatric disease. For 
example, high dopamine levels in the prefrontal cortex are believed to underlie the 
positive symptoms of schizophrenia, and blockade of the cognate receptors alleviates 
these symptoms
53
. Similarly, serotonin is believed to have some kind of link to 
signalling pathways involved in depression
54
. NMDAR antagonism by agents such as 
ketamine and PCP results in psychosis highly similar to schizophrenia
55
. 
Interestingly, NMDAR antagonism and agonism are being explored as anti-
depressant therapy
56
. Although the links between NMDAR signalling and psychiatric 
diseases are not yet fully understood, we do know that NMDAR signalling is crucial 
for some types of long term potentiation (LTP), which underlies synaptic plasticity 
via remodelling of the synapse, insertion of AMPARs, and increases in synaptic 
scaffold proteins
57
. This underlies learning and memory. Many synaptic scaffold 
proteins have been linked to schizophrenia by candidate gene studies. Neurexins are 
a group of presynaptic proteins which form trans-synaptic bonds with neuroligins, a 
group of postsynaptic proteins. Both neurexins and neuroligins bind to MAGUK 
proteins such as PSD-95 and are capable of inducing postsynaptic and presynaptic 
specialities in adjacent neuronal cells if they are ectopically expressed in non-
neuronal cells
58
. Mutations in several members of both families have been shown to 
segregate with several disorders ranging from Tourette’s syndrome to schizophrenia 
and autism
58
. De novo CNV studies looking at parent-affected offspring trios have 
found that mutations in NMDAR signalling related genes are enriched in cases of 
schizophrenia, as are mutations in the genes encoding targets of FMRP. This RNA 
binding protein, mutated in Fragile X syndrome, is neuronally expressed and targets 
many genes involved in LTP and synaptic activity such as ARC
59
. 
One of the largest GWAS for schizophrenia so far found 108 single nucleotide 
polymorphism (SNP) loci to be implicated in the inheritance of the disease, with 
genes near these loci having roles in synaptic activity, glutamatergic transmission, 
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later, larger GWAS found still more loci. These disproportionately included the 
targets of the FMRP protein, showing a convergence between CNV and SNP risk for 
schizophrenia. Genes involved in synaptic activity and calcium ion import were also 
overrepresented, further solidifying the evidence for these processes being involved 
in schizophrenia
60
. Calcium channel proteins have also appeared in GWAS for 
bipolar disorder alone, as well as in GWAS looking for SNPs predisposing to many 
disorders simultaneously
49
. Other neurotransmitter receptors or ion channels such as 
the NMDAR subunit GRIN2A (glutamate) and SCN2A (sodium) have been identified 
as significantly associated with bipolar disorder by the largest GWAS yet for this 
condition. CACNA1C in particular has been consistently associated with the 
condition
61
. The CACNA genes encode subunits of voltage gatedCa
2+
 channels; 
multimeric proteins prevalently expressed in the brain. There is evidence to suggest 
that calcium is depressed in manic bipolar patients and increased during the 
depression pole. Calcium channels are also upregulated in mouse models of 
addiction; agonists can help prevent withdrawal symptoms
62
. The signalling 
pathways are complex; but it is known that drug-mediated activation of dopamine 
receptor D1R activates signalling molecules such as CAMKII, leading to AMPAR 
insertion at the cell surface. As a calcium-activated molecule, this activation of 
CAMKII is via the L type voltage gated calcium channels. Antagonism of the 
channels reduces addiction behaviour in rats
63
. CACNA1C encodes one of the L type 
subunits; conditional null mice lacking hippocampal expression of it have LTP 
deficits. A mutation in the cognate human gene causes a condition characterised by 
autism and cognitive abnormalities
64
. Given its role in NMDAR-independent LTP, 
crucial for learning and memory, it is highly interesting that many studies converge 
on this gene. 
1.4 DISC1 
DISC1 is an example of a gene with rare mutations predisposing to psychiatric 
illness. The focus of much research, including this thesis, is on a t(1;11)(q42.1;q14.3) 
translocation disrupting this gene. The Scottish pedigree in which this translocation 
has been uniquely observed first came to the attention of researchers over four 
decades ago for the unusually high prevalence of psychiatric disease, ranging from 
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alcoholism and conduct disorder to diagnoses of schizophrenia. One major paper 
describing the clinical findings of the entire pedigree, stretching over four 
generations, is that of Blackwood et al.
65
. 67 individuals underwent karyotyping for 
the translocation, as well as psychiatric interviews (or their records were examined, 
were they available). Of 29 with the translocation, 21 were diagnosed with a 
psychiatric illness. A third of these diagnoses were of schizophrenia and 
approximately half were of major depressive disorder. Of 38 without the 
translocation, 5 had diagnoses; one case of alcoholism, one of conduct disorder, and 
three of minor depression. It is evident that both the prevalence and severity of 
psychiatric illness are greatly exacerbated by the translocation, although there may 
well be other genetic and environmental factors at play. A LOD score of 7.1 was 
obtained if the phenotype was modelled as being “schizophrenia, bipolar disorder, 
and major depressive disorder”; the LOD score was 3.6 if it was modelled as just 
“schizophrenia”. The translocation itself involves the exchange of a large amount of 
genetic material between chromosomes 1 and 11; approximately 18Mb and 45Mb 
respectively. The translocation disrupts a total of three genes; two on chromosome 1, 
and one on chromosome 11. The chromosome 1 breakpoint was the first described in 
detail; it consists of two genes on opposite strands. DISC1 is transcribed in the 
breakpoint proximal to distal direction and encodes a protein, DISC1. The opposite 
strand encodes the antisense DISC2, which has no hallmarks of a protein encoding 
gene (no long ORF, exceptionally long candidate 3’UTR) but appears to be 
expressed in some tissues
66
 . The 5’ end of DISC1 remains on chromosome 1 in the 
t(1;11) condition, as does the 3’ end of DISC2. DISC1 is a large protein, and the 
breakpoint is towards the end of the protein, after exon 8
66
. Its function has since 
been elucidated in more detail, in addition to its expression and distribution
67
. 
Multiple protein isoforms of DISC1 exist and it appears to be localised at the 
mitochondria, as disturbing microtubule formation results in aberrant mitochondria 
and DISC1 localisation
67
. However, DISC1 products are also found at the 
centrosome, where they interact with other proteins involved in cell division and 
migration
68
. DISC1 immunoreactivity is also seen at synapses, particularly the post-
synaptic density, and throughout neuropili. DISC1 immunoreactive neurons are seen 
in all layers of the human cortex
69
. Disturbing microtubule formation particularly 
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affects the DISC1 which is found along microtubules non-adjacent to the nucleus
67
. 
The protein is expressed in neural precursor cells as well as neurons, and is 
upregulated during neuronal differentiation
70
. It is expressed in a wide variety of 
human foetal tissues as well as the adult hippocampus. The mouse and monkey 
orthologues show a similar pattern of expression in a variety of brain areas and 
neuron types, suggesting a possible conservation of function
67,71
. Expression of 
DISC1 proximal to the breakpoint is depleted in lymphoblastoid lines carrying the 
t(1;11), suggesting that haploinsufficiency might be responsible in part for the 
phenotype of increased disease risk
72
. Transcripts from the truncated gene would 
produce proteins lacking the C-terminal domain rich in coiled coil regions which aid 
protein assembly. However, studies suggest that the t(1:11) could also have gain of 
function affects.  
Eykelenboom et al. found that the derived 1 chromosome of the t(1:11) translocation 
(consisting of the N terminal end of DISC1 fused to C terminal DISC1FP1) can be 
translated, although given that DISC1 regions proximal to the breakpoint are 
downregulated, this may not be at a high level
72
. The theoretical transcripts also 
contain features which tend to cause nonsense-mediated mRNA decay
72
. 
Hypothetically, the translated protein would consist of the first ~600 amino acids of 
DISC1 fused to either 60 or 69 amino acids from an open reading frame in 
DISC1FP1. These were labelled CP60 and CP69. They appear to have different 
properties to hypothetical truncation proteins containing just the first ~600 amino 
acids. A fragment of DISC1 fused to MBP displayed different properties if the extra 
69 amino acids were included. Dynamic light scattering indicated that the presence 
of these residues caused the DISC1-MBP fusion protein to be larger (non-
significantly p=0.056) and more resistant to heat-induced deformation. Ectopic 
expression of CP60/CP69 results in localisation to the mitochondria and loss of 
mitochondrial membrane potential. This does not co-present with cytosolic 
cytochrome c which would indicate increased apoptosis, however
72
. It must be noted 
that these proteins have not been detected in any of several cell models carrying the 
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1.4.1 DISC1 function 
The function of DISC1 protein involves the maturation and migration of neurons, 
synaptic activity, and centrosomal orientation, amongst many others. DISC1 shows 
no enzymatic capacity itself, but is known to interact with a large number of other 
proteins to exert its effects, which have been dubbed the DISC1-interactome. A Y2H 
screen for potential DISC1 interactors found a large number, with overrepresentation 
among these of GO terms including those relating to cytoskeletal organisation, 
transport, and cell division
73
. Many of these potential interactors are already 
candidate genes for schizophrenia
74
, or are expressed in the developing brain, as is 
DISC1
75
. For example, GSK-3β is a target of lithium chloride, the mood stabiliser 
drug used to aid management of bipolar disorder and related disorders
76
, and is 
important in synapse function. GSK-3β activity is mediated by DISC1 interaction, 
altering neural progenitor proliferation via the stabilisation of pro-growth signalling 
molecules such as β-catenin
77
. In the developing cortex, neural progenitors replicate 
for a time before producing postmitotic neurons and migrating through the cortex. As 
its interaction with GSK-3β shows, DISC1 appears to have a key role in maintaining 
developing cortical cells in their proliferating phase. Experiments show that DISC1 
knockdown increases the rate of cell cycle exit and subsequently increases the 
proportion of cells expressing Cux2, a cortical marker and neuronal transcription 
factor. This indicates that DISC1 acts as a check on early and improper cell 
differentiation. However, it also has a role in helping cells swap to migration via its 
interaction with the centrosome. The centrosome is a structure shown to be key in 
neurodevelopmental processes. Mutations in genes encoding centrosomal proteins 
often have severe consequences
78
, and some are DISC1 interactors. BBS4 is an 
example of a disease gene which encodes a centrosomal protein which is also a 
DISC1 interactor. Mutation in any BBS gene can cause BBS, a multisystem 
developmental disorder characterised by behavioural abnormalities, obesity, and 
retinal degradation among other phenotypes
79,80
. Its interaction with DISC1 is 
phosphorylation dependant. DISC1 interacts with and inhibits GSK-3β to enable 
neural precursor proliferation. However, DISC1 phosphorylation at Ser70 greatly 
reduces the GSK-3β interaction, blocking precursor proliferation. The 
phosphorylated DISC1 then recruits the BBS proteins to the centrosome to stimulate 
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neuronal migration. Mutations in DISC1 alter cell proliferation and migration; those 
in BBS1 only affect migration, consistent with this model
81
. Other DISC1 interactors 
linked to neural processes include LIS1 (causative of lissencephaly), NDEL1, and 
NDE1. These three proteins work together to affect neuronal migration via 
nucleokinesis. This process involves interactions between microtubules and the 
centrosome, where the protein products of NDEL1 and NDE1 reside and interact with 
dynein, gamma-tubulin, and other centrosomal proteins. They both can bind LIS1, 
which interacts with microtubules
82
. Mice with mutations in the LIS1 homologue 
have an unusually patterned cortex and a disorganised hippocampus with more 
scattered cells. Cells carrying a mutation also migrate poorly
83
. The genes also have 
roles in other critical neurodevelopmental processes such as cell proliferation and 
neurite outgrowth, and are regulated by PDE4
84
. PDE4B is another gene linked to 
psychiatric disease via a translocation co-occurring with psychosis as well as 
significance in the most recent large GWAS looking for variants associated with 
schizophrenia
60
. It also linked to DISC1 via direct protein-protein interaction
74
. 
PDE4B is crucial for cAMP regulation, which itself is vital in several neural 
processes, such as synaptic plasticity, memory formation and cognition. Rising 
cAMP levels can trigger dissociation of PDE4B and DISC1 via PKA-mediated 
phosphorylation, which results in higher PDE4B activity and presumably helps 
mediate cAMP signalling via cleavage of cAMP
74,85
. PKA also phosphorylates 
NDE1 on two sites (and may phosphorylate the similar NDEL1 region). This 
phosphorylation causes NDE1-LIS1 co-immunoprecipitation to decrease. This was 
also seen in a NDE1 phosphomimic mutant, which additionally displayed less neurite 
outgrowth. The suggested model is that DISC1’s interaction with PDE4 allows 
cAMP signalling to block neurite outgrowth and LIS1/NDE1 interaction
84
. 




A new area of research related to DISC1 is its interactions with NMDARs. As 
described in 1.3, NMDARs are important in psychiatric disease. Their agonism is 
being explored as an anti-depressant therapy, and can induce psychosis
55,56
. They 
have also been linked to the aetiology of schizophrenia by CNV studies and 
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stimulation of NMDARs is crucial for the initiation of the changes leading to 
synaptic plasticity. GluN1, an obligate subunit of the NMDAR, is trafficked to the 
synapse in order to regulate glutamate sensitivity. Such trafficking is necessary for 
NMDAR-dependent synaptic plasticity. A direct link between NMDARs and DISC1 
has now been revealed in a paper by Malavasi et al. using the same models as are 
utilised in this thesis
70
. For disclosure, I am a co-author on this paper. 
GluN1, encoded by GRIN1, is an obligate subunit of all NMDARs. NMDAR 
subunits are seen in the ER, where they reside before assembly and trafficking. It has 
now been shown that DISC1 co-immunoprecipitates with GluN1 via amino acids 
which are encoded proximal to the t(1;11) breakpoint. Exogenous DISC1 co-
localises with GluN1 in hippocampal neurons accordingly, in dendritic locations. It 
was suspected that DISC1 interactors involved in its trafficking role might also 
interact with NMDAR subunits. TRAK1, a DISC1 interactor and trafficking 
molecule which is targeted to the mitochondria, is also shown to co-precipitate with 
exogenous GluN2b in synaptosomes and light membranes when expressed 
exogenously. A portion of exogenous GluN1 co-localises with the exogenous 
GluN2b and TRAK1 in triple transfected cells. Since NMDAR are assembled in the 
ER, the implication is that the co-localising of GluN1 and GluN2B represents 
assembled NMDARs. It was also shown that DISC1 overexpression in hippocampal 
cells resulted in alterations of GluN1 trafficking. Increased fluorescence of distal fast 
moving GluN1 was seen, the speed of which corresponds with actively trafficked 
NMDAR-containing vesicles. The effect was also seen in mouse neurons carrying a 
mutation which models the translocation. Overexpression of a non-TRAK1 
interacting DISC1 mutant resulted in reduction of this fast moving fluorescence. The 
mouse mutation leaves the GluN1 and TRAK1 interacting regions intact. These mice 
also had increased puncta density of GluN1 and GluN2B in the homozygous and 
heterozygous mutation, in addition to increased GluN2A puncta density and 
GluN1/PSD-95 co-localisation in the homozygous state. Total protein levels and 
PSD-95 puncta volume were unchanged, implying differences in NMDAR subunit 
trafficking and subsequent synaptic formation rather than expression. PSD-95 
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distribution was also altered. The result is likely to be aberrations in synaptic 
plasticity.  
1.4.1.1 Mitochondria and DISC1 
The role of mitochondria in psychiatric disease has been recognized. A case study 
has been reported in which mitochondrial DNA mutations co-occur with psychiatric 
disease as well as histories of psychiatric disease on the maternal side of the family
86
. 
Another has been reported in which mitochondria DNA mutations in the tRNALeu 
gene coincide with a maternal family history of psychiatric disease as well as 
cardiomyopathy in a proband
87
. More generally, there are many links between 
mitochondrial dysfunction and psychiatric disease. Mood stabiliser drugs protect 
against mitochondrial damage, while there appears to be aberrant expression of genes 
involved in ATP generation and storage in psychiatric disease, as well as deficits in 
oxidative phosphorylation
88
. Neurons exhibit an unusually high energy demand and 
therefore might be especially sensitive to mitochondrial dysfunction, while the brain 
must supply this demand exclusively through the oxidative phosphorylation of 
glucose, further increasing the importance of mitochondria to brain metabolism
88,89
. 
Given the localisation of DISC1 to the mitochondria, it was not unreasonable to 
expect it might have some kind of function there. It has now been shown by several 
groups that DISC1 has an impact on mitochondrial trafficking. Expression or siRNA 
knockdown of DISC1 respectively increase and decrease the number of motile 
mitochondria in neurons
90
. A particular disease-associated DISC1 polymorphism of a 
conserved residue also rendered the protein incapable of restoring the motility 
deficiency caused by knock down of wild type DISC1
90,91
. Some detail on how 
DISC1 influences trafficking has now been elucidated. A group of proteins on the 
mitochondrial outer membrane, the Miro GTPases, function in mitochondrial 
trafficking
92
. When these are bound by the kinesin and dynein adaptor TRAK1, 
mitochondria can be trafficked along the kinesin/microtubule based transport 
system
92
. TRAK1 and DISC1 co-immunoprecipitate, suggesting some kind of 
interaction occurs between the two
93
. TRAK1/DISC1 co-transfection results in an 
altered localisation of DISC1 compared to DISC1 transfection alone
93
. Mutation of a 
relatively well conserved
94
 arginine-rich N-terminal sequence in DISC1 alters its 
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mitochondrial location as well as its interaction with TRAK1
95
. DISC1 appears to 





. It is therefore a confirmed interactor of mitochondrial 
membrane proteins and motor protein adaptors. The DISC1 interactors GSK-3β and 
NDE1 also associate with TRAK1, enhancing anterograde or retrograde 
mitochondrial movement respectively, although GSK-3β has been shown to have 
other effects in other studies
95,96
. Given that LIS1/NDE1/NDEL1 interact together 
with dynein and centrosomal proteins to effect microtubule-based nucleokinesis, it is 
unsurprising that these interactions are also seen in microtubule-based mitochondrial 
transport. LIS1 can bind to dynein to promote trafficking, and it had been suspected 
that this would include mitochondrial trafficking
89
. LIS1 or NDEL1 knockdown 
inhibits axonal mitochondrial transport in both directions or just retrograde, 
respectively
96
. It has also been reported that overexpression of LIS1 stimulates 
retrograde organelle transport, and as expected this requires dynein binding
97
. Given 
that TRAK1 co-immunoprecipitates with DISC1, NDE1, and GSK-3β, it has been 
suggested that DISC1 recruits GSK-3β into this complex, which likely contains 
NDEL1 and LIS1 as well
96
. DISC1 overexpression or knockdown increases or 
decreases mitochondrial motility, respectively, but a non-synonymous variant which 
disturbs DISC1-GSK-3β interaction prevents the stimulation of motility
90
. There are 
clearly extensive interactions between mitochondria, motor proteins, and DISC1-
interactors which are also seen at the centrosome. The exact nature of these 
interactions is yet to be fully elucidated. GSK-3β certainly plays a role, as does the 
kinase Cdk5 in rat, which phosphorylates Ndel1 in a manner necessary for organelle 
transport
97
. Given the importance of mitochondrial trafficking it is likely that the 
proteins at the centre of it, including DISC1, have the ability to incorporate signalling 
from multiple pathways. This might include PDE4 enzyme/PKA signalling, which 
has already been shown to be important for AMPAR subunit trafficking. This was 
not via PDE4B
98
. In any case it is clear that a large number of proteins important for 
the linking of mitochondria to motor proteins, or in stimulating their movement, 
appear to interact with DISC1, which appears to have a role in scaffolding these 
proteins and facilitating interactions. As discussed earlier, it also may be the case that 
gain-of-function chimeric DISC1 proteins, with 60 or 69 extra residues, assemble at 
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the mitochondria and cause loss of membrane potential
72
. Either by toxic gain of 
function caused by chimeric DISC1-DISC1FP1 proteins, or by haploinsufficiency of 
DISC1 necessary for assembling transport complexes, the t(1;11) is evidently capable 
of exerting effects upon mitochondrial activity with potential consequences for 
neuronal health.  
1.4.2 DISC1 mutations 
DISC1 mutations have been found elsewhere. An American family has been 
discovered with high rates of major mental illness, as well as a 4bp frameshift 
mutation in DISC1
99
. This family was originally discovered through sequencing of 
DISC1 in schizophrenia probands, leading to the discovery of the pedigree. However, 
inspection of the pedigree revealed that although two siblings with schizophrenia had 
the mutation, as did one with schizoaffective disorder, three of their siblings without 
the mutation had major depressive disorder and schizotypal personality disorder. The 
family’s unaffected father carried the mutation, while the mother, known to not have 
the mutation, had a family member with schizophrenia (who presumably did not 
have the 4bp frameshift of the proband’s pedigree). Although it is highly interesting 
that another mutation in DISC1 has been discovered, the evidence is not yet 
compelling for an association with schizophrenia. There are several key reasons as to 
why this is so, several of which were acknowledged directly or indirectly by the 
original paper. Firstly, the rate of diagnosis of any disorder is equal in carriers and 
non-carriers within the family. Secondly, individuals without the mutation display 
severe psychiatric disorders. Thirdly, the pedigree is too small for generation of LOD 
scores. Fourthly, the unaffected mother, whose family presumably do not have the 
4bp mutation, has a family history of schizophrenia which might partially explain the 
high rate of diagnosis we see. Fifthly, another study showed that this mutation was 
found in none of several hundred schizophrenia cases, but was present in two 
anonymous blood donors in the control group. These individuals did not undergo 
psychiatric evaluation but were unlikely to have a psychiatric diagnosis as they were 
not taking medication
100
. Although the case is highly interesting and is worthy of 
follow up, I argue it should be regarded as a familial case of idiopathic 
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schizophrenia, until more evidence, including full familial genotyping and clinical 
examination, emerges. 
Other mutations have been found not by pedigree investigations but by larger 
haplotype association studies. It should be noted that DISC1 is not a hit in either of 
the largest schizophrenia GWAS, a finding which might indicate common variation 
in the gene is less important to schizophrenia risk
29,60
. Some research groups have 
attempted to assess variation within the gene, and whether this variation has any 
phenotypic effect in psychiatric disease. Crowley et al. sequenced DISC1, along with 
9 other candidate genes (such as DRD2, NRG1), for variants in >700 schizophrenia 
cases and >700 controls
101
. Due to constraints, only limited regions of the gene were 
sequenced (exons, UTRs, promoters, splice sites, conserved introns) In addition to 
technical replication to ensure SNP validity, they chose a subset of 92 SNPs in 
DISC1 and other genes to verify in a secondary dataset of >2,000 cases and >2,000 
controls. DISC1 had the highest case:control SNP ratio, and two nonsense SNP 
variants found only in cases (only three such SNPs were found in the 10 genes). 
Despite this, no SNPs were found significantly associated with schizophrenia. 
Crowley et al. noted that they were the fifth group to search association of 
schizophrenia with DISC1 SNPs, and despite using a larger sample size had found no 
significant SNPs after multiple testing. Two previous groups had either failed to 
replicate findings in replicate samples
102
 or had not found significance
103
. Another  of 
the four groups had shown variants in patients which were not in 10,000 controls 
including a particularly interesting variant described below
104
, while the findings of 
the last group involve the DISC1 frameshift described above. The evidence suggests 
if variants other than the t(1;11) involve DISC1 and predispose to schizophrenia, they 
are likely very rare indeed. In contrast, there is evidence suggesting rare mutations in 
DISC1 might be important. Thomson et al sequenced 500kb around the DISC1 locus 
in ~900 cases (schizophrenia, bipolar disorder, and rMDD) and ~650 controls, 
including the entirety of the gene as opposed to just coding and conserved regions
105
. 
They found 2,000 rare variants with a frequency of <1%. A single SNP was 
significant for rMDD in the original dataset and a combined original and replication 
dataset, but not any of three rMDD replication datasets. Thomson et al. noted the 
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abundance of rare variation and low power due to sequencing costs meant it is highly 
difficult to ascertain the current impact of rare variation, particularly for a gene such 
as DISC1 in which variation might be pleiotrophic and only partially penetrant. 
Nevertheless some SNPs are of particular interest and have been shown to have 
direct functional consequences as they encode point mutations. R37W and L607F are 
two such mutations. L607 is a conserved residue from mouse to zebrafish and the 
non-synonymous mutation is within two haplotypes both associated with 
schizoaffective disorder. It is associated with high risk ratio of the disease (>2.4) and 
was located in a region of DISC1 that modulates interaction with ATF4
106
. Another 
study scanned 288 patients with schizophrenia for variation within DISC1 and found 
several mutations not found in 10,000 control alleles, including the mammalian 
conserved R37W
104
. L607F was also found to be not associated with schizophrenia, 
but given that the original study associated it with the related but not identical 
schizoaffective disorder this is less worrying than it might initially appear. Both 37W 
and 607F were subsequently functionally investigated by Malavasi et al.
107
. ATF4 is 
a cAMP-response element binding protein which acts as a transcription factor, 
mediating the effects of cAMP. It has been shown that it is bound by DISC1 and acts 
to effect transcriptional changes involving apoptosis, mitochondrial function, 
synaptic plasticity, and repression of LTP
107
. Both mutations decrease the abundance 
of nuclear DISC1 by approximately 50%, as shown by both immunocytochemistry 
and western blotting. Both approaches also confirmed DISC1 expression is unaltered, 
meaning that differential targeting of DISC1 was responsible. Exogenous DISC1 was 
also shown to inhibit the transcriptional activity of ATF4; both mutations decreased 
this inhibition, although it appeared that in 607F this was due to decreased protein-
protein interaction, while with 37W it was likely due to nuclear exclusion of 
DISC1
107
. In any case this series of papers defined a number of risk-associated 
alleles with confirmed consequences for DISC1 biology.  
1.4.3 IPSC and mouse DISC1 models 
This thesis expands upon previous work by investigating the RNA-Seq profiles of 
neuronal cells derived from iPSCs of members of the t(1;11) pedigree. It also looks 
Introduction and Literary Review 
54 
at RNA-Seq profiles of neural tissue from a corresponding mouse model, referred to 
as the Der1 model. In this model 100kb of DNA has been removed from the mouse 
chromosome carrying Disc1, with this being removed from downstream of exon 8 
and replaced with 115kb of human DNA corresponding to chromosome 11. The 
effects of the translocation upon DISC1 are therefore mimicked in the altered mouse 
chromosome, which both heterozygous and homozygous carriers of exist
70
. The 
backgrounds of each of these models are discussed in turn with reference to other 
similar models. A summary of the models is given in Figure 2. 
1.4.3.1 Mouse models of Disc1 mutations 
Tomoda et al. have summarised some of the difficulties in exploring mutant Disc1 
mouse models; primarily the fact that it is not yet known exactly how the t(1;11) 
exerts its effects and how this alters DISC1 in human. Numerous point mutation 
studies have indicated particular residues of the Disc1 protein as being particularly 
important in certain interactions, such as the L607 residue and ATF4 interaction 
described earlier
107
. Others have looked at Disc1 knockdown or frameshifts at 
particular developmental stages and the resulting effect on neuronal development, or 
behaviour, or have attempted to replicate some predicted effects of the t(1;11) on 
DISC1. Particularly relevant is the emergence of phenotypes related to psychiatric 
disease in some mouse models
108
, the impact on dopaminergic signalling caused by 
Disc1 abnormalities, and gene-environment interactions with Disc1 mutation and 
known schizophrenia risk factors.  
The early paper described by Clapcote et al. looked at two induced point mutations 
in exon 2, which encodes amino acids that are present in all isoforms and is proximal 
to the point where the t(1:11) occurs in the orthologous DISC1 gene. These 
mutations were Q31L and L100P, and mice carrying these exhibited a large number 
of schizophrenia related phenotypes. Both mutations caused deficiencies in prepulse 
inhibition (PPI), a known phenotype of schizophrenia. Latent inhibition (the 
phenomenon by which a previously encountered stimulus takes longer to acquire a 
new meaning) was also decreased in both mouse models, as was the ability to bind 
the candidate psychosis factor and cAMP regulator PDE4B. Some of these 
behavioural phenotypes could be diminished in severity by antipsychotic or 
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antidepressant drugs, depending on genotype. Both mouse mutants also displayed 
decreased brain volume, another commonly observed phenotype in schizophrenia
108
. 
It was later demonstrated that maternal immune activation during gestation interacted 
with one of these Disc1 mutations
109
. L100P offspring had enhanced IL-6 presence in 
foetal brains compared to WT or Q31L mice upon maternal immune activation. 
Similarly, genotype-alone PPI was normal, as was maternal immune activation alone, 
but both combined resulted in PPI deficits in offspring
109
. Lipina et al. noted that 
maternal immune activation is a risk factor for schizophrenia, which the L100P 
phenotype is putatively similar to, while it is not for depression, which the Q31L 
phenotype is putatively similar to. We therefore see a schizophrenia specific risk 
factor, interacting with a putative schizophrenia related mutation in a known disease 
gene Disc1. Not only this, but the L100P phenotype appears to cause increased 
dopamine release in response to amphetamine, and increased D2R striatal 
expression. Haloperidol, a D2R antagonist, curbed some of the earlier described 
phenotypes of latent inhibition and prepulse inhibition abnormalities
110
, consistent 
with dopamine’s role as a key molecule in the pathology of schizophrenia
53
. Finally, 
the L607F mutation found associated with schizoaffective disorder in humans and 
known to alter ATF4 interaction has recently been modelled in the mouse. The 
orthologous residue mutation L604F was induced by CRISPR and homozygous mice 
had PPI deficits. It will be interesting to see what future experiments with this 
schizoaffective risk allele model show
111
. 
A Disc1 truncating mutation in mice, giving rise to an aberrant short form of Disc1, 
also exhibited phenotypes including reduced prefrontal cortex size and diminished 
short-term potentiation in the CA3:CA1 synapses of the hippocampus
112
. These 
shorter isoforms are of interest as Disc1 is known to self-associate. Truncated 
proteins might therefore exert a dominant negative effect. It must be cautioned 
however that expression of such truncated proteins is not confirmed in the 
t(1;11)
70,113
. The recent L604F mouse model appears to show increased Disc1 
aggregation
111
. In any case, Tomoda et al. have noted that mutations modelling a 
truncated protein effect tend to have consequences for dopaminergic signalling
114
. A 
model in which the dominant Disc1 mutant is expressed in the cortex and 
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hippocampus displayed enhanced D2R receptor binding in the striatum, as well as 
corresponding hypersensitivity to methamphetamine
115
. The group also reported a 
decrease in parvalbumin-positive interneuron staining in the prefrontal cortex
115
. 
These interneurons are notable as both genetic and environmental risk factors for 
schizophrenia have been shown to cause their ablation
116
. Erbb4, encoded by a 
schizophrenia candidate gene, has been shown to play a role in the synaptic pruning 
of excitatory synapses onto these very interneurons during monkey adolescence, with 
lesser but stronger synaptic inputs remaining post pruning
117
. Dominant-negative 
Disc1 displays gene by environment interactions in common with point mutations, 
and as expected for an apparent schizophrenia-risk modelling mutation
118
. Immune 
activation provoked IL-1β, IL-4, and IL-5 release in wild type mice, but IL-2 in 
mutant Disc1 mice. Phenotypes such as hyperactivity, increased swim test 
immobility, and decreased sociability emerged only upon mutant Disc1 and maternal 
immune activation. Abnormalities in brain structure were also detected
118
. 
The final posited effect of the translocation, and one which could conceivably be 
altered by epigenetic factors and the local transcriptomic environment, is altered 
DISC1 expression. In mice, this has been typically modelled by shRNA mediated 
knockdown. Niwa et al. experimented with in utero transfection of shRNA against 
Disc1 in E14 foetal mice and showed that the resulting knockdown of Disc1 was 
transient and confined mainly to pyramidal neurons of the prefrontal cortex
119
. Cell 
migration and proliferation was impaired, as previously shown in Disc1 mutant mice, 
but postnatal mice also displayed dopaminergic phenotypes. Adult mice displayed 
deficiencies in tyrosine hydroxylase positive neurons and dopamine levels in the 
prefrontal cortex, but not until P56. Dopamine levels were corrected by clozapine 
administration, and the altered mice also displayed hypersensitivity to methamine 
administration, a phenotype which did not emerge until P56. One conclusion is that 
the developmental lack of Disc1 results in inappropriate dopaminergic neuronal 
maturation, and a consequential adaptation of the brain to function on this “lower 
dopamine” level. Subsequently dopaminergic stimulation by methamphetamine, or 
readjustment of the system during adolescence (synaptic pruning), might cause an 
abnormal state. Most interesting was the finding of Niwa et al. finding that 
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parvalbumin immunoreactivity at P56 was decreased in the prefrontal cortex; 
implying a reduction of parvalbumin positive interneurons
119
. Disc1 deficiency can 
cause developmental abnormalities even without an exacerbating factor such as 
maternal inflammation, or lead/cannabinoid poisoning, which have also been shown 
to interact with Disc1 in a gene by environmental fashion
114
. A summary of the point 
mutation, truncated, and knockdown models is given in Figure 2. 
 
Figure 2. Illustrated findings utilised mouse models of Disc1 point mutation, truncation, or knockdown. References 
given in text. 
Although the exact effect of the t(1;11) upon DISC1 is unclear, there is evidence that 
point mutations, haploinsufficiency, and truncations all can cause phenotypes of 
interest including dopaminergic and parvalbumin positive interneuron abnormalities. 
It will be particularly interesting to see what role DISC1 dominant negative 
aggregation may play. These phenotypes are of known relevance to psychiatric 
disease, particularly in conjunction with a secondary risk factor.  
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1.4.3.2 IPSC models of DISC1 mutations 
Induced pluripotent stem cells (IPSCs) are a cellular model derived from a non-
pluripotent cell type which has been ‘reprogrammed’ into a pluripotent, or stem cell-
like, state. iPSCs were first generated using mouse fibroblasts in 2006 and from 
human fibroblasts in 2007. They exhibited all the hallmarks of pluripotent cells 
including teratomagenicity, proliferative capacity, stem cell gene expression, 
telomerase activity, and appeared to retain these phenotypes throughout division
120
. 
Although initially iPSCs were created by retroviral transfection of Yamanaka factors 
(a group of key genes expressed by stem cells including Oct3/4, Sox2, c-Myc, Klf4 in 
the original mouse experiment), subsequent experiments have utilised small 
molecules or plasmid constructs to minimise retroviral-induced insertional 
mutagenesis
121,122
. The research potential of induced pluripotent stem cells (IPSCs) 
has become increasingly realised in the post-Yamanaka world
120,122
. iPSCs have been 
used to model neurological and muscular diseases
123
, but also schizophrenia
124
. 
iPSCs are specific to the individual and can generate otherwise hard to obtain neural 
cells, two factors making them of prime importance in the study of pedigrees with 
psychiatric illnesses. This will allow more “true to life” phenotypic analysis. This is a 
must, as laboratory recreations of biological events are not hypothesis free. As 
discussed earlier, several mouse models investigate aspects of DISC1 biology using 
RNAi against all isoforms
125
, point mutations, or truncations to produce dominant 
negative isoforms. The hypothesis that DISC1 knockdown (or dominant negative 
effects) is of relevance to the effects of the t(1:11) translocation is a valid one. Yet 
the model, however efficacious, will not model any other effects such as differential 
methylation of the t(1:11). It has been shown that there is differential methylation 
associated with the t(1;11) in blood samples from carriers and controls, with most of 
the significant loci being at chromosomes 1 and 11 and close to the breakpoints
126
. It 
is unknown if DISC1 disruption alone would replicate these and other effects. 
Indeed, given the importance of epistasis, and the relative ignorance we have of 
psychiatric disease aetiology, the creation of a model with the entire genetic 
background is a must, in order to accurately model any “two-hit” effects. To date the 
t(1;11) remains a well evidenced example of a psychiatric disease causing mutation 
involving DISC1. As discussed already, other mutations involving DISC1 do not 
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have the same calibre of evidence, or are not as penetrant. DISC1 is of valid 
biological interest by itself; but DISC1 disruption is only one of the outcomes of the 
t(1;11). iPSCs allow the close approximation of a real biological scenario, including 
not only well-studied events such as the t(1;11) but all genomic information. In any 
case the complexity of psychiatric disease, involving multiple cell types and 
interacting brain regions
127
, as well as a neurodevelopmental trajectory, will make 
complete reconstitution of phenotypes impossible. There are also significant 
drawbacks to iPSC-derived cell models. Yamanaka summarised some of these issues 
in a review
122
. The first major problem is inherent variability in the generation of 
iPSCs. The process generates mutation, and in any case the cells are derived in a 
clonal process typically from fibroblasts. Whether by production of mutation or 
selection of cells which carry mutation, iPSC-derived cells inevitably carry some 
variants not in the host genome. Yamanaka’s review noted that there is some 
reported variation in iPSC differentiation efficiency and gene expression, but 
suggested much of this might be due to inherent variation from one laboratory to 
another and noted larger studies were less likely to find differences between iPSCs 
and embryonic stem cells
122
. However a later paper did find some differences within 
iPSC lines, which is of more relevance to my approach than iPSC and embryonic 
stem cell differences
128
. 40 iPSC lines were differentiated to neurons, with 
approximately 75% of these showing less than 1% undifferentiated cells after 14 
days. However, a minority, approximately 20% of lines, showed more than 10% 
undifferentiated cells and were designated as “defective”. These lines had differential 
expression of retroviral associated elements. Subsequently, lines were differentiated 
to dopaminergic neurons and implanted in mouse brains. Mice that received a 
“defective” transplant had greater graft sizes and had teratomas in 85% of cases, 
compared to 22% of cases in non-“defective” lines. Finally, many but not all 
“defective” grafts continued to express pluripotent markers despite a 30 day 
differentiation protocol and a 60 day implantation period. We can clearly see that 
there are issues with line variability in iPSCs. The intrinsic variability of iPSC-
derived models is one problem; the other is that many of the phenotypes of interest 
(synaptic strengthening, etc.) change with time. Therefore, differences between cell 
lines may represent differences in culture time, which must be carefully controlled 
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for. Another problem is the relative immaturity of iPSC-derived neurons. Dolmetsch 
and Geschwind noted that these neurons are poorly characterised, are usually 
synaptically immature, and few fire action potentials
129
. Since this research project 
began, it has been reported that extended differentiation protocols result in a high 
proportion of electrophysiologically active neurons; such protocols require between 
56 and 70 days of culturing and result in mixed cultures primarily of astrocytes and 
neurons
130
. Another group also reported that they could produce iPSC-derived 
neurons which appeared to have dendritic spines; this production required an equally 
long differentiation time, twice as long as that used in our protocol
131
. Although there 
have evidently been advances in iPSC-neuron techniques, the issues of variability 
remain, and the protocol utilised to generate the neurons described in this thesis does 
not produce neurons with spines. 
Previous researchers have generated and utilised an iPSC-model carrying the t(1;11), 
as well as controls from the family without the translocation. They were 
subsequently differentiated to neural precursor cells, which were then differentiated 
to neurons and harvested for RNA utilised in RNA-Seq (see Materials and Methods). 
1.5 Deconvolution 
RNA-Seq data can be mined for a wealth of information other than the quantification 
of transcript levels for any one gene. Typically, as described in this thesis, RNA-Seq 
data is generated not solely from a unique cell type of interest but from a 
heterogeneous mixture of cells. If cells are collected from tissue, they will be 
heterogeneous given that tissues contain multiple cell types. If grown in vitro 
primary cell culture rarely results in a single cell type. Differentiation of neurons 
from iPSCs generates multiple neuronal cell types as well as non-neuronal cells
132
. 
This creates a challenge; we cannot directly distinguish between transcriptional 
changes caused by a relative change in cell proportions from those changes caused 
by a relative change in cell properties and/or activity. Both scenarios have biological 
relevance. The depletion of a particular subset of cells is of relevance to diseases as 
diverse as type 1 diabetes, Parkinson’s, and possibly schizophrenia
116
. Inappropriate 
or diminished activity of cells, without their relative proportions changing in any 
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way, can also be a pathological mechanism. Common variants predisposing to 
schizophrenia have been suggested to converge on only a few cell types, for 
example. Both schizophrenia associated mutations and environmental risk factors 
affect parvalbumin positive interneurons
116
, while a recent analysis by Skene et al. 
found that SNPs associated with schizophrenia are highly likely to affect genes 
which are specific to, or highly enriched in, certain cell types
3
. In deconvolution, we 
have a single signal comprised of multiple, individual components, a problem also 
presenting in audio signal and image processing, although in the case of RNA-Seq 
the components are cell types
134
. The goal is to “deconvolute” the data, changing it 
from one single convoluted signal into multiple deconvoluted signals. In a mixed cell 
RNA-Seq, each signal will correspond to a particular cell type. This will allow gene 
expression changes caused by variation in cell type to be distinguished from those 
caused by changed cell properties, in theory. 
The mathematics of deconvolution is relatively straightforward. If we have RNA-Seq 
samples for each of the pure cell types that make up the mixed sample, it is assumed 
that the mixed sample will have a gene expression value equivalent to the sums of 
the gene expression values of each pure cell type, weighted by their proportion in the 
mixture. If we have the expression of the gene in every pure cell type, then each gene 
produces an equation which indicates what proportions each cell type are in. If more 
genes than cell types are measured, then these equations can be solved to find out 
what the proportions are. In practice proportions usually cannot be found which 
satisfy the equation for all genes. However this problem is a well-established one in 
mathematics and a method known as the non-negative least linear squares method 
can be utilised to give the proportions that sum to one and minimise error for each 
separate equation. I utilised the DeconRNASeq package developed by Gong et al to 
carry out deconvolution
135
. A further discussion of deconvolution can be found in 
Chapter 5.  
1.6 Key papers 
Various experimental approaches have been taken by several other research groups 
interested in the biological effects of DISC1 mutation. In this thesis, I compare and 
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contrast some of their findings with my own. A discussion of some key papers is 
contained below, and the result of comparisons to those papers follows in the main 
body of the thesis.  
1.6.1 “Disrupted in Schizophrenia 1 Interactome: evidence for the close 
connectivity of risk genes and a potential synaptic basis for 
schizophrenia”-Camargo et al. 2007
73
 
This paper was the first to utilise a yeast two-hybrid screen to identify potential 
DISC1 protein interactors. 34 high-confidence interactors were identified in the 
initial study of full length DISC1 as a bait protein; a second round of yeast two-
hybrid screening was carried out with 8 of these as well as the N-terminal 350aa of 
DISC1 encoded proximal to the breakpoint. In total, 127 proteins were identified as 
interacting with DISC1 or one of the 8 interactors, with some multiple interactors 
identified. As expected, many established interactors such as PDE4B, NDEL1, and 
LIS1 were re-identified by this approach. Overrepresented GO terms among the 
potential DISC1-interactome related especially to cytoskeletal processes such as 
tubulin and dynein interactions, as well as actin based transport. These processes are 
especially relevant to multiple stages of neuronal migration
82
. DISC1 had a 
particularly large number of such overrepresented GO terms among its potential 
interactors. Finally, the group also screened using a DISC1 construct that was 
truncated at the translocation breakpoint. This construct’s interactors were quite 
different from that full length DISC1; only 16 were in common, while it interacted 
with 15 proteins that the full length DISC1 did not. It also lost interactions with over 
20 binding partners, and presumably their binding partners which full length DISC1 
indirectly interacts with (although it is of course possible that some of its novel 
partners interact with these secondary partners). This did not unambiguously suggest 
either a gain of function or loss of function mechanism was at play for the putative 
effects of truncated DISC1, but was a very interesting experiment highlighting that 
either could be responsible.  
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1.6.2 “Modelling schizophrenia using human induced pluripotent stem 
cells”-Brennand et al. 2011
124
 
This paper was the first account of iPSCs being used to study the phenotypes of 
schizophrenia. Researchers at the Gage lab utilised the classic lentiviral transfection 
approach to generate iPSCs from the fibroblasts of individuals with idiopathic 
schizophrenia, as well as age matched controls. Subsequently, the cells were 
differentiated to neural precursor cells, as well as neurons. This has been the usual 
method of generating neurons and our cells have followed a similar route. Brennand 
et al. aimed to determine whether any of the phenotypes observed in post-mortem 
studies were replicated, such as reduced spine density, or whether receptors of 
relevance to schizophrenia were dysregulated. The majority of these phenotypes 
were not replicated, which may be due to the limitations of neural development in a 
2D culture. Levels of synaptic PSD95, as well as VGAT, VGLUT1, GLUR1, and 
SYN were normal or not significantly different, although unlike some other papers 
they did not report a PSD95/SYN1 colocalisation assay. Electrophysiology and 
calcium imaging also did not reveal any difference between cells derived from 
individuals with SZ and those derived from control individuals. However, an RNA 
microarray indicated dysregulation of several hundred genes, 25% of which were 
previously implicated in SZ by post-mortem dysregulation or by association. The 
paper also included an experiment utilising the rabies virus, which spreads via 
synaptic connections. Connectivity (as measured by the ratio of initially infected 
cells to that of secondary infected cells, which could not spread the virus) appeared 
to be lower in the non-control cells, indicating possible deficits in neuronal 
organisation in SZ. 
Although its importance as a new application of iPSC technology to psychiatric 
disease research cannot be doubted, the Brennand et al. paper does have its 
limitations. Many of the disease phenotypes were not replicated, which might be due 
to the high variability of the cell lines (indicated by varying prevalence of GAD67+ 
cells between all lines). Alternatively, phenotypes may be more subtle. The pathways 
implicated by the RNA-array analysis carried out by Brennand et al. included Wnt 
and cAMP signalling, which are of relevance to psychiatric disease. A number of 
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these changes in genes such as WNT7A, TCF4, AXIN2, RAP2A and several 
phosphodiesterases (PDE4 family) were verified by qPCR. The Wnt pathway is 
involved in processes such as β-catenin signalling, inhibited by GSK-3β (itself 
inhibited by Lithium, a mood stabiliser
136
), while cAMP signalling has well 
documented effects on neural transcription and memory
85
. Changes in these 
pathways could lead to phenotypes not entirely obvious in cell culture. DISC1 of 
course, exerts effects on both pathways. 
A second paper from the Gage lab was published in 2014 and focused on the same 
cells, looking at neurotransmitter release
137
. The study was an analysis of basal and 
post KCl-stimulated neurotransmitter release, with technical replications. The cells 
stained positively for enzymes involved in catecholamine processing (such as 
dopamine decarboxylase, dopamine-β-hydroxylase, prohormone convertases and 
cathepsins), and showed that the iPSC-derived neurons originally from schizophrenic 
patients had an increase in the proportion of tyrosine hydroxylase positive neurons. 
This was mirrored by an increase in both basal and KCl stimulated catecholamine 
release. However, the paper also highlighted once again the variation between cell 
lines, even from the same patient source. Although the averages showed clear 
differences between SZ and WT lines, intragroup variation was high and the two 
groups were not cleanly distinguished from one another. This is a recurring issue 
with iPSC-derived models, and is a stumbling point for research. It is also difficult to 
draw conclusions from the tyrosine hydroxylase cell increases; Niwa et al. ‘s earlier 
discussed paper showed that a model of DISC1 mutation had reduced cells of this 
type
119
. Of course, the pathology of schizophrenia is more complex than a simple 
increase or decrease, and what cell type and when these changes occur will be 
important to eventual pathology. 
1.6.3 “Synaptic dysregulation in a human iPS cell model of mental 
disorders”-Wen et al. 2014
132
 
Further papers were to follow on the heels of those of Gage and colleagues. 
“Synaptic dysregulation in a human iPS cell model of mental disorders” by Wen et 
al. was published in 2014 and employed advances in iPSC generation methods, using 
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non-integrating plasmids as gene vectors. The group harvested fibroblasts from a 
small pedigree with a DISC1 frameshift and a high rate of psychiatric disease, 
inducing pluripotency and differentiating the resulting cells to NPCs and neurons. 
The use of a DISC1 frameshift carrying genotype is of obvious relevance to the 
t(1;11), and the group were able to establish that DISC1 protein levels were depleted, 
with a corresponding increase in DISC1 ubiquitination. The group also took control 
and carrier iPSC lines and induced or corrected the DISC1 frameshift, before 
differentiating these lines to neurons. TALEN mediated correction of the frameshift 
in carrier lines replenished levels of DISC1, as expected. In a similar manner, 
TALEN mediated causation of the frameshift caused loss of DISC1 protein in 
neurons. Given DISC1’s role as a scaffold protein, and its presence in the synapse, it 
is not surprising that Wen et al. elected to investigate synaptic phenotypes. They 
observed phenotypes including deficits in PSD95/SYN1 co-localisation (indicating 
decreased levels of synaptic maturity) and reduced levels of synaptic vesicle protein 
2, both capable of being induced or corrected by the presence of absence of the 
DISC1 frameshift. This is strong evidence in favour of DISC1 having an important 
role in synaptic strengthening and formation. The group also carried out RNA-Seq on 
their cells, although the number of lines was limited. Over 2,000 genes were 
differentially regulated, with the top three overrepresented gene ontology terms being 
“synaptic transmission”, “nervous development”, and dendritic spine”. Given the 
problem of variability, the near linearity between the RNA-Seq and qPCR (which 
used different differentiations of the same cell lines) is encouraging and the changes 
they verified by qPCR point towards synaptic dysregulation, matching their protein 
level phenotypic analysis. Changes in our RNA-Seq analysis which point towards the 
synapse and agree with Wen et al. should therefore be regarded with a greater 
measure of trust, especially given the similarities between the t(1;11) and a DISC1 
frameshift. It is also impressive that gene-corrected/altered controls displayed the 
same synaptic phenotypes; although these controls were not subjected to RNA-Seq.  
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1.6.4 “Genomic DISC1 Disruption in hiPSCs Alters Wnt Signaling and 
Neural Cell Fate”-Srikanth et al. 2015
138
 
An interesting paper by Srikanth et al. also looked at the effects of DISC1 
frameshifts. The group induced frameshifts in either exon 2 or exon 8 of DISC1 
using targeted nucleases, resulting in iPSC lines with premature stop codons. The 
resulting iPSC lines were homozygous for exon 2 frameshifts (ex2mm) or had one 
(ex8wm) or two (ex8mm) exon 8 frameshifts. The lines appeared to retain all their 
characteristic iPSC features. A particular strength of this paper was its breadth: the 
group looked at the above three genotypes at two developmental time points, neural 
precursor cell and neuron. They noted that all mutant neural precursor cells displayed 
extensive NMD (nonsense mediated decay) on the more 3’ exons (9, 11, 12/13), with 
only the ex8 mutants continuing to display late exon NMD into the neuronal stage. 
Of particular relevance to the t(1;11) was the discovery that ex8wm cells (d40, 
versus the d50 timepoint for neurons and d17 for neural precursor cells) had 
approximately ½ the wildtype level of DISC1 protein, while ex8mm appeared to 
display a complete absence. Although the ex8wm is not an exact replica of the 
t(1;11) it is interesting that they saw such a clear relation between genotype and 
phenotype. Most interesting of all however, was the observation that ex2mm cells 
had no protein at the 85kb band (WT DISC1 size) but had a novel band at ~64kb. 
Novel transcripts have been detected in the t(1;11), although a corresponding protein 
has not been detected. 
DISC1 frameshifts also appear to impact development. Srikanth et al. found that 
ex8wm, ex8mm, and ex2mm NPCs all had downregulated levels of the cortical 
genes FOXG1 and TBR2, with even more changes found solely in the ex2mm. At the 
neuronal stage the changes in FOXG1 and TBR2 were found to persist, and once 
again an additional set of changes were found in the ex2mm genotype involving 
decreases in neuronal receptors (VGLUT1, GRIN1) and cortical markers (CTIP2, 
TBR1, FEZF2). Srikanth et al. hypothesised that this represented a subtle shift in cell 
fate, and utilising RNA-Seq found that some ventral progenitor markers were 
decreased while dorsal ones were increased, although it should be noted that the 
changes were not universally significant. Believing that the changes may be due to 
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disinhibited Wnt activity, the group displayed by means of a TCF responsive 
luciferase assay that basal and stimulated Wnt signalling was higher in the mutant 
cells, especially the ex2mm. The scenario is evidently quite complex however: the 
Hh inhibitor cyclopamine did not alter the basal or stimulated signalling levels, 
although interestingly it did alter FOXG1 expression. Both Wnt agonism and 
antagonism (applied from days 7-17 of differentiation) exhibited the ability to alter 
cell fate markers in NPCs, although their effects on Wnt signalling were more 
complex, with agonism actually appearing to decrease signalling. Both Wnt agonism 
and antagonism exhibited the ability to alter cell fate markers in NPCs. Wnt 
antagonism increased FOXG1 and TBR2 in these cells, while agonism further 
decreased them and also increased MAP2 (neuronal marker) expression, more 
drastically in the ex8wm cells compared to WT ones. It appears that although the 
relationship between Wnt signalling and cell fate is not exactly a linear, simple one, 
Wnt signalling abnormalities prompted by DISC1 disruption appear to have effects 
on cell fate. The exact timing of the abnormalities appears to be important, with 
altering of signalling resulting in shifted cell fate marker expression even though the 
Wnt signalling levels later appeared to not be greatly affected. 
To summarise, it appears as though several of the papers utilising iPSC-derived 
neurons as a cellular model for SZ agree on some core concepts. Synaptic 
dysregulation is a prevalent theme, while evidence supporting a corresponding 
electrophysiological dysregulation is less strong. In the work of Brennand et al., 
these experiments had the greatest power and showed no positive results, while in 
Wen et al. electrophysiological abnormalities were inconsistent, and usually only 
evident in comparison to a certain control line. Wnt dysregulation is emerging as a 
common theme in DISC1 disruption, with cells often displaying abnormal expression 
of key Wnt signallers. The paper from Srikanth et al. is perhaps the best displayer of 
this trend, although it should be noted that the phenotype is complicated and that Wnt 
antagonism and agonism did not give expected, binary phenotypes. It appears that 
temporal factors are of importance. To an extent the prediction of Brennand et al. in 
2011 is bearing out, as more data becomes available an ever-narrowing number of 
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genes are being consistently disrupted across all models of schizophrenia, perhaps 
hinting at pathways which are ubiquitously disrupted in schizophrenia. 
1.6.5 “Biological insights from 108 schizophrenia-associated genetic 




The Common Disease Common Variant model of schizophrenia genetics predicts 
that many variants, each only mildly predisposing to schizophrenia, will exist in the 
population. These will be significantly enriched in schizophrenia cases compared to 
controls but by no means will they be absent from the control population. These 
variants will require large power to detect, and correspondingly large sample sizes. 
At the time, this paper was the largest genome-wide association study (GWAS) for 
schizophrenia. Utilising approximately 37,000 cases and 113,000 controls, this study 
looked at 9.5 million single nucleotide polymorphisms (SNPs). After disregarding 
SNPs in low linkage disequilibrium with more significant SNPs, they found 128 
SNPs implicating 108 loci. SNPs were significantly more likely to be transmitted to 
an affected offspring in parent-offspring trios and more likely to be found significant 
in the replication cohort. Over 300 genes were implicated in these loci, although of 
course it is likely that only one of the genes associated with SNP locus is actually 
affected by the SNP in such a way to increase risk for schizophrenia. It is also, of 
course, possible that the affected gene is at a great distance from the SNP (loci 
boundaries were defined by SNPs which highly correlate with the putative risk SNP). 
40% of loci contained only one gene, and genes included DRD2, many voltage gated 
calcium channels such as CACNA1C, CACNB2, and glutamatergic receptors such as 
GRIA1, GRIN2A, GRM3, some of which have roles in synaptic plasticity. Of 
particular interest was that the genes implicated had significant overlap with those 
found with de novo non-synonymous mutations in schizophrenia, intellectual 
disability, and autism spectrum disorder. As well as offering support to the 
“spectrum” model suggested by Craddock and Owen
12
, this also suggests that rare 
and common mutation converge on certain genes, a finding which bolsters the 
relevance of this thesis.  
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1.6.6 “Common schizophrenia alleles are enriched in mutation-intolerant 
genes and maintained by background selection”-Pardiñas et al. 2016
60
 
This new study, also by the Psychiatric Genomics Consortium, built upon their 
previous paper and utilised some of the same data. Here, the total sample was smaller 
(approximately 11,260 cases and 24,500 controls) but was phenotypically more 
consistent. This sample (derived from the CLOZUK cohort) had been filtered for 
high homogeneity based on genomic ancestry, limiting effects that could be due to 
population differences between cases and controls. Most patients were taking 
clozapine regularly, the exact figure was not given but 96% of the initial 15,000 
were, meaning that of the post-filtered group of 11,260 at least 94.7% must have 
been taking clozapine. 18 loci were discovered as significant. Approximately half of 
the cases and three quarters of the controls were also in the previous study (the PGC 
sample) with 37,000 cases and 113,000 controls; removing these from that group 
gave the PGC independent sample. The PGC independent sample and the CLOZUK 
derived one had high genetic correlation and agreement on the direction of SNP 
effects. Meta-analysis of the CLOZUK sample and the PGC independent sample 
gave 177 significant SNPs at 143 loci, 50 of which were novel. 98 of the loci 
appeared to implicate only a single gene; these included PDE4B, ERBB4, NRXN1, as 
well as CACNA1D and GABBR2, implicating calcium and GABA signalling. Many 
genes from the previous GWAS were also implicated again. Finally, gene set 
enrichment analysis revealed that genes of the sets “targets of FMRP” (discussed 
earlier in this introduction), “5HT2C-receptor complex”, “voltage -gated calcium 
channel complexes”, and those of “abnormal long term potentiation” were 
significantly enriched for hits. This paper not only reaffirmed the importance of 
calcium signalling, but also gave several hits novel for GWAS which implicated 
classic candidate genes and PDE4B, which encodes a DISC1 interactor.  
1.6.7 “Contribution of copy number variants to schizophrenia from a 
genome-wide study of 41,321 subjects”-CNV analysis group of the 
Psychiatric Genomics Consortium 2017
139
 
SNPs had been studied with large sample sizes, and the work of Guilmatre et al. and 
others had shown the importance of CNVs to the genetics of schizophrenia
48
. This 
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large study utilised ~21,000 cases and ~20,000 controls for the study of CNVs 
relating to schizophrenia. They found that in general schizophrenia cases had more 
CNVs (x1.03), which were larger (x1.1), and which contained more genes (x1.2). 
Most CNVs had a modest effect, and a number of rarer CNVs had a novel 
association with schizophrenia. Of 28 gene sets of relevance to schizophrenia, 15 
were enriched for excess CNV loss in cases and four for excess CNV gain in cases. 
None of 8 control sets were enriched in any way. Genes associated with GO terms 
“synapse” and “ARC complex” were highly significantly enriched for CNV loss and 
appeared to drive most of the significance of the other sets. Genes from these sets 
overlapping with CNVs had extensive protein-protein interactions with synaptic 
molecules including pre and postsynaptic markers, as well as glutamatergic 
receptors. They attempted to further delineate the exact loci which drove CNV 
significance and described 8 of these as being of genome-wide significance. 
1.6.8 “Genetic identification of brain cell types underlying 
schizophrenia”-Skene et al. 2018
140
 
Skene et al.attempted to determine what cell types the mutations discovered in the 
above papers might exert their effects in. They used a superset of scRNA-Seq data 
from the Karolinska Institute. Their hypothesis was simple; if schizophrenia affects 
certain cell types, mutations which predispose to schizophrenia should be 
overrepresented in genes which are exclusive or near exclusively expressed in those 
cells. Schizophrenia “genes” could of course be more akin to housekeeping genes 
which are universally expressed. But this did not appear to be the case. Using two 
types of analyses and the entirety of the schizophrenia associated SNPs from 
Pardiñas et al., they showed that enrichment for genes associated with these SNPs 
was found in several groups of genes. These included those highly specific to 
hippocampal CA1 pyramidal cells, striatal medium spiny neurons (MSNs), 
neocortical somatosensory pyramidal cells and cortical interneurons. More 
specifically, the group of genes highly specific to MSNs expressing Drd2, the group 
highly specific to MSNs expressing Drd1, as well as the group highly specific to 
parvalbumin positive interneurons were all heavily enriched for schizophrenia hits. 
This finding appeared to be specific for schizophrenia; depression, years of 
 
     71 
education, and height related hits produced different significantly enriched groups 
(although MSNs-related genes were significant in the education investigation as 
well). In general, these findings were replicated using other datasets, and the same 
cell types were highlighted as having gene enrichment when instead of GWAS hits 
the input was “genes affected by antipsychotics” or gene sets associated with 
schizophrenia such as “NMDAR complex”, “PSD-95 complex”, and “FMRP 
associated genes”. The effect was not found when gene sets related to Alzheimer’s 
disease or migraine were used. The paper was a highly interesting look at what cell 
types schizophrenia genetics converges on; the emergence once again of 
dopaminergic and parvalbumin positive interneurons as being important to 
schizophrenia is striking. 
1.7 Hypothesis and Aims of the PhD 
It is clear that the genetics of psychiatric illness, although characterised by both 
common and rare variation, have still not been fully elucidated. It is also not entirely 
evident how the t(1;11) exerts its effects. Research has however highlighted 
particular pathways related to synaptic activity and neurodevelopmental as being 
important in pathogenesis. Large CNV and GWAS studies have found some 
candidate genes, while studies of iPSCs and DISC1 have indicated the possible 
importance of cAMP and Wnt signalling in t(1;11) pathogenesis. In addition, new 
computational techniques can be applied to RNA-Seq profiles of iPSC-derived 
neurons, so as to go beyond the gene level changes and see if particular patterns 
emerge. 
The aim of this PhD was to study iPSC-derived neurons of the Scottish pedigree, and 
compare and contrast RNA-Seq profiles of lines with and without the translocation. I 
also planned to utilise the Der1 mouse model. By this I aimed to see 
1) What pathways or genes are altered by the translocation, with particular 
interest in those which are amenable to further investigation. Further 
experiments would depend on the nature of the altered genes.  
2) If there were convergences between genes altered by this unique mutation 
and those altered by more common SNPs and CNVs predisposing to 
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psychiatric illness. This would indicates that the t(1;11) is a good model for 
psychiatric illness more generally, and that insights from its investigation 
might be applicable to the field as a whole. 
3) If there were convergences with DISC1 models, which would be more 
evidence that the translocation exerts effects via effects on DISC1. 
4) If the changes observed could be linked to changes in relative proportions of 
certain cell  types. 
5) If the changes observed could be related dysfunctions in particular cell types 
and what this might mean on the molecular level. 
To answer questions 1-3, I utilised RNA-Seq investigation, comparing and 
contrasting the list of differentially expressed genes to those lists from major 
papers discussed earlier. I verified changes of particular importance utilising 
qRT-PCR with the idea of producing further experimental ideas. I aimed to 
answer question 4 using my deconvolution approach, and question 5 utilising the 
EWCE approach of Skene et al. 
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2.1 Generation of induced pluripotent stem cells (iPSC) from 
dermal fibroblasts 
The below text is replicated exactly (excepting formatting and clarification of some 
statements) from the Supplementary Materials of Malavasi et al
70
. I did not 
contribute to the production of the iPSC lines. As stated in my thesis declaration, 
only methods which have an explicit declaration of non-contribution as above were 
not carried out by the author (me). All these methods are clearly noted in the text and 
referenced. For convenience I have stated at the start of each section whether it was 
carried out by me, by collaborators, or in collaboration together. 
Ethical consent relating to the translocation family is as follows: Prior to 2014, 
Lothian Research and Development (2011/P/PSY/09), Scotland A Research Ethics 
Committee (09/MRE00/81); 2014 onwards, Lothian Research and Development 
(2014/0303), Scotland A Research Ethics Committee (14/SS/0039). Fibroblasts were 
cultured in DMEM with 10% FBS (all media and supplements used in 2.1 and 2.2 
from Life Technologies unless stated otherwise) at 37
o
C with 5 % CO2. Fibroblasts 
were reprogrammed by non-integrating methods, using episomal plasmids
141
. For 
episomal reprogramming of some lines we used a protocol adapted by Tilo Kunath, 
(University of Edinburgh) and Roslin Cells (roslincells.com). Other lines were 
reprogrammed by Roslin Cells. Plasmids incorporating Oct3/4, shRNA to p53, 
SOX2, KLF4, L-MYC and LIN28 were electroporated into fibroblasts using 
Nucleofection (Amaxa, Lonza). The episomal plasmids pCXLE-hOCT3/4-shp53-F 
(for OCT3/4 and p53 knockdown), pCXLE-hSK (for SOX2 and KLF4) and pCXLE-
hUL (for L-MYC and LIN28) were a gift from Shinya Yamanaka. (These correspond 
to Addgene plasmids 27077, 27078, 27080). 5 x 10
5
 fibroblasts were transfected with 
1.7ug of pCXLE-hOCT3/4-shp53-F, 1.6ug of pCXLE-hSK and 1.7ug of pCXLE-
hUL using the NHDF Nucleofector kit and Amaxa Nucleofector protocol U-023 
(1,650 V, 10 ms, 3 time pulses), according to the manufacturer’s instructions. Cells 
were then seeded into one well of a gelatin-coated 6 well tissue culture grade plate in 
Opti-MEM (ThermoFisher Scientific) supplemented with 10% FCS and 1% 
Antibiotic Antimycotic Solution (Life Technologies 15240062). All stages of cells 
were maintained in media supplemented with Antibiotic Antimycotic Solution 
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thereafter. The medium was replaced every 2-3 days before cells were replated into a 
10cm Vitronectin/Geltrex (ThermoFisher Scientific) or Matrigel (Life 
Technologies)-coated tissue culture grade dish after 6-7 days.  
The following day the medium was changed to Essential 6 medium (ThermoFisher 
Scientific) with added 100 ng/ml bFGF (Peprotech). The medium was changed every 
2 days until colonies were ready to be picked, at approximately day 25-30. Individual 
colonies were picked and expanded into 12, then 6, well Vitronectin/Geltrex or 
Matrigel-coated tissue culture grade plates in Essential 8 medium (ThermoFisher 
Scientific) with daily medium changes. Cells were passaged using 0.5mM EDTA in 
PBS. iPSCs were generated and cultured at 37
o
C, 5% CO2 and 21% O2. Quality 
control of iPSC lines was performed after clonal passage 10. 
Pluripotency of iPSC lines was assessed using markers SSEA-1 PE, SSEA-4- 
AlexaFluor647 and Oct3/4 PerCP-Cy5.5 and isotype controls using the BD Stemflow 
Human and Mouse Pluripotent Stem Cell Analysis Kit (BD Biosciences, 560477) 
according to the manufacturer’s instructions, or with SSEA-1-APC (301907), SSEA-
4-FITC (330409), TRA-1- 60-PE (330609), TRA-1-81-PE (330707) and isotype 
controls (all BioLegend) as follows: iPSCs were dissociated using StemPro Accutase 
(Life Technologies) and washed with Essential 8 medium. 1x105 cells were 
incubated with antibodies in 2% Fetal Bovine Serum in PBS for 1 hour on ice. Cells 
were washed once with 2% BSA/PBS, centrifuged at 200 x g for 5 min and 
resuspended in 200 ul 2% BSA/PBS. FACS analysis was performed on single cell 
suspensions using a FACS Aria cell sorter (BD Biosciences). Data were analysed 
using FlowJo v10 software. 
EBNA-1 primer sequences and amplification protocol were taken from the Epi5 
Episomal iPSC Reprogramming Kit (Life Technologies, A15960). Genomic DNA 
was extracted from iPSCs using the DNeasy kit (Qiagen). Cells that had not been in 
contact with episomes, were used as negative controls. Positive controls were low 
passage iPSC lines where episomes were still present. A non-template control (NTC) 
was also used. iPSC lines were only taken forward once episomal clearance had been 
confirmed by this method (data not shown). 
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The human Cytoscan 750 K Array (Affymetrix) was used to identify genomic 
abnormalities in the iPSC lines. The array consists of 550,000 unique non-
polymorphic probes and 200,000 SNPs for accurate genotyping. Genomic DNA was 
extracted from iPSC clones using the DNeasy kit (Qiagen) according to 
manufacturer’s instructions. Samples were sent to the NHS Cytogenetics Laboratory 
(Western General Hospital, Edinburgh) for processing of the arrays. Chromosome 
analysis was performed using Chromosome Analysis Suite version 2.0 (Affymetrix). 
Copy number, breakpoints and Loss Of Heterozygosity (LOH) regions were 
determined using the models and algorithms incorporated within the software 
package. To exclude possible false positives due to inherent microarray noise the 
CNV threshold of gains and losses for inclusion in analyses was 10 kilobase pairs 
(kbp) and 10 consecutive markers. iPSC lines with deletions or duplications greater 
than 5 MB, the limit typically applied by G-banding, were excluded from further 
studies. 
2.2 NPC culture and neuronal differentiation 
The below text is replicated exactly (excepting formatting) from the Supplementary 
Materials of Malavasi et al
70
. I did not contribute in the production of the neurons 
which were utilised and described in this thesis. 
iPSCs were converted into neuroectoderm by dual-SMAD signalling inhibition
142
. 
Long-term anterior neural precursor cells were generated and maintained under 
physiological normoxia (3% O2) and in the absence of EGF3. NPCs were cultured at 
37
o
C, with 5% CO2 and 3% O2  on Matrigel (Life Technologies)-coated 6 well tissue 
culture grade plates in Advanced DMEM/F-12 (Life Technologies) with 1% 
Glutamax-1 (Life Technologies), 1% N2 supplement (Life Technologies), 0.1% B27 
supplement (Life Technologies), 10 ng/ml bFGF (PeproTech) and 1% 
antibiotic/antimycotic solution (Life Technologies). NPCs were maintained up to 
passage 30 with feeding every 2-3 days and weekly passages using StemPro 
Accutase (Life Technologies). All NPC lines were tested every week for 
mycoplasma infection. For differentiation into cortical forebrain-like neurons
143
, 
NPCs were plated into Matrigel (Life Technologies) and Laminin (Sigma-Aldrich)-
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coated 12 well tissue culture grade plates in Advanced DMEM/F-12 with 0.5% 
Glutamax-1, 0.5% N2 supplement, 0.2% B27 supplement, 2 μg/ml Heparin and 1% 
antibiotic/antimycotic solution (Life Technologies). Neurons were maintained for 5 
weeks with feeding as necessary. During weeks 2 and 3 the neuronal differentiation 
medium was supplemented with Forskolin (Tocris Bioscience). During weeks 4 and 
5 the Forskolin was removed, and the medium was supplemented with BDNF (Life 
Technologies) plus GDNF (Life Technologies) to 5ng/ml each. 
2.3 Human cDNA synthesis 
I carried out synthesis of cDNA to produce standard curves and test primers. cDNA 
was synthesised from human cerebral cortex RNA using a 40µl reaction mix 
comprised as follows: 4µl GeneAmp 10x PCR buffer II, 8.8µl MgCl2 solution (both 
#N8080130, Life Technologies, Paisley, Glasgow, PA4 9RF), 2µl GeneAMP dNTP 
solution (#4303442, Life Technologies, Paisley, Glasgow, PA4 9RF), 0.8µl RNase 
Inhibitor (#N8080119, Life Technologies, Paisley, Glasgow, PA4 9RF), 1µl 
Multiscribe Reverse Transcriptase (#4311235, Life Technologies, Paisley, Glasgow, 
PA4 9RF), 4µl Random Hexamers (#N8080127, Life Technologies, Paisley, 
Glasgow, PA4 9RF), 18.4µl Ultrapure DNase/RNase-Free Distilled Water 
(#10977035, Life Technologies, Paisley, Glasgow, PA4 9RF), and 1µl of human 
cerebral cortex RNA solution (#636561, Takara Bio Europe, Saint-Germane-En-
Layn, France) as supplied by Takara Bio Europe, containing 1µg of RNA. The 
following protocol was utilised. 
The combined RNA and Ultrapure water solution (19.4µl total) was first denatured 
using the following protocol; 
65
o
C 10 minutes 
4
o
C 5 minutes 
And was subsequently placed on ice. The rest of the reagents were added and the 
tube subjected to the following protocol; 
25
o
C 10 minutes 




C 30 minutes 
95
o
C 5 minutes 
Tubes were then kept at 40
o
C before being checked for genomic DNA contamination 
via PCR of a suitable region of the genome which gives a different product in cDNA 
and genomic DNA. cDNA preparations without contamination were subsequently 
stored at -20
o
C until use, whereupon they were stored at 4
o
C.  
2.4 Polymerase Chain Reaction 
I carried out PCRs to determine if primers were producing solely the desired product. 
PCRs were carried out using a 20µl reaction mix comprised as follows: 15.4µl U 
Ultrapure DNase/RNase-Free Distilled Water, 2µl 10X PCR Buffer with MgCl2 
(#P2192, Sigma-Aldrich), 0.4µl DNA Taq Polymerase (#18038018, Life 
Technologies), 0.4µl of 10μM forward primer, 0.4µl of 10μM reverse primer, 0.4µl 
of 10mM dNTP mix, and 1μl of cDNA solution (or Ultrapure water as a negative 
control). Unmodified salt purified primers were purchased from Sigma-Aldrich and 
stored as a 100µM solution at -20
0
C. Working solutions of 10µM primer were kept at 
4
0
C. Ultrapure DNase/RNase-Free Distilled Water (#10977035, ThermoFisher 
Scientific (Life Technologies)) was used as the solvent. This mixture was subjected 




C 1 minute  






C 20 seconds 
X+10
o
C 30 seconds 
72
o
C 1 minute 
Then the following three steps repeated 30 times; 
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95
o
C 20 seconds 
X
o
C 30 seconds 
72
o




C 10 minutes 
PCR products were then subjected to DNA electrophoresis for purposes of 
examination. 
2.5 DNA Electrophoresis 
I carried out DNA Electrophoresis. DNA electrophoresis was used to assess the size 
of DNA fragments generated by PCR. Gels were created using LMP agarose, diluted 
in TBE Buffer to a concentration of 2%. After melting and casting of the agarose gel 
in a mould, it was left to solidify at room temperature. Subsequently, 5-10μl 
(depending on well width) of DNA loading solution was added to each well. This 
solution consisted of 9 parts PCR product to 1 part DNA Loading Buffer. 5-10μl of 
DNA marker (1 Kb Plus DNA Ladder, Invitrogen) was also pipetted into a well. The 
gel was then placed in an electrophoresis tank (Bioscience Service) and completely 
submerged in TBE buffer. A 100 volt current was applied and the gel was visualised 
after 1 hour, with subsequent visualisations if necessary. The DNA fragments in the 
gel were visualised by UV light illumination using an Uvidoc Lightbox (Uvitec) and 
photographed with the built-in camera. 
If the primers were intended to be used for qPCR, PCR products were subjected to 
DNA electrophoresis for purposes of examination. If the product size matched the 
expected size, and was the only product present, the reaction was deemed “clean” 
and the product was sequenced to ensure primer specificity.  
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2.6 Sequencing of Polymerase Chain Reaction products 
I prepared products for sequencing. Clean PCR products were subjected to 
sequencing. The following reagents were added to the wells of a 96-well plate; 1μl of 
PCR product, 1μl of ExoSapIT, and 3μl of Ultrapure DNase/RNase-Free Distilled 
Water (#10977035, ThermoFisher Scientific (Life Technologies). These were then 
subjected to the following protocol: 
37°C 60 minutes 
80°C 20 minutes 
Subsequently, the following was added to each well; 1μl BigDye, 1μl BigDye x5 
sequencing buffer, 1μl of 3.2μM primer solution, and 2μl Ultrapure DNase/RNase-
Free Distilled Water (#10977035, ThermoFisher Scientific (Life Technologies)). 
Unmodified salt purified primers were purchased from Sigma-Aldrich and stored as a 
100µM solution at -20oC. Working solutions of 10µM primer were kept at 4oC. 
Ultrapure DNase/RNase-Free Distilled Water (#10977035, ThermoFisher Scientific 
(Life Technologies)) was used as the solvent. 3.2μM primer solutions were generated 
from 10μM solutions and the solvent was the sane. The wells were then subjected to 
the following protocol: 
96°C 1 minute 
Then the following three steps repeated 30 times:  
96°C 10 seconds  
50°C 5 seconds 
60°C 4 minutes  
Then each well had the following added, in the order in which they are listed; 2.5μl 
of 125mM EDTAs solution, 30μl of 95% ethanol solution. Then the plate was sealed 
and the following protocol was carried out: 
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Inversion of plate 4 times 
Incubation at room temperature for 15 minutes 
Centrifuge 30 minutes at 3000rpm, at 8oC 
Removal of excess ethanol by inversion of opened plate onto absorbent tissue 
Addition of 30μl of 70% ethanol solution 
Centrifuge 15 minutes at 3000rpm, at 8oC 
Removal of excess ethanol by inversion of opened plate onto absorbent tissue 
Open air drying of plate for 3-5 minutes, then resealing 
Sequencing on a 3730 Genetic Analyzer (Applied Biosystems). This was carried out 
by appropriately trained staff at the IGMM Sequencing Facility, chiefly Stephen 
Brown.  https://www.ed.ac.uk/igmm/facilities/dna-sequencing-facility. 
Ultrapure DNase/RNase-Free Distilled Water (#10977035, ThermoFisher Scientific 
(Life Technologies)) was used as the solvent in all cases. 
Primers which did not produce a single, intended sequence were discarded for the 
purposes of qPCR. 
2.7 Quantitative Polymerase Chain Reaction 
This method is as in Malavasi et al. 2018
70
. qPCRs were carried out both by me and 
by Helen S. Torrance, and the section describing primers indicates gene by gene 
contributions by Helen S. Torrance. Note that housekeeping gene stability was 
assessed as described in Malavasi et al. and I did not contribute to the selection or 
quantification of housekeeping genes. I contributed solely to the selection and 
quantification of genes of interest. 
Non-template and minus reverse transcriptase controls were included in all 
experiments with three technical replicates for all samples. To control for inter-plate 
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variation a calibrator sample was included on every plate for normalisation purposes. 
Melting curve analysis was carried out for each primer pair to optimise amplification 
conditions and confirm amplification specificity. Specificity was also confirmed by 
PCR and sequencing (2.4 and 2.6). Melting curves of significant genes and 
housekeeping genes are provided in the Appendix, 9.2 and 9.3. PCR efficiency was 
assessed by running standard curves using serial dilutions of NPC or mouse brain 
samples for human and mouse primers, respectively. All samples were run in 
triplicate, and replications with more than 1 CT difference were discarded. Gene 
expression levels were calculated using the relative standard curve method; with 
normalisation to the geometric mean of the reference housekeeping genes (see 2.8 
and 2.9). They were then averaged for each set of replicates to give the expression 
score for that sample. 
From Malavasi et al. and relating to housekeeping genes which I did not contribute 
towards identifying
70
; For quantification of human gene expression, housekeeping 
gene stability was assessed across samples taken from NPCs through to five week 
neurons for several genes using geNorm (genorm.cmgg.be/). ACTB and GAPDH 
were subsequently selected as the most stable housekeeping genes for use in 
quantitative RT-PCR in these samples. ACTB was used as a reference gene for 
human iPSC-described neuron RNA-Seq follow up. For quantification of mouse 
gene expression, Cyclophilin (Ppib) and Hmbs were found to be stable in the mouse 
brain samples analysed.  
A typical qRT-PCR was as follows and closely follows that recommended by the 
manufacturer. Quantitative Polymerase Chain Reactions were carried out in triplicate 
in a 384-well plate. Each well was loaded with 4.8μl Power Sybre Green PCR 
Master Mix (#4367659, ThermoFisher Scientific (Life Technologies)), 0.6μl 10mM 
forward primer, and 0.6μl 10mM reverse primer, as well as 4μl cDNA sample. Non-
template control replaced cDNA with Ultrapure DNase/RNase-Free Distilled Water 
(#10977035, ThermoFisher Scientific (Life Technologies). Unmodified salt purified 
primers were purchased from Sigma-Aldrich and stored as a 100µM solution at -
20
o
C. Working solutions of 10µM primer were kept at 4
o
C. Ultrapure DNase/RNase-
Free Distilled Water (#10977035, ThermoFisher Scientific (Life Technologies)) was 
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used as the solvent. The plate was spun on a centrifuge for at least 3 minutes to force 
reagents to the ends of the wells. 
The plate was then run on a 7900HT Fast Real-Time PCR System with 384-Well 
Block Module (ThermoFisher Scientific (Applied Biosystems)) using the following 
protocol; 
50°C 5mins 
95°C 10 mins 
Then the following two steps repeated 40 times, with X varying between 57 and 63 
depending on primer pair; 
95°C 15 sec 
X°C 45 sec  
Dissociation curve step; 
95°C 15 sec 
X°C 15 sec 
95°C 15 sec 
QPCR products were occasionally subjected to DNA electrophoresis for purposes of 
examination. 
2.8 Human primers used in this thesis 
All primers were designed using UCSC hg38, at https://genome.ucsc.edu/, and were 
then checked for specificity using BLAST, at https://blast.ncbi.nlm.nih.gov/Blast.cgi. 
Primers which had a product greater than 250bp, or an offsite potential product less 
than 1kb were discarded. All products were examined by DNA electrophoresis to 
ensure correct product size and sequenced to ensure specificity. All primers span an 
exon-exon boundary containing an intron of at least 1kb in size. Note that DRD2, 
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ACTB, and GAPDH primer design was carried out by Helen S.Torrance. ACTB was 
selected as a housekeeping gene due to its stable expression; selection of this gene 




Gene Forward Reverse 
ACTB GTTACAGGAAGTCCCTTGCCATCC CACCTCCCCTGTGTGGACTTGGG 
BBS1 TGAAACTCAATGTGCCCCGA GTAGGCGCAGCAGGTATAGG 
CALB1 AATTTCCTGCTGCTCTTCCGA TCTATGAAGCCACTGTGGTCAG 
CHRNA4 GGCCGAAGACACAGACTTCTC AGCAGGCAGACGATGATGAAC 
DRD2 AAGGGCACGTAGAAGGAGAC GGTCACCGTCATGATCTCCA 
GAPDH GAGTCCACTGGCGTCTTCAC ATGACGAACATGGGGGCATC 
GPC1 CCATGCTTGCCACCCAG GCTCTGAGTACAGGTCCCG 
HAP1 GCCCCTAAGCTGATTTCGCA AGAGTGTCGAGTTGAGAGGC 
HIF1A TTTTGGCAGCAACGACACAG  GTGCAGGGTCAGCACTACTT 
KANSL1 GTTACAGCCAGCACATCGC AGACTGAAGATCAACCTCCCG 
METRN GCGACTTCGTAATTCACGGG TGGGGTACGAATGGAGGTCA 
NRP2 GGTGGACCCCTCAACAAAGC GCCGGTACACCATCCAGTC 
NTRK2 CTGGCCTGGAATTGACGATGG CGAGAGATGTTCCCGACCG 
PDYN TGTAAAGACCCAGGATGGTCC AGTCCTCCTTGTCATTGAGCC 
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Exon Forward Reverse 
Associated isoform accession 
number 














































































Transcript variant 1, NM_001046.2  









Note that DVL1’s exon matches a second isoform which is poorly annotated and has 
a retained intron. It has neither an associated mRNA nor an EST. The primers of 
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SHTN1 were designed to detect an exon found in multiple isoforms. In humans the 
exon is found in several isoforms distinguished by altered C and N terminals, and is 
only absent from one. See section 3.9.9 for more details on the properties of the 
analogous gene in rodents. NM_001127211, NM_001258298, NM_001258299, 
NM_001258300 are the isoforms listed in NCBI which contain the exon. Locations 
are as given by DEXSeq, with +/- indicating the strand as in UCSC. Note that the 
exons are visually identified in a series of images displayed in theAppendix 9.1. 
2.9 Mouse primers used in this thesis 
All primers were designed using UCSC mm10, at https://genome.ucsc.edu/ and were 
then checked for specificity using BLAST, at https://blast.ncbi.nlm.nih.gov/Blast.cgi. 
Primers which had a product greater than 250bp, or an offsite potential product less 
than 1kb were discarded. All primers span an exon-exon boundary containing an 
intron of at least 1kb in size. All products were examined by DNA electrophoresis to 
ensure correct product size and sequenced to ensure specificity. Note that Hmbs and 
Ppib (cyclophilin) primer design was carried out by Helen S. Torrance. These were 
selected as housekeeping genes due to stable expression; details are described in 
Malavasi et al. 2018 and I did not carry out the corresponding PCRs
70
. 
Gene Forward Reverse 
Apoe GTTGGTCACATTGCTGACAGG CCAGCGCAGGTAATCCCAG 
Arc GGTGAGCTGAAGCCACAAATG ACTTCTCAGCAGCCTTGAGAC 
Avp CACAGTGCCCACCTATGCTCG TTGGTCCGAAGCAGCGTCC 
Hap1 CTAAGGCTGAGACAGCGCAC ATAGCCTTCCAGCCTCAACAC 
Hmbs CCCTGAAGGATGTGCCTACCATA AAGGTTTCCAGGGTCTTTCCAA 
Metrn CCTTCCGTTTTGAACTGCACG AGCTCGGCATCACTGC 
Mt2 CCTGCAAATGCAAACAATGCAA TCGGAAGCCTCTTTGCAGAT 
Nrp2 AGTGAGAAGCCAGCAAGATCC GTTCGGGGGCGTAGACAATC 
Ppib GGAGATGGCACAGGAGGAAAG GCCCGTAGTGCTTCAGCTTGAA 
Slc1a1 ATGATCTCGTCCAGTTCGGC GGTCCAAGCCATTCAGTTGC 
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2.10 Harvesting of RNA from iPSC-derived neurons 
I did not carry out the culture or harvesting of the cells used to generate RNA but 
have exactly replicated the relevant text written by collaborators. I claim no credit in 
the production, harvesting, RNA-Sequencing, or initial data processing of the 
samples, which was the work of the following individuals; Kirsty Millar, Helen S. 
Torrance, Marion Bonneau, Susan Anderson, Daniel McCartney, Philippe Gautier, 
and the Wellcome Trust Edinburgh Clinical Research Facility.  
2.10.1 Culture and maintenance of iPSC-derived neurons 
High density neuronal cultures (approximately 2 million cells per well in 12 well 
plates) were differentiated for 5 weeks. Immunofluorescence staining of parallel 
cultures was used to confirm correct NPC morphology and Nestin expression at the 
time of plating, and successful neuronal differentiation by assessing morphology and 
acquisition of βIII-tubulin expression at the time of harvesting, for every culture 
used. Three independent neuronal differentiations were performed per NPC line. 
Neurons were harvested in RNAlater (ThermoFisher Scientific), stored at -80
o
C, then 
processed in batches to extract the RNA. Each batch consisted of one triplicate per 
line to minimise batch effects. 
2.10.2 Processing of RNA samples for RNA sequencing 
All subsequent steps were performed by the Wellcome Trust Edinburgh Clinical 
Research Facility (www.wtcrf.ed.ac.uk) . Total RNA samples were assessed on the 
Agilent Bioanalyser (Agilent Technologies, G2939AA) with the RNA 6000 Nano 
Kit (5067-1511) for quality and integrity of total RNA, and then quantified using the 
Qubit 2.0 Fluorometer (Thermo Fisher Scientific Inc, Q32866) and the Qubit RNA 
BR assay kit (Q10210). Samples were also assessed for DNA contamination using 
the Qubit DNA HS assay Kit (catalogue Q32851). 
Materials and Methods 
88 
Libraries were prepared from each total-RNA sample using the TruSeq Stranded 
Total RNA with Ribo-Zero Gold kit (RS-122-2301) according to the provided 
protocol. 
500ng of total-RNA was processed to deplete rRNA before being purified, 
fragmented and primed with random hexamers. Primed RNA fragments were reverse 
transcribed into first strand cDNA using reverse transcriptase and random primers. 
RNA templates were removed and a replacement strand synthesised incorporating 
dUTP in place of dTTP to generate double-stranded cDNA. AMPure XP beads 
(Beckman Coulter, A63881) were then used to separate the double-stranded cDNA 
from the second strand reaction mix, providing blunt-ended cDNA. A single 'A' 
nucleotide was added to the 3' ends of the blunt fragments to prevent them from 
ligating to another during the subsequent adapter ligation reaction, and a 
corresponding single 'T' nucleotide on the 3' end of the adapter provided a 
complementary overhang for ligating the adapter to the fragment. Multiple indexing 
adapters were then ligated to the ends of the double-stranded cDNA to prepare them 
for hybridisation onto a flow cell, before 15 cycles of PCR were used to selectively 
enrich those DNA fragments that had adapter molecules on both ends and amplify 
the amount of DNA in the library suitable for sequencing. 
Libraries were quantified by PCR using the Kapa Universal Illumina Library 
Quantification kit complete kit (KK4824) and assessed for quality using the Agilent 
Bioanalyser with the DNA HS Kit (5067-4626). Libraries were combined in three 
equimolar pools and sequencing was performed using the NextSeq 500/550 High-
Output v2 (150 cycle) Kit (FC-404-2002) on the NextSeq 550 platform (Illumina Inc. 
SY-415-1002). Sequences were aligned to the human reference genome Hg19 using 
the RNA-Seq Alignment v1.0 application (Illumina Inc.). 
2.11 Harvesting of RNA from mouse brain regions 
I did not carry out the harvesting of the mouse RNA but have exactly replicated the 
relevant text of the thesis of Marion Bonneau, a collaborator and fellow student, here 
to illustrate the sample preparation. I claim no credit in the production or harvesting 
of the samples. I have also replicated text from Malavasi et al in 2.11.1
70
.  2.11.2 and 
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2.11.3 are replicated exactly from Bonneau’s thesis with the exception of formatting. 
2.11.4 was carried out by Yasmin Singh (CeGaT GmbH, Paul-Ehrlich-Straße 23, 
Tübingen, Germany). 
2.11.1 Mouse colony production and maintenance 
I did not carry out this protocol and the text is replicated from Malavasi et al. (2018). 
VelociMouse® technology (Regeneron) was used to target embryonic stem cells and 
microinject them into mouse embryos
144
. In brief, F1H4 (129S6SvEv/C57BL6F1) 
embryonic stem cells were electroporated with the linearized vector construct and 
positive clones were microinjected into 8-cell stage mouse C57BL6 embryos. 
Microinjected embryos were transferred to uteri of pseudopregnant recipient females, 
weaned pups were scored, and high percentage chimera males were selected for 
mating with flp-positive C57BL6 females to remove the selection cassette, to prove 
germ-line transmission, and to generate F1 animals for further breeding. 
Because there is already a mutation (25bp deletion) at the Disc1 allele in exon 6 in 
the 129/Sv strain which causes a truncation of Disc15, F1 progeny were generated 
and a PCR assay which distinguishes the C57BL/6 allele versus the 129/Sv allele 
was employed to determine which F0 mice were correctly targeted to the C57BL/6 
locus (Supplementary Figure 10). Mice which carried the translocation on the 
C57BL/6 allele were then crossed to CMV-Cre mice to remove the Neo cassette via 
Cre-mediated recombination at the flanking loxP sites. Genotyping results were 
confirmed by Loss-of-Native-Allele assay. 
The exclusion of the differentially spliced DISC1FP1 exon 3a6 that is present in a 
minority of transcripts (www.genome.ucsc.edu) precludes production of transcripts 
encoding CP1. The exclusion of the differentially spliced DISC1FP1 exon 7b does 
not affect the potential production of CP60/69 proteins since the stop codon in 
chimeric transcripts encoding these proteins occurs in exon 66. Since the Disc1 allele 
was modified on a mixed background of 129 and C57BL/6J, a congenic breeding 
strategy was adopted to purify the strain background. Following repeated crossing to 
C57BL/6J mice, genotyping of polymorphic markers carried out by the Jackson 
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Laboratory found the mice to be >99.5% C57BL/6J. These mice were then mated to 
C57BL/6J for one final round and the progeny used for subsequent experiments. 
Mice were housed in the Biomedical Research Facility at the University of 
Edinburgh. All mice were maintained in accordance with Home Office regulations, 
and all protocols were approved by the local ethics committee of the University of 
Edinburgh. 
2.11.2 Collection of tissue 
The below text is replicated from the thesis of Marion Bonneau  (2018), and I did not 
participate in the collection of the tissue. 
The tissue was collected from 9 weeks old mice. Each group (wild type, 
heterozygotes, homozygotes) were composed of 4 males and 4 females. Mice were 
culled under the schedule 1 procedure by trained staff at the animal facility. The 
brains were then directly removed and washed in ice-cold PBS. Hippocampi, and 
cortices minus hippocampus, cerebellum and olfactory bulbs, were dissected from 
the right brain hemisphere mice at nine weeks of age. The tissues from the right 
hemisphere were incubated overnight at 4ºC, in 5 volumes of RNA later (Ambion). 
After 24h, the RNA later was discarded to prevent the formation of salt crystals and 
the samples were snap frozen in liquid nitrogen and stored at -80
o
C, then processed 
in batches of mixed genotypes to extract the RNA. 
2.11.3 RNA preparation from tissue samples 
The below text is replicated from the thesis of Marion Bonneau (2018), and I did not 
participate in the preperation of the RNA. 
The samples were purified using QIAGEN RNA extraction kit, according to the 
manufacturer’s instructions. To homogenise the tissues, the Tissueruptor was used. 
Then insoluble materials were removed and nucleoprotein complex dissociated. The 
RNA was re-dissolved in 100 μl of RNA free water. At that point, the RNA 
concentration was assessed using the nanodrop for a first time to assess its quality. 
To obtain the purest RNA possible, RNA clean-up was performed, according to the 
manufacturer’s instructions. Additional On-column DNase digestion was then done 
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by treating the samples with DNase I, as indicated by the manufacturer’s 
instructions. At the end, the RNA was eluted once for the hippocampal samples and 
twice for the cortical samples using 30 μl of RNAse free water, therefore 60 μl of 
pure cortical RNA and 30 μl of pure hippocampal RNA were obtained. 
2.11.4 Sequencing and initial processing of mouse RNA samples 
The below text is replicated from the thesis of Marion Bonneau (2018) and I did not 
contribute. 
Total RNA samples were assessed with a Fragment Analyser (Agilent) for quality 
and integrity of total RNA. Libraries were prepared using 100ng of each total RNA 
sample using the TruSeq Stranded mRNA Library Prep Kit (Illumina). Single end 
RNA Sequencing was carried out to a depth of approximately 60 to more than 100 
million reads. Sequencing was performed on a HighSeq4000 on HighOutput mode. 
Demultiplexing of the sequencing reads was performed with Illumina CASAVA 
(1.8.2). Adapters were trimmed with Skewer (version 0.1.116)
145
. Raw reads were 
mapped to the reference genome mm10 with STAR (Version 2.4.0h)
146
. Further 
analyses were performed with the Cufflinks Tool Suite (Version 2.1.1)
147,148
: 
Cufflinks was used to count mapped reads. FPKM values were computed with 
Cuffdiff using the “pooled-variance“ model, “geometric“ normalization and “multi-
read-correct“ option
149




Cortical reads were as follows; Total average raw read number was 75.39 ±11.9 x10
6
 
for WT, 89.2 ±6.3 x10
6
 for heterozygotes, and 98.7 ±17.3 x10
6
 for homozygotes. 
Hippocampal reads were as follows; Total average raw read number was 83.77 
±13.58 x10
6
 for WT, 82.8 ±13.8 x10
6
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2.12 Bioinformatics 
The version of R used varied as updates were released, but was between 3.4. & 3.5.1. 
R Studio versions used varied from to 1.0.153 to 1.1423. A number of different R 
packages were also utilised and details of particular packages are mentioned below. 
2.12.1 Gene and exon analysis 
Philippe Gautier at the IGMM carried out the analyses looking at gene differential 
expression between translocations and controls, or between mice of different Der1 
status. This was done utilising DESeq2 package version 1.2.. This was used with 
default settings enabled. As described in the main body of the thesis, DESEq2 
compares favourably to alternative packages and is effective at detecting genes 
which have been verified as differentially expressed by qRT-PCR. It was developed 
by Love et al.
151
 . When padj is referred to in the text of the thesis, this referes to p-
values produced by DESeq2 which have been adjusted according to the Bejamini-
Hochberg method. I also utilised DESeq2 to compare all human  lines against one 
another sequentially; the idea here was to produce lists of genes which might be 
highly reliably differentially expressed. 
Translocation status/genotype was utilised as the factor of interest and as 
recommended non-normalised counts were inputted for each replicate of each cell 
line, resulting in a 9 vs 9 comparison for the iPSC-derived neuronal cell lines and 6/8 
sex-balanced mice per genotype in the mouse analyses. Mouse wild types per 
compared against heterozygotes for each sample set in turn, then against 
homozygotes.  




2.12.2 Deconvolution analysis 
Deconvolution of the mouse and human samples is described in detail in the 
appropriate chapter, particularly the aspects relating to optimisation and 
troubleshooting. All deconvolution was carried out by me in R using the 
DeconRNASeq R package version 1.24.0. The accuracy of DeconRNASeq was 
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assessed by generating pseudosamples from the cell types being utilised. This 
consisted of generating a series of numbers for each pseudosample, which sum to 1. 
The length of the series corresponds to the number of pure cell lines which 
DeconRNASeq is assessing the proportions of. The expression profile of each pure 
line was then multiplied by its corresponding number, and the resulting profiles were 
summed to give a single pseudosample. Series were retained so as to compare the 
predicted proportions according to DeconRNASeq to the actual weightings. If pure 
cell profiles were removed from the roster (for example, during the Zeisel 
deconvolutions looking at the removal of Interneuron 5), fresh pseudosamples using 
the new roster were produced. 
Housekeeping gene normalisation was carried out as follows; a geometric mean of 
the expression of all utilised housekeeping gene was produced for each 
pseudosample/sample/pure cell line profile, then the profile was divided by that 
factor. Selection of housekeeping genes is described in the appropriate chapter. All 
genes except the utilised marker genes were then removed from the profiles prior to 
deconvolution. The datasets utilised in the deconvolution are described below.  
The deconvolution was then carried out with the DeconRNASeq function described 
in the package “DeconRNASeq” by Gong et al. DeconRNASeq implements an 
nonnegative decomposition by quadratic programming, and the function was used in 
R as below; 
DeconRNASeq(datasets, signatures, proportions = NULL, checksig = FALSE, 
known.prop = FALSE, use.scale = TRUE, fig = TRUE) 
datasets were the housekeeping normalised RNA-Seq samples, signatures were the 
housekeeping normalised  expressions of the pure cell types. These two datasets were 
filtered so as to only contain the marker genes. The other options mostly relate to 
illustrating the findings. 
The “Zhang dataset” is described in Zhang et al.
153
. This is deposited in the Gene 
Expression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo under accession 
no. GSE52564. For each pure cell profile the two provided profiles of that cell type 
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were averaged. Marker genes for the Zhang deconvolution were obtained from 
https://web.stanford.edu/group/barres_lab/brain_rnaseq.html which allows selection 
of genes enriched in one of the cell types versus a selection of other cell types. 
Markers were selected so as to be enriched in one pure cell profile versus all others 
utilised in the deconvolution. 
The comparison datasets in the Zhang deconvolution are as follows; 
The Zhang Two dataset is described in Zhang et al. and the data are deposited in the 




The Darmanis dataset is described in Darmanis et al. and the data are deposited in 
the NCBI Gene Expression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo 
under accession no. GSE67835
155
. 
The Dorsal Root Ganglion sensory neuron dataset is described in Li et al. and the 
data are deposited in the NCBI Gene Expression Omnibus (GEO) database, 
www.ncbi.nlm.nih.gov/geo under accession no. GSE63576
156
. 
The Allen Brain Atlas datasets are described in detail in their white paper as well as 
at the web address http://celltypes.brain-map.org/rnaseq (accessed on 16/10/2018), 
where they are available to download. The human dataset I utilised is comprised of 
single nucleus RNA-Seq of the middle temporal gyrus and is available in CPM form.  
The “Zeisel dataset” is described in Zeisel et al. and is available at 
http://linnarssonlab.org/cortex/ 
157
. The cortical samples were extracted and for each 
pure cell profile all provided profiles of that cell type were averaged. Markers were 
selected so as to be enriched in one pure cell profile versus all others utilised in the 
deconvolution, this was achieved by producing an SI value for each, a measure of the 
proportion of expression across all profiles attributable to that profile. Different SI 
values were experimented with for efficient pseudosample deconvolution. 
The comparison datasets in the Zeisel deconvolution are as follows; 
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The Allen Brain Atlas datasets are described in detail in their white paper as well as 
at the web address http://celltypes.brain-map.org/rnaseq (accessed on 16/10/2018), 
where they are available to download. The human dataset I utilised is comprised of 
single nucleus RNA-Seq of the middle temporal gyrus and is available in CPM form. 
I also utilised the mouse primary visual cortex dataset for the mouse deconvolutions.  
2.12.3 EWCE analysis 
EWCE package version 1.2 was utilised, following the manual and script provided 
by the author at  https://github.com/NathanSkene/EWCE/. These analyses were 
carried out by me. Two separate datasets were utilised, the first being the Zeisel 
dataset mentioned above, and the second being the Karolinska Institute (KI) superset. 
These are described in detail in Chapters 6 and 7, respectively. EWCE essentially 
quantifies the “enrichment”, represented by gene specificity, in a target list for all 
queried cell types. It then compares these to the enrichments of a large number of 
lists, each of the same length as the query list but comprised of genes randomly 
selected from the list of background expressed genes. 
The “Zeisel dataset” is described in Zeisel et al. and is available at 
http://linnarssonlab.org/cortex/
157
.There was some initially some difficulty in 
utilising the package effectively, and the Zeisel dataset was loaded from local storage 
(originally obtained from  http://linnarssonlab.org/cortex)  rather than using that 
portion of the script. Reading in the Zeisel data manually must be done with care. 
The function read_celltype_data will only operate on a dataset which is identical in 
dimensions to the Zeisel cortical dataset described in the manual. To read in the 
hippocampal data, false genes and samples were manually added to the hippocampal 
data until it was the same dimensions as the cortical dataset. After this, the false 
genes and samples are removed along with their corresponding data, and SI values 
are subsequently calculated by the instruction in the provided script. The cortical and 
hippocampal datasets were retrieved as above.  
The KI superset data is described in Skene et al. 2018
140
 and data are available at 
http://www.hjerling-leffler-lab.org/data/scz_singlecell/. The KI superset was loaded 
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as an Rda file into R. Embryonic cell types were then removed, and SI values were 
then recalculated by dividing by the sum of SI values for that gene. 
EWCE was carried out as follows. In the case of human gene list to mouse dataset 
comparisons genes were filtered for 1:1 homology using the list provided in the 
EWCE package. Query lists were the same as those utilised in the GO term analysis; 
utilising adjusted p value<0.05, and BaseMean at least half that of DISC1/Disc1. The 
background lists utilised were the remaining genes expressed in each utilised 
dataset.A total of 100,000 background lists of equal length to the query list were 
randomly selected and used to produce a distributuion of enrichment to which the 
query list could be compared for each cell type. The p values were subjected to 
Bonferroni corrections for multiple testing at both the class and subclass level. 
2.12.4 Data visualisation 
Heatmaps of gene expression were generated by me using R (version 3.4.2) and 
RStudio (version 1.0.143). Raw count data for all samples were together subjected to 
a regularised logarithm transformation using the DESeq2 package version 1.16.1. For 
each heat map, the transformed counts for each gene were normalised to Z-scores 
across all samples and subsequently visualised using the pheatmap package version 
1.0.8 (cran.r-project.org/package=pheatmap). 
GOrilla results were displayed using Microsoft PowerPoint. Deconvolution 
pseudosample results were displayed using R’s plot function. qPCR results and 
deconvolution results were displayed using GraphPad Prism 6. EWCE plots were 
generated using R’s “ggplot2”. Details as to numbers of genes and scales are 
displayed in or under each image. 
Volcano plots were produced in R using the “with” and “points” functions. 
2.12.5 Prism 
Figure legends detail the exact statistical test used in each analysis.  
Multiple testing was corrected for using the “Sidak-Bonferroni” option in t-tests, 
which is described at the following link, accessed on 31/7/19. 
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https://www.graphpad.com/guides/prism/6/statistics/index.htm?stat_the_method_of_
bonferroni.htm 
Multiple testing was corrected for using the “Sidak-Bonferroni” option in ANOVAs, 
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3.1 Introduction 
RNA-Seq allows insights into differential gene expression at both the gene and exon 
level, which can implicate particular isoforms of a gene. Differentially expressed 
genes of particular interest include those which link to known pathological processes, 
whether this link is by pedigree studies, gene ontology, or GWAS/CNV predisposing 
to psychiatric illness. Candidate genes can then be examined and the differential 
expression verified by quantitative PCR. The next two chapters describe this process 
for the human iPSC-derived neuron, mouse heterozygous/homozygous Der1 cortex 
and hippocampus RNA-Seq samples. I also hypothesised that there might be some 
regional effects on transcription around the breakpoints in the t(1;11) neurons. It has 
previously been shown that there is differential methylation around the breakpoints 
in the blood of t(1;11) carriers
126
. Chromosomal translocations are also known to 
cause some disturbances in local expression, although these do not affect the entirety 
of the chromosome. This is possibly as only cis-acting elements are directly 
disturbed. Harewood et al. showed that a translocation resulted in local expression 
disturbances, as well as an altered cellular location of the chromosomes
158
, and I 
therefore hypothesised that there might be some similar effects caused by the t(1;11). 
Finally, the effects of the translocation on DISC1 can also be examined by RNA-Seq.  
3.2 Pedigree and neuron generation 
The pedigree and effects of the translocation are described in greater detail in the 
introduction. A subset of the t(1;11) Scottish pedigree is shown in Figure 3 indicating 
prevalence of psychiatric illness. Fibroblasts from three individuals carrying the 
translocation and fibroblasts from three individuals without it were previously used 
to produce iPSCs. Figure 4 illustrates the familial relations between these 
individuals. 
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Figure 3. Subset of the Scottish pedigree carrying the t(1;11) translocation. Individuals with a psychiatric diagnosis are 
in solid black, those without one are in white. Individuals with a red asterisk carry the translocation. Diagnoses are 
given by acronyms; rMDD=recurrent major depressive disorder, CYC=cyclothymia, SCZ=schizophrenia, bipolar 
NOS=bipolar disorder not otherwise specified, gen anxiety=generalised anxiety disorder, ? =translocation status 
unknown 
 
Figure 4. Subset of Scottish pedigree with illustration of lines selected for iPSC, NPC, and neuron generation. Names of 
each cell line are given below the individuals they are derived from. Red indicates translocation lines (T), blue indicates 
controls (C). 
IPSCs were differentiated to neural precursor cells (NPCs). Each of these NPC lines 
was subsequently cultured in triplicate and differentiated to neurons in independent 
experiments. These neurons were harvested for RNA, which was sequenced, quality 
controlled, and aligned to the human genome hg19 commercially. Further details are 
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in the Materials and Methods where the appropriate contributors to each section are 
described. I did not contribute to the stages prior to RNA-Seq data analysis. 
3.2.1 Effects of sex on iPSC-derived neuronal expression  
There is a clear issue with sex imbalances between the three translocation and three 
control pedigree members selected for iPSC-derived neuron generation. Lines C1, 
C2, C3, and T3 were derived from female individuals, while lines T1 and T2 were 
derived from males. Translocation status is therefore highly associated with sex and 
the effects of the two may be difficult to distinguish. I attempted to resolve this 
complication by searching for studies of genes known to be differentially expressed 
between iPSC-derived neurons of individuals of different sexes. I did not find any 
such studies. However, after the submission of this thesis a study by Tiihonen et al. 
was published which examined this very phenomenon
159
. This study could not have 
informed my investigation, but it can critically inform my findings. It will be 
especially useful in identifying possible false positive genes which are altered by sex. 
Genes which may be affected by sex and which are discussed in the chapter have 
also been highlighted so as to be clear about any confounding effects; although as 
this is post hoc it can only exclude experiments I did do rather than inform new ones. 
Tiihonen et al. analysed the iPSC-derived neuronal lines of pairs of monozygotic 
twins discordant for schizophrenia. Like our samples, these neurons were derived 
from iPSC-derived NPCs and are described as “cortical neurons”. Five twin pairs 
(three female pairs, two male pairs) and six unrelated controls (four females, two 
males) were utilised. This study allowed the comparison of twin pairs (schizophrenia 
vs schizophrenia risk background), of unaffected twins vs controls (schizophrenia 
risk background vs no risk background), of affected twins vs controls (schizophrenia 
vs no risk background), and of male controls vs female controls (sex effects). In 
addition, Tiihonen et al. made comparisons of the twin pairs utilising only males and 
only females in turn, to identify if the pathology of the disease differs between the 
sexes. Comparisons of all males vs all females were not carried out. It should be 
noted the neurons were likely more mature than ours, with an 8-12 week 
differentiation protocol vs our five week protocol. It should be noted that the 
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numbers of lines are equivalent to or lower than our 3 vs 3 comparisons, e.g. the 
male only comparisons are only 2 vs 2. Each of our lines was also differentiated 
three times; similar replications were not reported by Tiihonen et al. 
Tiihonen et al. state that 12% of genes were differentially expressed between the 
male and female control samples (a 2 vs 4 comparison), however they only included 
genes that had a twofold or greater change. Including all genes which meet the 
standard I used (an adjusted pvalue of <0.05 and an average expression at least half 
that of DISC1) the number is 4,337, or 22%.  
360 of these genes are also differentially expressed in our study; however in the 
majority of these genes the putative sex effect is in the opposite direction to the 
putative translocation effect and sex is therefore unlikely to be a factor in the 
significance of the gene. However it is possible that sex could affect these genes to 
change in one direction in the Tiihonen et al. study and in the other direction in my 
study. This cannot be ruled out but is difficult to assess the likelihood of. 94 of the 
genes change in the same direction in both studies and these are highly likely to be 
significant on the basis of sex as opposed to the translocation. These are 7% of all 
significant genes. Where any of these genes are discussed they are specifically 
highlighted as potentially being problematic. 
3.3 DESeq2 
The first step in analysing the data was to determine what differences existed 
between the control and translocation carrying neurons. A number of programs have 
been developed to analyse differential gene expression, including DESeq2. DESeq2 
is a popular and user-friendly tool for which a large amount of literature exists, 
making it an ideal option as many further analyses and discussions are available. A 
study carried out by Costa-Silva et al. looked at human brain samples with over 400 
genes verified by RT-qPCR as differentially expressed. They found that DESeq2 
offered a satisfactory balance between low proportion of false positives and detection 
of true positives. Its “True Positive Rate” (true positives/all positives) was the second 
highest, its “Specificity” (true negatives/all negatives) the joint highest, and its 
“Accuracy” (correct predictions/all predictions) the highest of 9 different methods of 
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determining differential gene expression
160
. Although it would be incorrect to 
describe DESeq2 as the “best” package for all situations, it appears that it will be 
among the most satisfactory methods of determining differential gene expression in 
my samples.  
DESeq2 was used to analyse differential expression between all control translocation 
samples, with all XY genes removed from the analysis prior to running DESeq2.This 
resulted in the comparison of 21,916 genes in 9 control samples vs 9 translocation 
samples. It was reported that 1,372 genes were differentially expressed at the whole 
gene level. On examination of the list, it was noted that the BaseMean (a measure of 
the mean of the sequence depth normalised counts of all samples) was very low for a 
number of these genes. GRM6, for example, with BaseMean 4.5, has 0 counts in 4 of 
the 18 samples, and 12 out of 18 have less than 5 counts. At low levels of expression, 
differences between the translocation and controls could easily be due to minor 
differences in sequencing rather than true biological differences. There is also an 
issue of practicality; poorly expressed genes will be very difficult to investigate 
further via qPCR, western blotting, and other experiments. I therefore restricted the 
analysis to genes which had a reasonable level of expression. This was defined as 
being at least approximately half the expression of DISC1, a gene which has 
detectable expression at the transcript and protein level in these cells. The BaseMean 
of DISC1 is 21.8 and the threshold for expression was therefore set at 10. The 
threshold is somewhat arbitrary but has practical relevance considering future 
experiments, and analyses testing this list of differentially expressed genes compared 
it to the list of all expressed genes, not those with BaseMean over 10. A total of 
1,252 genes had whole gene differential expression and passed the BaseMean 
threshold. A volcano plot of the genes analysed by DESeq2 is available in Figure 5. 
 
     105 
 
Figure 5. A volcano plot of the DESeq2 for the iPSC-derived neuronal lines for all genes with BaseMean>10. X-axis 
represents the log2 fold change between WT and translocation lines, while the Y axis represents significance (-log base 
10 of p value). Black dots have an adjusted p value above 0.05, blue dots are significant with an adjusted value below 
0.05. Red dots with labels represent genes for which a qPCR was carried out. 
See Figure 6 for a heatmap of the normalised counts of the samples for all 
differentially expressed genes. We can clearly see that the samples cluster by line, 
and then by t(1;11) status. There is some variation in many of the genes but many 
show a reliable change depending on translocation status. 
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Figure 6. Heatmap of all differentially expressed genes with p<0.05 and BaseMean>10. Counts were normalised using 
the “rlog” function, which transforms counts to the log2 scale, normalises for library size, and minimises variation in 
poorly expressed genes. They were then antilogged, and changed to z scores by gene before generation of the heatmap. 
Red indicates z score above the mean, green indicates z scores below the mean. Each row is a gene. 
DISC1 was not a differentially expressed gene. However, transcription of the DISC1 
encoding regions from both the DISC1-DISC1FP1 and DISC1FP1-DISC1 loci on 
chromosomes 1 and 11 could mask effects of the translocation on DISC1 expression. 
The only accurate measure of intact DISC1 RNA is the number of reads which 
contain exon 8-9, and therefore cross the t(1;11) breakpoint. These reads could only 
come from the intact DISC1 allele. The transcript quantification was analysed in 
detail by Philippe Gautier using DEXSeq
152
 and Integrative Genomics Viewer
161
, and 
it was shown that the number of reads which spanned the breakpoints were 
significantly lower in the translocation carriers. See  for a comparison of the reads 
that cross the breakpoint and therefore could only come from an intact DISC1 gene. 
In addition, transcripts which could only have come from the derived chromosomes 
have been shown to exist in these neurons, and were found when searched for by 
Philippe Gautier (private correspondence)
70
. Reads from either side of the 
breakpoints are therefore likely contributing to the apparent non-significance of 
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DISC1. Differential expression of intact DISC1 protein was also confirmed in these 
neurons
70
. For the reasons given above, I do not have concerns about the apparent 
non-significance of DISC1.  
 
Figure 7. Cross comparison of normalised counts that span the t(1;11) breakpoint and therefore could only have come 
from an intact chromosome 1. Lines indicate the mean with smaller bars indicating the standard deviation. Counts 
normalised by dividing total counts spanning the DISC1 breakpoint by millions of total counts. Total spanning counts: 
Control=l90, Translocation=81,  p=0.033.  Total normalised counts: Control=4.19, Translocation=1.86,  p=0.0078. P 
values calculated by Mann-Whitney t test. Counts examined and quantified by Philippe Gautier using DEXSeq and 
Integrative Genomics Viewer. The control with ~1.2 normalised counts is not an outlier, taking outliers as being more 
than 3 standard deviations from the mean. 
The heatmaps show that the samples cluster by cell identity and subsequently by 
translocation identity. Philippe Gautier also generated a Principle Component 
Analysis plot from the DESeq2 data, a modified version of which is displayed in 
Figure 8. We can see that once again the samples cluster by cell identity. 
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Figure 8. PCA of the translocation (red) and control (blue) lines. We can see that the triplicates cluster together for the 
most part, with some digressions. We can also see that PC1 is the separating factor for the controls and PC2 is the 
primary separating factor for the translocations. C2 and T3 are close together; these lines were derived from a mother 
and daughter. This PCA utilised all differentially expressed genes 
In order to inform me as to what genes showed the most reliable differential 
expression, I also carried out DESeq2 comparing all possible combinations of cell 
lines in triplicate vs triplicate comparisons. This resulted in 15 comparisons, 9 
translocation vs control, 3 control vs control, and 3 translocation vs translocation. 
See Table 1 for numbers of differentially expressed genes between translocation and 
control lines. 24 genes were differentially expressed in every translocation vs control 
comparison and 7 of these were not differentially expressed in any other comparison. 
These 7 genes were PDYN, RELB, NUTM2F, MIR4458HG, LRRC37A2, GPC1, and 
BEST1. See Figure 9 for a heatmap of the 24 genes. Of course the greatly reduced 
power of a 3 vs 3 comparison means that these results should only be seen as an aid 
to selecting genes for further analysis. It is also the case that I am searching for 
effects of the t(1;11) generally; the control vs translocation cell lines have different 
genetic backgrounds (some lines are XX and some are XY) and these will be 
reflected in any 3 vs 3 comparison, even when XY genes are removed. 
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Figure 9. Heatmap of genes that are marked by all control vs translocation DESeq2 analyses as being differentially 
expressed. Counts were normalised using the “rlog” function, which transforms counts to the log2 scale, normalises for 
library size, and minimises variation in poorly expressed genes. They were then antilogged, and changed to z scores by 
gene before generation of the heatmap. Red indicates z score above the mean, green indicates z scores below the mean. 
Each row is a gene. 
Line C1 vs C2 vs C3 vs 
T1 4,912 3,995 5,003 
T2 8,633 6,942 7,235 
T3 6,138 1,835 6,688 
Table 1. Number of genes differentially expressed between pairs of triplicates according to DESeq2. 
3.4 DEXSeq  
DEXSeq analyses data for exon-level differential expression, which can be 
subsequently inspected to see if this provides evidence for differential expression of 
certain transcripts
152
. The ideal exon is found in only one transcript or a subset of 
transcripts, which have a defined biological role. The 9 vs 9 DEXSeq was carried out 
by Philippe Gautier, and I carried out subsequent analyses.  
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A total of 2,574 exons were described as differentially expressed at the p=0.1 level, 
with 1,932 of these unambiguously mapping to one gene. At the p=0.05 level 1,368 
exons were differentially expressed with 1,020 exons unambiguously mapping to one 
gene. 
As with the DESeq2 analysis, I carried out DEXSeq analyses comparing all possible 
combinations of lines to see which exons had the highest level of support for 
differential expression. At the p=0.05 level, 5 exons, all of which mapped 
unambiguously to 5 different genes, were significant in all translocation vs control 
comparisons. Three of these were also not significant in any control vs control or 
translocation vs translocation comparison. These three were from the genes 
GUSBP3, NRG1, and LRRC37A2.  
Results of DESeq2 and DEXSeq are summarised in Table 2. 
 Total Detected 
Significantly 
differentially expressed 
Genes 21,916 1,252 
Exons  1,368 in 1,020 genes 
Table 2. Summary of differential expression findings of non-XY genes when utilising DESeq2 (gene level analysis) and 
DEXSeq (exon level analysis), with “Significantly differentially expressed” meaning adjusted p value<0.05 and 
BaseMean>10 for genes. 
3.5 Local expression 
I analysed local expression around the breakpoints, as there is evidence that large 
chromosome rearrangements can result in altered chromosomal position within the 
nucleus. This appears to coincide with transcriptional effects
158
. I analysed this in 
two ways; by looking to see if more differentially expressed genes were found 
around the breakpoints than by chance, and whether expression showed an overall 
change regardless of gene significance.  
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3.5.1 Chromosome 1 
3.5.1.1 Differentially expressed genes 
One way to see if the breakpoints are affecting local expression would be to see if 
there is an unusually high number of differentially expressed genes around the 
breakpoint. I carried out a Monte Carlo simulation. To assess the background level of 
differentially expressed genes I selected 100,000 loci at random. These all came from 
chromosome 1 so as to ensure the background level of gene richness is an 
appropriate comparison. I then calculated the proportion of differentially expressed 
genes around those points within a “window”. I initially set the window size to 40Mb 
but reduced this to 37.5Mb as DISC1 is too close to the end of the chromosome. I 
then repeated this with windows of 20Mb and 10Mb. The results of this analysis are 
in Table 3. There are 273 genes within 20Mb either side of the chromosome 1 
breakpoint. 
Chromosome 1 18.7Mb  10Mb 5Mb 
Proportion of genes significant 
around DISC1 
0.069 0.038 0.051 
Average proportion of genes 
significant around 100,000 points 
0.069 0.070 0.067 
P value for DISC1 window 0.43 0.91 0.58 
Table 3. Assessment for significantly increased proportion of differentially expressed genes in 18.7, 10, and 5Mb 
windows around DISC1, by comparison to 100,000 windows around chromosome 1. 
We can see that for all analyses, shrinking the gene window by half reduces the 
average number of significant genes by about 50%, but does not affect the proportion 
of significant genes at all. It is evident that there is no significant enrichment of 
differentially expressed genes around the breakpoint on chromosome 1.  
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3.5.1.2 Local expression in FPKMs 
Expression in terms of raw counts, FPKMs, and normalised counts using rlog (a 
normalisation method included in the DESeq2 package) was assessed around the 
breakpoints. However, I realised that there were several arguments against assessing 
local expression in any of these terms except FPKMs.  
Raw counts would seem initially an attractive option for mapping the expression, but 
they do not adjust for sequencing depth and are therefore less than ideal. Since I am 
looking for relative change within a sample as I look around the breakpoints, with the 
idea of comparing this change to that of other samples, FPKMs are ideal. I am 
looking for regional changes within each sample, and then comparing these regional 
changes within each sample to those in other samples. I therefore made maps of 
genomic expression using FPKMs for each sample, which allow gene to gene 
comparisons to see areas of high and low expression normalised to sequence depth 
and gene length. 
I selected all the genes within approximately 18.7Mb on both sides of the DISC1 
gene and graphed their expression against their location. A graph was made for each 
of the 18 samples, and they were compared by eye to see local expression changes. A 
condensed version of the result, where averages for each genotype are compared, can 
be seen in Figure 10. There appears to be no pattern of depressed or increased 
expression and I therefore did not investigate further. Looking at the graphs for each 
of the 18 samples, there appears to be no clear pattern of change between 
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Figure 10. Genomic expression map of 37.5Mb around DISC1. Note that the chromosome ends approximately 17.5Mb 
after DISC1.Black indicates the average of the control FPKMs, red the average of the translocation FPKMs. Y-axis is in 
local minimum to local maximum expression, each point is a gene. 
3.5.2 Chromosome 11  
3.5.2.1 Differentially expressed genes 
I applied the same methods as in 3.5.1.1. The results are in Table 4. Note that a 
20Mb window was used as the breakpoint is not too close to the end of the 
chromosome to preclude this. There are 260 genes within 20Mb either side of the 
chromosome 11 breakpoint. 
Chromosome 11 20Mb  10Mb 5Mb 
Proportion of genes significant 
around DISC1FP1 
0.088 0.16 0.14 
Average proportion of genes 
significant around 100,000 
points 
0.065 0.068 0.069 
P value for DISC1FP1 window 0.18 0.016 0.11 
Table 4. Assessment for significantly increased proportion of differentially expressed genes in 20, 10, and 5Mb windows 
around DISC1FP1, by comparison to 100,000 windows around chromosome 11. 
The only significant result is the 10Mb window. There are two variants in 
chromosome 11 which may influence psychiatric disease in this family, which are 
located 3Mb upstream and 10Mb downstream from the chr11 breakpoint
162
. Neither 
of the two genes present in these loci which could be examined, CNTN5 and GRM5, 
were significantly differentially expressed
70
. The effect of these loci is not entirely 
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known but they may influence the diversity of phenotypic presentation in the 
Scottish pedigree. We can conclude that the translocation may have an effect on 
medium distance gene expression, although the evidence is weak considering one 
would expect the 5Mb window to also be perturbed if this was the case. One way to 
see if the effect is only on genes a certain distance away (rather than on genes up to a 
certain distance away) would be to redo the analysis with “bands” rather than 
windows, but given the slim evidence for any regional effect I elected not to do this. 
3.5.2.2 Local expression in FPKMs 
I selected all the genes within 20Mb on both sides of the DISC1FP1 gene and 
graphed their expression against their location. A graph was made for each sample, 
and they were compared by eye to see local expression changes. A condensed 
version of the result, where averages for each genotype are compared, can be seen in 
Figure 11. The two averages track one another closely and there appears to be no 
pattern of changed regional expression.  
 
Figure 11. Genomic expression map of 40Mb around DISC1FP1. Black indicates the average of the control FPKMs, red 
the average of the translocation FPKMs. Y-axis is in local minimum to local maximum expression, each point is a gene. 
3.6 GOrilla 
To analyse the data for gene ontology terms that are overrepresented among the 
differentially expressed genes, I utilised GOrilla
163,164
. I compared the differentially 
expressed genes meeting the BaseMean>10 and p<0.05 criteria together with the list 
of genes with a differentially expressed exon at p<0.05. The background was the list 
of all genes detected at the whole gene level. GOrilla analyses overrepresentation of 
terms at the Process, Function, and Component levels. The top 10 significant results 
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by p-value are displayed in Figure 12, Figure 13, and Figure 14 respectively. A full 
discussion of candidate genes for further investigation is elsewhere, but summaries 
for terms of interest in each category are below. It should be noted that I usually do 
not discuss the most significant GO terms, but have selected terms of interest to 
discuss. These terms are usually outside the top 10 GO terms but are far more 
specific. The top GO terms are usually broad in nature, and contain dozens of genes, 
many of which only loosely relate to the term. However even granted this it is true 
that I have been selective in my discussion of GO terms; my primary reason for this 
is that I originally generated GO terms to help produce candidate genes. Topics such 
as “ionotropic glutamate receptor binding” or “intracellular transport” seem more 
amenable to biological experimentation than “cell adhesion” or “nervous system 
development”, which are highly broad terms. In addition, I have provided p values, 
and all GO terms discussed are of course significant both nominally and at FDR-
corrected p values (Benjamini and Hochberg method). All significantly differentially 
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3.6.1 GOrilla Process 
 
Figure 12. Significantly overrepresented Process GO terms for the genes which have a differentially expressed exon or 
are differentially expressed (p<0.05). The enrichment figure is given after each bar and the scale is logarithmic. 
The top GO term is “biological adhesion”, which contains the gene DAG1, discussed 
in the context of “actinin binding” in the GO Function section below. It also contains 
the gene CLDN5, which is potentially involved in schizophrenia and downregulated. 
It is notable for being contained within a region of the genome 22q11.2, which is 
found deleted in patients with a syndrome presenting with cardiac abnormalities, 
craniofacial abnormalities, and an increased risk of schizophrenia
165
. We can see that 
a number of the other entries are similar, but of interest are “cell projection 
organisation” and “intracellular transport”. Intracellular transport of mitochondria is 
known to be affected by DISC1
95
, and the transport of synaptic vesicles containing 
neurotransmitters is necessary for neuronal activity. DISC1 is a known trafficker and 
can also affect GABAAR and NMDAR surface presentation
70,166
. A number of the 
genes with this GO term were good candidates for further investigation, including 
HAP1, SPIRE1, SLIT1, and SYT6. However as stated at the start of this chapter, a 
recent paper has highlighted genes which may be affected by sex. These genes 
include HAP1 and SLIT1. HAP1 is an interactor of the product of the HTT gene, 
which causes Huntington’s disease if mutated. SLIT1 is a guidance molecule which 
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assists neuronal axon directions, while SYT6 is a synaptotagmin, a family of genes 
involved in vesicular exocytosis
167,168
.  
Of particular interest to me was the presence of the BBS2 and BBS5 genes, which are 
mutated in Bardet-Biedl syndrome (BBS). BBS1 is also differentially expressed and a 
fuller discussion is in the introduction. GO terms with significant p values included 
“synapse assembly” (p=2.38x10
-6
, enrichment factor=2.99), which included genes 
such as APP, NRG1, BSN, DRD2 and ERBB4, some of which have relevance as they 
are schizophrenia candidates (ERBB4, NRG1) or are the targets of antipsychotic 
medication (DRD2). APP is best known as the gene encoding the amyloid precursor 
protein, while BSN is a large presynaptic protein involved in vesicle exocytosis and 
trafficking
169,170
. Nervous system development was another GO term (p=5.69x10
-6
, 
enrichment factor=1.86) of interest. However, it is difficult to assess the accuracy of 
this as two Hox genes (DLX2 and DLX6) are likely to be differentially expressed 
according to sex. However two other Hox genes VAX1 and VAX2 in a different GO 
term group were differentially expressed.  
 
 
Generation and initial analysis of human RNA-Seq data 
118 
3.6.2 GOrilla Function 
 
Figure 13. Top 10 significantly overrepresented Function GO terms for the genes which have a differentially expressed 
exon or are differentially expressed (p<0.05). The enrichment figure is given after each bar and the scale is logarithmic. 
ECM=extracellular matrix 
The most significant term is “actinin binding”. A number of genes were contained 
within this term, including a pair of potassium receptors KCNA5 and KCNN2. Both 
potassium receptors and NMDARs have been shown to interact with alpha-actinin
171
. 
Another associated gene DAG1 encodes an interactor of the protein encoded by 
NRXN1, which has mutations associated with autism and schizophrenia
172
. Under the 
“actin binding” term, the fourth most significant, a number of myosin and kinesin 
genes were found, indicating that trafficking molecules are abnormally expressed in 
these cells. An actin nucleator, SPIRE1, was also differentially expressed. Actin is 
important in growth cone organisation and initiating neuronal migration. Changes in 
these actin and cytoskeletal terms are interesting and may reflect possible migratory 
defects, as also evidenced by the dysregulation of centrosomal proteins
82
. The term 
“ionotropic glutamate receptor binding” with an enrichment factor of 3.46 is also 
relevant. Glutamate receptors such as the AMPARs and NMDARs are known to play 
a role in LTP, necessary for learning and memory. NMDAR antagonists such as 
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ketamine also induce psychosis
173
. Mutations in these families of genes have also 
been linked to psychiatric disease
174
. 
3.6.3 GOrilla Component 
 
Figure 14. Top 10 significantly overrepresented Component GO terms for the genes which have a differentially 
expressed exon or are differentially expressed (p<0.05). The enrichment figure is given after each bar and the scale is 
logarithmic. 
GO overrepresented component terms mostly relate to cell parts that are unique to 
the neuron, such as “axon part”, “synapse part”, and terms which relate to cell parts 
which have a special role in neuronal activity such as “vesicle”. This is unsurprising. 
It could be concerning if component terms uniquely related to some non-brain cell 
types had emerged as significant.  
3.7 Comparison to other studies 
It would be of interest to see if the genes differentially expressed in our experiment 
are also changed in analogous experiments. Comparisons can be made to other RNA-
Seq experiments (particularly involving DISC1 mutations and iPSC-derived 
neurons), GWAS, and CNV studies. Microarray studies are also a comparative 
option but have mostly been supplanted by RNA-Seq experiments. A search of the 
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literature was conducted and a number of studies which were apt comparisons were 
utilised.  
3.7.1 Studies used  
These studies are described in greater detail in the Introduction. All studies are in 
human cells or with human samples. 
3.7.1.1 Psychiatric Genomics Consortium GWAS 
GWAS search for genes predisposing to schizophrenia based on the concept of the 
“common disease, common variant” model, where many variants have a small but 
detectable impact on the risk of developing disease. The PGC have published 
multiple papers with ever-larger samples sizes. PGC1 refers to the first paper, 
implicating 108 loci and 348 genes
29
. PGC2-1 refers to the association analysis of the 
second, implicating 145 loci and 481 genes
60
, while PGC2-2 refers to the list of 
genes implicated by MAGMA in that paper (535 genes). 
3.7.1.2 Psychiatric Genomics Consortium CNV study 
The PGC have also searched for copy number variations (CNVs) predisposing to 
schizophrenia. PGC3 refers to this study
139
. I utilised the gene list associated with 
schizophrenia by the Gene-Association analysis carried out in this paper. 
3.7.1.3 Camargo et al. DISC1 interactors 
Camargo et al. utilised a yeast two hybrid screen to identify potential interactors of 
the DISC1 protein
73
. All genes indicated by this study were searched for.  
3.7.1.4 Brennand et al. idiopathic schizophrenia  
Brennand et al. were the first to look at differential expression in iPSC-derived 
neurons
124
. Although the numbers were small, lines were established from patients 
with idiopathic schizophrenia. It utilised a microarray approach to look at expression 
differences and found 596 genes differentially expressed at p<0.05 and fold-change 
>1.3. B refers to this study. 
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3.7.1.5 Wen et al. DISC1 frameshift 
Wen et al. looked at iPSC-derived neurons from a family carrying a DISC1 
frameshift mutation
132
. The number of genotyped family members is small however. 
The frameshift cannot be unambiguously linked with psychiatric illness, while it is 
also the case that members of the pedigree have psychiatric illness but no DISC1 
frameshift. They also did not use as large a number of RNA samples (one control and 
two mutants, all in triplicate). A total of 3,697 genes were differentially expressed in 
their study, although as we have already seen from my 3 vs 3 DESeq2 comparisons 
that smaller numbers appear to give more differentially expressed genes, likely due 
to false positives. W refers to this study. 
3.7.1.6 Srikanth et al. DISC1 truncations 
Srikanth et al. looked at two different timepoints in the production of neurons 
directly from iPSCs
138
, although their protocol is not identical to ours. They induced 
mutations in the iPSC lines prior to neuron differentiation, in exon 2 and exon 8 of 
DISC1. The first mutation should remove all DISC1 isoforms while the second is 
closer in effect to the t(1;11) translocation in its effect on DISC1 by inducing a 
truncation close to the breakpoint. They also looked at heterozygous and 
homozygous carriers of these mutations. S refers to this study, x2 and x8 to the 
mutations, w/m to wild type/mutant status, and 18 or 50 to the timepoints. For 
example, Sx8wm50 refers to the heterozygous carriers of the exon 8 truncation at the 












Paper Number of 
genes 
P value Selected genes of interest 
PGC1 32 7E-06 CHRNA4, DRD2 
PGC2-1 37 1E-03  CHRNA4, DRD2 
PGC2-2 47 1.4E-03 DRD2, CHRM4 (gene)  
PDE4B, NTRK3, ERBB4 
(exon) 
PGC3 13 0.36 HOMER2, SHANK1, SYT6 
DI 10 0.31  
B 87 1.8E-03 NRP2, NQO1, COBL 
W 300 4E-07 VAX1, DRD2, COBL, DLX2, 
DLX6 
Sx2mmd50 200 5.6E-07 BBS5, LRRTM1, SLIT1, 
SYT6 
Sx8mmd50 17 0.077  
Sx8wmd50 73 6.4E-04 SEMA3F 
Table 5. Summary of overlap with other papers. Each paper is indicated by the acronym given in 3.7.1. The number of 
genes significant in both our study and the indicated one is given in the first row. The hypergeometric probability is 
given in the second, and a subset of interesting genes within this list of overlapping genes is within the third. 
3.8 Gene level RT-qPCR  
To confirm the results of the RNA-Seq, a number of RT-qPCRs were performed. All 
68 genes with an absolute fold change >2 were considered as candidates. Most had 
no known relevance to major mental illness, while the remainder had poor evidence 
of line difference (e.g. a single line or sample drove significance). Seven were TRIM 
genes (tripartite motif containing), four were olfactory receptor family members, 
while three were prame family members. None of these appeared to be directly 
relevant to psychiatric illness. The largest fold change gene was MIR4458HG, a 
microRNA encoding gene about which little is known. A number of interesting 
candidates were discarded in cases where one line clearly drove the significance of 
the gene. These included genes such as VIPR2, DDC, CCK and NRCAM. All 24 
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genes which were significant in every WT vs t(1;11) line DESeq2 analysis (i.e., three 
samples from one WT line compared against three from a translocation line) were 
also assessed as candidates. Having exhausted these obvious possibilities and finding 
only a few genes, I attempted to select candidates from the remaining bulk of genes. 
Genes were chosen on the basis of high fold change, clear difference between 
genotypes, convergence with other papers, existing evidence of relevance to 
psychiatric disease, and contributing to a GO term of relevance. OMIM and Pubmed 
were also examined for disease associated variants or papers of interested. Of some 
use in selecting candidates was an approach searching for convergences between 
papers; a table displaying the numbers of genes significant between any pair of 
papers described in 3.7.1 as well as in the DESeq2 analysis is displayed as Table 6. 
Descriptions are given for each gene in turn and a table summarising the rationales is 
given in Table 7. Primer design is described in Materials and Methods.  
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Table 6. Table of overlaps. Numbers represent the number of genes significant in our DESeq2 study of human neurons, 
in addition to the two papers in the corresponding row and column. Grey blocks indicate genes from only one paper (the 
same row and column index). Abbreviations as in 3.7.1. 
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Table 7. Highlighted information about candidate genes selected for qPCR. TRUE indicates that the gene is 
differentially expressed in the model of interest. Paper abbreviations are as in 3.7.1. 
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3.8.1 BBS1 
Bardet Biedl Syndrome 1, BBS1, is a one of a number of genes which when mutated 
cause Bardet-Biedl syndrome, characterised by developmental delay, obesity, 
intellectual disability, and retinal problems. These genes participate in the 
construction of the BBSome, a protein complex seen at cilia and centrosomes
175
. In 
cilia it participates in trafficking, and interestingly BBS4 is seen to interact with 
dynactin, the component of the dynein motor complex HAP1 interacts with. At the 
centriole many of the BBS proteins interact with DISC1 along with other 
centrosomal proteins such as PCM1
176
. A number of these proteins are DISC1 
interactors, including BBS1 and BBS4. BBS1, BBS2, and BBS5 are all significantly 
downregulated according to the RNA-Seq data. The interaction with BBS1 is 
particularly interesting; phosphorylation on a key S70 residue of DISC1 results in a 
functional change. Upon phosphorylation of this residue, DISC1 loses its ability to 
enhance Wnt signalling and aids the centrosomal location of BBS1, which aids 
neuronal migration. Blocking this phosphorylation event, knocking down DISC1, or 
BBS1, hinders mouse neuronal migration in the developing cortex
81
. Given its role in 
migratory neurons and direct interaction with DISC1, as well as the downregulation 
of other BBS proteins, BBS1 stands as a good candidate for qPCR analysis as well as 
future study.  
3.8.2 CALB1 
Calbindin is encoded by this gene and is a calcium binding protein abundant in the 
brain. It is found downregulated here
177
. Given calcium’s importance as a secondary 
messenger this presented as an interesting candidate. The protein has a known role in 
buffering calcium increases which may be protective against excitotoxicity
178
. 
Expression of CALB1 in neurons marks them out for survival against neurotoxic 
drugs in a mouse model
179
. Calbindin is known to exert anti-apoptotic roles via 
inhibition of caspase-3 and of calpain, which activates BAX
180
. Its protective effect 
against hyperdopaminergic signalling may be particularly relevant given the 
upregulation of DRD2. Finally, calbindin is known to interact with and enhance the 
activity of inositol monophosphatase, which is a target of lithium. This mechanism is 
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inositol production catalysed by IMPase is important as inositol is a key substrate for 
the production of many signalling molecules. The hypothesis of inositol and bipolar 
disorder holds that lithium-induced inositol depletion helps reduce deleterious 
signalling. However, in the case of the t(1;11), this fits oddly with the finding that 
CALB1 is downregulated. If the inositol hypothesis of bipolar disorder is correct, 
downregulated calbindin would be beneficial
181
. To further complicate matters, 
calbindin deficient mice show deficits in LTP, possibly via a failure to appropriately 
buffer calcium. In any case there are several lines of evidence tying CALB1 to 
psychiatric pathology, although the evidence is perhaps not as strong as one would 
like and is occasionally contradictory. For example, one group found that calbindin 
had no anti-apoptotic effect and appears to mark surviving cells rather than aid cells 
to survive apoptotic challenge
182
. Nevertheless, this seemed an interesting gene to 
examine. 
3.8.3 CHRNA4 
This gene encodes neuronal acetylcholine receptor subunit alpha-4, a subunit of the 
nicotinic acetylcholine receptor. It was the first gene discovered to be causative of a 
type of frontal lobe epilepsy when mutated. All causative mutations appear to be 
gain-of-function, causing increased acetylcholine sensitivity, and some mutations 
(but not all) are linked to aberrant cognition
183
. The gene is upregulated in our t(1;11) 
samples compared to the WT. Especially interesting is the finding that a particular 
familial mutation in CHRNA4 frequently co-presents with frontal-lobe epilepsy and 
schizophrenia, although the pedigree is small and no LOD score can be calculated. 
This mutation does not appear to be a loss-of-function (it is characterised by an extra 
Leucine residue) and other families with different CHRNA4 mutations have epilepsy 
but no increased incidence of schizophrenia
184
. The product of CHRNA4, α4, is a 
protein that cooperates with a number of other subunits to form functional nicotinic 
acetylcholine receptors. α4β2 is one of the better studied nicotinic receptors 
consisting of alpha-4 and beta-2 protein subunits. These receptors allow the entry of 
cations such as Ca
2+
 and are triggered by acetylcholine, and by the exogenous ligand 
nicotine. This NAcR-triggered calcium influx in particular has been shown to help 
stimulate synaptic LTP
185
. The α4β2 receptor is widely expressed in the brain and is 
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highly expressed in the cerebral cortex, substantia nigra, thalamus, and hippocampus. 
There are also differences in receptor expression across some regions of the brain in 
post-mortem studies of individuals with schizophrenia, with greater expression in the 
striatum and some layers of the cingulate cortex. It is also notable that the prevalence 
of smoking is far greater among schizophrenic patients than the general 
population
186
. Although our cell culture is neither comprised primarily of 
GABAergic interneurons, nor dopaminergic ones, the α4β2 receptor formed by the 
product of CHRNA4 seems to have effects on both these cell types that may be of 
relevance to the pathophysiology of schizophrenia. VTA dopaminergic neurons are 
stimulated greatly by nicotine, via α4-containing receptors, and dopaminergic 
signalling has long been implicated in schizophrenia. However, it cannot be said if 
the α4 increase in our neurons would also be apparent in VTA dopaminergic 
neurons. More directly however, there is evidence that activation of the receptor in 
cortical tissue alters circuit excitability. This could be of relevance to the 
pathophysiology of schizophrenia and other disorders
185
. 
CHRNA4 was indicated by Tiihonen et al. as being differentially expressed 
according to sex in iPSC-derived neurons. The putative change is upregulation in 
females, and here it is downregulated in translocation samples (which are 
disproportionately male). Therefore sex may well be a factor in CHRNA4’s 
significance and the results must be judged critically in this regard. 
3.8.4 DRD2 
DRD2 encoding Dopamine Receptor D2 is perhaps one of the best known genes in 
schizophrenia research. All known antipsychotics that treat the positive symptoms of 
schizophrenia antagonise this dopamine receptor, and it has been recently implicated 
by GWAS
60
. In addition, iPSC-derived neurons from patients with schizophrenia 
show increased secretion of dopamine compared to control neurons, although the 
effects are very variable
137
. It also has relevance to bipolar disorder; both this and 
schizophrenia respond to dopamine bloackade
51
. Finally, other studies of DISC1 
mutants have shown elevated levels of DRD2 binding in mouse brain
115
. All of these 
lines of evidence link perfectly with the observation that DRD2 is significantly 
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upregulated in neurons carrying the t(1;11). Dopamine is a neurotransmitter 
important in diverse neurological activity leading to movement, pleasure, and 
memory
53
. Given the pharmacological relevance, its dysregulation in our cortical 
mouse model and others, as well as the support from GWAS, DRD2 is a natural 
choice for further investigation. 
DRD2 was indicated by Tiihonen et al. as being differentially expressed according to 
sex in iPSC-derived neurons. However, the putative change is upregulation in 
females, whereas here it is upregulated in translocation samples (which are 
predominantly male). Therefore sex does not appear to be a factor in DRD2’s 
significance. 
3.8.5 ERBB4 
The analysis of this gene was carried out by Helen Torrance and Kirsty Millar, but is 
also reported here due to its relevance. Results were previously described in 
Malavasi et al. 2018
70
 . 
ERBB4 is a receptor tyrosine kinase; its ligand is NRG1. The gene encoding NRG1 
is also differentially expressed. It is expressed in the glutamatergic synapse and 
overexpression enhances AMPA currents, while RNAi reduces dendritic spine 
density and size
187
. ERBB4 appears to be the primary receptor for much of NRG1’s 
effects, as null mouse neural progenitors are immune to NRG1-induced 
proliferation
188
. Erbb4 mouse mutants also have behavioural phenotypes, while mice 




Glypican-1 is encoded by this gene. It is one of a group of heparan sulfate 
proteoglycans, a type of modified protein which has been studied for its roles in 
development. Of the six glypicans, the one encoded by GPC1 appears to be the most 
widely and highly expressed in the CNS. It appears to be expressed broadly within 




. GPC1 is perhaps most notable for the phenotype of 
GPC1 homozygote and heterozygote mouse nulls as described by Jen et al.; they 
observed a reduction in brain size proportional to the number of null alleles. 
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Homozygote nulls have an approximately 20% reduction in brain size due to lower 
numbers of cells, not evident at E8.5, but evident at E9.5 through to adulthood. There 
was some evidence suggesting that Fgf signalling was decreased, meaning that 
proliferative neural precursors could be decreased in number, leading to the later 
lower number of cells. Correspondingly, increased numbers of Tuj1
+
 cells were seen 
in the developing brain at E9.5 with no increase of apoptosis, implying that cells 
were differentiating aberrantly
191
. Glypican-1 is also a known interactor of Slit2, 
known for its roles in neuronal guidance and axonal repellence, and the two proteins 




What relevance might the downregulation of GPC1 have to the pathology of the 
t(1;11)? As with the case of SLC12A2/Nkcc1 (see 3.9.10), it appears that a 
developmental change is occurring earlier than expected. Oikari et al. looked at 
proteoglycan expression during differentiation of NSCs and found that GPC1 was 
highly upregulated during neuronal differentiation to a TUJ1
+




upregulated during this differentiation). Interestingly, a NSC GPC1 
knockdown line, at an early stage of differentiation, had downregulations of both the 
NPC markers Nestin and MSI1, and of the neuronal markers TUJ1 and NEFM
190
. 
One hypothesis is that GPC1 downregulation causes two aberrant processes: the first 
being early exit from cell cycle, as elaborated in Jen et al. and causing 
downregulation of NSC markers as in Oikari et al., resulting in less neurons due to a 
reduced precursor pool. The second is possible entrance into an unusual cell fate, 
resulting in less neuronal markers. This would explain the downregulation of both 
marker types. Such a process could well be occurring in our neuronal cultures, 
resulting in premature development leading to a lower number of neurons, or of an 
unusual fate for some of those cells. The gene was significant in every WT vs t(1;11) 
DESeq2 analysis, and never significant in a t(1;11) vs t(1;11) or WT vs WT 
comparison. 
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3.8.7 HAP1 
Huntingtin Associated Protein 1 (HAP1) is a neuronally enriched protein found in 
many areas of the cell, including cell bodies and axons. It was first discovered as an 
interactor of the Huntingtin protein, a protein in which glutamine repeat expansions 
are causative of Huntington’s Disease (HD), a progressive neurological disorder 
characterised by chorea, cognitive decline, and behavioural abnormalities. Hap1 
knockout mice display reduced body weight and thalamic degeneration, as do human 
HD patients and transgenic HD mouse models. HAP1 appears to have roles in 
cellular trafficking. It interacts with dynactin, an essential component of the dynein 
motor complex, as well as KLC2 and synaptic vesicles
193
. The homologue in 
Drosophila is also critical for kinesin dependant anterograde transport of 
mitochondria, although this has yet to be investigated in human cells
193
. Transfected 
HAP1 increases numbers of surface GABARs, apparently by drastically reducing the 
rate of internalized receptor degradation
194
. It is especially interesting that DISC1 
appears to promote GABAAR surface presentation
166
. This is conceivably via HAP1. 
This concept is summarised in Figure 15. 
 
Figure 15. Illustration of theoretical DISC-HAP1-GABAAR interactions. Links between DISC1 and GABAARs described 
by Wei et al.166,links between HAP1 and GABAAR described by Kittler et al.
194. DISC1-HAP1 link described in this 
thesis. 
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Particularly of note are the links between HAP1 and BDNF signalling described by 
Gauthier et al.
195
. siRNAs against Htt (the Huntingtin protein) increase the 
proportion of stationary BDNF-containing vesicles in neuronal cells, and cause 
slower movement of the vesicles overall. Transfection of Htt increases vesicular 
trafficking in cortical neurons, while empty vectors or the glutamine-expanded 
deleterious Htt isoform do not aid trafficking. The increase was especially evident in 
neurites and was not displayed by htt lacking the HAP1 interaction domain, strongly 
suggesting that the increase in transport is mediated by HAP1
195
. Htt also interacts 
with the aforementioned dynactin protein, an interaction which is potentiated by 
HAP1. It has been shown that direct HAP1 knockdown or indirect destabilisation 
decreases levels of TrkB, the BDNF receptor encoded by NTRK2, in the cerebellum 




Given the necessity of transport for extended cells such as neurons, as well as its ties 
to a pathological process, HAP1 presents as a strong candidate for qPCR 
investigation. It is also downregulated in the mouse model of the t(1;11), lending 
further credence to it being genuinely changed and perhaps functioning as the 
“missing link” between DISC1 and GABAAR. Particularly interesting is the role 
HAP1 has in effecting the Htt protein’s functions. Lack of HAP1 has been shown to 
abrogate the stimulatory effects of increased Htt on cellular trafficking; it is possible 
that lack of HAP1 in cells with normal levels of Htt similarly disrupts trafficking. 
I had examined HAP1 via qRT-PCR, but HAP1 was later indicated by Tiihonen et al. 
as being differentially expressed according to sex in iPSC-derived neurons. The 
putative change is upregulation in females, and here it is downregulated in 
translocation samples (which are disproportionately male). Therefore sex may well 
be a factor in HAP1’s significance and the results must be judged critically in this 
regard.  
3.8.8 HIF1A 
Hypoxia-inducible factor 1-alpha (HIF1A) is a transcription factor which acts as the 
master regulator of response to hypoxia
197
. Prenatal and perinatal hypoxia have been 
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established by epidemiological studies as a schizophrenia risk factor, and a large 
number of candidate genes for schizophrenia are related to hypoxia signalling in 
some way. These include BDNF, the ligand for NTRK2, and NRG1, the ligand for 
ERBB4 (described in 3.8.13 and 3.8.11 respectively). They also include COMT 
encoding the dopamine degrading catechol O-methyl transferase, found in the 
22q11.2 deletion region mentioned previously. Finally, these include CHRNA7 
(Cholinergic Receptor Nicotinic Alpha 7 Subunit, mice lacking this gene have 
deficits in parvalbumin positive interneurons
198
), and RELN encoding reelin
199
. Many 
of these appear to be disturbed in the t(1;11) neurons as well. However, it remains to 
be seen in if this remains true in the post-GWAS era. It also appears that neonatal 
hypoxia and genetic propensity for schizophrenia can interact, lending more evidence 
to the importance of hypoxia signalling
200
. It therefore seemed of interest to 
investigate its apparent upregulation further. 
3.8.9 KANSL1 
KANSL1 encodes KAT8 regulatory NSL complex subunit 1. Gene expression is 
increased in the neurons carrying the translocation. It encodes a chromatin modifying 
protein. Haploinsuffiency or point mutation in humans causes a developmental 
phenotype including intellectual disability, hypotonia, and distinctive facial 
morphology
201
. Differential expression of a large number of genes related to cell-cell 
signalling and synaptic transmission is found in cell lines carrying the human 
mutation. Mutation of the Drosophila homolog results in deficits in learning, and 
decreased binding of the protein to chromatin around genes related to those same 
functions, including synaptic transmission
201
. It is interesting that the gene is 
upregulated in our cells, but it could be some kind of compensatory mechanism. The 
gene appears to be involved in endosomal maturation, which could be relevant given 
the role of endosomes in the recycling and clearance of neurotransmitters. Genes 
related to synaptic trafficking, such as SYT6, are also differentially expressed in our 
neurons.  
Generation and initial analysis of human RNA-Seq data 
134 
3.8.10 METRN 
This gene encodes Meteorin and is highly downregulated in our samples, as well as 
in the model described by Wen et al.
132
. METRN was primarily of interest due to its 
ability to promote axonal extension in neurons. It is expressed in neuronal 
progenitors, and is highly expressed in myelinating oligodendrocytes. It appears to 
have a role in promoting glial differentiation
202,203
. It therefore is of importance to 
neuronal differentiation and the formation of networks, which are processes of 
interest. It is also differentially expressed in the mouse heterozygote cortical model. 
3.8.11 NRG1 
The analysis of this gene, encoding Neuregulin 1, was carried out by Helen Torrance 
and Kirsty Millar, but is reported here due to its relevance. Results were previously 
described in Malavasi et al. 2018
70
 . 
NRG1 and its cognate receptor ERBB4 are both downregulated in the t(1;11) 
neurons, as described in the ERBB4 section 3.8.5.NRG1 has many roles of relevance 
to psychiatric disorder processes; it assists in the migration of cortical neurons, 
progenitor proliferation, and axonal guidance. It also aids synapse formation via 
induction of PSD95, and plasticity
188
. Mouse mutants of Erbb4 or Nrg1 display 
hyperactivity and impaired prepulse inhibition, phenotypes which bear relevance to 
psychiatric disease in humans
204
. NRG1 also has a role in parvalbumin-positive 
interneuron migration, a cell type which is thought to be of relevance to 
schizophrenia in particular
116
. Given its historic relevance as a schizophrenia 
candidate, and its links to multiple processes of relevance to synaptic activity and 
neuronal development, NRG1 is a good choice for qRT-PCR.  
3.8.12 NRP2 
Neuropilin-2 is encoded by this gene and is one of a family of receptors which help 
mediate the chemo-attractive and chemo-repulsive effects of the semaphorin ligands. 
These effects are necessary for neuronal extensions to reach their eventual 
destination and make synaptic connections. Nrp2 deficient mice have been studied, 
and are seizure prone, although this phenotype is of more relevance to epilepsy. They 
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also have fewer interneurons, including parvalbumin positive and GABAergic 
interneurons, which many schizophrenia risk factors converge on
116
. CA1 pyramidal 
neuron dendrites also show decreased length and complexity
205
. It is possible that the 
downregulation of NRP2 causes similar phenotypes here. However, it is unusual that 
the DLX1/2 Hox genes are also downregulated in the t(1;11) neurons. Mouse nulls of 
the DLX homologues are embryonic lethal, with a malformed cortex with impaired 
GABAergic interneuron migration. The Dlx genes appear to promote GABAergic 
interneuron migration via the repression of Nrp2, and downregulation of them causes 
a concurrent upregulation of Nrp2
206
. It is difficult to reconcile these contradictory 
findings of Nrp2’s effects on GABAergic interneuron placement, although the 
answer may have something to do with timing of expression or the importance of 
signalling cues being balanced. However a consistent result from investigation of Dlx 
null mutants is impairment of GABAergic interneuron development, a finding which 
is likely to be of relevance to schizophrenia.  
3.8.13 NTRK2 
NTRK2 encodes a protein named TrkB, a receptor tyrosine kinase which binds the 
neurotrophic ligands BDNF and NT-3. BDNF in particular has important roles in 
neuronal survival, dendritic outgrowth, and synaptic strengthening (LTP). Like all 
receptor tyrosine kinases TrkB must dimerise to become enzymatically active, and 
propagates intracellular signalling cascades via a series of phosphorylation events. 
Isoforms lacking the intracellular phosphorylation domain can inhibit full length 
isoforms and prevent the BDNF-TrkB effects of neurite outgrowth, calcium efflux, 




Two separate qPCRs were performed for this gene. One differentially expressed 
exon is the unique C terminal exon for a pair of isoforms f and b which truncate early 
and do not have an intracellular signalling domain (referred to as TrkB-T1 in 
PubMed). It is highly downregulated, while the gene itself is also significantly 
downregulated at the whole gene level. Two primer pairs were designed, one pair to 
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match transcripts of isoforms f and b, and one pair for a ubiquitous set of 
extracellular domain exons found in all isoforms.  
One paper has shown that TrkB-T and TrkB have distinct roles in dendritic extension 
in the ferret visual cortex. Transfected full length TrkB promoted proximal dendritic 
branching, while truncated TrkB promoted distal dendrite extension
209
. However, 
even without distinct roles for different isoforms, TrkB oversignalling could have 
pathological consequences. BDNF signalling can make neurons vulnerable to 
excitotoxicity, despite its necessity for neuronal survival and avoidance of apoptosis. 
One hypothesis has proposed that TrkB signalling is enhanced in fragile X syndrome 
not as a pathological process, but as a compensatory one due to the lack of LTP
210
. 
This is a highly interesting idea, and it must be borne in mind that cells are living 
organisms employing homeostatic mechanisms. It will be difficult to discern whether 
enhanced TrkB signalling is a cause or effect of the pathologies we observe in the 
t(1;11) neurons, particularly as BDNF trafficking may also be affected due to HAP1 
dysregulation. Finally, BDNF signalling has been shown to alter the phosphorylation 
of DPYSL2 and DPYSL3, two proteins encoded by genes which have altered exon 




NTRK2 was indicated by Tiihonen et al. as being differentially expressed according 
to sex in iPSC-derived neurons. However, the putative change is downregulation in 
females, whereas here it is downregulated in translocation samples (which are 
disproportionately male). Therefore sex does not appear to be a factor in NTRK2’s 
significance. 
3.8.14 PDYN 
PDYN’s product prodynorphin is the precursor protein for several opioid peptides, all 
of which are ligands for the Κ opioid receptor, which is encoded by a significantly 
downregulated gene (OPRK1). Both genes are expressed in many regions of the 
brain, including in certain layers of the cortex and especially in the prefrontal cortex. 
Within the medial prefrontal cortex, their products are seen at presynaptic axon 
terminals and activation decreases release of dopamine, serotonin, and other 
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neurotransmitters
212
. Diminished inhibition of dopaminergic transmission could have 
profound effects on our cultured neurons, especially in synergy with increased DRD2 
expression. The result would be overactive dopamine signalling. However it is 
notable that OPRK1 agonism (rather than antagonism) results in visual disturbances, 
dissociative effects, and other symptoms
213
. This apparently counterintuitive 
observation could be due to the fact that PDYN products mediate the release of a 
number of various neurotransmitters including GABA, and would be present in many 
parts of the brain during administration to human subjects. There is also some 
evidence suggesting that genetic variance in PDYN and OPRK1 predisposes to some 
neuropsychiatric disorders
212
. The gene was significant in every WT vs t(1;11) 
DESeq2 analysis, and never significant in a t(1;11) vs t(1;11) or WT vs WT 
comparison. 
3.8.15 QKI 
QKI encodes a protein named Quaking for its mouse mutant phenotype, which 
includes body tremor and CNS myelination deficits. Quaking protein binds RNA and 
integrates cell signalling by interacting with receptors. It contains a number of SH3 
domains for this purpose and can be phosphorylated by Src family kinases, 
modulating its RNA binding ability
214
. The dysmyelination phenotype is evident 
even in mice which are just lacking two QKI isoforms solely in glial cells. Deletion 
of QKI is embryo lethal. Other mutants have cranial defects and altered development, 
or seizures and possible neurodegeneration
214,215
. Developmentally, the gene is 
initially expressed in many neural precursors but decreases in expression in neurons 
and increases in glial cells, with isoform specific expression changes. The number of 
RNAs Quaking binds is unknown but a possible consensus sequence has been 
generated and in post mortem human frontal cortex expression of QKI is correlated 
with the expression of a number of oligodendrocyte/myelin related genes, the 
expression of which is perturbed in schizophrenia
216
. QKI is downregulated in our 
neurons, leading to a few possible scenarios. Myelination deficits could lead to 
impaired neuronal activity. One scenario is that QKI is downregulated as the cell 
type in which it is highly expressed, oligodendrocytes, is lacking in our cell culture. 
However, our cell model should not contain a large number of oligodendrocytes, 
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although a reasonable expression of immature markers such as PDGFRA and CSPG4 
along with small amounts of mature oligodendrocyte markers such as OLIG1, 
OLIG2, OLIG3, and SOX10 are all expressed. None of these are differentially 
expressed. It is also possible that the oligodendrocytes that are present will be non-
functional due to poor QKI expression. Although QKI is expressed by neural 
precursors, our neurons are past this stage and the dysregulation should be unrelated 
to the typical downregulation seen in the precursor to neural cell fate change
217
. As I 
show in a later chapter, the cell proportions of our various t(1;11) models do not 
appear to be abnormal, implying the deficit is in existing oligodendrocytes rather 
than a lack of the cell type itself. 
3.8.16 Results of RT-qPCR 
qPCRs were carried out on all the aforementioned genes for the three samples of 
each of the six lines. Results were fitted to a standard curve and normalised to the 
scores for BACT expression as described in Materials and Methods. Owing to poor 
expression and the inability of primers to reliably detect it in all cell lines, the results 
of PDYN are not displayed. A summary of the results is shown in Table 8
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 and 
the expression plots are shown in Figure 16 and Figure 17. Samples were averaged 
by line before calculation of p values; a more conservative approach. Note that the 
results of DRD2 have been previously published
70
. We can see that 10 of the 14 
genes were confirmed at the RT-qPCR level, a good level of consistency. The gene 
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NRP2 was also near significant, an observation that reoccurred with the mouse 
orthologue in the mouse cortical heterozygous mutant samples. However it should be 
noted that for some genes the samples may be affected by sex imbalances, as the 
t(1;11) sample which was originally derived from a female patient has the t(1;11) 
value closest to the WT (all originally derived from females). This occurs with the 
genes CALB1, GPC1, METRN and NRP2. This is 4 of 14 genes, close to the expected 
number that would appear by chance (as one of the three t(1;11) samples must be 
closest to the WT samples). Nevertheless, should information emerge that any of 
these genes are also differentially expressed according to sex in iPSC-derived 
neurons, these two facts together are strong evidence in favour of the changes 
observed here being related to sex rather than to translocation status. In addition, the 
significance of HAP1 is suspect and should be disregarded. This is because putative 
sex effects are in the same direction as the putative translocation effects. 
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Figure 16. Expression plots for RT-qPCR results of BBS1, CALB1, CHRNA4, DRD2, ERBB4, GPC1, HAP1, and HIF1A 
differential whole gene expression. P values are given underneath each gene name. Each trio of neuronal samples from 
each line has been averaged. Lines indicate overall genotype average expression with smaller lines indicating one 
standard deviation above and below the mean. Colours indicate genotype and shape indicates line number. Blue=C line, 
Red=T line. Circles indicate 1, squares indicate 2, and triangles indicate 3. Lines C1, C2, C3, and T3 were derived from 
females.The RT-qPCR of ERBB4 was carried out by Helen S. Torrance. N=3. 
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Figure 17. Expression plots for RT-qPCR results of KANSL1, METRN, NRG1, NRP2, NTRK2 PDE4B and QKI 
differential whole gene expression. P values are given underneath gene name. Each trio of neuronal samples from each 
line has been averaged. Lines indicate overall genotype average expression with smaller lines indicating one standard 
deviation above and below the mean. Colours indicate genotype and shape indicates line number. Blue=C line, Red=T 
line. .Circles indicate 1, squares indicate 2, and triangles indicate 3. Lines C1, C2, C3, and T3 were derived from 
females. The RT-qPCRs of was carried out by Helen S. Torrance. The primers used for the RT-qPCR of NTRK2 shown 
here were designed to detect all isoforms of the gene. N=3. 
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RT-qPCR 
results 
P value t(1;11) Fold change 
expression 
Significance 
BBS1 0.010 0.52 * 
CALB1 0.0099 0.25 ** 
CHRNA4 0.09 2.03  
DRD2 0.045 3.98 * 
ERBB4 0.036 0.29 * 
GPC1 0.030 0.54 * 
HAP1 0.041 0.32 * 
HIF1A 0.39 0.93  
KANSL1 0.39 1.03  
METRN 0.041 0.32 * 
NRG1 0.019 0.33 * 
NRP2 0.053 0.50  
NTRK2 0.040 0.50 * 
QKI 0.0030 0.50 ** 
Table 8. Summary of RT-qPCR gene level expression results for human neurons. * =p<0.05, **=p<0.01, ***=p<0.001. 
t(1;11) expression is given as a percentage of the WT expression rounded to the nearest %. P values calculated by t test, 
with each trio of individual differentiation of each iPSC-derived neuronal line being treated as a single averaged sample. 
The three genes ERBB4, NRG1, PDE4B, were analysed by Kirsty Millar and Helen S. Torrence. n=3. 
A measure of how reliable the RNA-Seq findings are is given by how closely the 
RT-qPCR results track their respective samples’ RNA-Seqs scores. In theory, these 
should be linearly related. I looked at the log2 foldchange between translocation and 
WT samples, seen in Figure 18. 
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Figure 18. Graph displaying log2 fold change of normalised counts vs log2 fold change of normalised PCR score for each 
of the 12 genes I carried PCRs out on. Log2FC=Log2 fold change between WT and t(1;11) samples. Positive values 
indicate the t(1;11) samples have a higher score on average. Gene legends on right, differentiated by colour. Counts 
normalised using the “rlog” function in DESeq2 package. R2=0.899 
We can see that most genes show an apparently linear relationship between fold 
change of counts and fold change of qPCR score, showing that although there is 
indeed variance within genotypes, the overall trend is apparent (R
2
=0.899). However, 
HIF1A and KANSL1 show no apparent relationship. Indeed; these are the genes, 
along with CHRNA4, which were not found significant at the qPCR level. Individual 
qPCR results are displayed in Figure 16 and Figure 17. It should be noted that I 
designated one of the three C2 CHRNA4 qPCR results as an outlier; it had a qPCR 
measurement which was 15 times greater than any other with a value 3.6 standard 
deviations from the mean, and if excluded changes the log2fold change from 1.41 to 
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3.9 Exon level RT-qPCR 
Genes were chosen for investigation on the same basis as the gene level candidates. 
All exons which belonged to genes implicated by the PGC GWAS or CNV studies 
were analysed as potential RT-qPCR candidates, as were exons belonging to genes 
encoding possible DISC1 interactor. Subsequently exons were also inspected to see 
where in the gene they are. Exons that implicated a unique transcript, especially one 
that encoded a protein isoform with a known physiological role, were prioritised. N-
terminal and C-terminal exons which implicated particular transcripts were also 
prioritised. A minority of potential targets were discarded due to the impossibility of 
designing specific primers, or because there is only one isoform in RefSeq according 
to the UCSC Genome Browser, genome hg19 (https://genome.ucsc.edu/). Of some 
use in selecting candidates was an approach searching for convergences between 
papers; a table displaying the numbers of genes significant between any pair of 
papers described in 3.7.1 as well as in the DESeq2 analysis is displayed as Table 9. 
Descriptions of each gene are given in turn and a table summarising the rationales is 
displayed as Table 10. 
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Table 9. Table of overlaps. Numbers represent the number of genes significant in our DEXSeq study of human neurons, 
in addition to the two papers in the corresponding row and column. Grey blocks indicate genes from only one paper (the 
same row and column index). Abbreviations as in 3.7.1. 
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Table 10. Highlighted information about candidate exons selected for qPCR. TRUE indicates that the gene is 
differentially expressed in the model of interest. Paper abbreviations are as in 3.7.1. 
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3.9.1 DLG2 
This gene encodes the protein PSD-93, and a total of three exons are differentially 
expressed. One leads to a region annotated by UCSC as being intronic, while the 
other two are a unique N terminal exon for a shorter isoform and an exon found 
within but not exclusive to said isoform. The isoform is described in PubMed as 
being the “alpha” isoform. PSD-93 is a synaptic protein that helps the clustering of 
various signalling proteins. It associates with other synaptic proteins such as the 
neuroligins, and associates with NMDARs, increasing their surface expression
218,219
. 
It also forms supercomplexes with NMDARs and PSD-95
220
. It is henceforth 
important to LTP and also associates with AMPARs via proteins like stargazin, 
which facilitate the increased synaptic strength following LTP
221
. Mutant mice 
display impaired LTP
222
. Furthermore, CNVs deleting DLG2 are associated with 
schizophrenia
35
. Although not all the functional effects of the various isoforms are 
fully understood as of yet, DLG2α specifically being upregulated is of interest and 
should be investigated further.  
3.9.2 DPYSL2 
A number of exons are also dysregulated in the homologous mouse gene in the 
cortical heterozygous model. The pattern of exon dysregulation is the same as in the 
related gene DPYSL3 described in the next section; one N terminal exon is 
upregulated and the alternative one is downregulated. The upregulated exon is only 
found in an isoform containing a number of metal binding residues, while the 
downregulated one is only found in isoforms lacking these residues. DPYSL2 binds 
to tubulin molecules to promote microtubule assembly, and promotes axonal 
outgrowth in hippocampal cell culture
223
. Indeed, DPYSL2 overexpression promotes 
the formation of excess axons, a phenotype shared by the overexpression of SHTN1 
(see 3.9.9) 
224
. It is also a possible DISC1 interactor, and may have mutations linked 
to schizophrenia
73,223
. Finally, knockdown of Dpysl2 and Dpysl3 leads to motor 
neuron misplacement, a phenotype also produced by Cdk5 and rescued by 
phosphomimetic Dpysl2
225
. It also incorporates signalling from GSK-3β and fails to 
inhibit axonal growth unless phosphorylated by it
211
, while antipsychotic drugs 
inhibit the phosphorylation of this site, conceivably via GSK-3β
226
. It is clear that 
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DPYSL2 is a gene of importance to axonal development, kinase signalling, and is 
even a possible DISC1 interactor. The rationale for investigating further was clear, 
especially given that the related gene DPYSL3 shows the same pattern of change. A 
PCR was carried out to detect changes in the upregulated exon. 
3.9.3 DPYSL3 
The protein encoded is DPYSL3, or CRMP4 (Collapsin response mediator protein 
4). It is a possible DISC1 interactor according to a Y2H screen
73
. It is localised in 
neurites and axonal growth cones, where it appears to oligomerise and bundle F-
actin
227
. It is also phosphorylated by GSK-3β, as is DPYSL2, and the 
phosphorylation of this site can be blocked by antipsychotic drugs
211,226
. Expression 
is at its highest during peak axonal growth, and mutations in the highly conserved 
nematode homologue cause severe axon defects in all neurons
228
. Cleavage of 
DPYSL3 post excitotoxic NMDA signalling prevents oligomerization and therefore 
actin bundling, which could have implications for the maintenance of axonal growth 
cones
227
. The exon which is upregulated corresponds to the N-terminal exon of an 
isoform which possesses a number of metal ion binding residues, while the 
alternative isoform without these residues has its N terminal exon downregulated. 
The corresponding mouse gene also has some differentially expressed exons. Given 
the alternating N terminal exon pattern and the fact that the isoforms have known 
differences, this is a strong candidate for RT-qPCR. Both DPYSL2 and DPYSL3 
appear to incorporate signalling from multiple kinases known to promote neuronal 
development, which can be modulated by antipsychotic drugs, and are both involved 
in axonal growth. They present as a pair of highly interesting candidates. A PCR was 
carried out to detect transcripts containing the upregulated exon. 
3.9.4 DVL1 
Two isoforms of the encoded protein, Dishevelled-1, are described in the UCSC 
genome browser and are differentiated by differing versions of a central exon. The 
unique segment of one version is upregulated. DVL1 is a highly conserved and 
broadly expressed developmental gene important for Wnt signalling and in 
establishing planar cell polarity. A null Dvl1 mouse model was viable but exhibited 
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reduced sociality, altered behaviour, and reduced prepulse inhibition in response to 
acoustic or tactile startles
229
. Given the similarity to some known schizophrenia 
phenotypes, as well as the known links between DISC1 and Wnt signalling, DVL1 
presented as a very interesting candidate for qPCR. 
3.9.5 GRIA4 
A number of exons are differentially expressed in this gene. One in is a C-terminal 
exon found only in isoform 3 of the gene. It is important to note that the “flip” and 
“flop” exons are not altered. GRIA4 encodes GluR4, a glutamate receptor subunit 
found in AMPARs. AMPAR expression and trafficking is believed to underlie 
synaptic plasticity and from this many physiological aspects such as learning and 
memory
230
. The expression of an alternative isoform of GRIA4 may have some 
biological impact on these functions, although the isoform is currently not well 
characterised in terms of a unique biological role. Nevertheless given the relevance 
of the gene it makes sense to investigate expression further. 
3.9.6 NTRK2 
The rationale for investigating NTRK2 is described in detail in 3.8.13. The primers 
used in the following analysis were designed to only detect isoforms with a unique C 
terminal exon resulting in an early truncation of the protein and a corresponding lack 
of an intracellular signalling domain. 
3.9.7 NTRK3 
Like NTRK2, NTRK3 encodes a receptor tyrosine kinase that dimerises to form active 
signalling complexes. As with NTRK2, the exons found only in truncated isoforms 
lacking the intracellular signalling domain are downregulated. NTRK3 encodes a 
protein called TrkC which is the receptor for the neurotrophin NT-3. The truncated 
isoforms may inhibit the full-length ones, but importantly appear to have roles of 
their own. The extracellular domain of TrkC can bind both NT-3 and PTPσ, resulting 
in formation of glutamatergic excitatory synapses. Overexpression of the truncated 
isoforms results in increases in VGLUT1 expression but not VGAT, while 
knockdown of the gene results in decreased VGLUT1-PSD95 co-localisation. This is 
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rescuable by expression of the truncated isoforms. This implies a special role for the 
truncated isoforms of TrkC, so it is highly interesting to find these downregulated. 
The ratios of both TrkB and TrkC truncated to non-truncated isoforms increase at the 
peak of synaptogenesis
231
. Overexpression of the full length isoforms in mice results 
in behavioural abnormalities including abnormal responses to threats (increase flight 
response, frozen response, and decreased approach)
232
. The decrease in the truncated 
isoforms’ unique exon is therefore very interesting, and might imply deficits in 
excitatory synapse formation, conceivably linked to altered behaviour. 
3.9.8 PDE4B 
The analysis of this gene was carried out by Helen Torrance and Kirsty Millar, but is 




PDE4B is another gene linked to psychiatric disease, with a balanced translocation in 
the gene segregating with schizophrenia risk
74
. It is crucial for cAMP regulation, 
which itself is vital in several neural processes, such as memory
74,85
. PDE4B 
interacts with DISC1, and its inhibitor rolipram is a prototypical antidepressant. 
Mutations in the corresponding Drosophila gene cause learning deficits. PDE4B has 
also been shown to have a role in the functions of a number of other DISC1 
interactors such as LIS1, NDE1, NDEL1, the genes of which have been found 
mutated in cases of lissencephaly (a developmental brain malformation) or are linked 
to crucial processes such as neurite outgrowth. Interaction with DISC1 appears to 
inhibit PDE4B’s phosphodiesterase ability, while the subsequently high cAMP levels 
stimulate PKA-mediated phosphorylation of NDE1. NDE1 phosphodead NS-1 cells 
have inferior neurite outgrowth to wild type
84
. We can see that control of PDE4B via 
DISC1 is important for neural processes, yet we know from Drosophila and the 
PDE4B translocation that insufficiency is also problematic. The gene therefore 
presented as an interesting candidate for RT-qPCR. 
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3.9.9 SHTN1 
This gene is also known as KIAA1598 and produces a protein called Shootin1. It has 
a role in axonal sprouting. Studies involving rat hippocampal neurons showed that 
Shootin1 is initially expressed in neurites sprouting from cells. It fluctuates in 
expression but eventually is only expressed in one neurite, which is destined to 
become the neuron’s axon. Knockdown delays axon formation, while overexpression 
results in accelerated accumulation of the protein in neurites and a corresponding 
chance to form multiple axons. It persists in the axonal growth cone where it 
activates PI3K. The authors theorised a model where Shootin1 is actively trafficked 
to neurite termini and passively diffuses back. The longer the neurite, the longer 
Shootin1 stimulated activity continues, and the greater the corresponding effect on 
neurite extension and axon formation. Shootin1 presence therefore determines axonal 
identity in a self-propelling loop
233
. Another paper showed that the formation of 
multiple axons caused by Cdkl5 overexpression in mouse could be mitigated by 
Shtn1 knockdown and that the two genes are found expressed in cortical neurons
234
. 
It also interacts with cortactin, an actin bundling protein. This is enhanced by an 
axonal chemoattractant, netrin-1
235
. Although data on the human isoforms is sparse, 
the isoforms appear to be analogous in the mouse and rat. The differentially 
expressed exon is downregulated in the rat PC12 line, and the isoform containing the 
analogous exon is constitutively expressed. The isoform without the analogous exon 
is expressed after NGF signalling and is necessary for subsequent neurite extension. 
Protein expression of both isoforms subsequently decreases
236
. Given its evident 
importance in neurite outgrowth, as well as a verified different expression pattern for 
the isoform containing the exon (in the rat PC12 line at least), I deemed SHTN1 
worthy of investigation via qRT-PCR. 
3.9.10 SLC12A2 
The product of this gene is known as NKCC1, a protein which is highly expressed in 
developing cortex but declines in expression over the first year of life to a baseline 
level equivalent to that of the adult cortex. This occurs in both rat and human
237
. The 
protein is a chloride transporter maintaining high levels of intracellular Cl
-
, which 
when coupled with low levels of intracellular K
+
 results in a high transmembrane 
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potential. Upon activation of GABA receptors the efflux of charged chloride results 
in neuronal depolarization and firing. The reverse effect is seen in adult tissue. High 
KCC2 expression (a potassium importer) and low NKCC1 expression keeps 
intracellular Cl
-
 low and K
+
 high. GABAR activation here allows chloride ion influx 
resulting in hyperpolarization. Therefore in adult tissue GABA acts as an inhibitory 
neurotransmitter rather than an excitatory one. This GABAergic switch is a key 
developmental step and neonates who have yet to complete the switch are vulnerable 
to GABA-mediated excitatory neuronal activity causing seizures
238
.  
The differentially expressed exon is found in one isoform, NKCC1A, and not the 
other, NKCC1B, although both form functional transporters. NKCC1A is expressed 
in both foetal and adult prefrontal cortex and appears to follow a general trend of 
increasing in expression postnatally, being very poorly expressed foetally
239
. In the 
mouse, the excitatory activity of GABA (and high Nkcc1 expression) is required for 
immature hippocampal neurons to develop properly. Nkcc1 knockdown or Kcc2 
upregulation both result in defective dendrite growth and synapse formation. Disc1 
knockdown, meanwhile, enhances dendrite outgrowth at this stage, which can be 
undone by concurrent Nkcc1 knockdown preventing excitatory GABAergic 
signalling. Complementary experiments showed that GABAR agonists or inhibitors 
of GABA degradation enzymes further enhanced the Disc1 knockdown induced 
dendrite outgrowth. The effect of Disc1 knockdown is eventually lost, but can be 
regained if Kcc2 expression is kept low
240
. Although NKCC1 isoforms have not yet 
been fully characterised, NKCC1A downregulation could indicate that our neuronal 
model is developing aberrantly, with a possible early switch in the role of GABA 
which would have severe consequences. 
3.9.11 Results of RT-qPCR 
qPCRs were carried out on all the aforementioned genes for the three samples of 
each of the six lines. Results were fitted to a standard curve and normalised to the 
scores for BACT expression. A summary of the results is given in  and the expression 
plots are given in Figure 19 and Figure 20. 




Figure 19. Expression plots for RT-qPCR results of DLG2, DPYSL2, DPYSL3, DVL1,GRIA4 and PDE4B differential 
exon expression. P values are given underneath each gene name. Lines indicate overall genotype average expression with 
smaller lines indicating one standard deviation above and below the mean. Colours indicate genotype and shape 
indicates line number. Blue=C line, Red=T line. Circles indicate 1, squares indicate 2, and triangles indicate 3. Each trio 
of neuronal samples from each line has been averaged. N=3. 
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Figure 20. Expression plots for RT-qPCR results of NTRK2, NTRK3, SHTN1 and SLC12A2 differential exon expression. 
P values are given underneath each gene name. Each trio of neuronal samples from each line has been averaged. Lines 
indicate overall genotype average expression with smaller lines indicating one standard deviation above and below the 
mean. Colours indicate genotype and shape indicates line number. Blue=C line, Red=T line. Circles indicate 1, squares 
indicate 2, and triangles indicate 3.The primers used for the qRT-PCR of NTRK2 shown here were designed to only 

















DPYSL3 Alternative N-terminal exon 0.0054 0.35 ** 
NTRK2 Alternative C-terminal exon 0.031 0.34 * 
PDE4B 
Central exon found in 
isoforms with an 
alternative promoter start 
0.024 0.45 
* 
SLC12A2 Alternative central exon 0.031 0.49 * 
Table 11. Summary of RT-qPCR exon level expression results. * =p<0.05, **=p<0.01, ***=p<0.001. t(1;11) expression is 
given as a percentage of the WT expression. Only significant results are displayed. 
We can see that a much lower proportion of the exon level changes have been 
confirmed; four out of ten as opposed to 10 out of 14 for the gene level changes. The 
reason is difficult to discern but may be due to the fact the counts for any exon are 
likely to be much lower than the counts mapping to a gene, given the vastly 
increased size of a gene compared to an exon. The lower number of counts may 
allow chance variation a greater role, resulting in falsely indicated differentially 
expressed genes. As before it should be noted that for some genes the samples, if 
judged by sex, cluster together (the red triangle with all blue shapes). This occurs 
with the qPCRs for exons in genes NTRK3 and SHTN1. This is 2 of 10 genes, lower 
than the expected number that would appear by chance (as one of the three t(1;11) 
samples must be closest to the WT samples). As before the same conclusion applies. 
If any of these exons are differentially expressed according to sex in iPSC-derived 
neurons, this is evidence in favour of the changes observed here being related to sex 
rather than to translocation status. 
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As with the gene level qPCRs, I looked at how closely the RT-qPCR results track 
their respective samples’ RNA-Seqs scores. Figure 21 shows the relation between 
qPCR score and normalised count for each of the 18 samples for 9 genes
 
Figure 21. Graph displaying log2 fold change of normalised counts vs log2 fold change of normalised PCR score for each 
of the 8 exons I carried PCRs out on. Log2FC=Log2 fold change between WT and t(1;11) samples. Positive values 
indicate the t(1;11) samples have a higher score on average. Gene legends on right, differentiated by colour. Counts 
normalised using the “rlog” function in DESeq2 package. 
There appears to be a more linear relationship between the qPCR and normalised 
count scores when samples are averaged, as in the gene level analysis. There is more 
scatter, and correspondingly less significant genes. However the overall linearity 
indicates that the changes may be genuine, and that the relatively small number of 
samples, as well as the low magnitude of the changes, may be the reason for the lack 
of significance at the qPCR level. As always, larger sample sizes would be ideal. 
Individual qPCR results are shown in Figure 19 and Figure 20. 
3.9.11.1 NTRK2 results 
The qPCR results suggest that both “all transcripts” and truncated transcripts of 
NTRK2 are downregulated. It is entirely possible that the change in one is 
responsible for the apparent change in the other. An estimation of the ratio of 
truncated NTRK2 to full length NTRK2 can be obtained by looking at RNA-Seq 
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counts for unique exons. The C-terminal exon of the fully truncated isoforms b and f 
has an average of over 19,000 reads per WT sample, while the averages of the C-
terminal exons for partial length isoforms d and e and full length isoforms a and c are 
approximately 2,000 and 2,100, respectively. The samples do not display drastically 
different counts for the partial and full length C-terminal exons, while those for the 
truncated C-terminal exon have been confirmed by qPCR as significantly 
downregulated to approximately one third of the levels of the WT samples. 
It appears likely that the change at the “whole gene” level is driven mostly, if not 
entirely, by the downregulation of the truncated transcripts, given that it is the major 
isoform and is confirmed as downregulated. The reduction in the truncated isoforms 
is approximately 70%, while “all isoforms” are reduced by approximately 50%. The 
hypothesis that the change in “all isoforms” is driven entirely by a 70% reduction in 
the truncated isoform bears some relation to the observed ratios of the average counts 
of each C-terminal exon, although there may be some minor changes in partial length 



















WT 19644 1977 2109 23730 100% 100% 
t(1;11) 6100 1251 2011 9362 50% 30% 
Table 12. Examination of counts of C-terminal exons unique to each isoform of NTR2. Note that the Total counts 
decreases by 14,000 counts, while Trk-T1 decreases by 13,000. The truncated isoforms are referred to as “b” and “f”, 
the partial length isoforms as “d” and “e”, and the full length isoforms as “a” and “c”. Note that the accession numbers 
are not necessarily an exhaustive list of all accession numbers that may contain the exon. Only 6 transcripts have a 
verified mRNA in Ensembl, 2 have neither an mRNA nor an EST and are similar to isoforms “a” and “c”.  
We can conclude that the ratio of truncated: full NTRK2 transcripts is lower in the 
t(1;11) samples. This would imply that TrkB signalling is enhanced, particularly as 
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3.10 Discussion 
To summarise, over 1,200 genes appear to be differentially expressed between the 
WT and t(1;11) human neurons. There is little evidence to suggest regional effects of 
the translocation, but DISC1 displays the expected phenotype of cross-breakpoint 
reads being halved. Differential expression at the protein level was also confirmed by 
other researchers
70
. The GO terms overrepresented among the differentially 
expressed genes relate to psychiatric disease and there is extensive overlap with other 
researchers using both iPSC-derived neuronal models and GWAS/CNVs. A number 
of candidate genes have been confirmed at the qRT-PCR level and the results are 
generally in good alignment with the RNA-Seq.  
3.10.1 Evaluating the evidence  
There are consistent areas of interest which are implicated by this investigation into 
t(1;11) pathology. These areas have been implicated by GO terms, have associated 
genes which are relevant to disease and/or are DISC1 interactors, and have 
associated genes confirmed at the RT-qPCR level.  
 Intracellular trafficking. Although HAP1 may be sex regulated,other 
differentially expressed genes include KIF1A, MYO10, MYH11 encoding 
kinesin-related and myosin proteins. DISC1 has already been associated with 
this function via recent papers (see Introduction), as well as interactome 
studies
73
. Potential DISC1 interactors include dynactin, NDEL1, FEZ1, and 
KIF1B
241
. DISC1’s confirmed trafficking of GABAARs is also relevant. A 
review by Devine et al. also suggested that HAP1 and DISC1 might 
cooperate in the trafficking of AMPARs
241
. This balance between excitatory 
and inhibitory synaptic activity is relevant to cell-specific disturbed GO 
terms, as I elaborate in the Discussion. Trafficking of mitochondria is 
important for neuronal energy demands, as receptor trafficking is for synaptic 
formation. Both are essential to neuronal function. 
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 Neuronal migration and placement, including BBS1 (and other BBS genes, 
not subjected to qPCR), NRG1, ERBB4. A well established DISC1 function 
(see Introduction). 
 Neuronal developmental in terms of timing of developmental switches and 
dendritic outgrowth, including SLC12A2, SHTN1, GPC1 and METRN , 
PDE4B, DPYSL2/3 respectively. GOrilla Functions which are 
overrepresented are heavily cytoskeletal in nature; including actin nucleators 
such as SPIRE1. This has relevance as the cytoskeleton undergoes 
reorganisation to form axonal growth cones. SHTN1 and DPYSL2/3 have 
functions directly related to this. 
 Synaptic activity including altered plasticity and strengthening including 
NTRK2, DRD2. As elaborated in the Discussion and Introduction, altered 
synaptic plasticity is highly relevant to psychiatric illness. Our research group 
(published as Malavasi et al.) showed that the Der1 mice have altered PSD95 
distribution
70
. Differentially expressed genes include those related to 
neurotransmtter release and receptors, such as SYNJ2, SYT4, SYT6, DNM2 
(synaptojanin, two synaptotagmins, and dynamin), GLRA1, GABRD,GRIN2D 
(receptors for glycine, GABA, and glutamate).  
 Particularly interesting is the emergence of paired genes such as 
OPRK1+PDYN, ERBB4 + NRG1, SHANK1 + HOMER2 (possibly), and 
several examples of paired developmental cue genes such as the semaphorins, 
netrins, and plexins.  
Other interesting genes which I did not carry out a qPCR on include APP, BBS2, 
BBS5, BSN, VAX1, VAX2, amongst others. Many of these are synaptic, are Hox genes 
which play a role in development, are trafficking molecules, or are actin/microtubule 
organisers which will alter dendritic outgrowth. These are all functions of great 
relevance to psychiatric disease aetiology and are further explored in tandem with the 
results of other chapters in the Discussion. 
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4 GENERATION AND INITIAL 
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4.1 Generation and initial analysis of mouse cortical RNA-Seq 
data 
4.1.1 Introduction 
The mouse data was for the most part analysed using the same methods as the human 
data, utilising differential expression analyses and using GOrilla to analyse gene 
ontology. Local expression changes were not analysed as there is no translocation. 
The cortical samples included much of the brain excepting the hippocampus. 
Philippe Gautier found that one of the WT mice was an outlier in RNA-Seq profiles; 
it was removed from the analyses. A second WT mouse was randomly chosen and 
also removed to balance the sex ratios. 
4.1.2 WT vs heterozygous 
4.1.2.1 DESeq2 
The six WT and eight heterozygous samples were analysed using DESeq2. Since sex 
ratios were balanced, X and Y reads were not removed. A total of 2,112 genes were 
described as significantly differentially expressed between the two sample groups 
with a BaseMean at least half that of Disc1’s. As shown by the volcano plot in Figure 
22, most of these genes showed only a mild difference in fold change with very few 
showing a twofold change. This is particularly evident if this volcano plot is 
contrasted with that of Figure 5. I also produced a heatmap of all differentially 
expressed genes between the wildtype and heterozygous mouse cortices, seen in 
Figure 23. In general, genotypes cluster together but there is an exception. 
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Figure 22. A volcano plot of the cortical DESeq2 for all genes with BaseMean>44 (half that of Disc1). X-axis represents 
the log2 fold change between WT and heterozygous Der1 lines, while the Y axis represents significance (-log base 10 of p 
value). Black dots have an adjusted p value above 0.05, blue dots are significant with an adjusted value below 0.05. Red 
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Figure 23. Heatmap of all differentially expressed genes with p<0.05 and at least half the expression of Disc1. Counts 
were normalised using the “rlog” function, which transforms counts to the log2 scale, normalises for library size, and 
minimises variation in poorly expressed genes. They were then antilogged, and changed to z scores by gene before 
generation of the heatmap. Red indicates z score above the mean, green indicates z scores below the mean. Each row is a 
gene. The groups do not cleanly separate by genotype; 7 heterozygotes are the left cluster, while the right cluster consists 
of 6 WTs and one heterozygote designated by an asterisk (*). 
 
4.1.2.2 DEXSeq 
At adjusted p value<0.05, a total of 8,993 exons were differentially expressed, found 
in 3,570 different genes.  
4.1.2.3 GOrilla 
As in the human analysis in 3.6, GOrilla was utilised to analyse gene ontologies 
overrepresented among the differentially expressed genes. This analysis was carried 
out by Marion Bonneau and Kirsty Millar and is described in the corresponding 
thesis.  
4.1.2.4 Comparison to other papers 
An analysis identical to that described in 3.7. was carried out by Kirsty Millar using 
the PGC and CNV papers which found significant overlaps between PGC-1 and the 
list of differentially expressed genes. I carried out an analysis utilising the other 
* 
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papers mentioned in section 3.7. I also searched for RNA-Seq experiments utilising 
Disc1 mouse models but did not find any suitable published papers. In all cases, the 
genes implicated by DESeq2 (BaseMean>10, p<0.05) and DEXSeq (p<0.05) were 
combined, and duplicate gene caused by multiple significant exons, as well as 
duplicates caused by overlap between DESeq2 and DEXSeq, were removed. Where 
DEXSeq assigned one exon to multiple genes, I used UCSC to manually assign the 
exon to the correct genes. Since some genes will have diverged in function, 
significance in overlap between the genes implicated by the Disc1 mutation and 
those implicated in the various papers is less informative than in the human 
translocation study. Nevertheless many genes will have retained their functions and 
may be of relevance to the processes disturbed by psychiatric illness. A summary of 
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Cortex Heterozygous  
Paper Number of genes 
 
P value Genes of interest 
DI 18 4.3E-02 Dpysl2, 
Dpysl3, 
Kif5a 
B 79 1.3E-02 Nrp2, 
Cobl W 272 1.3E-05 App, 
Gpc1, 
Cobl,  
Sx2mmd17 174 5.8E-03 Slc1a1 
Sx2mmd50 202 6.3E-03 Apoe 
Sx8mmd17 74 8.8E-03 ~ 
Sx8mmd50 14 6.6E-02 ~ 
Sx8wmd17 133 2.7E-03 Apoe 
Sx8wmd50 53 3.9E-03 ~ 
Table 13. Summary of overlap with other papers. Each paper is indicated by the acronym given in 3.7.1. The number of 
genes significant in both our study and the indicated one is given in the first row. The hypergeometric probability is 
given in the second, and a subset of interesting genes within this list of overlapping genes is within the third. 
It is clear that there is significant overlap with other Disc1 mutant models. We can 
see that many genes which have homologues differentially expressed in the human 
cells such as Gpc1 and Nrp2 appear, as do the potential Disc1 interactors encoded by 
Dpysl2 and Dpysl3. Genes which are of interest to neuronal processes, appeared in a 
GO term, were also changed in the human cells, and were implicated by one of the 
above papers were particularly prioritised when looking to validate the RNA-Seq via 
RT-qPCR. A full summary of the overlaps is given in the Appendix. 
4.1.2.5 Gene level RT-qPCR 
To confirm the results of the RNA-Seq, a number of RT-qPCRs were performed. 
Genes were chosen on the same basis as the human neuron gene candidates but 
special attention was paid to genes differentially expressed in both models and many 
of these were examined. A summary of the overlaps between any pair of papers 
described in 3.7.1 and the list of genes significant according to DESeq2 is given in 
Table 14. A description of each gene is given in turn with a summary table given as 
Table 15. 
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Table 14. Table of overlaps. Numbers represent the number of genes significant in our DESeq2 study of 
Der1heterozygous  cortical samples, in addition to the two papers in the corresponding row and column. Grey blocks 
indicate genes from only one paper (the same row and column index). Abbreviations as in 3.7.1. 
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Table 15. Highlighted information about candidate genes selected for qPCR. TRUE indicates that the gene is 
differentially expressed in the model of interest. Paper abbreviations are as in 3.7.1. 
4.1.2.5.1 Arc 
Arc is an immediate early gene, capable of being rapidly translated to protein upon 
cellular signalling. It is expressed following learning, seizures, or LTP caused by 
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BDNF or high frequency afferent stimulation. Antisense Arc oligonucleotides inhibit 
the maintenance but not the induction of LTP. Its mRNA is targeted to the dendrite 
before translation; implying an important role there. It appears to have a role in 
organising actin at the dendrite, which is needed to enlarge dendritic spines. It also 
appears to have a role in AMPA receptor trafficking, particularly in AMPAR 
internalisation in LTD
57
. CNVs predisposing to schizophrenia have also been 
reported as converging on genes involved in Arc signalling
35
. All of this adds up to 
this gene having a crucial role in synaptic plasticity. A number of other immediate 
early genes are also downregulated, including Egr1, Egr2, and Egr4. 
BDNF’s receptor NTRK2 is differentially expressed in the human neurons; it has an 
important role in LTP and appears to stimulate expression of ARC. Interestingly Aβ 
in cortical neurons appears to attenuate this expression increase, and in this context it 
is notable that the Apoe gene, known for a genotype which increases the risk of 
Alzheimer’s disease, is also dysregulated in the mouse cortex
242
. Apoe appears to 




Apoe is a lipoprotein known for transporting cholesterol, and is the most abundant 
lipoprotein in the brain. It is perhaps best known for a common variant which 
predisposes to Alzheimer’s disease, with homozygote carriers of this ε4 variant 
suffering from the disease at a rate 8 times higher than the base rate. Apoe is 
important for carrying lipids around the brain and may even bind amyloid 
peptides
244
. Apoe also appears to have effects on neurons which do not appear to be 
directly related to its role in Alzheimer’s pathology. Mouse cortical adult and 
embryonic neurons from Apoe KO mice have shorter dendrites, an effect which may 
be mediated in vivo by the expression of Apoe isoforms from astrocytes. Apoe 





This gene encodes arginine vasopressin, a neuropeptide which is both necessary and 
sufficient for pair bonding in a species of vole
246
. Given its immense importance as a 
social neuropeptide I investigated further whether it had any other roles in brain 
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activity. Interestingly, the gene Oxt, encoding oxytocin is also dysregulated in our 
mouse heterozygote cortex. Avp receptor activation is necessary in the ventral 
palladium to allow pair bonding in males, while Oxt receptor activation is necessary 
in the nucleus accumbens to allow the same in females. The two are complementary 
in this regard and both are downregulated in our mouse cortex. Differential 
expression of the cognate receptors across related species appears to determine 
monogamous behaviour in the vole, and the two peptides control other behaviours as 
well, such as parental, aggressive, and in the case of Avp, social recognitive
247
. An 
older study looking at Avp co-administration during ethanol administration in mice 
found that Avp could maintain acquired ethanol tolerance (which otherwise lasted 
less than 6 days). Cessation of Avp administration began the process of losing 
acquired tolerance. The relevance is unknown but it is an interesting finding
248
. In 
any case, I thought it of special interest that both the Avp and Oxt peptides were 
dysregulated and thought this might be indicative of wider dysfunction in 
behaviours, especially social ones.  
4.1.2.5.4 Hap1 
The analogous human gene, HAP1, is differentially expressed in the human neurons 
and the function is more fully explained in the relevant section, 3.8.7. 
However, the apparent convergence of significance in both mouse and human 
samples may be due to sex effects in the human cells. Hap1 was not found 
significant in these mice samples, perhaps suggesting that the sex effects in humans 
and chance effects in mice converged, and that the gene is not truly involved in 
DISC1 pathology. 
4.1.2.5.5 Metrn 
The analogous human gene, METRN, is differentially expressed in the human 
neurons and the function is more fully explained in the relevant section, 3.8.10. 
4.1.2.5.6 Mt2 
This gene encodes metallothionein 2, a protein involved in metal-binding and control 
of oxidative stress. The related gene Mt3 was also differentially expressed. Mt2 
mouse mutants have impaired spatial learning, and the protein appears to be involved 
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in the protective response against brain damage or chemical insult. Correspondingly, 
the mice have higher mortality post brain ischaemia
249
. It and the other 
metallothioneins can be induced by metal exposure. Lack of these proteins results in 
reduced oxidative stress gene expression post arsenic exposure, as well as increased 
cell lethality
250
. They are also involved in the response to non-metallic stress agents 
such as kainic acid, which induces seizures. Lack of metallothioneins here results in 
increased seizure phenotype as well as increased neuronal apoptosis
251
. It has a 
similar protective effect against dopamine toxicity
252
. Clearly the metallothioneins 
are important in protection against a variety of environmental and excitotoxic agents. 
The gene was also analysed as a standard bearer for the other genes; it has one of the 
best separations between the genotypes, as well as a reasonable fold change. RT-
qPCR for this gene would also gauge how reliably differential expression in the 
RNA-Seq can be confirmed at the qRT-PCR level in addition to analysing its 
expression in its own right. 
4.1.2.5.7 Nrp2 
The analogous human gene, NRP2, is differentially expressed in the human neurons 
and the function is more fully explained in the relevant section, 3.8.12. 
4.1.2.5.8 Slc1a1 
Slc1a1 encodes the protein Eaat3, a glutamate transporter expressed in neurons 
which is important in preventing excitotoxicity, over-signalling, and neuronal 
desensitization. It has been found that membrane presentation of the transporter, and 
subsequent increased glutamate uptake, occurs post-LTP
253
. Conversely, 
amphetamine causes the internalization of the receptor in dopaminergic neurons, 
which would presumably cause higher levels of glutamine at the synapse and 
subsequent excitatory signalling
254
. Excessive excitatory signalling in dopaminergic 
neurons has been proposed as being critical to psychosis
53
. Aged Slc1a1 null mice 
have behavioural alterations consistent with neurodegeneration
253
.  
4.1.2.5.9 Results of RT-qPCR 
The expression plots of the genes are displayed in  while a summary is given in 
Table 16.  
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Figure 24. . Expression plots for RT-qPCR results of Arc, Apoe, Avp, Hap1, Metrn, Mt2, Nrp2, and Slc1a1 differential 
gene expression. P values given underneath and gene names above. Results have been normalised to the geomean of 
three housekeeping genes. 
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RT-qPCR results P value Heterozygous Fold Change  Significance 
Arc 0.010 0.44 * 
Avp 0.0099 0.09 * 
Table 16. Summary of RT-qPCR gene level expression results for mouse cortical samples. * =p<0.05, **=p<0.01, 
***=p<0.001.Mutant expression is in percentage of the WT expression. Only significant results are displayed. 
A low proportion of the genes differentially expressed in the mouse heterozygous 
cortex were confirmed by RT-qPCR. Only two of 8 genes were confirmed. This is a 
surprisingly low number. However, the results of the RT-qPCR are not exceptionally 
different from the RNA-Seq. Only 10 genes suffer a reduction in expression of 50% 
or greater in the mouse samples, while no genes double in expression (see  for 
detail). Only a tiny minority of gene expression plots show the heterozygous and WT 
samples separating into two groups which do not overlap. Only 46 genes (including 
Avp) have counts which fulfil this criterion. So it appears as though the effects on the 
mouse cortex are relatively mild or subtle, and do not reliably appear except in a few 
cases. This may be the reason for their failure to replicate in the RT-qPCR. This 
hypothesis is borne out by more detailed analysis of the relationship between qPCR 
and counts shown in Figure 25. 
 
Figure 25. Graph displaying log2 fold change of normalised counts vs log2 fold change of normalised PCR score for each 
of the 8 genes I carried PCRs out on. Positive values indicate the mouse Der1 samples have a higher score on average. 
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Gene legends on right, differentiated by colour. Counts normalised using the “rlog” function in DESeq2 package. 
R2=0.971 
Figure 25 also shows a relatively linear relationship, although for most samples the 
fold changes are very small. Only for those two with larger fold changes (Apoe and 
Arc) was a significant difference found. This therefore lends some credence to the 
hypothesis that the mouse adult brains show relatively subtle changes.  
4.1.3 WT vs homozygous 
4.1.3.1 DESeq2 
The six WT and eight homozygous samples were analysed using DESeq2. Since sex 
ratios were balanced, XY reads were not removed. Only five genes were found 
differentially expressed between WT and homozygous samples. However, it was 
noted by Kirsty Millar that the homozygous samples show a very unusual pattern and 
the results of the subsequent investigation are discussed here with permission. As a 
PCA reveals, clustering of the samples is very unusual. The PCA plot of the 
normalised counts can be seen in Figure 26 and utilises the top 500 most divergent 
genes, as five genes would be uninformative. We can see that the WT samples are 
separated by sex primarily, as in the previous section looking at WT and 
heterozygous mice. A new PCA using only the homozygous samples can be seen in 
Figure 27, where we again see a pattern of 4 pairs of samples. PC1, explaining 43% 
of the variance, separates samples 9, 10, 13 and 14 from samples 11, 12, 15 and 16. 
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Figure 26. PCA of normalised counts for 6 WT (blue) and 8 homozygous (red) mouse hippocampal samples. Triangles 
are male. Circles are female. PCA generated using the top 500 most divergent genes. 
The split is not related to sex as each group is comprised of two males and two 
females. The split in these homozygous cortical samples is interesting. Kirsty Millar 
found that the divergence is due to approximately 200 genes, which are differentially 
expressed in both groups from the WT, but in opposite directions. A DESeq2 
analysis carried out by Philippe Gautier confirmed this and it is discussed in 4.1.3.3.  
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Figure 27. PCA of normalised counts only utilising homozygous samples. Samples 9-12 are male, 13-16 are female. 
Group One is samples 9,10, 13,14, while group Two is 11,12,15,16. PCA generated using the top 500 most divergent 
genes. PC1=43%, PC2=29% variance 
In total, only five genes were differentially expressed between WT and homozygous 
samples and had a BaseMean higher than half that of Disc1’s. The high level of in-
group variation in the homozygous sample is probably contributing to the low 
number of genes found. This is further discussed in section 4.1.3.3. One of the 
differentially expressed genes was Disc1. Given the exceptionally low number of 
differentially expressed genes I opted to concentrate my efforts on the heterozygous 
cortical samples and did not carry out RT-qPCRs. 
4.1.3.2 DEXSeq 
As with DESeq2, few changes are observed between the WT and homozygous 
samples. A total of six exons in three genes had an adjusted p value below 0.05, 
which rose to 10 exons in six genes at adjusted p value<0.1. 
4.1.3.3 Divergence of two homozygote groups 
Philippe Gautier carried out two further comparisons of the WT samples vs each of 
the homozygote groups using DESeq2. I then subsequently used GOrilla to analyse 
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the list of differentially expressed genes in each case, comparing and contrasting the 
two lists against each other and against the heterozygote list. 692 genes were 
differentially expressed by group one, and 2,619 by group two, applying the 
threshold of halved Disc1 expression and Padj<0.05. 249 of these genes are in 
common and the patterns within these were examined by Kirsty Millar. The results 
of this examination are printed in 4.1.3.3.3.  
I searched for potential explanations for the divergence in two homozygote groups. 
Two putative explanations were litter effects (uterine environment and co-dissection 
effects) and circadian rhythms. A full picture of the pedigree is available in Figure 
28. Group One consisted of mice 9, 10, 13, and 14, while Group Two Consisted of 
mice 11, 12, 15, and 16. These are sex-balanced. As seen in Figure 28, there are no 
litters which contain members from both groups. In addition, two litters make up 
each group. These contain mice 9/10/13 and mouse 14 for Group One, in addition to 
mice 11/16 and mice 12/15 for Group Two.  
 
Figure 28. Pedigree of mice used to generate homozygous Der1 cortical samples. Squares indicate male, circles female. 
Blue and pink represent unutilised mice, yellow indicates Group One homozygotes and grey Group Two homozygotes. 
Regrettably, as the dissections for the mice were done by a variety of collaborators 
not all the dissection times are available. These times do point towards potential 
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effects either of circadian rhythms or dissection factors, however. The times are 
given in Table 17. 
Mouse number Group Dissection time Notes 
9 One 2pm Dissected with mouse 10 
10 One 2pm Dissected with mouse 9 
11 Two Not recorded Dissected with mouse 16 
12 Two Not recorded Dissected with mouse 15 
13 One  11:45am  
14 One  12am (Noon)  
15 Two  Not recorded Dissected with mouse 12 
16 Two Not recorded Dissected with mouse 11 
Table 17. Mouse numbers and dissection times, carried out by collaborators Marion Bonneau, Laura Murphy, and Elise 
Malavasi. Times provided by Marion Bonneau (private correspondence).  
Group One litters were dissected either close to midday or at 2pm. The times for 
Group Two mice were not recorded and circadian rhythms can neither be implicated 
nor ruled out from the known times. Given that mouse 13 is part of the litter 
containing 9 and 10 there must have been a delay in processing these two mice. 
However, we can see that for most litters all constituent mice were dissected 
simultaneously, as expected.  It is highly possible that litter effects (uterine 
environment, dissection effects), and possibly circadian rhythms, are responsible for 
the observed phenomenon of two groups. 
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4.1.3.3.1 Group One 
4.1.3.3.1.1 GOrilla Process 
 
Figure 29. Top 10 significantly overrepresented Process GO terms for the genes which are differentially expressed 
(p<0.05). The enrichment figure is given after each bar and the scale is logarithmic. 
There are a number of interesting GO terms, with “behaviour” having perhaps the 
most relevance to our model The genes associated with this GO term include 
interesting candidates, including many that were also seen in other comparisons. 
These included Arc, Apoe, Avp, Oxt, (all mouse heterozygous cortex), Drd2 (human 
neurons), Drd1a, Chrna7 (mouse heterozygous cortex, CNV studies), Synj1, Cacnb4 
(mouse heterozygous hippocampus), Grid1. “Regulation of cation transmembrane 
transport” included many of these genes, but also Shisa6 and five potassium channel 
proteins Kcns2, Kcnc2, Kcna1, Kcnab1, Kcnj2 and the interacting protein Kcnip2. 
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4.1.3.3.1.2 GOrilla Function 
 
 
Figure 30. Top 10 significantly overrepresented Function GO terms for the genes which are differentially expressed 
(p<0.05). The enrichment figure is given after each bar and the scale is logarithmic. 
Many of the terms contain the same genes found in the term “GABA-A receptor 
activity”, p value= 3.8x10
-4
. This has the five genes Gabre, Gabrg1, Gabrb2, 
Gabra1, Gabrq, all subunits of the GABAA receptor which mediates inhibitory 
synaptic activity. Gabre and Gabrq encode the subunits ε and θ, which are less 
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4.1.3.3.1.3 GOrilla Component 
 
Figure 31. Top 10 significantly overrepresented Component GO terms for the genes which are differentially expressed 
(p<0.05). The enrichment figure is given after each bar and the scale is logarithmic. 
As before, the terms relate to specialised structures of the neuron. Grin2a is one of 
the genes highlighted in “synapse”, and its location on the neuron is known to be 
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4.1.3.3.2 Group Two 
4.1.3.3.2.1 GOrilla Process 
 
Figure 32. Top 10 significantly overrepresented Process GO terms for the genes which are differentially expressed 
(p<0.05). The enrichment figure is given after each bar and the scale is logarithmic. 
One term of interest is “translation”, which has 53 genes encoding either 
mitochondrial ribosomal or ribosomal small and large protein subunits. This is a 
highly interesting change and may be of relevance to the needs of neurons, which 
require localised protein translation. “Oxidation-reduction process” may have some 
relevance to mitochondrial dysfunction.  
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4.1.3.3.2.2 GOrilla Function 
 
Figure 33. Top 10 significantly overrepresented Function GO terms for the genes which are differentially expressed 
(p<0.05). The enrichment figure is given after each bar and the scale is logarithmic. 
These functions closely relate to the processes described in the previous section, and 
highlight ribosomal and mitochondrial dysfunction as themes, with 12 genes relating 
to oxidoreductase activity.  
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4.1.3.3.2.3 GOrilla Component 
 
Figure 34. Top 10 significantly overrepresented Component GO terms for the genes which are differentially expressed 
(p<0.05). The enrichment figure is given after each bar and the scale is logarithmic. 
The top terms are broad, but terms 10-13 are mitochondria related, and the 
significance of the top terms appears driven by genes within these terms. 
4.1.3.3.3 238 genes in common that diverge 
Of the 249 genes that were differentially expressed between the each group and the 
wild-type, and in common, only 11 change in the same direction in both homozygote 
groups. The following of these 11 are downregulated; Arc, Disc1, Dusp5, Gadd45b, 
Junb, Per1, Plk3, Sertad1, Zfp948. The following are upregulated; Gm2115, Nkx3-1.  
Therefore the majority of the other genes in common are differentially regulated in 
opposite directions, with a difference from the WT being 30% on average. Taking 
the absolute % deviation from the wildtype expression, the difference between Group 
One and Group Two was on average 1.4%. This change was an average of 10% for 
the 11 genes that were in common, and 1% for the 238 which are different in sign. 
Therefore, the changes in opposite directions are strikingly similar in magnitude, 
being about 1% different from one another in terms of wildtype expression, and 
deviating around 30% from the wild type. 115 were increased in Group One, with 
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123 decreased, and these were decreased and increased in Group Two compared to 
wild-type respectively. The 249 genes are highly enriched for GO terms relating to 
“cognition” (5.82, p=1.16x10
-11





), among other terms. In addition, 120 are shared with 
the list of genes differentially expressed in the heterozygous Der1 cortex, with the 
vast majority of these having an unexpected division in sign change. Of the 120, 
three changed in the same direction in all lists; Group One and Group Two of the 
homozygotes, and the Heterozygous Der1. These were Disc1, Nkx-3.1, and Zfp948, 
which are downregulated, upregulated, and downregulated respectively. However, all 
120 genes were changed in the same direction in Group Two and in the 
Heterozygous Der1. We therefore see a surprising overlap between these three 
groups of genes, and a highly unusual convergence of sign change between one of 
the homozygous and one of the heterozygous mutations. The changes were also 
similar in magnitude between Group Two and the Heterozygous Der1, with the mean 
difference between the changes being 2% of wildtype expression, and the maximum 
being 35%. This was in Disc1, which is at only 18% of wildtype expression in Group 
Two, but at 53% in the heterozygous Der1. It is interesting that the expression 
remains at 18% despite both loci being mutated; 9% per loci is higher than the 3% of 
expression the damaged locus appears to produce in the Der1 condition. The next 
largest change is 10%, in Zfp948.  
4.1.4 Discussion 
The cortical heterozygous samples show differential expression of a large variety of 
genes compared to the wild type samples. These converge on some particularly 
interesting pathways. The differential expression of AMPAR and NMDAR subunits, 
proteins such as Arc (confirmed by RT-qPCR) and Egr1 involved in learning and 
memory, and trafficking molecules such as the kinesins and myosins indicates that 
there may well be synaptic abnormalities in the mouse cortex. Overlaps with other 
papers highlight Neurexin-1, protocadherins, and other synaptic structural proteins. 
There is therefore evidence for LTP related abnormalities in these cells; from the 
nucleus, to dendritic trafficking, to the synapses themselves. It should be noted that 
the majority of changes are low in absolute level. Many of the differentially 
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expressed genes have low fold changes and the noise inherent to RT-qPCR makes 
detecting them unlikely. As I showed, the qPCR is a good reflection of the RNA-Seq, 
but the small changes make verifying the differential expression difficult, and it is 
quite likely that given the small effect sizes chance is playing a role in the apparent 
differential expression of some genes. 
In contrast, there are very few differentially expressed genes between the wild type 
and homozygote samples when taken as a whole. The minority of genes that are hold 
interest however; Junb is a transcription factor while Per1 encodes a gene key in 
circadian rhythms. One aspect of particular interest is the splitting of the 
homozygous cortical samples into two groups which are not separated by sex, and 
the distinctive phenomenon of about 238 genes with the same fold changes but in 
opposite directions in each group. This set of genes includes many of those 
candidates which were looked at in the cortical heterozygous analysis, which are 
changed in the same direction in Group Two and the cortical heterozygote compared 
to Group One. 
We therefore have a scenario with several groups of genes which must be clearly 
delineated. These are 
1. Genes altered solely in the heterozygous Der1 cortex 
2. Genes altered solely in Group One of the homozygous Der1 cortex 
3. Genes altered solely in Group Two of the homozygous Der1 cortex 
4. Genes which overlap between Group One and Group Two which are changed 
in the same direction. These are the minority, numbering 11, and are 
theoretically the invariant aspects of Der1 homozygous mutation. Three also 
overlap with the heterozygous Der1 cortex mutation and change in the same 
direction there. One is Disc1. 
5. Genes which overlap between Group One and Group Two with changes in 
different directions. These are the majority of overlapping genes, numbering 
238 and the magnitude is nearly the same. They are overrepresented for genes 
involved in behaviour, cognition, and learning. 
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6. Of these 238, there are 117 that overlap with those changed in the 
heterozygous Der1 cortex and move cleanly as a group. 71 are upregulated in 
Group Two and the heterozygous cortex, and downregulated in Group One, 
with vice versa for the other 46. 3 other genes change in the same direction in 
all three. 
There are some theoretical explanations.  
The first is that the aberrant Der1 locus is giving rise to mutant Disc1 proteins, which 
are interfering in the activities of oligomeric Disc1. This hypothesis requires that 
oligomeric and monomeric Disc1 have differing functions which at least in part are 
non-overlapping, and that the mutant Disc1 proteins cannot perturb the wild-type 
Disc1 in its monomer form, only when it oligomerises. The effect of the lost 
oligomeric functions is represented by the differentially expressed gene list in 
common between the homozygote and heterozygote functions, as these will be 
disturbed in both models. These genes included Mt2, Ntrk3, Metrn, Drd2, Chrna7, 
Apoe, Slc1a1. The monomeric functions that full length Disc1 carries out should be 
partially disrupted in the heterozygotes, and fully in the homozygotes, so under this 
model some of these genes may be related to Disc1’s monomeric functions as well. 
However, it is very difficult to explain the very clear phenomenon of a large group of 
genes changing in with the same magnitude but in different directions in the two 
homozygote groups, and that the majority of differentially expressed genes are not 
overlapping between the homozygote groups. As discussed in 4.1.3.3, both litter 
effects and circadian rhythms may be confounding or even causing the observed two 
group phenomenon. It is difficult to identify exactly how many genes might be 
altered by circadian rhythms; a recent study found that 43% of mouse genes showed 
circadian rhythms in translation in at least one of 12 organs, while the database 
CGDB names 9,580 gene as having daily oscillating expression
256,257
. However, I did 
find a list of genes which, when mutated, give behaviour phenotypes in mice relating 
to circadian rhythms
258
. These genes numbered 28. They were listed in Lowrey et al. 
as Bmal1, Bmal2, Ccrn41, Clock, Cry1, Cry2, Cry3, Csnk1a1, Csnk1d, Csnk1e, Dbp, 
Dec1, Dec2, Fbx13, Mtnr1a, Mtnr1b, Npas2, Nrld2, Opn4, Per1, Per2, Per3, Prok2, 
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Rora, Rorb, Rorc. Vip, Vipr2. I searched both Group One and Group Two for these 
genes, using both the above names and the synonyms given in Lowrey et al. Per1 
and Per2 were differentially expressed in Group One, while Cry1, Csnk1a1, Per1, 
Per2, and Rorb were differentially expressed in Group Two. This is evidence in 
favour of circadian rhythms being partially or wholly responsible for the presence of 
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4.2 Generation and initial analysis of mouse hippocampal 
RNA-Seq data 
4.2.1 Introduction 
The mouse hippocampal data was analysed in the same way as the mouse cortical 
data. 
4.2.2 WT vs heterozygous 
4.2.2.1 DESeq2 
As previously mentioned in the cortical analyses, two WT mice had to be removed 
from the analyses due to one being an outlier. The second was randomly chosen and 
removed to balance the sex ratios. This outlier mouse was also used to generate 
hippocampal RNA-Seq data, so two WT mice have therefore been removed from the 
hippocampal analyses as well. A total of 184 genes were found differentially 
expressed, which are displayed in a volcano plot in Figure 35. 
 
Figure 35. A volcano plot of the hippocampal RNA-Seq data for all genes with BaseMean>55. X-axis represents the log2 
fold change between WT and heterozygoys Der1 mice, while the Y axis represents significance (-log base 10 of p value). 
Black dots have an adjusted p value above 0.05, blue dots are significant with an adjusted value below 0.05. Red dots 
with labels represent genes for which a qPCR was carried out. 
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A PCA of the normalised counts for the 14 samples is in Figure 36. The result is very 
similar to that of the WT vs heterozygous comparison for the cortical samples. The 
samples are separated by a factor which corresponds to sex, and then by a factor 
which corresponds to Disc1 mutant status for the females. However this second 
factor does not correspond to mutant status for the males. WT and heterozygotes are 
clearly interspersed. The translocation does not appear to exert as strong an effect 
here as in the cortical samples, where translocation status clearly was associated with 
PC2. This is in some way unsurprising; there were over 2,000 genes differentially 
expressed in the cortical heterozygotes, while here the number is closer to 200. 
 
Figure 36. PCA of normalised counts for 6 WT (blue) and 8 heterozygous (red) mouse hippocampal samples. Triangles 
are male. Circles are female. PCA generated using the top 184 most divergent genes. 
175 genes were significantly differentially expressed and had a BaseMean greater 
than half that of Disc1’s. 
4.2.2.2 DEXSeq 
A total of 136 exons in 131 genes were found differentially expressed between the 
two groups of samples, with adjusted p value below 0.10. This fell to 52 exons in 50 
genes when the filter of p<0.05 was applied.  
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4.2.2.3 GOrilla 
As in the human analysis in 3.6, GOrilla was utilised to analyse gene ontologies 
overrepresented among the differentially expressed genes. This analysis was carried 
out by Marion Bonneau and Kirsty Millar and is described in the corresponding 
thesis. 
4.2.2.4 Comparison to other papers 
I carried out an analysis identical to that described in 3.7. using the same papers. 
Removal of duplicate genes and determination of a match was carried out in the 
same manner as previously. A summary of the results is given in Table 18. 
 
Hippocampus Heterozygous 
Paper Number of 
genes 
P value Selected genes 
of interest PGC1 10 1.2E-04 Cacnb2 
PGC2-1 21 2.9E-10 Erbb4, Ntn5 
PGC-2 15 0.99 Erbb4, Ntn5 
Nrxn1, Cacnb2 
PGC3 2 1.8E-1 Nrxn1 
DI 4 2.2E-03 Disc1, Snap91 
B 18 7.7E-08 Grin2a 
W 56 1.6E-19 Gpc1, Calb2, 
Nrxn1 
Sx2mmd17 22 2.3E-05 Erbb4 
Sx2mmd50 30 1.9E-08 ~ 
Sx8mmd17 9 8.9E-03 ~ 
Sx8mmd50 4 5.8E-03 Nrxn1 
Sx8wmd17 37 1.9E-17 Cacnb2 
Sx8wmd50 4 1.7E-01 ~ 
Table 18. Summary of overlap with other papers. Each paper is indicated by the acronym given in 1.8.1. The number of 
genes significant in both our study and the indicated one is given in the first row. The hypergeometric probability is 
given in the second, and a subset of interesting genes within this list of overlapping genes is within the third. 
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There were some highly interesting findings in this analysis. As with the mouse 
cortical analysis, almost all sets of genes from the papers had significant overlap with 
the list of differentially expressed features, with the exception of a Srikanth et al. 
neuronal model. It is also noteworthy that many genes appear in several studies, such 
as Erbb4, Nrxn1, and Cacnb2. In many cases, the genes are implicated by both a 
GWAS/CNV study and by a RNA-Seq analysis of an iPSC-derived model, indicating 
convergence between these different approaches. Some gene orthologues are also 
differentially expressed in the human t(1;11) neurons, such as GPC1 and ERBB4. 
Snap91 is also differentially expressed in the hippocampus of the homozygous 
mutant. We can see that there is overlap between both models of the t(1;11), as well 
as with other investigations of psychiatric illness.  
4.2.2.5 Genes of interest 
Although I did not carry out qPCRs, I had selected some candidates which are 
described in turn. A summary table of fold changes, etc. is also given in Table 19. 
One primary reason for not carrying out qPCRs was the low fold change (never 
>35%) of samples, as well as the lack of clear distinctions between the WT and Der1 
samples (in no cases did they cluster into two separate groups). 
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Table 19. Highlighted information about possible candidates. TRUE indicates that the gene is differentially expressed in 
the model of interest. Paper abbreviations are as in 3.7.1. 
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4.2.2.5.1 Foxp2 
Foxp2 encodes a transcription factor known for its role in language; it is mutated in 
hereditary language disorders and the human homologue appears to have undergone 
human specific evolution. Foxp2 can induce neurite outgrowth, migration, and 
progenitor proliferation
259
. These are all processes which DISC1 is well known to 
have a role in, and the two genes are further linked by the fact that in human cells 
FOXP2 can repress DISC1 expression. Lack of this repression is found in two alleles 
of the FOXP2 gene which segregate with developmental verbal dyspraxia
260
. It 
seemed interesting that the gene was dysregulated here; it appears to be upregulated. 
Although no direct regulation of FOXP2 by DISC1 has been shown, it is interesting 
that both genes have overlapping functions. It could be possible that the two are 
capable of repressing one another in order to prevent over-stimulation of the relevant 
pathways; this would explain the upregulation of the gene in the mutant mice. 
4.2.2.5.2 Ndst3 
NDST3 (N-acetylase and N-sulfotransferase 3), the human homologue, is 
differentially expressed in the studies of Wen et al., Brennand et al., and the mouse 
heterozygous hippocampus model. It has also previously been implicated by a 
schizophrenia GWAS
124,132,261
. It therefore has support for its role in schizophrenia 
by a wide variety of investigative methods. The function of the encoded protein is to 
alter heparan sulfate, a molecule which is often found attached to various 
extracellular proteins. The modification it carries out is the first step for all other 
heparan sulfate modifications. Heparan sulfate proteoglycans usually have roles in 
the extracellular matrix; one example is GPC1, which is differentially expressed in 
the human neurons, see 3.8.6. It has been suggested that the heparanase/heparan 
sulfatase balance may alter the in/out trafficking of these altered proteins
262
. Heparan 
sulfate can also potentiate FGF-FGF receptor signalling and glycoproteins have roles 





Netrin-5 is one of a family of proteins involved in axonal guidance and neuronal 
development. Ntn5 is expressed particularly highly in regions of the brain which 
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undergo neurogenesis after development, including the hippocampus. It is co-
expressed with Dcx and Mash1 in neuroblasts. Expression decreases as the cells 
mature, and some of these cells are destined to become GABAergic interneurons
264
. 
Mutant mice had a phenotype similar to other axonal guidance genes nulls such as 
Nrp2 or Sema6a; ectopic migration of motor neuron cell bodies
265
. Given the 
dysregulation of other axonal guidance molecules, as well as its possible role in the 
hippocampus, Ntn5 seemed like an interesting gene. 
4.2.3 WT vs homozygous 
4.2.3.1 DESeq2 
A PCA of the normalised counts is in Figure 37. The sex of the mice separates the 
samples. The number of differentially expressed genes is one, Disc1; even lower than 
in the WT vs heterozygote comparison, where mutant status did not correspond with 
principalcomponent 2. We can see in Figure 37 that mutant status does not 
correspond with principal component 2 here either. 
 
Figure 37. PCA of normalised counts for 6 WT (blue) and 8 homozygous (red) mouse hippocampal samples. Triangles 
are male. Circles are female. PCA generated using the top 500 most divergent genes. 
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4.2.3.2 DEXSeq 
At adjusted p value<0.1, 305 exons in 251 genes were differentially expressed 
between the two groups of samples. 118 exons in 103 genes met the criterion of 
adjusted p value<0.05. Disc1 has two differentially expressed exons. The two Disc1 
downregulated exons are on both sides of the breakpoint; however the changes are 
more severe after the breakpoint, indicating expression is more severely affected 
here.  
4.2.3.3 GOrilla 
The genes from the DEseq2 and DEXseq were combined to compare against the 
background list of expressed genes. The only gene differentially expressed at the 
whole gene level also has exons differentially expressed. It is Disc1. A total of 103 
genes at the p<0.05 level were implicated by DEXSeq, and these were compared 
against the background list of 27,957 genes detected at the whole gene level. 
Significance was set at p<1x10
-3
. 
4.2.3.3.1 GOrilla Process 
 
Figure 38. Top 10 significantly overrepresented Process GO terms for the genes which have a differentially expressed 
exon or are differentially expressed (p<0.05). The enrichment figure is given after each bar and the scale is logarithmic. 
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The top 10 GO Process terms are displayed in Figure 36. We can see that some of the 
terms in the top 10 are of particular interest to synaptic activity, such as “regulation 
of synaptic vesicle endocytosis”. The genes within this group were Snap91, a 
synaptosome associated protein, Pip5k1, a phosphatidylinositol-4-phosphate 5-
kinase, and Mff, a gene named “mitochondrial fission factor”. The GO terms of 
relevance to apoptosis also seemed of possible relevance and included the well-
known oncogene Src. 
4.2.3.3.2 GOrilla Function 
Two terms were significant. One, “binding”, is too vague to be of any use. The other 
is far more specific, “acetylcholine receptor inhibitor activity” (p value=5.8x10
-4
, 
enrichment factor=53.54), containing the genes Ly6e and Ly6h. 
4.2.3.3.3 GOrilla Component 
Three terms were significant. These were “extrinsic component of endosome 
membrane” (p value=3.1x10
-5
, enrichment factor=46), “postsynaptic density” (p 
value=2.5x10
-4
, enrichment factor=4.8) and “postsynaptic specialization” (p 
value=2.8x10
-4
, enrichment factor=4.8). All of these relate to the synapse, and 
therefore may point towards some sort of synaptic alteration in the mouse 
hippocampus. 
4.2.3.4 Comparison to other papers 
I carried out an analysis identical to that described in 3.7 using the same papers. 
Removal of duplicate genes and determination of a match was carried out in the 
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Hippocampus Homozygous  
Paper Number 
of genes 
P value Selected genes of interest 
PGC1 6 6E-04 ~ 
PGC2 
 
13 1.5E-08 ~ 
PGC2-2 7 0.99 Ino80e, Snap91 
PGC3 2 6E-2 Ino80e 
DI 2 2.4E-02 Snap91 
B 6 6.4E-03 Wnt7a 
W 16 3.2E-04 Wnt7a 
Sx2mmd17 14 1.5E-05 Kif1a 
Sx2mmd50 10 6.5E-03 Kif1a 
Sx8mmd17 8 2.4E-04 ~ 
Sx8mmd50 0  ~ 
Sx8wmd17 12 3.4E-05 ~ 
Sx8wmd50 4 3.3E-02 ~ 
Table 20. Summary of overlap with other papers. Each paper is indicated by the acronym given in 3.7.1. The number of 
genes significant in both our study and the indicated one is given in the first row. The hypergeometric probability is 
given in the second, and a subset of interesting genes within this list of overlapping genes is within the third. 
All the implicated genes have only exon level differential expression, perhaps 
indicating subtle splicing changes rather than whole gene differential expression. 
Nevertheless, we see some significant overlaps with other papers, although not as 
many as with the heterozygous mutation hippocampal or cortical samples. Of interest 
is Snap91, which as already mentioned is also differentially expressed in the 
heterozygous mouse hippocampus.  
I also investigated the differentially expressed exon locations within their genes. 
Snap91’s exon is an N-terminal exon which appears to be in all isoforms. Kif1a’s is 
the 40
th
 exon on UCSC, which appears to be in all isoforms. Wnt7a’s exon is the N-
terminal exon which appears to be in all isoforms. Ino80e’s is an alternative N-
terminal exon found in two isoforms; these appear to encode longer proteins than 
other transcripts but there is little functional information.  
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4.2.4 Discussion 
The changes in the hippocampus appear to be of a far lesser number than the changes 
in the human neuron or mouse cortical models, with the total number being only 
about 10% of that in the other models. The heterozygous hippocampus does show 
some interesting changes, and the overlapping genes with other papers are of known 
interest. They are also seen in the mouse cortex as well (Nrxn1) or the human 
neurons (Erbb4, Gpc1). The overall enrichment of synaptic genes corresponds with 
the findings of the mouse heterozygous cortex. 
In the case of the mouse homozygous hippocampus, only Disc1 was differentially 
expressed at the whole gene level, while 103 genes showed splicing differences. It 
was also seen that the PCA did not identify mutation status as being one of the two 
principal components and male and female samples differed greatly from the WT 
samples without clustering together, although sex appeared to be a major component 
of sample differences. The splicing differences in Snap91 (in both heterozygous and 
homozygous samples) and Kif1a might have suggested some kind of alteration with 
synaptic vesicles, but the exons do not appear to have any unique functional 
significance, as they appear in all isoforms. Overall it is difficult to identify a clear 
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5 DECONVOLUTION OF THE 
RNA-SEQ DATA USING 
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5.1 Introduction 
Deconvolution is an approach to extract data from a complex RNA-Seq sample. Each 
gene is a point of information which helps inform the estimated proportions of pure 
cell types making up the complex sample. Deconvolution algorithms are widely 
available. They typically assume that the contribution of each cell type to the mixed 
cell type expression is linearly related to the proportion of the mixed sample that is 
that pure cell type. This is described by the following equation; 




Where the transcriptional value X for gene j in pseudosample a is equivalent to the 
linear sum of the respective gene’s values from pure samples Xs….q, multiplied by 
their relative proportion ps….q, with all proportions adding to 1. This of course 
assumes that the transcriptional activity of pure cell types does not alter in the 
presence of other cell types. Each measured gene gives an equation similar to that 
above; if there are more measured genes than cell types the proportions can be 
determined. However, in practice the equations are not correct as it is unlikely that 
proportions can be found which solve the above equation for every gene. Therefore, 
close approximations are given as answers. These optimal proportions can be found 
using a non-negative least linear squares approach, although Cobos et al. discuss 
other approaches and deconvolution as a problem in a useful review
266,267
.s 
To briefly summarise, RNA-Seq deconvolution has three components.  
 The mixed transcriptional profile, M 
 The reference profiles G, each corresponding to one of the pure cell types 
present in the mixed cell population. Most genes are unlikely to be 
specifically expressed in a single cell type and are therefore not informative, 
so a subset of highly informative genes are used for the deconvolution. 
 The relative proportions of the cell types, C, which have their expression 
profiles described by G.  
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 Given any two of these components we can derive the third, assuming that 
there is a relationship between the proportion of cell types and their 
representation in the sequenced sample. Such a relationship is likely to be 
linear. 
DISC1 immuno-reactive neurons have been found throughout all layers of the human 
cortex, but also in rat cortical astrocytes, neurons, oligodendrocytes, and 
microglia
69,268
. Hence, there is potential for the t(1;11)/Der1 to impact a wide variety 
of cell types, not just neurons. I first sought to deconvolute the wild-type and 
heterozygous Der1 mouse RNA-Seq profiles. My interest in this was primarily to see 
if there were any differences in relative cell types caused by the Der1 mutation. This 
could be due to altered cell development and differentiation, or degeneration, 
resulting in unusual levels of some cell types. Due to the importance of 
neurodevelopment to the aetiology of psychiatric illness, it seemed a plausible 
method by which the Der1 exerted its effects. I initially aimed to deconvolute the 
profiles on a gross scale, looking for changes not within subtypes of neurons but for 
changes in neuronal vs various non-neuronal cell types such as astrocytes, 
oligodendrocytes, microglia, and endothelial cells. 
I next sought to deconvolute the iPSC-derived cell profiles. Although the cultures are 
primarily neuronal in nature, it has been shown by Bilican et al. that the efficiency of 
the neuronal differentiation is not total. About 86% of cells are TUJ1
+
 neurons, and 
glial cells are present. GFAP
+
 cells (astrocytes) constitute 5-10% of cells
143
. I 
hypothesised changes in broad classes (astrocytes, oligodendrocytes, etc.) might be 
present, and describe my efforts to investigate this in this chapter. In the next chapter 
I looked at more detailed subclasses of neuron, interneuron, and other cell types.  
5.2 Deconvolution datasets and program 
5.2.1 Selection of an appropriate reference dataset 
Regardless of the program used, successful deconvolution of mixed RNA-Seq data 
samples requires pure cell RNA-Seq data, G. For practical reasons I determined to 
use freely available data sets, which also fulfilled the following criteria:  
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 They utilized a variety of brain cell types. 
 The identification of each cell type was trustworthy. This is important so as to 
determine which genes are “markers” for the cell types of interest. It is likely 
that there will be some contaminating cells even within each “single-origin” 
RNA-Seq profile. 
 The sequencing depth was comparable to our own. 
Sequencing depth is especially important. Even post normalisation to total read 
number, samples sequenced to different depths are not directly comparable. There 
are two main reasons. It can be immediately appreciated that with increased 
sequencing depth comes an increase in the number of detected genes, as poorly 
expressed RNA features now have a greater likelihood of being sequenced. This 
alone can lead to false positive claims of differential expression between two 
biologically identical samples of different sequencing depth, as it will now appear 
that the gene is expressed in one sample and not in the other. For example, Tarazona 
et al. noted that regardless of total sequencing depth (from 20 million up to 200 
million), increased depth always increased the number of genes with at least five 
counts
269
. Furthermore, this increase was especially pronounced the lower the total 
number of reads. The comparison of a 20 million sequencing depth sample to a 60 
million depth sample will therefore be more problematic than the comparison of a 60 
million depth sample to a 100 million depth sample. Secondly, genes with lower 
expression are more dramatically affected by increased sequencing depth, even post 
normalisation. Mortazavi et al. showed that after only 8 million reads, over 95% of 
the most highly expressed genes had RPKM normalised values within 5% of the 
values they would have at 40 million reads. Of the genes with the lowest expression, 
approximately only 50% had RPKM values within 5% of the value they would have 
at 40 million reads 
270
. Since RPKM values are normalised to total sequencing depth, 
a comparison between sequencing at eight and 40 million reads might lead to the 
erroneous conclusion that these poorly expressed genes are differentially expressed, 
given that over half have differences in RPKM of over 5%. We can conclude that 
even normalising for the increase in sequencing depth, genes with low expression 
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show changes that are more dramatic in apparent expression as sequencing depth 
increases. 
I conducted a search of the literature to find a comparable data set for deconvolution 
of mouse samples, and chose the data set described in Zhang et al.
153
. This is 
accessible through the NCBI GEO under accession number GSE52564. These data 
were obtained via sequencing of 100bp paired-end reads, with 65.6 ± 5.4 million 
reads sequenced (mean ± standard deviation). In comparison, the data from our 
mouse cortices were obtained via sequencing of 100bp single-end reads, so the 
length and therefore the number of mapped reads should be similar. For six WT 
samples, 75.3 ± 11.9 million reads were sequenced, for eight heterozygous Der1 
samples 89.2 ± 6.3 million reads were sequenced, and for eight homozygous Der1 
samples 98.7 ± 17.3 million reads were sequenced. 
The sample generation method described by Zhang et al. is summarised in Figure 39. 
They pooled dissected cerebral cortices from three to twelve mice for each cell type, 
before purifying cell types via immunopanning and FACS, which they stated were 
equally viable and effective methods of cell purification with no discernible 
differences in expression profiles in purified cells. Astrocytes and endothelial cells 
were FACS-purified, while neurons, microglia, and oligodendrocyte lineage cells 
were purified by immunopanning. Oligodendrocyte lineage cells were isolated from 
P17 mouse brains, while astrocytes, endothelial cells, and neurons were isolated from 
P7 mouse brains. In total seven different RNA-Seq profiles were generated, from 
astrocytes, neurons, oligodendrocyte precursor cells, newly formed oligodendrocytes, 
myelinating oligodendrocytes, microglia, and endothelial cells. Two pools were 
generated for each cell type and I averaged these for each of the seven enriched 
RNA-Seq profiles. It should be noted that the ages of the mice utilised by Zhang et 
al. are not the same as our own; it is the case with astrocytes at least that age alters 
transcriptional profiles; Zhang et al. produced a follow up paper which segregated 
astrocytes by age and found differences
271
. This is likely to be the case with other 
cell types as well. 
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Figure 39. Adapted from Zhang et al. 2014203. Summary of Zhang et al. sample generation method. The Oligodendrocyte 
samples were further purified into Oligodendrocyte Precursor Cells, Newly Formed Oligodendrocytes, and Myelinating 
Oligodendrocytes before sequencing.  
5.2.1.1 Comparing units across datasets 
I sought to use values of RNA-Seq expression which are comparable across samples 
in an experiment. Zhang et al. have provided their data as Cufflinks-generated 
FPKMs (version 1.3.0) as well as in raw format. Cufflinks-generated FPKMs 
(version 2.2.1) were also provided for all our WT and Der1 mouse RNA-Seq 
experiments as part of the commercial RNA-Seq data generation process. I therefore 
initially opted to use the conveniently generated FPKMs, which are comparable 
across samples as they have been normalised to total millions of reads for each 
sample. FPKM estimations appear to be near-identical regardless of Cufflink version 
number, see (http://cole-trapnell-lab.github.io/cufflinks/benchmarks/ visited on 
14/6/18). However, deconvolution carried out on Cufflinks-generated FPKMs 
underperforms compared to deconvolution carried out on many other measurements 
of gene expression. Jin et al. undertook a comparative analysis of deconvolution 
utilising several expression quantification methods including Cufflinks. They utilised 
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RNA-Seq of pure RNA (universal reference human RNA and brain RNA), as well as 
RNA-Seq of mixed RNA of the two pure samples, mixed in a 3:1 ratio. They then 
compared projected values of expression (0.75)(Universal reference expression) + 
(0.25)(Brain expression) against the actual value of expression of the mixture. See 
Figure 40
272
. Jin et al. have here analysed the RNA-Seq profiles with a number of 
diffierent quantification methods including EdgeR, Salmon, Kallisto, and FPKMs 
generated by Cufflinks. They then display the rank of each gene or isoform’s 
expression as projected by the 3:1 ratio of universal:brain against the rank of the 
gene in the RNA-Seq of the 3:1 mixed RNA. We can see that for some quantification 
methods, such as RSEM.count, the predicted by deconvolution and actual rank are 
highly similar for all genes. In general there is a strong linear relationship between 
predicted and actual rank, but this is weaker in isoforms than in genes and especially 
weak in FPKM-generated cufflinks. By this we can state that the use of Cufflinks as 
a quantification tool greatly deviates predicted gene expression from actual 
expression in deconvolution approaches. It can also be observed that more poorly 
expressed genes/isoforms are more likely to deviate from linearity.  
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Figure 40. Comparison of expected versus observed gene expression generated by different programs at the gene level 
(A) and isoform level (B). Here, a gene/isoform’s expression rank has been normalised by total number of 
genes/isoforms. The Y axis indicates the normalised rank as predicted by linear weighting of the pure reference sample 
expression according to their proportion in the mixture, while the X axis indicates the actual normalised rank of a 
mixture utilising those proportions. Figure replicated from Jin et al.272. 
However, upon using the FPKMs, I discovered some error had evidently occurred 
during the production of FPKMs from the raw counts. I describe this in more detail 
in the relevant section.  
5.2.1.2 Selection of marker genes 
Deconvolution is faster, more accurate, and less variable if only the most useful 
subset of the pure cell transcriptome is utilised. Many transcripts do not inform 
deconvolution and may in fact introduce noise, making their exclusion desirable. The 
most informative transcripts of all for deconvolution are those which are uniquely 
expressed in a cell type of interest, and which also display low variation across 
replicates. A minimum level of expression, so as to be free of low count biological 
noise, is also to be desired. Transcripts such as these are referred to as “markers”, 
although given the paucity of such clear identifiers, in practice transcripts which 
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show high expression in a single cell type and reliably low expression in others are 
used as markers
266
. Expression values at both the gene and isoform level can be 
utilised. Isoform-level markers may add discriminating power, especially where the 
overall transcriptomic profile of the cells within the convoluted sample is quite 
similar and may be distinguished more by alternative splicing rather than by 
alternative gene transcription. I used genes as identifiers, given that the Zhang et al. 
cell types are broadly distinguished and the gene level data is already available.  
Zhang et al. identified marker genes as having a FPKM >5 and carried out analyses 
using this benchmark. Given the ready availability of their data I used these marker 
gene lists as a starting point and further narrowed the lists to increase accuracy. 
5.2.1.3 Range filtering of data 
Filtering of the upper and lower bounds of marker gene expression prior to 
deconvolution has been investigated as a means to improve deconvolution accuracy. 
Genes with low expression can be unreliable, as the variation between cell types 
might be due to poor transcript detection rather than absence of the transcripts. A 
practical approach to this was taken by Mohammadi et al. in their review of 
deconvolution methods
134
. They noted that for microarray data, a theoretical upper 
and lower bound can be established. Upper limits are bounded by microarray 
sensitivity, while below a certain threshold, the assumption of linearity between 
transcript prevalence and measured expression has been shown to not exactly hold. 
However these limits do not offer any practical guidance as most values are not close 
to them and cannot be excluded on this basis. RNA-Seq data is even more untethered 
from a fixed standard, as the sequencing of a particular transcript does not become 
“saturated” as a fluorescent signal can. Mohammadi et al. attempted to establish 
upper and lower limits for marker expression filtering, but often found that these 
limits diminished the quality of the deconvolution rather than enhancing it. Even a 
method they described as “adaptive filtering”, in which limits were delineated based 
on sudden changes of expression between a gene and the next highest/lowest 
expressed gene, was often detrimental in deconvolution quality, although it did 
occasionally outperform bluntly selecting cut off points without prior information. It 
appeared that approximately half of the datasets showed improved deconvolution, 
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while half showed inferior deconvolution (measured by the mean difference between 
all estimated cell frequencies and their respective true frequencies for all samples).  
It is intuitive that range bounding could have a negative effect on deconvolution. The 
optimal situation would be to have very many moderately expressed, cell type 
unique, low cell to cell variance transcripts as markers. However, markers can also 
be highly expressed. A marker gene may well have a biological role in the cell type it 
marks, and therefore can be highly expressed in order to carry out that role. Range 
bounding therefore is highly likely to exclude the very genes which are informative 
marker genes. If the optimal moderately expressed markers were extremely 
prevalent, then bounding would likely have a positive effect on deconvolution. 
Improvements in deconvolution from range bounding likely result from the exclusion 
of genes which might well be cell-specific but are too variable in expression within 
the cell type they mark, introducing inaccuracy. It is therefore imperative to adopt a 
heuristic, flexible approach. 
Given that even sophisticated range bounding is often detrimental to deconvolution, I 
opted for a simple approach. For all sets of marker genes for all cell types, I imposed 
different range bounding, or none, and observed what combinations resulted in the 
superior deconvolution of in silico convoluted pseudosamples (see 5.2.2.1). This 
approach is conceptually simple and is easily carried out, allowing a full comparison 
of possible combinations of range bounding. 
5.2.2 Selection of deconvolution programme 
I searched the literature for a deconvolution software package that I could utilise. 
DeconRNASeq described by Gong et al. was one example. Like most deconvolution 
methods it assumes that the formula described below accurately describes the 
relationship of a mixed sample’s transcriptional values to those of the pure samples 
of which it is a mixture
135
. Their algorithm then determines the values for all cell 
proportions by solving the non –negative least squares problem for each marker 
transcript. Since all proportions are assumed to add up to 1, the algorithm cannot 
account for “missing” cell types. The data are also scaled to prevent highly expressed 
genes from becoming overwhelmingly weighty (since there is a squaring 
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component). Their paper showed good deconvolution for samples with over 5% 
prevalence of each cell type. 
5.2.2.1 In silico generation of 100 convoluted samples 
In order to assess the accuracy of the deconvolution, I generated pseudosamples. By 
producing these pseudosamples, I could assess the accuracy of deconvolution on 
samples of known mixed proportions. Each pseudosample was comprised of values 
for all genes measured in the samples described in Zhang et al., so that 




Where the transcriptional value X (FPKMs, reads per million (RPMs), etc) for gene j 
in pseudosample a is equivalent to the linear sum of the respective gene’s values 
from pure samples Xs….q provided by Zhang et al., multiplied by their relative 
proportion ps….q, with all proportions adding to 1. The generation of pseudosamples 
operates under the same linearity assumption which underlies most deconvolution 
models. Relative proportions were generated randomly in R.  
The concept behind utilising pseudosamples was to benchmark the performance of 
the deconvolution. Although it is impossible to know the true extent of cell 
proportion changes (if any), the use of pseudosamples is proof that the deconvolution 
of similar depth samples can be carried out, and that the error between the 
deconvolution predicted proportions and actual pseudosample proportion can be 
quantified. As I show in this chapter, use of optimal settings brought the mean 
absolute difference between predicted proportion and actual proportion to >7% of the 
actual proportion for deconvolution of mouse cortical, mouse hippocampal, and 
human iPSC-derived neuronal samples.  
5.3 Initial DeconRNASeq and troubleshooting using FPKMs 
My initial investigation utilised FPKMs, but did not examine comparison datasets as 
I did not initially know how to compare these datasets on different scales. 
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5.3.1.1 Optimising the approach by utilising pseudosamples 
I performed DeconRNASeq using different sets of marker genes from Zhang et al.. I 
also applied a number of different “top and tail” filters to the marker gene data, 
excluding marker genes if their expression in the cell type they mark fell outside of 
the filter. Different marker gene sets produced by different filters were evaluated on 
the basis of how well the deconvolution performed on the in silico pseudosamples for 
each cell line. 
5.3.1.1.1 Pseudosample results  
I used DeconRNASeq to deconvolute my 100 pseudosamples, each generated from 
random proportions of the enriched cell RNA-Seq FPKM profiles from Zhang et al.. 
The cell types included were all of those investigated by Zhang et al., namely 
astrocytes, neurons, oligodendrocyte precursor cells, newly myelinating 
oligodendrocytes, mature oligodendrocytes, microglia, and endothelial cells. I used 
different marker genes for each cell type, and used varying numbers of marker genes. 
This first deconvolution was performed three times, once with 40 marker genes per 
cell type, once with 125, and once with 500. This meant that my “pure” RNA-Seq 
profiles generated from the data of Zhang et al. utilised 280, 875, and 3500 genes in 
each comparison, as there are seven different cell profiles.  
The results of the deconvolution were initially very poor, both overestimating and 
underestimating the actual proportions for each cell type. In astrocytes, the maximum 
overestimation was by a factor >300, in a pseudosample with relatively low astrocyte 
proportions. The standard deviation of the estimated/actual ratio was also very high. 
An optimum would be an average ratio of 1, and a standard deviation of 0, indicating 
perfect prediction. The average ratio was typically very high across the 100 samples 
and across cell types. I found that the standard deviation varied by cell type but no 
value was lower than 3, indicating the vast majority of samples had extremely poorly 
predicted levels of each cell type. Briefly experimenting with maximum and 
minimum expression filters did improve the results, but the range of ratios still 
varied. Two examples are given in Table 21 and Table 22, for the deconvolutions 
using 125 marker genes. We can see that the results are initially extremely incorrect, 
largely overestimating cell types. With filtering, they begin to fail to predict some 
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cell types’ presence at all. We can see as an example that oligodendrocyte precursor 
cell estimated/actual ratios vary from 0.02 to 3.16 across the 100 pseudosamples. 
Biologically, variance in cell types to this degree would be grossly pathological. I did 
not find these results satisfactory and decided that a greater number of measures 
needed to be taken to ensure accuracy. 
 
Astrocytes Neuron OPC MO Microglia 
Endothelial 
Cells 
Max 314.7 66.2 8.57 219.73 23.3 66.09 
Min 0.63 0.58 0.102 0.35 0.73 0.53 
Standard 
deviation 
31.2 6.61 1.23 21.85 2.62 7.22 
Table 21. Average maximum, minimum, and standard deviations of the ratio of estimated:actual proportions of each 
cell type for 100 pseudosample deconvolutions using 125 marker genes. 1 is optimum for max and min, 0 is optimum for 
standard deviation. OPC=Oligodendrocyte precursor cell, MO=Myelinating oligodendrocyte 
 
Astrocytes Neuron OPC MO Microglia 
Endothelial 
Cells 
Max 3.11 2.1 3.16 3.26 1.16 1.88 
Min 0 0 0.03 0.08 0.05 0.09 
Standard 
deviation 
0.65 0.48 0.72 0.71 0.23 0.44 
Table 22. Average maximum, minimum, and standard deviations of the ratio of estimated:actual proportions of each 
cell type for 100 pseudosample deconvolutions using 125 marker genes, filtering marker gene expression for those with a 
value between 5 and 5000 FPKMs in the cell type they mark. 1 is optimum for max and min, 0 is optimum for standard 
deviation. OPC=Oligodendrocyte precursor cell, MO=Myelinating oligodendrocyte 
5.3.1.1.2 Pseudosample results restricting cell type proportions to greater than 0.1 
Given the highly inaccurate results of the initial deconvolution, some means of 
improving the predictions were necessary. Since the estimates were extremely 
inaccurate, I reasoned that selecting different numbers of marker genes for each line 
would not by itself improve deconvolution to an acceptable degree. 
Deconvolution of the RNA-Seq data using Zhang et al. Cell type enriched datasets 
214 
However I noted that if cell proportions were very low (<5%) the estimated 
proportions were highly incorrect. Gong et al. have also struggled to detect cell types 
which are less than 5% of the mixed cell population
267
. I therefore decided to 
optimise deconvolution with the assumption that all cell types would be greater than 
10% of the overall population. I believe that this is the best approach as cells with a 
low proportion will be incorrectly predicted anyway and many research groups have 
experienced difficulties with predicting these low proportion cell types at all. The 
increased difficulty in optimising for the <10% scenario offsets the potential gains in 
accuracy, which would not be great in any case. Finally, I am comparing genotypes 
for relative changes to cell types, not for absolute prevalence of each cell type. I 
therefore determined to limit all proportions in my pseudosample generation, so that 
each cell type contributed a minimum of 10% towards the in silico RNA-Seq profile 
of each pseudosample. I also removed the newly myelinating oligodendrocytes from 
the pseudosamples, reasoning that these cells would not be prevalent at greater than 
10%.  
I then reassessed the profiles for marker genes, using data from Zhang et al. to find 
the genes with the largest fold changes between the marked cell type and all other 
cell types. See Figure 41, Figure 42, and Figure 43 for heatmaps of the marker gene 
profiles using 40, 125, and 500 markers per cell type (240, 750, and 3,000 markers 
total). Each marker gene block is distinguished by high expression in the cell type it 
marks, and is characterised by low expression in other cell types. 
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Figure 41. Heatmap of expression for the top 240 marker genes for cell types from Zhang et al. with each row 
representing a gene and columns indicating cell types. Scale is in Z scores (standard deviations from the mean), with red 
indicating expression higher than the mean of all cell types and green lower. Note that a minority of marker genes for 
astrocytes and OPCs in particular are not quite as specific.  OPC=Oligodendrocyte precursor cell, MO=myelinating 
oligodendrocyte. 
  
Figure 42. Heatmap of expression for the top 750 marker genes for cell types from Zhang et al. with each row 
representing a gene and columns indicating cell types. Scale is in Z scores (standard deviations from the mean), with red 
indicating expression higher than the mean of all cell types and green lower. Note that a greater number of genes have 
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Figure 43. Heatmap of expression for the top 3,000 marker genes for cell types from Zhang et al. with each row 
representing a gene and columns indicating cell types. Scale is in Z scores (standard deviations from the mean), with red 
indicating expression higher than the mean of all cell types and green lower. Note that a large number of genes have 
reasonable expression in many cell types. It is unlikely that this will be the number of marker genes which will give 
optimum deconvolution.  
Figure 44 displays the results of the deconvolution, using varying numbers of marker 
genes for each of the six cell lines. Several facts can be observed. Firstly, a larger 
number of marker genes appears to introduce greater variation in the ratio of 
estimated/actual proportions of each cell line. At 40 genes per line, there is very little 
variation in five out of six cell line estimations, whereas variation is greater at 125 
genes (indicated by broader peaks) and is even larger at 500 genes. We can also see 
that microglia, indicated by orange, are often overpredicted, except when 500 genes 
are used. Finally, when using 500 genes for each line, DeconRNASEQ fails to detect 
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Figure 44. Deconvolution of 100 pseudosamples, shown as a density plot. Each cell type is represented by a different 
colour; Astrocytes=Red, Neurons=Blue, Oligodendrocyte Precursor Cells=Green, Myelinating 
Oligodendrocytes=Purple, Microglia=Orange, Endothelial Cells=Yellow. X axis = deconvolution prediction of cell 
proportion divided by actual cell proportion. Optimum is 1. Y axis = frequency of this ratio, displayed as a density plot. 
Each graph indicates the results using a different number of marker genes for each cell line, always using the markers 
with the largest fold changes. 
We can conclude that restricting each cell type’s proportion to 10% or greater 
exerted a large effect on the accuracy of the deconvolution, and that an increase in 
the number of marker genes appeared to initially bring the deconvolution ratios 
closer to one, but also introduced other variation. 
5.3.1.1.3 Pseudosample results filtering marker genes, restricting cell type 
proportions to greater than 0.1 
I aimed to further increase the accuracy of the deconvolution by combining the 
previous steps, but using differing numbers of marker genes, with a new step, 
filtering marker genes for high and low expression. I evaluated deconvolution with 
different variations of these criteria. Mohammadi et al. had shown that expression 
filtering improved deconvolution only about half of the time, so it was doubtful 
whether I would observe any improvements
134
. A subset of the results is displayed in 
Figure 45.  




Figure 45. Results of the deconvolution using between 150 and 400 marker genes per line. In all cases the genes with the 
greatest fold changes between the marked line and other lines were utilised. Filters for expression are indicated in the 
titles of each graph by MaxFPKM, indicating the maximum expression allowed for a marker gene in the cell it marks, 
and MinFPKM, the relative minimum expression. Each cell type is indicated by a different colour; Astrocytes=Red, 
Neurons=Blue, Oligodendrocyte Precursor Cells=Green, Myelinating Oligodendrocytes=Purple, Microglia=Orange, 
Endothelial Cells=Yellow. 
 
     219 
There are several findings to be observed. Firstly, if the number of marker genes per 
cell line is low, microglia, indicated by orange, are overestimated. Secondly, if the 
number of marker genes per cell line is high, oligodendrocyte cells, indicated by 
green, are not detected at all, indicated by the line being at 0. This is undone by 
excluding marker genes with an expression above 5000 FPKM in the line they mark. 
Excluding genes with less than 5 FPKMs appeared to result in no change. On further 
investigation it was evident this was due to a lack of marker genes with expression 
below this level. Several settings are about equal in accuracy, not overestimating or 
underestimating any lines to a degree of >4 or <0.25. These include all 100, 150, and 
200 gene settings, and all higher marker gene number settings which have the FPKM 
5000 maximum expression filter. Given the ambiguous results of expression 
filtering, I opted to not continue using it.  
5.3.1.1.4 Initial deconvolution of mouse cortical samples using FPKMs 
I deconvoluted my mouse cortical RNA-Seq profiles to investigate whether any of 
the six cell types were changed due to the Der1 mutation. I used different numbers of 
marker genes as there were no clearly superior sets. I used both Cufflinks-generated 
FPKM values to deconvolute my data. Using FPKMs is a natural choice as the data 
described in Zhang et al. are in FPKMs. However, as we shall see, it became evident 
to me that a serious error had occurred in the generation of the Der1 mouse cortical 
FPKMs. 
In the process of the FPKM deconvolution I noted that a minority (<10%) of the 
marker genes had expression in all the mouse samples which was greater than the 
expression in my pure Zhang et al. samples. This is likely due to a number of factors; 
different sequencing depths, different origin of RNA (brain tissue vs enriched plated 
cells). Given that these markers are a minority I opted to remove them, as they 
clearly invalidate the assumption that the markers will have their maximum 
expression in the cell type that they mark. My concerns about this process were a 
major factor in later deciding to utilise housekeeping gene normalisation (see 5.4 for 
a full discussion). I emphasise that no particular cell type was singled out to have 
certain markers removed-all markers with greater expression in the samples versus 
the cell type they mark were removed.  
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5.3.1.1.4.1 Results 
Regardless of the number of marker genes utilised, we can see a distinctive split in 
the samples (see Figure 46). One group of samples has a moderate proportion of 
many cell types, and is reported as being approximately 50% neurons; close to 
reported biological reality
273,274
. The second is reported as being approximately 70% 
myelinating oligodendrocytes. The two groups are not separated by genotype, with 
the oligodendrocyte heavy group consisting of two wild-type, three heterozygous, 
and two homozygous mouse samples. The two groups are also not distinguished by 
the sex of the mice. We can also see that there is little variation in the estimation of 
all cell types between samples of different genotypes within the two groups. We can 
also see that the number of marker genes seems to have little if any effect on the 
estimations of the various cell type proportions.  
 
Figure 46. Deconvolution of the Der1 mouse cortical sample FPKMs using 100, 150, or 200 marker genes. Genotypes are 
differentiated by colours. 
The reported proportion of a number of the samples being mostly myelinating 
oligodendrocytes when using FPKMs is very surprising. This proportion is not close 
to most histological estimates by researchers looking at mouse cortex, and seems 
biologically impossible. It also seems unlikely that such enormous variation could 
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present in such a binary fashion within genotypes. I investigated the samples further 
and found that the FPKM expression of the myelinating oligodendrocyte marker, 
Mbp, encoding myelin basic protein, varied enormously and in a binary fashion. The 
samples reporting high myelinating oligodendrocyte proportions had high FPKM 
expression of this gene (it is the highest expressed gene of all), while those reporting 
lower proportions had near nil expression. The fold change between the two groups 
was over 800. I subsequently inspected the RNA-Seq counts directly and found that 
all samples had similar count values (variation <5%). It is not possible that the 
FPKMs of the samples are genuinely different to this degree. It was evident that 
some error had been made in the processing of the RNA-Seq data which caused Mbp 
to have large variation between samples despite the counts varying very little. 
Removal of Mbp from the list of marker genes resulted in predicted proportions 
which were biologically plausible and similar in all samples, regardless of genotype 
(data not shown). The extremely potent power of Mbp is likely due to its high 
expression, as well as the stark contrast between the samples. I have not yet 
discerned what the processing error is and the miscounting of Mbp calls into question 
the Cufflinks-generated FPKMs from Der1 cortex as the units of deconvolution, as 
many other genes may also have been affected. 
5.3.1.1.4.2 Rejection of FPKM deconvolution as a valid approach 
The Der1 FPKM deconvolution is clearly untrustworthy. Although I have noted a 
problem with Mbp, other problems may still be present. It is also true that Cufflinks-
FPKMs are the worst possible units to carry out deconvolution with, as shown by the 
research of Jin et al. (see Figure 40) showing these units give the highest variation in 
deconvolution estimates compared to other measurements
272
.  
However, RPM units may not be ideal either, as the data described in Zhang et al. are 
in the form of Cufflinks-generated FPKMs. Since FPKMs are normalised to both 
transcript length and sequencing depth, the scale of FPKMs will be entirely different 
to the scale of RPMs which are normalised to the number of base reads. It is also not 
a simple matter to relate the two, as Cufflinks does not utilise a predetermined set of 
transcript lengths but rather empirically determines the length of transcripts from the 
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data. It is possible given Mbp’s complex splicing arrangement that the error in 
quantifying the transcript occurs due to different estimated transcript lengths. 
Finally, there is the question of the <10% of genes that were removed because their 
expression in the samples was greater than their expression in pure cell types. This 
was a concerning finding, and was a major reason for my redoing the deconvolution 
in the next section, using housekeeping gene based normalisation, which I believed 
would result in all genes being on a similar scale of expression. This would also 
allow me to look at other datasets to assess the accuracy of the deconvolution. 
It was also evident to me that there were other issues. Although I had generated 
pseudosample data and carried out the deconvolution using DeconRNASeq, I had not 
at any stage verified the deconvolution by testing it on a secondary dataset. Going 
forward, I would also need to do the deconvolution using RPMs, as there had clearly 
been an error with FPKM generation. I would need to develop a method allowing the 
comparison of multiple data types so as to continue using the Zhang et al. dataset. I 
describe in the next sections my solutions for these three challenges. 
5.4 Mouse Cortical RNA-Seq deconvolution 
5.4.1 Housekeeping gene normalisation to compare multiple datasets 
5.4.1.1 Introduction 
To compare the Zhang et al. dataset to others, I needed some method of 
normalisation. I decided to see if housekeeping gene based normalisation could work 
to ensure easy comparison between pseudosamples and an exterior dataset. I could 
empirically test this by comparing the efficiency of housekeeping gene normalised 
pseudosample deconvolution to non-normalised deconvolution. I utilised an 
objective method to do this. 
5.4.1.2 Selection of housekeeping genes 
Housekeeping genes (HKs) should be as uniformly expressed as possible, as well as 
being expressed in all cell types. In order to gauge the suitability of genes as 
housekeeping genes, I calculated the coefficient of variation (standard deviation 
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divided by mean, referred to as CV) for each gene across all Zhang cell types and 
within my Der1 mouse samples. Each Zhang et al. cell type has only two high depth 
replicates, so it seemed wise not to average by cell type. I calculated two CVs: the 
ZhangCV, the CV for all of Zhang’s samples for a gene, and the mouseCV, the CV 
of the gene across my cortical Der1 mouse samples. The geometric mean of these 
two values was calculated and used to rank the genes as putative housekeeping 
genes. I also restricted housekeeping gene selection to those genes which had a no 
greater than fourfold difference between the maximum and minimum values in both 
the mouse and Zhang sets. This seemed like a good approach to filter out otherwise 
good housekeeping genes which had extraordinary expression in a single mouse 
sample or cell culture, which would result in this cell type or sample giving 
erroneous results. Genes which were not universally expressed were also discarded 
as potential housekeeping genes. The criteria for expression were more counts than 
Disc1 in the case of the cortical mouse samples and at least 5 FPKM in the Zhang 
samples (I chose this as Zhang et al. had chosen it as the cut off level for marker 
gene expression). Of the >19,000 genes expressed in both sample sets, approximately 
3800 met al.l the criteria. The geometric means varied from 0.004 to 0.356. I selected 
housekeeping genes from this list, starting with those with the lowest geometric 
mean. 
I subsequently used GOrilla to check the ranked housekeeping gene list for 
overrepresented ontologies. I expected that overrepresented gene functions would 
relate to typical housekeeping gene functions such as translation, transcription, and 
cell metabolism. If ontologies related to particular brain cell types appeared, such as 
synapse formation (related to neurons, but not to microglia) then this would be 
alarming and would indicate that my selection of housekeeping genes was faulty. 
For the Cortical vs Zhang comparison, the top 10 ontologies overrepresented at the 
top of the list of ranked potential housekeeping genes can be seen in the Appendix. 
Although Process and Component were as expected for housekeeping genes, I was 
unsure of what some of the Functional ontologies related to. The BAT3 complex 
appears to be involved in the insertion of proteins into the ER membrane
275
. 
Agmatinase is an enzyme which produces precursors for polyamines, while its target 
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agmatine is brain-expressed and may have a role in depression. However Agmatinase 
is expressed in a wide variety of cell types according to Meylan et al.
276
, so I decided 
to retain it. The two genes related to angiostatin binding are ATP-synthase subunits, 
which would likely be expressed in a non-cell specific manner. To summarise, with 
the possible exception of Agmatinase, there did not appear to be any alarming gene 
ontologies among my putative housekeeping genes. I also manually looked at the top 
100 genes, which housekeeping genes were selected from. Three seemed initially 
alarming as their functions might be related to neuronal activity; these were Wisp1, 
Creb3, and Fxr2. However the first two appear to function in stress response, while 
Fxr2’s functions are not yet well understood. Nevertheless the low variation in all the 
genes across all samples means that there are unlikely to be any issues in 
normalisation. 
5.4.1.3 Measures of error 
I needed a more objective method of analysing pseudosample deconvolution. In all 
my deconvolution optimizations, I analysed error using two measures. The mean 
absolute difference, MAD, is given by the following formula: 




So that the MAD for pseudosample i, MADi , is equivalent to the sum of the 
deviations of the predicted to actual ratios of cell types s…q from one, divided by the 
total number of cell types. However, since I used 100 pseudosamples, MAD will 
always, unless specifically stated otherwise, refer to the average MAD of 100 
pseudosamples. 















Therefore the RMSE for a deconvolution is the square root of the sum of the squares 
of the relative difference between the predicted and actual proportions across all cell 
types across all pseudosamples. Both MAD and RMSE are discussed in Mohammadi 
et al.
134
. MAD in particular seemed like an intuitive way to describe the accuracy of 
a deconvolution in a single figure. 
5.4.2 Deconvolution using housekeeping gene normalised data of Zhang 
et al. 
5.4.2.1 Initial deconvolution 
Initially, I used a number of marker genes, ranging from 25 to 500 in increments of 
25, and numbers of housekeeping genes ranging from 10 to 100 in increments of ten. 
This meant that a total of 200 deconvolutions were carried out to determine the 
optimum settings. Since range filtering had not been especially helpful previously, I 




The results showed superior deconvolution to non-housekeeping gene normalisation. 
Figure 47 shows the effect of varying Marker Gene#, while Figure 48 shows the 
effect of varying Housekeeping Gene#. The best deconvolution is shown in detail in 
Figure 49. The minimum MAD was 0.059 (marker #=25, HK=40) and the maximum 
was 0.096 (marker #=500, HK=90). 
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Figure 47. Set of ratio of predicted to actual proportions for 100 pseudosamples against density of estimates, for the 
deconvolutions where HK#=40 and Marker gene # varies from 25 to 500. Optimum is 25 as shown in more detail in 
Figure 49. Each cell type is indicated by a different colour. Astrocytes=Red, Neurons=Blue, Oligodendrocyte Precursor 
Cells=Green, Myelinating Oligodendrocytes=Purple, Microglia=Orange, Endothelial Cells=Yellow. The ideal scenario 
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Figure 48. Set of ratio of predicted to actual proportions for 100 pseudosamples against density of estimates, for the 
deconvolutions where Marker gene #=25 and HK # varies from 10 to 100. Optimum is 40 as shown in more detail in 
Figure 49. Each cell type is indicated by a different colour. Astrocytes=Red, Neurons=Blue, Oligodendrocyte Precursor 
Cells=Green, Myelinating Oligodendrocytes=Purple, Microglia=Orange, Endothelial Cells=Yellow. The ideal scenario 
would be a straight line at 1, indicating perfect invariant deconvolution. 
 
Figure 49. Detailed look at ratio of predicted to actual proportions for 100 pseudosamples against density of estimates, 
for the optimum deconvolution where HK#=40 and Marker gene#=25. Each cell type is indicated by a different colour. 
Astrocytes=red, Neurons=Blue, Oligodendrocyte Precursor Cells=Green, Myelinating Oligodendrocytes=Purple, 
Microglia=Orange, Endothelial Cells=Yellow. 
As the number of marker genes increased the optimum HK decreased. The MAD 
values were low enough that I felt further optimisation was not necessary; an error 
range within 6% is quite good, and the limiting factors beyond this are unlikely to be 
resolved by better deconvolution parameters. Importantly, the estimations also 
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cluster relatively well, even when inaccurate. For example, in the marker#=25 
KH=40 deconvolution, myelinating oligodendrocytes are consistently 
underestimated, but the estimates are always between 84 and 91% of the actual 
proportion, a quite small range. Since it is differences in relative cell type proportions 
between samples I am looking for, not absolute differences, it is more important that 
the deconvolution treats highly similar cells in the same way, although estimates 
varying between 97 and 104% would obviously be more ideal. We can also see in 
Figure 47 that the deconvolution of astrocytes, neurons, endothelial cells and 
microglia is very good, with the estimates for these four cell types varying between 
93% (an astrocyte estimate) and 104% (a neuron estimate) of the actual proportions.  
5.4.3 Deconvolution of comparison datasets to verify deconvolution 
To ensure that my deconvolution was accurate it was imperative to test it on other 
datasets where the cellular composition has already been determined. Since the 
composition of my experimental samples was unknown, there was no other way to 
know whether the deconvolution was accurate. I searched for comparison datasets 
which fulfilled some of the criteria described in 5.2. They had to have similar RNA-
Seq depth, and they had to have identified the cells in a trustworthy manner. I 
deemed it of less importance that the same dataset provide all cell types, although 
this would obviously be optimal. I could not find a truly independent dataset 
providing data from all brain cell types at an appropriate sequencing depth. I did find 
several which, together, provided pure RNA-Seq profiles of neurons, 
oligodendrocytes, astrocytes, microglia, and endothelial cells, from both human and 
mouse and at various ages and disease states. I decided to use these data sets to 
determine whether my deconvolution was accurate. If it was, it should predict each 
pure cell profile from each of these experiments as being entirely or almost entirely 
of that cell type. 
5.4.3.1 Zhang Two  
I had decided to use the dataset described in 5.2 by Zhang et al. for carrying out 
deconvolution
153
. The same research group released a follow up paper in 2016, 
looking at a number of human and mouse astrocytes from various disease states. 
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They also used immunopanning to isolate neurons, oligodendrocyte precursor cells, 
myelinating oligodendrocytes, and endothelial cells and subjected these to RNA-
Sequencing (at a lower sequencing depth than previously). In some cases, different 
antibodies were used in the immunopanning process, but they were often the same as 
in the prior paper (CD45 for microglia, BSL-1 for endothelial cells, O4 for 
oligodendrocyte precursor cells). In particular, it should be noted that the antibody 
used to select astrocytes was specifically selected using the information from the 
previous paper by Zhang et al.. They also found, as expected, that each cell uniquely 
expressed a set of classic markers along with the marker used to isolate it. For 
example, neurons isolated using Thy1 expressed Vglut1, Stmn2, Syt1, and Syn1 at 
high levels, while other cells did not express these. 
The second paper by Zhang et al. is not a completely independent comparison. Being 
from the same research group, many of the culture techniques and methods of cell 
isolation are identical, and the data from the first paper even informed the selection 
of the astrocyte marker. Accurate deconvolution of these cells will show that the 
deconvolution is applicable to another closely related dataset, although testing 
against a more independent dataset is also necessary to show it is also applicable to 
our samples. Nevertheless this is an important step to show basic reliability as well as 
aid in troubleshooting. For the sake of clarity,the second dataset described by the 
2016 paper by Zhang et al.
271
 will be referred to as “Zhang Two”.  
I carried out a series of deconvolutions of the Zhang Two dataset using all possible 
settings and examined the predictions of each cell types. In total, there are 6 astrocyte 
samples of varying ages and sorting methods, along with two of each other cell type 
and three whole cortex samples. I made several observations. Firstly, regardless of 
marker gene or housekeeping gene number, neurons, oligodendrocyte precursor 
cells, myelinating oligodendrocytes, microglia, and endothelial cells are highly 
predicted as being their respective cell type. Usually the prediction was >95%, with 
the exception of one myelinating oligodendrocyte sample which consistently 
remained at 80%. The main changes observed were in astrocytes and in the whole 
cortical samples. The differences between deconvolutions with the same marker gene 
number but different housekeeping gene numbers was difficult to discern. Changing 
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housekeeping gene number appeared to have relatively little effect at any stage, 
unlike marker gene number.  
At 300 marker genes and over, astrocytes began to be poorly predicted, with 
predictions between 50-90%. Above 425 markers, this dropped to 50-70%. This was 
also seen for the 125 marker gene deconvolutions, regardless of housekeeping gene 
number, where the astrocyte prediction for astrocytes was 60-90%. The rest of the 
prediction was typically a mix of endothelial cells and microglia. A few astrocytes 
(the immunopanned ones) always had less than optimal deconvolution, even at lower 
marker gene numbers. They were typically predicted as 60-80% astrocytes. However 
between 150-275 markers they tended to be better predicted with less variation 
between immunopanned samples and values above 80%. Examples of all cell types 
are given in Figure 50. 
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Figure 50. Set of predictions of Zhang Two dataset for the deconvolutions where HK#=40 and Marker gene # varies 
from 25 to 500. Optimum is 25. Each cell type is indicated by a different colour. Astrocytes=Red, Neurons=Blue, 
Oligodendrocyte Precursor Cells=Green, Myelinating Oligodendrocytes=Purple, Microglia=Orange, Endothelial 
Cells=Yellow, Whole Cortex=Black. Predicted cell types are on X axis and proportions are on the Y. 
Whole cortex samples followed a pattern as well, which is described in Table 23.  
 
 
Deconvolution of the RNA-Seq data using Zhang et al. Cell type enriched datasets 
232 
Marker Genes Astrocyte Neuron OPC  
25 – 75 45% dropping 
to 30% 
12% 35% increasing to 42% 
100 20% 30% 40% 
125 30% 30% 30% 
150 – 500 30% gradually 
dropping to 
20% 
40% to 45% 20% to 30% 
Table 23. Description of proportions predicted by DeconRNASeq when varying marker gene number. OPC= 
oligodendrocyte precursor cell. All percentages approximate averages of the three samples across all housekeeping gene 
numbers. 
The results of the deconvolution are displayed in Table 24 using the optimum 
settings of marker gene number=25 and HK#=40. 
 
Table 24. Results of the deconvolution of the Zhang Two dataset using cortical optimum settings. OPC=Oligodendrocyte 
precursor cell, MO=Myelinating oligodendrocyte  
We can see that in general the cells are predicted very well, with 10 of 16 cells 
predicted as a mixture comprised of >95% of the actual cell type. Three of the most 
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problematic predictions are of aged astrocytes, so it is possible that the maturation 
process results in more distinctive cell profiles due to differentiation. The best 
deconvolution setting for the 16 Zhang Two samples is HK=10, Marker Gene=225, 
which gives the lowest deviation from 1 for the 16 cell samples (average deviation 
3.8%). Regardless of HK number, Marker Gene=225 is always best. 
Three datasets from whole cortex from the Zhang Two paper were also deconvoluted 
and had highly similar profiles to one another. For the optimal deconvolution, the 
estimates were of a mixed cell profile consisting of an average of 49% astrocytes, 
12% neurons, 30% oligodendrocyte precursor cells, 1.6% myelinating 
oligodendrocytes, 1.4% microglia and 5.7% endothelial cells (does not sum to 1 due 
to rounding up). The average difference between the highest and lowest estimates for 
the three samples for all cell types was 0.9% and the largest was 2.5%, for neurons.  
However, these levels are at odds with the expected proportions for mouse cortical 
samples. It has been estimated by modern counting methods, using isotrophic 
fractionation and calculating the resulting neuronal:non-neuronal nuclei ratio, that 
the mouse cerebral cortex consists of 54% neurons by number, and 68% neuron by 
mass
274
. Other estimates looking at a variety of sources, including staining, estimate 
that mouse cortical neurons are slightly less, at 42%. It must be noted that the 
staining densities used to estimate this have high variability
273
. It is also true that 
more endothelial cells should be predicted; no setting predicts more than a small 
minority of endothelial cells. It is possible that they do not contribute many reads to 
the RNA-Seq, either due to loss during tissue harvesting or little transcriptomic 
activity. With this in mind, I reassessed the results of the Zhang Two deconvolution 
and have given a full discussion in the section before the Der1 deconvolution. 
The best deconvolution of the Zhang pseudosamples was obtained using HK=40, 
Marker Gene=25, MAD=0.059. In the Zhang Two dataset this gave a deviation of 
6.7% from perfect prediction of the 16 individual cell samples, and predicted whole 
cortex as being ~12% neuron, ~45% astrocyte, and ~35% oligodendrocyte. The best 
deconvolution of the Zhang Two individual cell samples was obtained using HK=10, 
Marker Gene=225. This gave a MAD=0.073, and a deviation of 3.8% from perfect 
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prediction of the 16 Zhang Two samples. However, using these settings the 
prediction of mouse whole cortex samples was closer to values suggested by 
empirical data and informed the settings I eventually used. 
5.4.3.2 Dorsal Root Ganglion Neurons 
I also found a dataset generated by Li et al. in 2016, describing the RNA-Seq results 
of approximately 200 dorsal root ganglion neurons from WT mice
156
. Dorsal root 
ganglion neurons are a type of sensory neuron found in the spine; so these cells are 
clearly distinct from the cortical and hippocampal cells we have sequenced. The 
comparison is therefore less than ideal, but if the deconvolution can accurately 
identify these neurons it is evidence that the general neuron markers are acceptable. 
It also indicates that the markers for other cell types do not have appreciable 
expression either in the cortical/hippocampal cells they will be optimised for, or in 
these more distinct sensory neurons. There are other arguments for using this dataset 
as a comparison for the Zhang deconvolution. The sequencing depth is an average of 
58.2 x10
6
 mapped reads, highly comparable to the average of 65.6 x10
6 
sequenced 
reads described by Zhang et al. (on average 87% of these map, giving around 57x10
6
 
mapped reads). The comparison is therefore very apt. Another reason is the quantity 
of cells. Li et al. carried out this high depth sequencing on nearly 200 neurons. I can 
therefore be confident in the accuracy of the deconvolution, should it reliably 
identify these neurons as being a “mixture” comprised mainly of neurons. 
I carried out deconvolution of the roughly 200 neurons described in the Li et al. 2016 
paper
156
 using the same spread of HK and marker gene numbers. Each RNA-Seq 
sample was normalised to total mapped reads, and then to the geomean of the 
housekeeping gene expressions. Some samples could not be included in the analysis. 
Since the housekeeping normalising factor is the geometric mean of multiple 
housekeeping expressions, if any one of these is zero then the normalising factor is 
nonsensical. A minority of samples, between 10-20% depending on housekeeping 
gene number, do not express every housekeeping gene and therefore become 
excluded from the analysis. With increasing housekeeping gene number, this 
proportion increases. The designation of a gene as “housekeeping” was defined by 
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the original Zhang sample and the mouse Der1 cortical samples, so it is inevitable 
that some cells are excluded.  
Regardless of the number of housekeeping genes used, a distinct trend was evident. 
All ~200 samples had very similar values for the predicted proportion of neuron 
across all settings. This proportion was typically low, especially if only a few 
markers were used. If 25 markers (150 total since there are 6 cell types) were used, 
the overall average predicted neuron proportion across all samples was 0.102 to 
0.111, depending on the housekeeping gene number. This increased to an average of 
0.164 at 50 markers (the average of approximately 1800 measurements, 180 in each 
housekeeping gene number group). At 75 this was 0.217, but at 100 it leaped to 
0.5948 and increased unevenly, with another leap to 0.899 at 300 markers. A graph 
of all averages is seen in Figure 51. 
The number of housekeeping genes has little effect on the average amount predicted 
to be neurons. This is a reasonable finding; 10 is a large number of housekeeping 
genes to normalise to initially. Since these genes are chosen specifically because of 
minimal variation in Zhang et al. and in our samples, it is reasonable that they show 
less variation in this new group of samples too (as all three sample groups are of the 
same tissue and species). I was surprised that there seemed to be no effect of 
housekeeping gene number at all; to investigate further I looked at the standard 
deviation of the neuron proportion across the >150 neuron deconvolutions. The result 
of this is displayed in Figure 52. We see that in all cases, having only 10 
housekeeping genes for normalisation results in greater deviation in the proportion 
predicted to be neuron, although the average does not change much. It also appears 
that having 100 is inferior to having 20-80. It is also notable that the standard 
deviation drops considerably at the 300 marker gene level, where the prediction of 
average neuron proportion reaches its peak.  
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Figure 51. Graph displaying how neuronal prediction of >150 dorsal root ganglion RNA-Seq profiles using Zhang et al. 
cell types varies with housekeeping and marker gene number. The Y axis indicates the average proportion predicted to 
be neuron across >150 dorsal root ganglion RNA-Seq profiles; if identification is always perfect, it would be 1. The X-
axis indicates the quantity of marker genes (per cell type) used in the deconvolution, while colour indicates the number 
of housekeeping genes utilised. Since six cell types were used, the total marker gene number varies from 150 to 3,000. 
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Figure 52. Graph displaying how neuronal prediction of >150 dorsal root ganglion RNA-Seq profiles using Zhang et al. 
cell types varies with housekeeping and marker gene number. The Y axis indicates the standard deviation in the 
proportion predicted to be neuron across >150 dorsal root ganglion RNA-Seq profiles; if identification is always perfect, 
it would be 1. The X-axis indicates the quantity of marker genes (per cell type) used in the deconvolution, while colour 
indicates the number of housekeeping genes utilised. Since six cell types were used, the total marker gene number varies 
from 150 to 3,000. Housekeeping genes chosen using Zhang and mouse cortical datasets. 
Similar graphs to Figure 51 and Figure 52 looking at the maximum and minimum 
predicted proportion show similar findings. Although the maximum predicted 
proportion is of course 1 (with most HK numbers achieving this at 100 markers and 
all by 175), the minimum predicted proportion remains below 0.4 until 300 markers, 
where it increases to an average of about 0.7 across HK numbers, with the outlier of 
10 HK which remains with a minimum of about 0.5. We can conclude that in general 
more markers are better, with a particular leap at the 300 marker level. As to why 
this is, it is possible that the markers selected prior to the 300 level are those which 
relate to function found in cortical neurons specifically. Markers were chosen on the 
basis of the Zhang et al. dataset; comparing cortical neurons to cortical astrocytes, 
glia, etc. The top neuron markers include genes such as Reln, Dlx2, Nkx2.1 as well as 
other Lhx and Dlx genes. These genes are known to have roles in the formation of the 
cortex and therefore may not be particularly well expressed in terminally 
differentiated sensory neurons. This appears to be the case; when ranking genes by 
expression, the neuronal marker genes occupy much higher rankings in the Zhang 
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dataset than they do in this sensory neuron dataset compared in both cases to the list 
of all expressed genes (see Table 25). 
 
Rank of expression in Zhang Neurons Rank of expression in Sensory Neurons 
Reln 2 17 
Sst 6 18 
Npy 8 50 
Uchl1 18 58 
Stmn3 25 71 
Stmn2 27 80 
Atp1a3 31 92 
Gap43 32 134 
Tubb3 36 139 
Nsg2 37 142 
Snhg11 43 147 
Table 25. Comparative ranking of marker genes in Zhang and sensory neuron datasets, for the top 10 marker genes 
expressed in both datasets. It can clearly be seen that the genes have higher expression in the Zhang dataset. The 
average position of the first 10 genes is 22.2 vs 80.1, the first 100 is 526 vs 1333, and all genes have average rankings of 
4746 vs 8251 in the Zhang and sensory neuron datasets, respectively. 
The pressing question is how to integrate this information into the selection of the 
optimal deconvolution. Looking at the DRG deconvolution using 300 marker genes, 
housekeeping gene number does not greatly alter the average neuron proportion. 
However, the optimal number of marker genes in the deconvolution of my 
pseudosamples was 25, with HK=40, at a MAD of 0.059. There is no conflict with 
HK number as 40 is not inferior to any other number in the DRG deconvolution. 
Using 300 marker genes takes the MAD up to 0.074 (this is across all cell types, not 
just neurons). 
I conclude that my explanation regarding neuron marker genes is likely why more 
markers are better in the deconvolution of the DRG neurons, and less is better for the 
pseudosamples. We can see that the change in deconvolution of the pseudosamples is 
not severe (MAD goes from 5.9% to 7.4%) with these extra markers. A side by side 
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comparison is given in Figure 53. It is likely that if I found a more apt dataset, I 
could use fewer markers and securely know that the deconvolution is adequate. 
However a full discussion in the context of the Zhang Two deconvolution is given in 
the next section.  
 
Figure 53. Detailed look at ratio of predicted to actual proportions for 100 pseudosamples against density of estimates 
for two deconvolutions. Labels above indicate housekeeping gene (HK) and marker gene numbers. HK#=40 and Marker 
gene#=25 is the overall optimum in terms of MAD. Each cell type is indicated by a different colour. Astrocytes=Red, 
Neurons=Blue, Oligodendrocyte Precursor Cells=Green, Myelinating Oligodendrocytes=Purple, Microglia=Orange, 
Endothelial Cells=Yellow. 
5.4.4 Deconvolution of mouse Der1 cortical samples 
It was important to evaluate all the evidence I had received in choosing the optimal 
settings for the deconvolution. There are three sets; the Zhang pseudosample 
deconvolution, the Zhang Two deconvolution of comparative samples and whole 
cortex, and the Dorsal Sensory neuron deconvolution. There are several factors to 
consider; how a deconvolution setting alters predictions of the 100 pseudosamples, 
how it alters identification of the Zhang Two samples and neurons, how it predicts 
the whole cortical samples and whether these predictions are similar to biological 
reality. 
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 The Zhang pseudosample deconvolution revealed good deconvolution with all 
settings, from the best (HK=40, Marker Gene=25) with a MAD of 0.059, to the worst 
(HK=90, Marker Gene=500) with a MAD of 0.095. In general, MAD increased 
slowly and steadily with increasing Marker Gene number and with deviation of HK 
from 40. The conclusion is that the settings should be kept as close to HK=40, 
Marker Gene=25 as possible but the worst possible settings are only 50% less 
accurate than the best. 
The Zhang Two dataset gives the conclusion that most cells are well identified, but 
over 300 marker genes results in poor astrocyte identification. Correspondingly, 
there is a major jump in inaccuracy with the increase from 275 to 300 marker genes 
(from average of 5.2% to 13.3% across housekeeping gene settings). More important 
is the relation to whole cortex samples, which our Der1 samples will presumably be 
similar to. In general, higher markers give more neuronal proportion in the cortical 
samples, with 275 markers giving 40% neuron and the highest, 500 markers, giving 
45% where HK=10. 
The Dorsal Sensory neuron deconvolution confirms a finding already seen in the 
Zhang and Zhang Two deconvolutions; changing housekeeping gene number does 
not substantially alter the results in any way. However, it states that neuronal 
prediction leaps up at 300 markers, and above. As discussed in that section, this is 
possibly due to the lower expression of the markers in these more distinctive sensory 
neurons.  
Given the uncertainties inherent in the deconvolution, I concluded that the best 
approach was to select a variety of high accuracy settings, starting with the marker 
gene number first, then the housekeeping gene number. A finding that appeared in all 
of the settings would be reliable. 275 marker genes gives the most accurate 
prediction of whole cortical samples with neuronal proportions approaching 
biologically plausible levels, but does not veer into underestimation of astrocytes. 
275 is also a better predictor of the dorsal sensory neurons than lower marker gene 
numbers, although 250 is nearly as accurate. For both the Zhang and Zhang Two 
deconvolutions, the optimal HK is 10 for 275 marker genes, with a MAD of 6.9% 
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and a deviation from perfect prediction of 4.5%, respectively. HK=40 is a close 
contender in each case.  
I therefore deconvoluted the Der1 mouse cortical samples using six different 
settings, HK=10, HK=40 and Marker gene #=250, 275, or 300. I deconvoluted the 
depth normalised count data. The results can be seen in Figure 54. 
Importantly, we can see that the samples are behaving the same way, proving that the 
existence of two groups seen in the FPKM deconvolution, one with many MOs, is an 
artefact of the process of generating Cufflinks-FPKMs. Removing Mbp has little 
effect on the deconvolution (data not shown); as expected given its low variance. 
This confirms that the issue seen before was due to that effects of FPKM generation. 
The higher accuracy of this deconvolution, as shown by superior performance in 
pseudosamples, makes this a trustworthy result. 
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Figure 54. Deconvolution of mouse Der1 cortical samples, showing cell types against proportions for four settings 
varying in marker gene and housekeeping gene numbers. WT=Wild-type, Het=Heterozygous, Hom=Homozygous, 
colours are green red and blue respectively. OPC=Oligodendrocyte precursor cell, MO=Myelinating oligodendrocyte, 
EC=Endothelial Cell 
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An ANOVA for each cell type was performed to determine the effects of genotype 
on each of the cell proportions. There was a significant effect of genotype on the 
proportion of astrocytes in all comparisons except for the HK=40, Marker 
Gene=250, and of neuron proportions in half of the deconvolutions. Post-hoc testing 
using Tukey’s multiple comparisons test found no significance for pairwise 
comparisons between any genotype in any deconvolution. 
As described in the corresponding chapter, there had appeared to be an internal 
structure within the homozygous samples. I therefore looked at these two groups, 
distinguished as shown by PCA in Chapter 2. Figure 54 is repeated in Figure 55 with 
the split in the homozygotes highlighted. I again carried out ANOVAs for each cell 
type and subsequent pairwise comparison testing, splitting the Homozygotes into two 
groups. There was a significant effect of genotype on the proportion of 
oligodendrocyte precursor cell proportions in the HK=10, Marker Gene=250 
comparison, but post-hoc testing using Tukey’s multiple comparisons test found no 
significance for pairwise comparisons between any genotype.  
The two homozygote groups are shown alone in Figure 56. Pairwise t-tests for each 
cell type revealed significant differences in neurons, astrocytes, and myelinating 
oligodendrocytes in all HK=10 deconvolutions, and the HK=40, Marker Gene=275 
deconvolution. 
P values HK10M250 HK10M275 HK10M300 HK40M250 HK40M275 HK40M300 
Astrocyte 0.0012 0.0008 0.0004 ns 0.0012 ns 
Neuron 0.0018 0.00043 < 0.0001 ns 0.00019 ns 
MO 0.0028 0.0027 0.0025 ns 0.0030 ns 
EC ns ns 0.0004 Ns ns ns 
Table 26. Results for homozygote pairwise t-tests, with Sidak-Bonferroni correction for multiple testing within each 
deconvolution. MO=Myelinating Oligodendrocytes, EC=Endothelial Cells, ns=non significant 
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Figure 55. Deconvolution of mouse Der1 cortical samples, showing cell types against proportions for four settings 
varying in marker gene and housekeeping gene numbers. WT=Wild-type, Het=Heterozygous, Hom Group 
1=Homozygous Group 1, Hom Group 2=Homozygous Group 2, colours are green red, dark blue and light blue 
respectively. OPC=Oligodendrocyte precursor cell, MO=Myelinating oligodendrocyte, EC=Endothelial Cell. 
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Figure 56. Deconvolution of mouse Der1 cortical samples, showing cell types against proportions for four settings 
varying in marker gene and housekeeping gene numbers. Hom Group 1=Homozygous Group 1, Hom Group 
2=Homozygous Group 2, colours are grey and yellow respectively. OPC=Oligodendrocyte precursor cell, 
MO=Myelinating oligodendrocyte, EC=Endothelial Cell. 
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5.5 Mouse Hippocampal RNA-Seq deconvolution 
Since the cortical deconvolution had low MAD for the pseudosamples and Zhang 
Two dataset, I continued on to the Der1 hippocampal samples, utilising the same 
methods. The difference here is that I am comparing the hippocampal samples to 
cortical datasets, and I am making the assumption that the cell types will closely 
relate across these two brain regions. Since FPKMs were confirmed as not being 
reliable, I moved straight to housekeeping-normalisation based deconvolution of the 
depth normalised counts. I also did not use marker gene range filtering as it had not 
been useful in the cortical deconvolution. Although the marker genes are the same, 
the housekeeping genes will be different as they are selected based on the enriched 
cell profiles and the mouse samples. Both marker genes and housekeeping genes 
were selected as in the cortical deconvolution. 
For six WT samples 83.877 ± 13.58 million reads were sequenced, for eight 
heterozygous Der1 samples 82.81 ± 13.84 million reads were sequenced, and for 
eight homozygous Der1 samples 79.9 ± 14.08 million reads were sequenced. 
Housekeeping genes were filtered for universal expression, less than fourfold 
variation, and an average minimum expression. A similar number of genes matched 
these criteria as in the cortical housekeeping gene selection. Of approximately 17,000 
genes expressed in both sample sets, 3,832 met al.l the criteria and were ranked in 
order of the geometric mean of both coefficients of variation. This list was subjected 
to ranked GO term analysis using GOrilla. The results of this are displayed in the 
Appendix. As with the cortical set, there were no alarming results. None of the terms 
related to specialised components of nervous cells, particular processes unique to a 
subset of them, or functions which are other than general housekeeping ones.  
5.5.1 Deconvolution using housekeeping gene normalised data from 
Zhang et al. 
The measure of inaccuracy used was MAD. Since Zhang et al. only used a few cell 
types, graphs were also utilised and examined by eye. 
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5.5.1.1 Initial deconvolution 
As in the cortical deconvolution, I used housekeeping gene numbers from 
10,20,30…100, and marker gene numbers 25,50,75….500 for a total of 200 
deconvolutions. The results were of a similar quality to the cortical deconvolution 
and the min and max MAD values were similar. The minimum MAD was 0.0498 
(marker=25, HK=10) and the maximum was 0.103 (marker=500, HK=100). Figure 
57 and Figure 58 show the effects of varying marker gene number and HK, 
respectively. 
 
Figure 57. Set of ratio of predicted to actual proportions for 100 pseudosamples against density of estimates, for the 
deconvolutions where HK#=10 and Marker gene # varies from 25 to 500. Optimum is 25 as shown in more detail in 
Figure 59. Each cell type is indicated by a different colour. Astrocytes=Red, Neurons=Blue, Oligodendrocyte Precursor 
Cells=Green, Myelinating Oligodendrocytes=Purple, Microglia=Orange, Endothelial Cells=Yellow. The ideal scenario 
would be a straight line at 1, indicating perfect invariant deconvolution. 
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Figure 58. Set of ratio of predicted to actual proportions for 100 pseudosamples against density of estimates, for the 
deconvolutions where Marker gene #=25 and HK # varies from 10 to 100. Optimum is 40 as shown in more detail in 
Figure 59. Each cell type is indicated by a different colour. Astrocytes=Red, Neurons=Blue, Oligodendrocyte Precursor 
Cells=Green, Myelinating Oligodendrocytes=Purple, Microglia=Orange, Endothelial Cells=Yellow. The ideal scenario 
would be a straight line at 1, indicating perfect invariant deconvolution. 
The results of the best deconvolution can be seen in Figure 59. 
 
Figure 59. Set of ratio of predicted to actual proportions for 100 pseudosamples against density of estimates, for the 
deconvolution in which marker=25, HK=10. Each cell type is indicated by a different colour. Astrocytes=Red, 
Neurons=Blue, Oligodendrocyte Precursor Cells=Green, Myelinating Oligodendrocytes=Purple, Microglia=Orange, 
Endothelial Cells=Yellow. The ideal scenario would be a straight line at 1, indicating perfect invariant deconvolution. 
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It can be seen that the difference between the maximum and minimum estimate for 
each cell type is relatively close. With the exception of oligodendrocyte precursor 
cells, the difference is less than 0.05, while the actual estimates themselves vary with 
averages of 0.93 (astrocytes), 1 (neurons), 1.07 (oligodendrocyte precursor cells), 
0.92 (myelinating oligodendrocytes), 1.02 (microglia) and 1.05 (endothelial cells). 
5.5.2 Deconvolution of comparison datasets 
5.5.2.1 Zhang Two 
I carried out a series of deconvolutions of the Zhang Two dataset using all possible 
settings and examined the predictions of each cell types, as in the cortical analysis. 
Since many of the housekeeping genes are the same, I expected the results would be 
similar. With the exception of poorer astrocyte predictions if there were 300 or more 
marker genes, all settings were highly predictive. The results were near identical to 
the cortical deconvolution. All trends were the same and the conclusions reached in 
the corresponding cortical section apply here too.  
Using the optimum settings of marker=25 and HK=10, the deconvolution of the 
“Zhang Two” dataset is shown in Table 27. 
 
Table 27. Results of the deconvolution of the Zhang Two dataset using hippocampal optimum settings. 
OPC=Oligodendrocyte precursor cell, MO=Myelinating oligodendrocyte. 
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The results are highly similar to those of the cortical deconvolution, with 11 of 16 
cells predicted as >95% of the cell type that they are. As before, astrocytes were 
increasingly poorly predicted with age. 
Zhang Two’s three cortical datasets were also deconvoluted using the optimal 
hippocampal settings and had highly similar profiles to those predicted by the 
optimal cortical deconvolution. Profile estimates averaged at 51% astrocytes (2% 
more from cortical), 11% neurons (1% less), 30% oligodendrocyte precursor cells 
(same), 1.6% myelinating oligodendrocytes (same), 2.8% microglia (1.4% more) and 
5.7% endothelial cells (1.4% less). The average difference between the highest and 
lowest estimates for all cell types was 0.8% and the largest was 1.7%, for neurons. In 
general these results are very similar to the cortical data, although they are less 
variable. The issues of predicting whole cortex samples will likely apply here as 
well. 
5.5.2.2 Dorsal Root Ganglion Neurons 
As in the cortical deconvolution testing, I carried out deconvolution of the roughly 
200 neurons described in the Li et al. 2016 paper
156
 using the same spread of HK and 
marker gene numbers. Each RNA-Seq sample was normalised to total mapped reads, 
and then to the geometric mean of the housekeeping gene expression. Since some 
samples (usually 10-20%) did not have all the housekeeping genes expressed, some 
samples could not be included in the analysis. 
Given that the marker genes are the same, I expected a similar result to that of the 
cortical settings deconvolution; housekeeping genes not having much impact, and a 
sudden jump in neuron identification at 300 markers. This is exactly what I observed 
in Figure 60 and Figure 61, looking at the average and standard deviation neuron 
proportion in the deconvolution of >150 DRG neurons using the hippocampal 
settings. One difference is that having a low number of housekeeping genes (red) 
appears to give better neuron prediction at the 100-275 marker gene settings. 
However, the results are essentially the same and the same conclusions can be drawn 
as in the analysis which looked at the cortical settings.  
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Figure 60. Graph displaying how neuronal prediction of >150 dorsal root ganglion RNA-Seq profiles using Zhang et al. 
cell types varies with housekeeping and marker gene number. The Y axis indicates the average proportion predicted to 
be neuron across >150 dorsal root ganglion RNA-Seq profiles; if identification is always perfect, it would be 1. The X-
axis indicates the quantity of marker genes (per cell type) used in the deconvolution, while colour indicates the number 
of housekeeping genes utilised. Since six cell types were used, the total marker gene number varies from 150 to 3,000. 
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Figure 61. Graph displaying how neuronal prediction of >150 dorsal root ganglion RNA-Seq profiles using Zhang et al. 
cell types varies with housekeeping and marker gene number. The Y axis indicates the standard deviation in the 
proportion predicted to be neuron across >150 dorsal root ganglion RNA-Seq profiles; if identification is always perfect, 
it would be 1. The X-axis indicates the quantity of marker genes (per cell type) used in the deconvolution, while colour 
indicates the number of housekeeping genes utilised. Since six cell types were used, the total marker gene number varies 
from 150 to 3,000. Housekeeping genes chosen using Zhang and mouse hippocampal datasets. 
The ramifications for the hippocampal deconvolution are similar to those of the 
cortical deconvolution. The 300 marker gene number appears to give optimal neuron 
deconvolution as in the cortical analysis. This is unsurprising given that these are the 
same 300 genes as in the cortical deconvolution. Looking at the deconvolution of the 
Zhang pseudosamples, the optimal setting always had 10 housekeeping genes 
regardless of marker gene number. There is no major issue here, although the 
standard deviation of the estimates with >300 markers is larger if 10 housekeeping 
genes were utilised. Taking HK=10, the minimum MAD was 0.049, at marker=25. 
At marker=300, the MAD is 0.059, a not tremendous increase in error. The 
comparison is displayed in Figure 62 where it is evident that there are only minor 
changes, mainly in neuronal prediction.  
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Figure 62. Detailed look at ratio of predicted to actual proportions for 100 pseudosamples against density of estimates 
for two deconvolutions. Labels above indicate housekeeping gene (HK) and marker gene numbers. HK#=10 and Marker 
gene#=25 is the overall optimum in terms of MAD. Each cell type is indicated by a different colour. Astrocytes=Red, 
Neurons=Blue, OligodendrocytePrecursorCells=Green, Myelinating Oligodendrocytes=Purple, Microglia=Orange, 
Endothelial Cells=Yellow 
5.5.3 Deconvolution of mouse Der1 hippocampal samples 
Given that all the conclusions from each set of deconvolutions are the same as in the 
cortical deconvolution (unsurprisingly as most housekeeping genes and all markers 
are the same), the same rationales apply. Correspondingly, there is a major jump in 
inaccuracy with the increase from 275 to 300 marker genes (from average of 4.3% to 
13.6% across housekeeping gene settings). As before, higher markers give more 
neuronal proportion in the cortical samples, with 275 markers giving 45% neuron 
and the highest, 500 markers, giving 47% where HK=40, but at the cost of poor 
astrocyte prediction. The rationales are therefore the same as before in choosing 275 
markers, with the best housekeeping gene set. Zhang pseudosamples have MADs of 
5.8% if HK=10, with a mild increase of MAD with HK. Zhang Two’s best 
deconvolution is if HK=40, with a deviation of 3.91% from perfect identification. 
The second best is if HK=10, with a deviation of 3.92%, a minor difference. 
Therefore the optimal settings are marker=275, HK=10, the same as in the cortical 
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deconvolution. This maximises pseudosample deconvolution accuracy and is almost 
identical in quality to the Zhang Two deconvolution. 
I deconvoluted the mouse hippocampal samples using the same spread of marker and 
housekeeping genes as in the cortical deconvolutions, given the similarities. The 
results can be seen in Figure 63. An ANOVA for each cell type was performed to 
determine the effects of genotype on each of the cell proportions. There was no 
significant effect of genotype on the proportion of any cell type in any 
deconvolution.  
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Figure 63. Deconvolution of mouse Der1 hippocampal samples, showing cell types against proportions. WT=Wild-type, 
Het=Heterozygous, Hom=Homozygous, colours are green red and blue respectively. OPC=Oligodendrocyte precursor 
cell, MO=Myelinating oligodendrocyte, EC=Endothelial Cell 
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5.6 Human iPSC-derived neuron deconvolution 
I moved on to deconvoluting the human t(1;11) samples. Housekeeping gene 
normalisation of the datasets prior to deconvolution was carried out exactly as 
before. I excluded genes with a fourfold difference between the maximum and 
minimum samples values, took the geometric mean of the coefficient of variations 
for both datasets, and used the geometric mean of several genes as a normalisation 
quotient. In addition, if the deconvolution reference dataset was mouse, then only 
orthologous genes were utilised.  
5.6.1 Selection of appropriate datasets for human deconvolution 
5.6.1.1 Zhang et al.  
I decided to use the Zhang et al. dataset as it has several advantages over other 
datasets I examined. The read depth is high and comparable to that of our human 
neurons, unlike the Darmanis et al. dataset which I next describe. There are relatively 
few cell types, but their identification is trustworthy and they have many marker 
genes, ensuring the deconvolution should be relatively accurate. However, the main 
disadvantage is that this dataset was derived using mouse cells. 
5.6.1.2 Darmanis et al.  
I did not find a high read depth dataset of human cortical cell types, although many 
datasets exist which employ single cell RNA-Seq of hundreds or even thousands of 
human cortical cells. One such dataset is described by Darmanis et al.
155
. In this 
paper, they describe their analysis of several hundred cortical cells obtained via 
surgical resection of adult human brain, as well as a complementary set of cells 
obtained from foetal cortex. The adult humans were undergoing surgery for mesial 
temporal sclerosis and associated intractable seizures. RNA-Seq data was generated 
from 466 cells with a minimum sequencing depth of 4x10
5
 reads, with an average of 
2.83x10
6
. Reads were 75bp and paired-end.  
Darmanis et al. performed biased and unbiased clustering analyses, which were in 
broad agreement about cell cluster identities. They found that unbiased clustering 
gave 10 groups. The biased clustering approach used the top 50 cell markers from 
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Zhang et al. to separate the cells into a total of 7 groups, which matched to 8 of the 
unbiased groups, with the other two appearing to consist of a hybrid of cell types. 
The cell groups are distinguished by expression of many marker genes and both of 
their analyses show very broad agreement on which group a cell clusters with. 
Subsequent sub-clustering of the neuronal group (defined as cells clustered as 
neurons by both analyses) gave rise to two excitatory and five interneuron groups
155
. 
Regrettably neither the paper nor its supplementary information is sufficient to 
identify which subgroup the neuronal cells belong to, so this paper will not be useful 
for identifying neuronal subtypes. 
To utilise the dataset, I obtained the RNA-Seq counts for all 466 cells described in 
the Darmanis et al. paper. I then removed those which were classified as “foetal 
quiescent” or “foetal replicating”, leaving 331 cells in classes astrocyte, neuron, 
oligodendrocyte, oligodendrocyte precursor cell (OPC), hybrid, microglia, 
endothelial. I then normalised to read depth for each single cell RNA-Seq sample. I 
then generated pseudosamples using the Darmanis et al. dataset in the same manner 
as with the Zhang et al. dataset. 
The dataset has one key advantage over the Zhang et al. dataset, in that it is 
generated from human cells. The cells are resected from living brain tissue rather 
than grown in cell culture like our own, and in contrast to the Zhang et al. cells 
which have spent some time in cell culture. However, the sequencing depth is far 
lower than our dataset. With this in mind, I decided to utilise both the datasets 
described by Zhang et al. and Darmanis et al.. 
5.6.1.3 Allen et al. datasets  
The Allen Brain Atlas datasets are described in detail in their white paper as well as 
at the web address http://celltypes.brain-map.org/rnaseq (accessed on 16/10/2018). 
The human dataset I utilised is comprised of single nucleus RNA-Seq of the middle 
temporal gyrus. Single nucleus RNA-Seq is somewhat less than ideal as many 
transcripts in human neurons are locally translated at dendrites and other non-nuclear 
locations. These transcripts number as high as 2,550, although of course many of 
these may also be partially translated in the nucleus and will appear in the datasets
277
. 
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It is clear that single nucleus sequencing, as opposed to single cell sequencing, will 
not capture all the information available. There are 15,928 nuclei derived from 8 
post-mortem human adult brains. The average sequencing depth is 2.63x10
6 
reads, 
comparable to Darmanis et al. but only about a tenth of the depth of our samples. 
Accordingly, far fewer genes were detected, ranging from 6,186 to 9,937, depending 
on the cell subclass (GABAergic, glutamatergic, unassigned, non-neuronal).  
5.6.2 Zhang et al. deconvolution 
I first utilised the Zhang et al. dataset, optimising the deconvolution by 
deconvoluting Zhang pseudosamples, the Zhang Two dataset, and the Dorsal Root 
Ganglion neurons. The t(1;11) samples were then deconvoluted using the settings 
these datasets suggested were optimal. 
For the Zhang et al. deconvolution, pseudosamples were deconvoluted using a 
variety of marker gene numbers (25 to 500 in increments of 25) per cell line, and HK 
values ranging from 1-10, and then 15 to 50 in increments of 5. It should be noted 
that these pseudosamples and marker genes are identical to those used in the mouse 
cortical deconvolution; the difference is that different housekeeping genes are being 
utilised, and that the marker genes have been filtered beforehand so that only genes 
orthologous between human and mouse have been retained. I chose to filter for 
orthology before selecting the genes; therefore the deconvolution with 50 genes 
utilises the top 50 orthologues for each sample rather than the top 50 overall. I chose 
to do this as I had observed that having the same number of marker genes per cell 
line had given good deconvolution in the mouse deconvolutions.  
MAD ranged from 0.07 (marker=100, HK=2) to 0.23 (marker=425, HK=50). 
Increasing marker numbers or HK numbers appeared to cause a gradual and gentle 
increase in MAD. The results of the two deconvolutions with the lowest and highest 
MADs are shown in Figure 64. We can see the clear contrast between the two results. 
The best deconvolution has narrow peaks for all cell types, five of which peak within 
0.1 of the optimal value of 1. The worst has broad graphs indicating a wide variety of 
estimations, and none of these have peaked within 0.1 of the optimum of 1. It is 
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notable that the lowest MAD is lower than that in either of the mouse deconvolutions 
with the Zhang et al. dataset. 
 
Figure 64. Set of ratio of predicted to actual proportions for 100 pseudosamples against density of estimates. On the left 
is the best deconvolution, while on the right is the worst. Each cell type is indicated by a different colour. 
Astrocytes=Red, Neurons=Blue, Oligodendrocyte Precursor Cells=Green, Myelinating Oligodendrocytes=Purple, 
Microglia=Orange, Endothelial Cells=Yellow. The ideal scenario would be a straight line at 1, indicating perfect 
invariant deconvolution. 
5.6.2.1 Deconvolution of comparison samples 
5.6.2.1.1 Zhang Two 
I deconvoluted the Zhang Two dataset using all settings. When calculating MAD 
from this deconvolution, for 16/20 marker gene numbers the optimal MAD was seen 
if HK was 3 or less. The lowest MAD was 0.0413 at HK=1, marker=150, while the 
largest was 0.291 at HK=40, marker=425. MAD increased sharply at HK=25 or 
more and Marker Gene=250, where it roughly doubles across HK, or 350, where it 
roughly increases by 50%. Overall the results as marker gene varies are similar to the 
deconvolution of the Zhang pseudosamples, as expected. Examples are shown in 
Figure 65. The graphs are highly similar to the mouse cortical Zhang Two 
deconvolution. However, the results when marker=100, or 125, are not very similar 
and show a different prediction of the mouse whole cortex samples.  
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Figure 65. Set of predictions of Zhang Two dataset for the deconvolutions where HK#=2 and Marker gene # varies from 
25 to 500. Optimum is 100. Each cell type is indicated by a different colour. Astrocytes=Red, Neurons=Blue, 
Oligodendrocyte Precursor Cells=Green, Myelinating Oligodendrocytes=Purple, Microglia=Orange, Endothelial 
Cells=Yellow, Whole Cortex=Black. Predicted cell types are on X axis and proportions are on the Y. 
Using the optimum Zhang pseudosample settings of marker=100 and HK=2, I 
deconvoluted the Zhang Two dataset. The deconvolution of the “Zhang Two” dataset 
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is shown in Table 28. We can see that all cell types are quite well predicted; most are 
at >90% predicted as being what they are, with a mixed result for newly formed 
oligodendrocytes as being between oligodendrocyte precursor cells and myelinating 
oligodendrocytes. 
 
Table 28. Results of the deconvolution of the Zhang Two dataset using human optimum settings. *Newly Formed 
Oligodendrocytes were matched to Oligodendrocyte Precursor cells. They also were predicted as 0.205 and 0.241 
proportions of Myelinating Oligodendrocyte. Each row represents a different Zhang Two sample. 
A full discussion of what settings were chosen is in the corresponding t(1:11) 
deconvolution section. 
5.6.2.1.2 Dorsal Root Ganglion Neurons 
As in the mouse deconvolution testing, I carried out deconvolution of the roughly 
200 neurons described in the Li et al. 2016 paper
278
 using a spread of HK and marker 
gene numbers. Since some samples (usually 10-20%) did not have all the 
housekeeping genes expressed, some samples could not be included in the analysis. 
As with the deconvolutions of this dataset using the mouse cortical and hippocampal 
optimum settings, I have displayed the average estimations (Figure 66) and standard 
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deviations (Figure 67) of the neuron content of the >150 neurons using all 
combinations of HK and marker gene numbers.  
 
Figure 66. Graph displaying how neuronal prediction of >150 dorsal root ganglion RNA-Seq profiles using Zhang et al. 
cell types varies with housekeeping and marker gene number. The Y axis indicates the average proportion predicted to 
be neuron across >150 dorsal root ganglion RNA-Seq profiles; if identification is always perfect, it would be 1. The X-
axis indicates the quantity of marker genes (per cell type) used in the deconvolution, while colour indicates the number 
of housekeeping genes utilised. Since six cell types were used, the total marker gene number varies from 150 to 3,000. 
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Figure 67. Graph displaying how neuronal prediction of >150 dorsal root ganglion RNA-Seq profiles using Zhang et al. 
cell types varies with housekeeping and marker gene number. The Y axis indicates the standard deviation in the 
proportion predicted to be neuron across >150 dorsal root ganglion RNA-Seq profiles; if identification is always perfect, 
it would be 1. The X-axis indicates the quantity of marker genes (per cell type) used in the deconvolution, while colour 
indicates the number of housekeeping genes utilised. Since six cell types were used, the total marker gene number varies 
from 150 to 3,000. Housekeeping genes chosen using Zhang and human datasets. 
The maximum predicted proportions start at 250 marker genes and from then on 
there is no increase in predicted proportion with increased marker gene numbers. 
There is a similar pattern with standard deviation of estimates; the variation increases 
from 100-150 and then decreases until 250, when it steadies. We also see that one 
deconvolution has a particularly high standard deviation across all marker gene 
options; this corresponds to the deconvolution with 1 housekeeping gene. The pattern 
is similar to the deconvolution using the mouse cortical and hippocampal 
housekeeping sets, although the change is at 250 markers instead of 300.  
Although the optimal for pseudosample deconvolution was marker=100, HK=2, it 
appears that these settings do not give the lowest standard deviation in neuron 
prediction rates. I examined the MAD of the deconvolutions of the pseudosamples in 
more detail, as initially described in 5.6.2.1. The optimal MAD was 0.07376, but at 
marker=250, HK=2, it increased merely to 0.0768, a 4% increase in what was 
already a very small MAD. A comparison of the two is shown in Figure 68. 
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Figure 68. Set of ratio of predicted to actual proportions for 100 pseudosamples against density of estimates. On the left 
is the best deconvolution, while on the right is that with the same HK but more markers so as to minimise standard 
deviation. Each cell type is indicated by a different colour. Red=Astrocytes, Blue=Neurons, 
OligodendrocytePrecursorCells=Green, Myelinating Oligodendrocytes=Purple, Microglia=Orange, Endothelial 
Cells=Yellow. The ideal scenario would be a straight line at 1, indicating perfect invariant deconvolution. 
5.6.2.1.3 Deconvolution of human t(1;11) samples using Zhang et al. datasets 
As with the mouse Der1 samples, it is important to use the settings that give accurate 
deconvolution of whole cortical samples and have high accuracy in Zhang 
pseudosample deconvolution and Zhang Two identification. In all cases, the optimal 
settings were suggested by low HKs, but not HK=1. 
The Dorsal root ganglion proportion estimates suggest that 250 marker genes would 
be ideal to avoid underestimation of neurons. However, it is at this change, from 225 
to 250 marker genes, where inaccuracy most sharply increases across deconvolution 
of the Zhang Two dataset. This is particularly at lower HKs and is mainly driven by 
poor astrocyte prediction. Marker gene changes have a far less dramatic effect on the 
Zhang pseudosamples, especially at HK 1-10 where the difference between the 
optimal and least optimal marker gene number for each HK changes MAD by ~1%. 
The mouse whole cortex samples are deconvoluted differently across changing 
marker gene numbers, as expected. As numbers over 350 show exceptionally poor 
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astrocyte prediction, these can be ruled out. Astrocyte prediction is also poor over 
250. Numbers up to 175 show very low neuron prediction in the whole cortical 
samples, which should be predicted as at least 40%, with isotropic fractionation 
estimates being much higher. This leaves numbers 200-250 as being plausible 
choices, with 200 having larger sensory neuron estimate deviation than 225 or 250. 
Both 225 and 250 have similar estimates for whole cortex; 30/33% astrocyte, 45/48% 
neuron, 17%/17% oligodendrocyte precursor cell, and minor amounts of the other 
cell types. The increase in MAD is drastic at the 250 marker for Zhang Two, but not 
for the Zhang dataset. I chose to utilise the three marker gene sets 200, 225, and 250, 
with HK=2 which is the optimum in each case. 
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Figure 69. Deconvolution of human t(1;11) samples using Zhang et al. datasets, with data for separate cell lines shown. 
Controls are in blue and translocations in red, with different shapes for each cell line. The mean for each cell line is 
indicated by a black line and the three samples for each of the six lines are displayed.. 
The deconvolution predicts a mixed neuronal-immature oligodendrocyte culture with 
a minority of astrocytes. In addition, t-tests detected a significant change in astrocyte 
levels between the C and T genotypes for all deconvolutions, and a change in 
neurons in the HK=2, Marker Gene=250 genotype. The astrocytic change was a 






, depending on 
the deconvolution. In all cases Sidak-Bonferroni correction for multiple testing was 
applied. 
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5.6.3 Darmanis et al. deconvolution 
Next, I deconvoluted the t(1;11) samples using the Darmanis datasets. Darmanis 
pseudosamples, and the comparison Allen dataset were deconvoluted, then the 
t(1;11) samples.  
As before, housekeeping genes were selected based on less than a fourfold difference 
between the maximum and minimum values of a sample, then the coefficients of 
variation in both our t(1;11) samples and the pure cell profiles of Darmanis et al. 
were used to rank genes by minimal variation. Only 18 genes met the fourfold 
variation criteria in both groups and were expressed in all samples and profiles. I 
therefore varied the number of housekeeping genes from 1 to 18 and the marker gene 
numbers from 25 to 500, in increments of 25. 
The minimum MAD was found for the HK=16, Marker Gene number=225 
deconvolution at 0.069, while the largest was found at HK=1, Marker Gene 
number=500 at 0.209. The optimal MAD is quite good, comparable to the Zhang et 
al. deconvolutions of the mouse samples (0.059 and 0.049 for cortical and 
hippocampal settings). 
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Figure 70. Set of ratio of predicted to actual proportions for 100 pseudosamples against density of estimates for the best 
deconvolution. Each cell type is indicated by a different colour. Astrocytes=red, Neurons=Blue, Oligodendrocyte 
Precursor Cells=Green, Myelinating Oligodendrocytes=Purple, Microglia=Orange, Endothelial Cells=Yellow, 
Grey/Black=Hybrid. The ideal scenario would be a straight line at 1, indicating perfect invariant deconvolutions 
5.6.3.1 Deconvolution of comparison samples 
5.6.3.1.1 Allen dataset 
I carried out deconvolution of Allen samples using the same variety of HK and 
marker gene numbers and the Darmanis dataset, so as to test the deconvolution. Due 
to constraints on computing power, I was unable to utilise the entirety of the Allen 
dataset. I therefore randomly selected 4,000 cells from the dataset and carried out the 
deconvolution on these. 2,571 were “Glutamatergic”, 1,083 “GABAergic”, 234 
“Non-Neuronal”, while 112 were described as “No Class”.  
The first observation I made was of an extremely high dropout rate of cells with 
increasing HK, due to lack of expression of one or more of these housekeeping 
genes. The “Non-Neuronal” cells were particularly badly affected; even at HK=2 
only 23 of these remained. In general oligodendrocytes were predicted accurately 
with HK=2, Marker Gene=225 predicting them as being 67% oligodendrocyte, 
changing to 69% at Marker Gene=250. Oligodendrocyte precursor cells were 
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predicted as a hybrid cell type rather than as a oligodendrocyte; 62% and 55% at the 
above settings. Astrocytes were less well predicted, as were microglia. Regardless of 
setting, several observations could be made. These are primarily regarding the 
GABAergic and Glutamatergic cell types of the Allen dataset; as described earlier, 
most other cells quickly dropped out due to lack of housekeeping gene expression. 
At no setting were these cells predicted as having an average of >~5% of either the 
endothelial or microglia cell types. A minority did have a larger predicted cell 
proportion of endothelial cells at high marker and housekeeping gene numbers, up to 
about 20%. I observed that at higher marker gene numbers the cells were predicted 
consistently and mostly as neurons; this appeared to plateau at 250 markers for 
HK=16, as might be expected from the previous deconvolutions. Low marker gene 
numbers predicted neuron proportion poorly, again reaffirming that these were not 
ideal settings. At these lower HKs, where non-neuronal cells were still included, it 
could be seen these cells had increasingly predicted neuronal proportion at high 
marker gene numbers, >400. 
To conclude, these deconvolutions reaffirm that high marker gene numbers are 
suboptimal for non-neuronal cell types, but neurons are relatively well predicted at 
lower marker gene numbers of 250. The jump from 225 to 250 marker genes appears 
to mark the last step in increasing neuron prediction. At HK=16, there were 20 
GABAergic neurons and 139 glutamatergic. The 20 GABAergic neurons were 
predicted as 78% neuron and 10% hybrid at marker gene=225, while at 250 this 
changed to 89% and 5%. The 139 glutamatergic neurons also changed from 83% 
neuron, 11% astrocyte to 88% neuron 7% astrocyte. Clearly, there is an increase in 
accurate prediction from what was already a relatively high number. This trend is 
also seen at other HK numbers, e.g. increases of 64% and 70% for the two cell types 
to 74% and 79% at HK=2. AT HK=16, much lower marker gene numbers result in 
large predictions of hybrid cell type, clearly inaccurately. This deconvolution 
therefore reaffirms that the choice is between 225 and 250 marker genes, where the 
increase at HK=16 in the Darmanis pseudosample deconvolution brings MAD from 
0.069 to 0.085. I therefore deconvoluted using both settings. 
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Figure 71 displays the results of the deconvolution using HK=16, Marker Gene=225 
and 250. T tests for differences in cell proportion across genotype revealed no 
significant differences in any cell. However, we can see that there is evidently much 
more variation in these iPSC-derived neuron samples than there was in the mouse 
Der1 samples, as might be expected in non-genetically homogenous samples that 
may differentiate to slightly different extents, as is typical of iPSC-derived neurons. 
This makes the outcome somewhat unreliable; it is possible that the samples are just 
too variable to accurately assess the proportions. The high similarity of the two 
deconvolutions highlights that the variability is likely a product of the cells rather 
than of the deconvolution.  
 
Figure 71. Deconvolution of human t(1;11) samples using Darmanis et al. datasets, with data for separate cell lines 
shown. Controls are in blue and translocations in red, with different shapes for each cell line. The mean for each cell line 
is indicated by a black line. Settings used were HK=16, Marker=225. 
5.7 Summary of findings and discussion  
There is little evidence from this investigation to suggest that the t(1;11) has an effect 
on cell proportions, and the same applies with the mouse hippocampus Der1. No 
pairwise effects were determined in the cortical analysis. Overall, the results suggest 
that the t(1;11)/Der1 do not exert their effects via altering cell proportions. However, 
caveats do apply. For a start, the accuracy and power of the deconvolution is difficult 
to quantify. It can certainly be said from the pseudosample analysis that 
pseudosamples of appropriate RNA-Seq depth were accurately deconvoluted with 
 
     271 
MADs at or below 7% in all cases. We can also confidently state that actual RNA-
Seq profiles of similar depth (the Zhang Two datasets) were accurately identified in 
cases of pure cell types, and plausible cell proportions were given in the case of 
whole cortical samples. Should changes in magnitude be lower than 7%, or if they 
are in cell types which make up less than 10% of the total cell mixture (as 
pseudosamples had >10% of all cell types due to intrinsic limitations), then the 
power to detect these would be very low. I therefore cannot make any comment on 
whether such changes exist. It must be stated that a better method of quantifying cells 
would be to count them via staining or perhaps FACS sorting. Nevertheless, this 
limited analysis indicates that large changes in cell proportions are unlikely to be 
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6.1 Selection of a single cell RNA-Seq dataset to examine 
specific cell subclasses 
6.1.1 Introduction 
It is accepted that the brain is comprised of a large number of distinctive cell types, 
including subsets of various neuronal types. As discussed in the Introduction, some 
psychiatric illnesses may be caused by disturbances in only a particular subset of 
cells. A database described by Zeisel et al.
157
 is available at http://linnarssonlab.org/ 
and contains single-cell RNA-Seq data for about 3,000 cells, taken from both the 
somatosensory cortex and hippocampus of wild-type mice. Given that the data are 
generated from cells from both the cortex and hippocampus, this dataset can be used 
to deconvolute both my cortical and hippocampal RNA-Seq samples. I therefore 
used the cortical cell profiles described by Zeisel et al. in the deconvolution of my 
cortical Der1 and t(1;11) datasets, and likewise used the hippocampal cell profiles in 
the deconvolution of my hippocampal Der1 dataset.  
The cortical subset of the dataset described by Zeisel et al. consists of 1,515 single-
cell RNA-Seq profiles. There are a total of 8 major classes (interneuron, 
astrocyte/ependymal, oligodendrocyte, 3 classes of pyramidal neuron, microglia, and 
pericytes/vascular smooth muscle cells together known as mural cells) which further 
divided into 41 subclasses, all distinguished by the clustering method used by Zeisel 
et al.. The hippocampal subset is similar in size and character, consisting of 1,390 
cells of 6 major classes (as above, but only one class of pyramidal neuron) divided 
into 38 subclasses. Subclasses are typically distinguished from one another by the 
expression of combinations of transcription factors. I used these subclasses for my 
deconvolution. Every subclass was found in at least two mice, and the total number 
of cells for each subclass ranged from 2 (for Interneuron 3) to 337 (for 
Oligodendrocyte 6) within each dataset, although some cell subclasses such as Int13 
were present in only one dataset.  
The data utilised by Zeisel et al. are not in the standard form of counts. Rather, they 
used a form of transcript tagging where each sequenced read has a unique molecular 
identifier (UMI) attached to its 5’ end. This means that they eliminate some sources 
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of technical error, important when sequencing at a low depth. Given that my samples 
were normalised to total sequencing depth, I consider that the analogous 
normalisation for the data of Zeisel et al. is to divide by total number of molecules 
sequenced. The median number was 24,287 and the average was 27,154.62. Each 
cell was normalised in this manner before being averaged with other cells of the 
same subclass to give the “pure” class or subclass profile.  
6.1.1.1 Caveats 
There are two issues with using the dataset described by Zeisel et al.. The first is 
intrinsic to using a large number of cell types in deconvolution; the low accuracy of 
DeConRNASEQ if cell proportions are low. Gong et al. have reported reasonable 
accuracy in deconvolution with cell proportions over 5%
135
. We can clearly see that 
the majority of cell types will be under 5% if there are 41 cell types. Since all cell 
proportions must sum to 1, severe over or underestimations of low cell types will 
result in “knock on” effects and will cause inaccuracies even in cell types which have 
reasonable prevalence. For this reason the deconvolution of a large number of cell 
types is intrinsically inaccurate.  
The second possible issue is the low sequencing depth of the samples used by Zeisel 
et al. . I was unable to find high depth datasets with the same number of cell types as 
Zeisel et al., which is to be expected given that they sequenced over 3,000 cells to 
retrieve these cell types. As discussed in the previous chapter, differences in 
sequencing depth cannot be accounted for just by normalising to sequence depth, 
especially for genes which are not among the most highly expressed. The issue here 
is that the internal structure of the dataset will differ between two datasets of 
different sequencing depth. However, there is one advantage in that since all the cell 
profiles are low-depth, they should be affected equally. In addition, I am looking for 
differences between samples rather than absolute proportions of cells. Therefore, I 
believe this issue should be relatively minor but warranted a discussion. More 
importantly, the low sequencing depth of the samples used by Zeisel et al. may also 
lead to problems with marker gene identification, as a gene may be moderately 
expressed in many cell types, yet only appear in the ones it is more highly expressed 
in due to lack of sequencing depth. For example, in the data described by Zeisel et al. 
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Disc1 is only found expressed in the cortical cell type S1PyrL4, a pyramidal neuron 
found in layer 4 of the cortex. However, Disc1 is known to be expressed in a wide 
variety of cortical cell types
268
. It is likely that only in S1PyrL4 is expression high 
enough to result in some Disc1 transcripts being sequenced. Disc1 therefore appears 
to be a marker gene, but we know that it is probably not specific to that cell type at 
the higher sequencing depth. Therefore its power to accurately predict that cell type’s 
prevalence in the deconvoluted datasets may be low, unless of course it is genuinely 
a marker gene and there is substantial enrichment in S1PyrL4. My solution to this 
will be to use a wide variety of settings, as before, and attempt to maximise 
deconvolution accuracy, particularly by using markers settings with high enrichment.  
6.1.1.2 Markers  
I experimented with another method of marker gene selection which was of use with 
the deconvolution of the Zeisel dataset. I hypothesised that one source of error was 
the expression of marker genes in cell types other than the line that they were 
supposed to be a marker for. To illustrate this, see Figure 42. Using Oligodendrocyte 
precursor cells as an example, we can see that many markers have quite good 
expression in neurons, and a minority have reasonable expression in astrocytes and 
endothelial cells. I was aware from the data described by Zhang et al. that fold 
changes for markers between the marked cell type and other cell types typically vary 
greatly. There was not a paucity of good marker genes. Most of the top marker genes 
have an expression level in their marked line several hundredfold larger than the 
average expression level of the other cell types, and even the least differentially 
expressed marker gene (Piga3, the 500
th
 myelinating oligodendrocyte marker) has an 
expression at least threefold above the average of the other cell types. I saw that the 
problem might be that a marker had a large fold change between its marked line and 
all other lines on average, but might have reasonable expression in one of those other 
lines. High prevalence of a marker would then indicate either moderate levels of the 
primary cell type, or high levels of the secondary one. The marker would no longer 
function as a unique delineator for a single cell type. A better marker would even be 
one with high expression in one cell type and moderate but invariant expression in all 
others-but this gene would not be a sensitive detector, only a reliable one. Using 
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highly enriched markers would likely solve this problem, taking highly enriched as 
meaning not only much higher than in the next cell type but very high compared to 
the summed expression in all other cell types. 
There is a second issue with the Zeisel dataset and markers. Unlike the Zhang 
dataset, where each of the six cell classes has several hundred markers with moderate 
fold changes >3, and several dozen with much larger fold changes, the cell 
subclasses are not similarly positioned here. The 41 cortical subclasses identified by 
Zeisel et al. are different in nature. Some, like Int3, Int4, and Int5, have one entirely 
specific marker each, while Oligo6 has 241. Therefore, picking any arbitrary number 
of markers and using this for each cell line either includes inferior markers, or leaves 
a large number of perfectly good ones out. I wanted to use a metric for maker 
selection which could flexibly integrate large numbers of markers if they were of an 
acceptable quality but exclude poor markers for other cell lines which did not have a 
similar number. Using a known metric rather than just picking numbers also means 
that all the marker genes are held to a certain standard.  
I calculated a factor for all genes that I refer to as the specificity index (SI). The SI 
for a marker gene is equivalent to the maximum expression (the expression in the 
marked line) divided by the total expression of all lines. I decided to use markers 
with a specific SI, rather than ranking and taking the same number of genes for each 
cell subclasses. By filtering for markers above a certain SI, I could be sure that all 
cell subclasses had a number of markers above a threshold of specificity, and that 
there would not be issues due to one subclass having a handful of excellent, near-
entirely specific markers. I thought this appropriate for the Zeisel dataset, where 
there were a large number of cell subclasses which had different numbers of markers. 
SI is functionally equivalent to “enrichment” as calculated by many papers; an 
SI=0.75 is equivalent to a fold enrichment of 3, while an SI=0.8 is equivalent to 4, 
SI=0.875 equivalent to 7, and SI=0.9 equivalent to 9. Using the same SI means that 
all the markers are at a certain standard of enrichment, but different lines have 
different numbers of markers if they are a suitable standard. The validity of this 
approach is shown by the reasonable MADs I found produced by the method.  
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6.1.2 Selection of comparison datasets to verify deconvolution 
6.1.2.1 Introduction 
As in the previous chapter, it was important to have datasets that could verify the 
accuracy of my deconvolution. For this, they needed to be similar in composition to 
the Zeisel et al. dataset in terms of RNA-Seq depth, and they had to have identified 
the cells in a trustworthy manner. 
6.1.2.2 Allen Brain Atlas 
The Allen Brain Atlas consists of several types of data including a database of single 
cell RNA-Seq for regions of the mouse, human, and macaque brains. Currently, cell 
type calls for the human middle temporal gyrus, mouse primary visual cortex and 
mouse anterior lateral motor area are available, along with the RNA-Seq results 
themselves. Several other datasets are soon to be released with cell type calls, but as 
it stands the datasets provide a large number of comparison cells to test my 
deconvolution on. I decided to use the human middle temporal gyrus and mouse 
primary visual cortex datasets. 
The Allen Brain Atlas datasets are described in detail in their white paper as well as 
at the web address http://celltypes.brain-map.org/rnaseq (accessed on 16/10/2018). 
Mouse cells were harvested from P51-P59 animals for the most part, and then 
subjected to FACS sorting with neurons identified by expression of NeuN. The 
mouse dataset consists of over 15,000 cells, of 117 neuronal types and 16 non-
neuronal types. The human middle temporal gyrus dataset was produced from post-
mortem samples and has over 15,000 cells, which have been FACS sorted into 
neurons (90%) and non-neurons by the presence of NeuN. RNA was then harvested, 
converted to cDNA, and sequenced. All datasets are described as using 50bp paired 
end reads and were sequenced on a HiSeq 2500 instrument, so the technical details 
are somewhat different from our dataset. There are also some issues in that the brain 
regions in the Allen datasets are not hippocampus and cortex. The mouse dataset is 
cortical, but there is not a hippocampal dataset to match. There are many cell types 
which are only found in certain brain regions, and it must be noted that the cell types 
used in deconvolution are defined as such in the paper they originate from. This 
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means that the datasets in Zeisel et al. and Allen et al. will differ on the number of 
interneurons, pyramidal, etc cell subtypes they identify, depending on how different 
their clustering methods are. It will not be the case that each Allen subclass will 
easily map to a Zeisel subclass. It therefore seems likely that the Zeisel et al. 
deconvolution will misidentify many of the Allen categories in terms of subclass, 
although it should not misidentify them within the class of cells that they belong to. 
For example, an Allen cell being identified as a mixture of Interneuron subclasses 2 
and 3 may not be biologically worrying (as these cell types may indeed be highly 
similar), but being identified as 40% Astrocyte 1 and 60% Pyramidal Cell 3 is 
worrying. Having access to so many cell profiles will be helpful. 
6.1.3 Housekeeping gene normalisation to compare multiple datasets 
6.1.3.1 Introduction 
As it had successfully improved deconvolution using the Zhang dataset, and the 
rationales were the same, I decided to also use housekeeping gene normalisation to 
compare datasets here. 
6.1.3.2 Selection of housekeeping genes 
The rationale for housekeeping gene (HK) selection is the same as in the Zhang et al. 
deconvolution. They should be as uniformly expressed as possible, as well as being 
expressed in all cell subclasses.  
In order to gauge the suitability of genes as housekeeping genes, I calculated the 
coefficient of variation (standard deviation divided by mean, referred to as CV) in 
the following manner for the datasets from the Zeisel et al. paper; I calculated the 
CV of the averages of each cell subclass (AvCV). In this case each cell profile was 
represented by the average of the cells within that profile, so that the 380 cells within 
the CA1Pyr1 group, for example, were averaged to give the CA1Pyr1 profile. The 
same was repeated with all cell subclasses, so that I had approximately 40 profiles. 
The AvCV of a gene is the CV of the gene across these profiles. Next, I determined 
the mouseCV, which is the CV for the gene across the Der1 mouse samples. Since 
both CVs are directly comparable, I then determined the geometric mean of the 
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AvCV and mouseCV and ranked the genes by this measure as putative housekeeping 
genes from lowest geometric mean of the CVs to highest. As in the Zhang et al. 
dataset, I also restricted housekeeping gene selection to those genes which had a no 
greater than fourfold difference between the maximum and minimum values in both 
the mouseCV and the AvCV. Genes which were not universally expressed were also 
discarded as potential housekeeping genes. I also used GOrilla to check the gene 
ontologies of my putative housekeeping genes. 
For the Cortical vs Zeisel comparison, the top 10 ontologies overrepresented at the 
top of the list of ranked potential housekeeping genes can be seen in the Appendix. It 
appears that none of the ontologies for process, function, or component are unique to 
any cell type in particular but rather denote general cell maintenance, exactly as 
expected for housekeeping genes.  
I generated pseudosamples of the averaged cell subclasses described by Zeisel et al. 
in the same manner as in the Zhang deconvolution. I selected various numbers of 
housekeeping genes to use for normalisation, and I also varied the number of marker 
genes I utilised by SI. This was used to determine the optimal HK/SI settings for 
pseudosample deconvolution, and subsequently for comparison dataset 
deconvolution.  
6.1.4 Measures of error 
MAD and RMSE were calculated as in the Zhang deconvolution and utilised to 
determine pseudosample deconvolution efficiency. 
6.2 Mouse Cortical RNA-Seq Deconvolution 
6.2.1 Initial deconvolution of pseudosamples 
After generation of 100 pseudosamples using the 41 cell subclasses found in the 
cortical dataset, I normalised both pure cell subclasses and the pseudosamples to a 
number of different housekeeping genes. The normalisation factor was equivalent to 
the geometric mean of all the utilized housekeeping gene values, selecting genes by 
the least variable genes first. I carried out the deconvolution using 1-10 housekeeping 
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genes, then 15, 20, 25…50. I also utilised marker genes, selecting these by SI value. I 
utilised marker genes with the specificity values of 0.75-0.95, at intervals of 0.025, 
as well as a final comparison with genes of values >0.999. There are therefore 10 
different marker gene specificity indexes (SIs), and 18 different numbers of 
housekeeping genes (HKs), so this deconvolution of 100 pseudosamples has been 
carried out 198 times.  
Examination of the deconvolution results indicated that the lowest MAD value was 
0.22 (SI=0.925, HK=45) and the largest was 0.33 (SI=0.75, HK=3), indicating 
relatively good deconvolution, with estimates usually being less than 30% wrong. 
This is better than expected given the difficulty with predicting rarer cell types. In 
general increasing the SI appeared to increase the accuracy of the deconvolution. 15 
of 18 HK deconvolutions had their maximum accuracy if SI=0.925, a pattern also 
seen in the RMSE (14/18 deconvolutions most accurate at SI=0.925). 8 of 10 SI 
deconvolutions had their maximum accuracy if HK=45. Since RMSE values seemed 
to reflect the MAD patterns, I therefore just looked at MAD for subsequent 
deconvolutions. I looked at the SI=0.925, HK=45 deconvolution in more detail. 
Across the 100 pseudosamples a source of particular error stood out. Each 
pseudosample is comprised of 41 cell subclass and has ratios of estimated:actual 
proportions for each cell subclass. Across these 100 pseudosamples and 41 
subclasses, the average ratio per cell subclass is 1.09, the average minimum is 0.946, 
and the average maximum is 5.46. Given that the optimum is 1, this is a surprisingly 
accurate deconvolution, although it appears to be prone to overestimation. Looking 
in greater detail, I saw that the Interneuron 5 cell subclass was consistently 
overestimated. The average ratio across 100 pseudosamples was 3, meaning this cell 
subclass is usually overestimated by 300%. The maximum ratio was 26, and the 
minimum 1.5. In total, there are 101 out of 4100 cell estimation ratios which are 
greater than 2, 49 of which are of Interneuron 5. The issue was clearly with this cell 
subclass. If I could cause it to be deconvoluted correctly, I would have an accurate 
deconvolution of the cell subclasses, despite their low proportions. Why this 
particular celltype is prone to overestimation is difficult to assess. However it may be 
due to a poor number of markers for the cell. Int5 has only one marker, Ltb, which is 
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solely expressed in this cell type. It does not express any markers of other cell types. 
Int3 has the next lowest number of markers, 2, and also does not express any markers 
of other cell types. It is likely this combination of poor marker number and lack of 
expression of other genes which combine to make it extremely difficult to assess the 
proportions of Int5, as it intrinsically has a low amount of data points that can inform 
its possible prevalence. Int3 is not characterised by similar overestimation; it is 
estimated at being on average 0.93 of the true proportion across 100 pseudosamples. 
6.2.2 Removal of Interneuron 5 
My first potential solution was crude; I removed the Interneuron 5 line from the cell 
subclasses, re-generated new pseudosamples without Interneuron 5, and 
deconvoluted them using the same spread of HKs and SIs as before. 
The results were relatively similar to those with Interneuron 5 retained. The lowest 
MAD was 0.28 (SI=0.999, HK=15) and the largest 0.41 (SI=0.725, HK=3). I looked 
at the best deconvolution in more detail. 
Across these 100 pseudosamples and 40 subclasses, the average ratio per cell 
subclass is 1.16, the average minimum is 0.95, and the average maximum is 9.59. It 
is evident that this deconvolution is more error prone than the previous one, as 
reflected in the larger MAD. The major difference between this deconvolution and 
the previous is that the error is not concentrated in any particular cell subclass. The 
cell subclass with the largest number of estimations which are more than twice or 
less than half the true proportion is Oligo6. It has 15 out of 100 samples which meet 
either of these criteria. In the previous deconvolution, Int5 had 49 of 100 samples 
meeting either of these criteria. 
I also looked at the deconvolution with SI=0.925 and HK=45, as this was optimal 
when Int5 was retained. The average ratio per cell subclass is 1.19, the average 
minimum is 0.92, and the average maximum is 11.8, brought up by a handful of 
extremely large overestimations.  
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6.2.3 Merging Interneuron 5, 6 ,7, 8 cell types 
Since removing Interneuron 5 had clearly exerted an effect on the other 
deconvolutions, changing not only the optimum settings but also causing other cell 
subclasses to be incorrectly predicted, I looked for another option to minimise the 
error introduced by Int5. One option would be to merge the cell subclass with other, 
similar cell subclasses, and see if this amalgamated subclass would be accurately 
deconvoluted. Looking at Zeisel et al., we can see that their clustering analysis 
places Interneuron 5 with another group of interneurons. These are distinguished by 
the expression of certain genes and Interneurons 5, 6, 7 and 8 form a clade. I 
therefore decided to average the profiles of all cells from the subclasses Interneuron 
5, 6, 7 and 8, to make a new subclass Interneuron 5678. I then generated 100 
pseudosamples using this subclass, and the other 37, and deconvoluted these 
pseudosamples using the sample range of SIs and HKs as before. 
MAD values were broadly similar to those of the initial deconvolution. The smallest 
was 0.286 (SI=0.99, HK=10) and the largest 0.398. 7 of 10 SI values gave their 
lowest MAD if the HK was 10, while the best SI value across HKs was 0.95 (8/18 
times) or 0.999 (10/18 times). The optimum SI and HK was similar to that of the 
previous section, where Interneuron 5 was just removed. I therefore looked at the 
SI=0.99, HK=10 deconvolution in more detail. 
Across the 100 pseudosamples and 38 cell subclasses, the average ratio of 
estimated:actual proportion was 1.16, slightly worse than the unmerged interneuron 
deconvolution. The average minimum estimate was 0.95 and the average maximum 
8.98 (brought up by one particularly egregious overestimation by a factor of 65). 
Although these figures appear to show that the deconvolution is inferior to the 
unmerged interneuron deconvolution, there are some advantages. 
Firstly, the source of error is not concentrated in any particular cell subclass. 88 out 
of 3800 cell proportion estimations are greater than 2. This is almost exactly the 
same proportion with this degree of error as in the unmerged deconvolution (0.023 vs 
0.024). However the error is less concentrated. 18 of these estimates are of the 
Oligo6 subclass, 11 are in the Interneuron 15 subclass, and the rest are dispersed 
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throughout the various subclasses, with 1 in the merged Interneuron 5678 subclass. 
We can conclude that the merged deconvolution is less accurate overall, but the 
unmerged deconvolution is extremely inaccurate in the prediction of Interneuron 5. 
The results are quite similar to those where Interneuron 5 was merely removed. 
I concluded that the best approach would be to carry out deconvolution of my mouse 
cortical samples using all options at their respective optimum settings; the unmerged, 
removed Int5, and merged Int5 profiles of the cell subclasses. I thought it likely but 
not a certainty that there would be errors in the prediction of Interneuron 5, so the 
other deconvolutions are likely to be more reliable but less informative due to less 
detailed information on the interneurons. 
6.2.4 Deconvolution of Allen comparison dataset 
I first tested the deconvolution using the cortical subset of the Allen Brain Atlas 
dataset. I utilised the same range of HK values to normalise as well as the same range 
of SI values to select marker genes. Although there are 15,000 RNA-Seq single cell 
profiles, not all of these were retained during the deconvolution process. Since the 
housekeeping genes I utilised were selected by expression in the Zeisel and 
heterozygous Der1 cortex datasets, they are not all expressed in every Allen 
subclass. I noted that non-neuronal Allen subclasses particularly tended to lack 
expression of some of the housekeeping genes, although many of these cells did 
express all housekeeping genes and were correspondingly retained for the 
deconvolution. Cells not expressing all the required housekeeping genes were 
discarded. A number of cells were also removed on the basis of intermediate subclass 
characterisation (not being part of the “Core” cluster for each subclass). Although it 
would be interesting to see how these intermediate cells were deconvoluted, the 
Allen dataset does not note what they are intermediate to, only what they were 
primarily identified as being. They are therefore not useful for deconvolution. 
I thought it likely that there will be Allen cells which are predicted to be a mixture of 
several Zeisel subclasses. This could be due to a lack of one to one relationship 
between Allen categories and Zeisel subclasses. However, we should expect at least 
that Allen cells will not present as a mixture of classes, i.e., Astrocytic and 
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Interneuronal, Oligodendrocytic and Interneuronal, etc. To analyse the efficacy of the 
deconvolution, I took all estimations for all cell subclasses across the thousands of 
Allen cells, then summed the Zeisel subclass estimates for each Zeisel class 
(“Oligo”, “Interneuron”, etc). I then produced violin plots for all classes. This 
allowed me to observe the Allen identification against the spread of predicted 
proportions for each cell class. 
For the several thousand cells which have been deconvoluted, there are several 
different classes and subclasses according to Allen et al.. The classes are 
“Glutamatergic”, “GABAergic”, “Non-Neuronal”, “Endothelial”, “No Class”, and 
“Non-Neuronal”. The Allen subclasses are typically named according to the 
expression of certain markers such as parvalbumin, or are given a designation if the 
cell is well characterised (e.g., “Astro” and “Oligo” for astrocyte and 
oligodendrocyte, both subclasses in the “Non-Neuronal” class). In the results below, 
cells are divided by Allen subclass, coloured by Allen class, and have the spread of 
predicted proportions for each Zeisel class graphed (with each Zeisel class proportion 
defined as the sum of Zeisel subclass proportions within that Zeisel class). The 
question is how well the optimum setting performs. If it shows exceptionally poor 
identification of each cell type compared to other settings, this is strong evidence that 
this line of inquiry should be abandoned. 
6.2.4.1 Results 
It is not possible to assign a single measure of accuracy, such as MAD, to each 
deconvolution. As stated before, the list of housekeeping genes is generated from the 
Zeisel and Der1 datasets, and therefore these are not necessarily housekeeping genes 
across the Allen cells. The different conditions will in some cases mean they are not 
expressed. I found that non-neuronal cells particularly lacked expression of the 
housekeeping genes when higher numbers of housekeepers were required. Different 
deconvolutions might optimise identification for a subset of cells but predict the 
majority very poorly. I elected to examine all deconvolutions by eye and particularly 
note how well the optimum settings performed. An example result is given in Figure 
72, which contains the violin plots of the predicted proportions of the Zeisel class 
“Interneuron”, which is the sum of the Zeisel subclasses “Int1”, “Int2”….“Int16”. 
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This is for the SI=0.7, HK=7 deconvolution. Violin plots were used as this allows the 
display of a large amount of data simultaneously. 
 
Figure 72. Violin plots of predicted Interneuron proportion for 23 subclasses of Allen cell, colour coded by class. 
Red=Endothelial, Yellow=GABAergic, Green=Glutamatergic, Blue=No class, Purple=Non-Neuronal. These results are 
of the SI=0.7, HK=7 deconvolution. Subclass types are as in the Allen dataset. The thickness of the violin plot at each 
predicted proportion represents its frequency according to the kernel density estimation of the deconvolution results for 
each subclass type. 
We can see that there is a large spread of results regardless of Allen class type. Non-
neuronal cells appear to be randomly distributed in their predicted “Interneuron” 
proportion, with the exception of macrophages which are mostly predicted as having 
a high level of interneurons. All GABAergic cells have a high probability of being 
predicted as mostly interneuron, while it appears glutamatergic cells have a broad 
spread. The perfect result would of course be that all cells except GABAergic ones 
had all results at 0 for the GABAergic cell proportion.  
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Figure 73. Violin plots of predicted Neuron proportion for 23 subclasses of Allen cell, colour coded by class. 
Red=Endothelial, Yellow=GABAergic, Green=Glutamatergic, Blue=No class, Purple=Non-Neuronal. These results are 
of the SI=0.7, HK=7 deconvolution. Subclass types are as in the Allen dataset. 
Figure 73 is of the same deconvolution result but displays the predicted sums for the 
Zeisel class “Neuron”. Here we see that most oligodendrocytes are predicted to be 
about 20% neuron, while most astrocytes are predicted as near 0%. The neuron 
classes have varying degrees of predicted neuron proportion but for most Allen 
subclasses (which correspond to cortical layers) cells are highly likely to have a 
predicted proportion below 50%. In general these deconvolution settings are not 
great but do display that when looking at any cell class, the cells which are of that 
class will have higher predicted proportions of it than cells of other classes do.  
I noticed several trends across deconvolutions. The first was that the largest 
proportion of predicted cell type was typically Interneuron. Initially this was 
regardless of cell type, but with increasing SI the levels of predicted Interneuron in 
non-GABAergic cell type typically fell, as did the levels in Interneuron in 
GABAergic cell types (but to a lesser degree and from a higher initial proportion). I 
noted this at the HK values 20, 25, 30, 35, and 45. Low HK values typically gave 
erratic results with a large scatter of predicted proportions in each Zeisel class 
Deconvolution of the RNA-Seq data using Zeisel et al. scRNA-Seq datasets 
288 
regardless of actual cell identity. At SI<0.9, this large scatter was also generally seen 
in predictions except those of Neuron and Interneuron. 
 
Figure 74. Violin plots of all 6 Zeisel class proportions for 18 subclasses of Allen cell, colour coded by Allen class. 
Red=GABAergic, Yellow=Glutamatergic, Blue=No class, Purple=Non-Neuronal. These results are of the SI=0.925, 
HK=45 deconvolution. Note different colours to Figure 72 and Figure 73 
The SI=0.925, HK=45 deconvolution is shown in Figure 74. Note the decreased 
number of Allen subclasses compared to Figure 72 and Figure 73 due to the lesser 
number of cells and cell types which express all housekeeping genes. There are 
several observations to be made, in conjunction with the summarised non-graphic 
results as shown in Table 29. First, we can see that astrocytes and microglia are 
predicted as being essentially absent from the Allen cells. This is reasonable; there 
are neither astrocytes nor microglia within the cells which express all 45 
housekeeping genes. Oligodendrocytes are most likely to be predicted as 0 in all 
glutamatergic and GABAergic cell types, but many of these cells are predicted as 
containing reasonable proportions of oligodendrocytes, or even as being 100% 
oligodendrocyte. Due to the low number of actual oligodendrocytes (four) the 
efficiency of prediction is hard to gauge; the average for these four is 42%, but for 
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two of them it is 0% and the other two are from the same subclass of 





of cells Astrocytes Other Neuron Interneuron Microglia Oligodendrocyte 
GABAergic 3,709 3.5% 3.9% 18.8% 51.6% 0.49% 23.7% 
Glutamatergic 5,340 4.8% 3.5% 42.9% 28.7% 0.5% 19.1% 
Non Neuronal 5 ~ 3.5% * * * * 
Table 29. Table of the average predicted proportions of each Zeisel class within each Allen class with SI=0.925, HK=45 
the best deconvolution for the pseudosamples. Due to the low number of non-neuronal cells, these have been described 
verbally. The “No class” group has been removed as this has no information as to the quality of the deconvolution. *=1 
oligodendrocyte predicted as 68% neuron,1 oligodendrocyte predicted as 30% interneuron, 1 cell identified as 100% 
microglia. 1 oligodendrocyte predicted as 84% microglia.,2 oligodendrocytes predicted as 85% oligodendrocyte. 
To further understand the quality of the deconvolution of the Allen samples, I took a 
look at the deconvolution which produced the highest MAD in the original 
deconvolution of pseudosamples. This was HK=3, SI=0.75 and the results are 











of cells Astrocytes Other Neuron Interneuron Microglia Oligodendrocyte 
GABAergic 5,178 0.73% 3.4% 12% 82% 0.5% 4.8% 
Glutamatergic 6,709 0.8% 2.6% 41.3% 58.1% 0.47% 1.2% 
Non Neuronal 182 9.8% 8.1% 22.3% 51.4% 5.9% 2.2% 
Endothelial 44 ~ 11% 21.9% 30.7% 1.2% 1.3% 
Table 30. Table of the average predicted proportions of each Zeisel class within each Allen class with SI=0.75, HK=3. the 
worst deconvolution for the pseudosamples. The “No class” group has been removed as this has no information as to the 
quality of the deconvolution. 
We can see that the average proportion of interneurons has been inflated across all 
cell types. Endothelial cells have also made an appearance as they now fit the criteria 
for inclusion by expression of all 3 of the housekeeping genes, as opposed to the 45 
they would have needed in the previous deconvolution. None of the cells (except 
GABAergic cells which will contain interneurons) are on average predicted to be 
mostly the cell type that they are.  
The overall accuracy is low, but there is at least a trend towards increasing accuracy 
with the better deconvolutions. The housekeeping gene selection in particular 
influences the deconvolution outcome, and given that the selection is based upon the 
variation within our mouse samples and the Zeisel et al. deconvolution profiles, the 
accuracy will be suboptimal for other datasets. It is extremely difficult to draw 
recommendations from the Allen dataset, and given that the deconvolution has not 
been accurate in identifying Allen cells it is difficult to trust its findings when 
applied to the mouse and t(1;11) samples, particularly given their different sample 
depth. I therefore suggest that the results found should be viewed as preliminary- 
although it is gratifying that the pseudosample deconvolution was relatively accurate. 
It should also be noted that housekeeping genes were selected based on validity 
across the samples and the Zeisel profiles; the deconvolution will be correspondingly 
more accurate. The methods used by the Allen institute to generate scRNA-Seq 
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should also be borne in mind. Neurons were distinguished by NeuN, which is a 
neuronal specific but not a neuronal universal marker
279,280
. However, if some 
neurons are being incorrectly identified as non-neuronal cell types, this doesn’t 
explain the poor recognition of non-neuronal cells by my analysis. Cells were also 
sampled to a reasonable degree; at least 16 cells per type (133 types), and many cell 
types were specifically selected for using Cre recombinase mice. I therefore do not 
have doubts about the validity of the Allen dataset in this regard, and although the 
sequencing depth is low, so is that of the Zeisel dataset.  
6.2.5 Deconvolution of mouse t(1:11) cortical samples 
Deconvolution of the cortical samples was carried out in three analyses, once with 
marker genes from 41 pure cell subclasses, once with markers from 40 pure 
subclasses (lacking Int5), and once with marker genes from 38 subclasses, one of 
which represents the merged Interneuron subclasses 5, 6, 7, and 8. Since the HK 
genes were chosen for minimal variation in both Zeisel et al. datasets and those of 
the mouse cortical Der1 carriers, they were the same in both the pseudosample 
deconvolution and in the mouse cortical Der1 deconvolution. Deconvolution was 
performed on 8 heterozygous, 8 homozygous, and 6 wild-type mouse cortical 
samples. For each analysis I used a variety of settings, as the Allen deconvolution 
had been quite poor. I utilised HK and SI numbers which were optimal for each of 
the three analyses in turn, but also applied them in every combination across all 
analyses, giving a total of 9 deconvolutions per analysis. As discussed previously, the 
homozygous samples appear to have an unusual interior structure; therefore ANOVA 
was carried out with both the homozygotes kept together, and with them split into 
two groups.  
6.2.5.1 Unmerged deconvolution results 
Although an issue with overestimation of Interneuron 5 was expected, this does not 
appear to have materialised at the HK=45 settings, which were optimal for this 
deconvolution. There is a high degree of variation in cell estimations for many cell 
subclasses, particularly interneurons. One-way ANOVAs were carried out for each 
cell subclass to examine the effects of genotype on proportion. It should be noted that 
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there are a total of 41x9=369 ANOVAs and results are therefore expected by chance. 
There were statistically significant differences between group means as determined 
by one-way ANOVA for several cell types in various deconvolutions. S1Pyrl5a was 
significant in both the SI=0.9, HK=10 and SI=0.925, HK=45 deconvolutions, and 
Vend2 appears three times, in every deconvolution where SI=0.925. However, 
Tukey’s posthoc test for difference between groups did not in any case find a 
significant group difference for any comparison. In total, 7 cell findings were 
significant in the ANOVA across all 9 deconvolutions.  
Given the findings, and given that there is a known difference between the 
homozygous samples, which divide into two groups, I carried out one-way ANOVAs 
in which the homozygous samples were split into their two groups, Group One and 
Group Two. A total of 29 ANOVAs were found significant across the 41 cell 
subclasses and 9 deconvolutions. Of these, Tukey’s posthoc test for difference 
between groups found a significant difference in cell type S1PyrL6 between Group 
One of the homozygotes and Group Two (p=0.029), and between Group One and the 
heterozygous samples (p=0.045). This was in the SI=0.9, HK=10 deconvolution. The 
results can be viewed in Figure 75. 
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Figure 75. Deconvolution of mouse cortical samples using profiles from Zeisel et al., with all cell profiles retained. 
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6.2.5.2 Interneuron 5 removed results 
The results can be viewed in Figure 76. One-way ANOVAs were carried out for each 
cell subclass to examine the effects of genotype on proportion. There were 
statistically significant differences between 4 group means as determined by one-way 
ANOVA for several subclasses, bearing a high degree of similarity to the previous 
deconvolution. Vend2 was again significant in every SI=0.925 deconvolution. As 
before, Tukey’s posthoc test found no significant combinations. 
I then carried out one-way ANOVAs in which the homozygous samples were split 
into Group One and Group Two. There were significant differences between 20 
group means, which were strikingly similar to the previous deconvolution and are 
therefore discussed in length in the discussion section. No pairwise comparisons 
were significant.  
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Figure 76. Deconvolution of mouse cortical samples using profiles from Zeisel et al., with Int5 cell profile removed. 
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6.2.5.3 Merged Interneuron 5-6-7-8 results 
The results are displayed in Figure 77. The results are highly similar to the 
deconvolution without Interneuron 5. One-way ANOVAs were carried out for each 
cell subclass to examine the effects of genotype on proportion. There were 
statistically significant differences between 5 group means as determined by one-way 
ANOVA the same subclasses of Vend2 and S1PyrL5a, in the same deconvolutions as 
before. Once again, Tukey’s posthoc test found no significant differences in pairwise 
comparisons. 
I then carried out one-way ANOVAs in which the homozygous samples were split 
into Group One and Group Two. There were 15 statistically significant differences 
between group means, which again bore a close resemblance to previous analyses.  
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Figure 77. Deconvolution of mouse cortical samples using profiles from Zeisel et al., with Interneurons 5, 6 , 7 and 8 
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6.2.5.4 Conclusion 
The results of the three deconvolutions are typically in agreement across one another, 
but across only some deconvolutions. Statistically significant differences were found 
in the comparisons and appeared in all three of the deconvolution approaches, 
summarised in Table 31. Note that only one deconvolution showed pairwise 
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 ANOVA   ANOVA split    
Cell 
subclass 
Unaltered No Int5 Int5678  Unaltered No Int5 Int5678 
Int3    1 1  1  
Int4       
Int5    3   
Int10    6 6 6 
Int12       
Int13       
Int14 1   3 1  
Int15      5 1 1 
Oligo2    5 5  
Peric 
 
       
Vend2 3 3 3 3 2 3 
S1PyrDL    2 2 1 
S1PyrL5       
S1PyrL5a 2 1 2 1 1 2 
S1PyrL6 
 
   1 1 1 
Table 31. Condensed summary of deconvolution results. #=Number of ANOVA significances with p<0.05 in that set of 9 
deconvolutions. Results with the homozygotes treated as one group are on the left, those in which they were split into 
two groups are on the right under “ANOVA split”. 
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6.3 Mouse Hippocampal RNA-Seq deconvolution 
6.3.1 Initial deconvolution of pseudosamples 
The hippocampal dataset described in Zeisel et al. 1,301 single cell RNA-Seq 
profiles from 6 classes of cell and 38 subclasses. The data were treated in the same 
manner as the cortical subset of data; normalised to total transcripts sequenced, then 
averaged by subclass to give 38 subclass profiles. 
For housekeeping normalisation, only 51 genes meet al.l the criteria laid out in 
5.4.1.2. Therefore, when carrying out my deconvolution, the SI ranged from 
0.7,0.725,0.75….0.975 and 0.999, and the HK ranged from 1 to 10, 15, 20, 25….50, 
51. Pseudosamples were generated in the same manner as previously and error was 
measured in MAD. 
The minimum MAD was 0.24 (at SI=0.975, HK=1) and the maximum was 0.98 
(SI=0.999, HK=50). Increasing HK resulted in a roughly linear increase in MAD, 
and increasing SI resulted in small decreases, except for SI=0.999 which had the 
largest MAD for all HKs. I looked at the SI=0.975, HK=1 deconvolution in more 
detail, although using one housekeeping gene for normalisation is problematic. 
Increasing the number of housekeeping genes increased the number of cell types for 
which the average estimate was more than twofold greater than the actual proportion 
(at HK=1 one cell type met this criterion, at HK=3 three did, at HK=5 four did). 
In the SI=0.975, HK=1 deconvolution the error seemed to be concentrated in one 
subclass, Choroid. Every single pseudosample underestimated its proportions by at 
least 50%. The only other subclass which was occasionally mis-estimated by a factor 
of 2 was Int12, with 16 proportions mis-estimated by this factor. It appears the issue 
may be with sufficient cell numbers as the hippocampal subset of  the Zeisel et al. 
dataset only contains one Choroid cell. 
6.3.2 Removal of Choroid 
I removed the Choroid cell from the dataset, recalculated the pseudosamples, and 
deconvoluted with the same spread of SI and HK values. 
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As before, the minimum MAD was at HK=1, where it equalled 0.23 (SI=0.85). 
Maximum was 0.475, indicating that deconvolution is overall more accurate if 
Choroid is removed. I then looked at the HK=1 SI=0.85 deconvolution in more 
detail. 
The mean of the average of the 100 estimation ratios per cell subclass was 1.17, 
while the average of the minimums was 0.87, and the maximum was 8.64. This is 
relatively poor compared to the unaltered deconvolution, where the figures were 
1.002, 0.94, and 1.088. The main difference appeared to be that the altered 
deconvolution occasionally produces estimates which are highly inaccurate (ranging 
as high as x227 fold overestimated) while the unaltered deconvolution does not (it’s 
highest overestimation is x2 fold). On this basis, it does not appear that removing the 
Choroid subclass is a satisfactory solution. 
6.3.3 Merging Choroid and Ependymal cell types 
Since the results had been favourable in the cortical deconvolution, I merged the 
Choroid subclass with the other subclass it clustered with, Epend, and recalculated 
pseudosamples. 
The minimum MAD was 0.235 (SI=0.925, HK=1) and the maximum was 0.495 
(SI=0.725, HK=50). I examined the best deconvolution in more detail. Several 
subclasses, including CA1PyrInt, Choroid/Epend and Vsmc, were consistently 
underestimated with maximum estimates of 0.56, 0.75, and 0.74 respectively. 
However, the mean of the average estimation ratios per cell subclass was 1.0009, 
while redoing the deconvolution with more housekeeping genes resulted in a higher 
“average of averages”. It appeared that averaging the Choroid and Epend subclasses 
had barely improved Choroid deconvolution, but had introduced an equally severe 
problem with the CA1PyrInt subclass and a lesser one with Vsmc. I therefore elected 
not to deconvolute by merging these lines.  
6.3.4 Deconvolution of Allen comparison dataset 
I deconvoluted the Allen dataset using the same spread of HK and SI values as used 
in the Zeisel deconvolution. These are cortical cells, so the deconvolution is not 
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likely to be as accurate as it would otherwise be. The greatly decreased number and 
quality of housekeeping genes may also result in inferior deconvolution compared to 
the cortical Allen deconvolution. As with that deconvolution, the goal here is to 
ensure that a minimum level of accuracy is retained. The discussion in 6.2.4 is 
relevant to this deconvolution as well, and the results are presented in the same 
manner.  
6.3.4.1 Results 
I deconvoluted the Allen dataset with the same housekeeping genes, and range of HK 
and SI values as in the pseudosample deconvolution. The minimum MAD there was 
at SI=0.975, HK=1, while the maximum was SI=0.999, HK=50. A summary of the 
results of these Allen deconvolutions using these settings are shown in Table 32 and 






Astrocytes Other Neuron Interneuron Microglia Oligodendrocyte 
GABAergic 5,288 11.60% 23.20% 33.70% 42.50% 0.37% 5.80% 
Glutamatergic 6,736 8.60% 33.30% 48.70% 20.70% 0.97% 11% 
Non Neuronal 431 8.90% 20% 39.90% 19.80% 9.30% 9.60% 
Endothelial 144 2.50% 47.90% 14.90% 6.90% 0.99% 16.70% 
Table 32. Results of deconvolution of SI=0.975, HK=1 deconvolution, the most accurate settings for pseudosample 
deconvolution. 
We can see that at the minimum MAD settings the GABAergic and glutamatergic 
cells have a relatively high average predicted proportion. The Non-Neuronal cells are 
heavily predicted as being neurons; this is concerning as these are mostly astrocytes 










of cells Astrocytes Other Neuron Interneuron Microglia Oligodendrocyte 
GABAergic 2,626 25.1% 16.3% 31% 38% 2.2 % 2.8% 
Glutamatergic 5,340 14.4% 22.5% 57.2% 19.6% 1.3% 6.6% 
Non Neuronal 2 ~ 1 * ~ ~ ~ 
Table 33. Results of deconvolution of SI=0.999, HK=50 deconvolution, the least accurate settings for pseudosample 
deconvolution. *=1 VLMC cell predicted as 89% due to 89% predicted as VSMC. Both are smooth muscle cells.*= 1 
oligodendrocyte predicted as 71% 
At the maximum MAD settings, the settings are if anything slightly better at 
predicting each cell type identity, although it is possible that this is due to the higher 
HK settings removing more cells, leaving only those which are closer in character to 
those of the Zeisel dataset.  
I thought it might be of use to look at the standard deviation of each guess, as this 
would indicate whether similar cells (by Class) gave similar values. The results of 
this are given in Table 34 and Table 35 for the most and least optimal deconvolution 





of cells Astrocytes Other Neuron Interneuron Microglia Oligodendrocyte 
GABAergic 5,288 0.172 0.311 0.338 0.386 0.022 0.15 
Glutamatergic 6,736 0.148 0.351 0.346 0.311 0.026 0.239 
Non Neuronal 431 0.261 0.329 0.404 0.328 0.246 0.249 
Endothelial 144 0.135 0.415 0.289 0.188 0.046 0.345 
Table 34. Results of deconvolution of SI=0.975, HK=1 deconvolution, the most accurate settings for pseudosample 
deconvolution. 







Astrocytes Other Neuron Interneuron Microglia Oligodendrocyte 
GABAergic 2,626 0.231 0.238 0.305 0.338 0.044 0.126 
Glutamatergic 5,340 0.154 0.262 0.323 0.285 0.037 0.186 
Non Neuronal 2 0 0.266 0.357 0.082 0.021 0.05 
Table 35. Standard deviation of deconvolution of SI=0.999, HK=50 deconvolution, the least accurate settings for 
pseudosample deconvolution. 
There does not appear to be any particular pattern of standard deviation; the better 
settings do not give any noticeable decrease in standard deviation and occasionally 
have a higher value, indicating more variation. The same findings as in the cortical 
deconvolution apply- the analysis must be viewed with caution. 
6.3.5 Deconvolution of mouse Der1 hippocampal samples 
6.3.5.1 Unmerged deconvolution results 
As before, I deconvoluted using a variety of settings. I had shown that increasing HK 
increased MAD in pseudosample deconvolution, and that SI=0.99 also had very high 
MAD. The lowest MAD was at SI=0.975. I therefore utilised the settings of 
SI=0.925, 0.95, 0.975, and HK=1, 2, and 5. The results of the deconvolution can be 
seen in Figure 78. There is also large variation in the proportion of the CA1Pyr1 
subclasses in the HK=1 deconvolutions. Both these issues are possibly due to using 
just one housekeeping gene in normalisation. One-way ANOVAs were carried out 
for each cell type to examine the effects of genotype on proportion. There were 15 
statistically significant differences between group means as determined by one-way 
ANOVA. Tukey’s posthoc test for difference between groups found that no pairwise 
differences were significant. Int4 and Int14 were each significant 5 and 4 times 
respectively, while Peric was 3 times, and Int3 was twice. Int12 was significant in a 
single deconvolution. 
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Figure 78. Deconvolution of mouse hippocampal samples using profiles from Zeisel et al.. WT=Wild-type, 
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6.4 Human iPSC-derived neuron deconvolution 
As it had shown itself to be an acceptable method of comparing datasets, and gave 
superior deconvolution, I carried out housekeeping gene normalisation of the datasets 
prior to deconvolution. This was carried out exactly as before; excluding genes with 
a fourfold difference between the maximum and minimum samples values, taking the 
geomean of the coefficient of variations for both datasets, and taking a number of 
genes to take the geomean of as a normalisation quotient. In addition, if the 
deconvolution dataset was mouse, then only orthologous genes were utilised.  
6.4.1 Selection of appropriate datasets for human deconvolution 
6.4.1.1 Zeisel et al. dataset 
The Zeisel et al. dataset has been previously described and was utilised in addition to 
the Zhang et al. dataset. The cortical subset of this dataset was utilised as this is the 
most appropriate comparison for the human neurons. 
6.4.1.2 Allen et al. datasets  
The Allen Brain Atlas datasets are described in detail in their white paper as well as 
at the web address http://celltypes.brain-map.org/rnaseq (accessed on 16/10/2018). 
The human dataset I utilised is comprised of single nuclei RNA-Seq of the middle 
temporal gyrus. Single nuclei RNA-Seq is somewhat less than ideal as many 
transcripts in human neurons are locally translated at dendrites and other non-nuclear 
locations. These locally translated transcripts number as high as 2,550, although of 
course many of these may also be nuclearly translated and will be partially 
represented in the Allen datasets
277
. It is clear that single nuclei sequencing, as 
opposed to single cell, will not capture all the information available. There are 
15,928 nuclei derived from 8 post-mortem human adult brains. The average 
sequencing depth is 2.63x106 reads, comparable to Darmanis et al. but only about a 
tenth of the depth of our samples. Accordingly, far fewer genes were detected, 
ranging from 6,186 to 9,937, depending on the cell subclass (GABAergic, 
glutamatergic, unassigned, non-neuronal). The dataset therefore suffers from many 
of the same issues as the Zeisel et al. dataset used in the examination of detailed cell 
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subclasses in the mouse deconvolutions, but it has the advantage of being of human 
origin. 
6.4.2 Deconvolution of pseudosamples 
I carried out deconvolution of pseudosamples using a variety of SI and HK gene 
values. The values for SI ranged from 0.725, 0.75, 0.775… up to 0.975 and 0.999. 
HK values ranged from 1 to 10, then 15, 20, 25….50. A total of 216 deconvolutions 
were therefore carried out.  
As with the analogous mouse deconvolutions, increasing SI tended to increase the 
accuracy of the deconvolution. This could be because genes involved in specialised 
subclass functions have tended to be well conserved, so comparisons to a new 
species do not heavily alter the pattern of deconvolution. Deconvolution was actually 
superior in terms of MAD; the minimum was 0.14 (SI=0.925, HK=2) and the 
maximum was 0.26 (SI=0.725, HK=50). This compares to a low of 0.22 up to a high 
of 0.33 in the mouse cortical deconvolution. The optimum SI was always 0.925, 
while the next was always 0.95 or 0.975. It is noteworthy that the largest number of 
housekeeping genes and the most loosely defined markers gave the worst 
deconvolution; a result which makes sense. Although high SIs are typically superior 
in other deconvolutions, high HK numbers are not always. 
I examined the optimum deconvolution in more detail. There were no cell subclasses 
with over 10 estimations which were more than twofold incorrect, although as with 
the mouse deconvolution the “Int5” subclass was the worst predicted with a 
maximum overestimation of 7.49 fold and an average overestimation of 1.75 fold. 
On average though, cell subclasses were well predicted. The average of the average 
estimated:actual proportion for each cell subclass across 100 pseudosamples was 
1.02, while the average of the minimum and maximums were 0.96 and 2.16. All in 
all, these are reasonable deconvolutions. I decided to not attempt to remove “Int5”, 
as this had not helped in the mouse deconvolution to any great degree. I also looked 
at the deconvolution with SI=0.925 and HK=15, which has a MAD of 0.199. I was 
interested in whether this would be a useful alternative setting due to concerns about 
using two housekeeping genes to normalise. Unfortunately the “Int5” subclass was 
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badly overestimated here with an average estimation of 2.75 times the correct 
proportion and with one third of samples having an estimation which was at least 
twofold incorrect. I therefore elected to continue with the SI=0.925 HK=2 settings, 
although I would first need to see how these deconvoluted another dataset.  
6.4.3 Deconvolution of Allen comparison dataset 
I used the same range of settings for SI and HK, and the dataset described in 5.6.1.3. 
As described in the Allen section in the mouse cortical and hippocampal 
deconvolutions, the data is presented as violin plots where appropriate. 
Although I expected some cells to be dropped as HK increased (due to lack of 
expression for some of these genes) the dropout rate was extremely high. By HK=20, 
only 43 cells were left in the analysis, all of them Glutamatergic. It is possible that 
this is reflected in the fact that the human optimal HK number is frequently low 
regardless of the deconvoluting dataset, while the mouse deconvolution optimal 
varies but is 45 in the cortical Zeisel deconvolution and 40 or 25 in the cortical and 
hippocampal Zhang deconvolutions, respectively. Another likely factor is the 
relatively restricted number of cell types (primarily astrocytic and neuronal) in an 
iPSC-derived neuronal culture compared to an adult mouse brain; selection of 
housekeepers from this will likely discriminate against non-neuronal cell types. By 
HK=10, 3806 cells remain, and at HK=15, it is 500.  
It was very difficult to discern a pattern across deconvolutions at the lower HK 
numbers, especially if I looked at Allen subclasses. To resolve this I looked at class 
level rather than subclass level. See results of the optimal deconvolution in terms of 
MAD, SI=0.925, HK=2, in Figure 79. Cell types had what appeared to be a nearly 
binary split between cells that were 100% of that type and those that were 0%.  
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Figure 79. Violin plots of all 6 Zeisel class proportions for 4 classes of Allen cell, colour coded by Allen class. 
Red=GABAergic, Yellow=Glutamatergic, Blue=No class, Purple=Non-Neuronal. These results are of the SI=0.925 HK=2 
deconvolution. Allen classes are shown rather than classes for ease of viewing.  
We can see that all classes show a clear split between these binary options, regardless 
of actual cell identity. This is most pronounced in the “Interneuron” proportion and 
least in the “Astrocyte”. I also observed that in general, very low SI values (0.725 
chiefly) had a high propensity for higher levels of Interneuron prediction across all 
cell types, although a substantial proportion of cells were still reporting 0 proportion 
of this. In addition, there was little change in deconvolution proportions with 
increasing SI after SI=0.925, across almost all HK values. Finally, there was no 
deconvolution which had a majority of cells of any type predicted as mostly being of 
that cell type.  
To conclude; it does appear that the deconvolution as applied to other datasets gives 
very poor results. This is probably partially due to the choice of “housekeeping” 
genes, as these were chosen specifically for each dataset and the human t(1;11) 
samples. I believe this is the case as the majority of Allen cells do not even express 
all of these housekeeping genes. There are some notable facts; firstly, that the 
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deconvolution giving the optimal pseudosample deconvolution is in no way inferior 
to other deconvolutions, and that no deconvolution gives even majority correct 
proportions for each cell type. Secondly, the deconvolution appears to “settle” at 
SI=0.925, probably indicating that this is at least a stable if not optimal setting for 
gene specificity. Given this, I decided to press ahead and deconvolute the human 
t(1;11) samples.  
6.4.4 Deconvolution of human t(1;11) samples 
I carried out the deconvolution of the human t(1;11) samples using a variety of 
settings, normalising to total count depth for all samples. The results are displayed in 
Figure 80.  
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Figure 80. Deconvolution of human t(1;11) samples using profiles from Zeisel et al.. WT=Wild-type, t(1;11)=carrier, 
colours are green and red respectively.  
T-test revealed that no cell type was significantly different in proportion across the 
two genotypes once multiple testing correction (Sidak-Bonferroni) was applied.  
Discussion of the three deconvolutions is in the Discussion chapter, but the overall 
findings are of low reliability. 
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7 INVESTIGATION OF 
DIFFERENTIALLY 
EXPRESSED GENES 
PERTAINING TO CELL TYPES 
Investigation of differentially expressed genes pertaining to cell types 
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7.1 Introduction 
Expression weighted cell type enrichment (EWCE) is a method developed by Skene 
et al. to determine whether a list of genes, or SNPs associated with genes, have 
greater expression in a particular cell type than expected by chance
281
. In addition to 
a list of genes of interest, the approach requires a database of expression profiles for 
reliably identified cell types such as that of Zeisel et al. Skene et al. have applied this 
method with success to investigate whether genomic variants associated with 
schizophrenia converge on particular cell types
133
. The rationale behind this approach 
is to determine which cell types are of particular relevance to disease, which will be 
of use in drug design and disease modelling. EWCE essentially sums for a list of 
genes the specificity values (similar to SI) in each cell type to give a set of specificity 
scores, then selects a large number of lists of equal length from the background list 
of expressed genes to give a probability distribution of scores for each cell type. One 
can then see how whether a list of interest contains more highly specific genes for a 
particular type cell than the background rate of specificity in a large number of lists. 
Skene et al. recommend utilising at least 10,000 background lists to give a fair 
sampling of specificity.  
Skene et al. used a large database from the Karolinska Institute, of which the Zeisel 
et al. dataset is a subset. This encompassed mouse scRNA-Seq datasets generated 
from nearly 10,000 cells, identified by hierarchical clustering, originating from the 
midbrain, hypothalamus, striatum, cortical interneurons, an oligodendrocyte dataset, 
and the somatosensory cortex and hippocampal datasets described by Zeisel et al. 
Data were generated in the same manner as Zeisel et al. They found that hits from 
the CLOZUK and PGC GWAS (both schizophrenia GWAS) were significantly 
enriched in the broader cell classes of striatal medium spiny neurons, cortical 
interneurons, neocortical somatosensory pyramidal cells, and CA1 hippocampal 
pyramidal cells, and looked at more specifically defined subclasses as well
29,60
. For 
depression they found enrichment for genes specific to GABAergic and 
dopaminergic interneurons. It should be noted that they didn’t impose a minimum 
value for what was considered a “specific gene”, as the values are summed across all 
genes for each cell type, although they did exclude genes with low expression. They 
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also found that genes that encoded proteins which are i) Antipsychotic drug targets 
ii) loss of function mutation intolerant iii) part of the postsynaptic density and iv) 
RBFOX binding were significantly enriched for specificity in the aforementioned 
medium spiny neurons and pyramidal cell types. Finally, it should be noted that they 
carried out further analyses controlling for the enrichments found in significant cell 
types- a way to see if the significance signals were overlapping. This analysis 
showed that the significance of the hippocampal and cortical pyramidal cells were 
not independent, i.e., were caused by the same genes. This implies a common 
pyramidal cell dysfunction in schizophrenia. 
I wanted to investigate whether the lists of differentially expressed genes from my 
mouse and human RNA-Seq t(1;11) and controls showed any enrichment for genes 
specific to particular cell types. My question was simpler to answer than that posed 
by Skene et al.. Since I do not have GWAS level data, but only lists of differentially 
expressed genes from particular brain regions or tissue cultures, I do not need to 
consider factors such as LD, ambiguously placed SNPs, or gene length. I was 
particularly interested in whether there would be any convergence between my 
results looking at a unique and highly penetrant translocation, and those of Skene et 
al., who used information from GWAS looking for common variation associated 
with mental illness.  Given that pyramidal cells seemed to be of particular 
importance in the Skene et al. analysis, I was especially curious to see if this would 
re-emerge. If there were overlaps, this would imply that the aetiology of the t(1;11) 
related psychiatric illness is similar to that of psychiatric illness related to common 
variation. If not, this could imply that a different route to the disease state is found in 
each scenario, meaning that the same phenotype is reached through different 
biological processes. There are some drawbacks; Skene et al. were able to look at 
schizophrenia and depression associated variants separately, while in the Scottish 
pedigree the t(1;11) predisposes to both and accounts for most of the genetic risk for 
psychiatric disease. The genetic aetiology across family members with the 
translocation is likely to be very similar and it will not be possible to parse out risk to 
the different disorders, as Skene et al. did.  
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It should also be made explicit what this study is and what it is not. EWCE does not 
mean that the alterations necessarily exert their effects in the cell types indicated by 
the analysis; just that those cell types highly express those altered genes. It is of 
course likely that these genes would have important functions for that cell type, and 
it would be the logical starting point when searching for altered physiology. There 
are similarities to the deconvolution approach in that both look for altered genes 
associated with particular cell types; however there are key differences. First is that 
input and output of deconvolution is quantitative, even if only roughly so. Second is 
that the downregulation or upregulation of a gene associated with a particular cell 
type both implicate it in EWCE; while these signals have opposing effects in 
deconvolution approaches. Thirdly, the comparison dataset is important. It should be 
as close as possible in nature to the sample the gene list originated from. A test may 
indeed highlight certain cell types as significant; but if these cell types don’t exist in 
the original sample it is questionable how useful this is. Since the approach utilised 
by Skene et al. uses gene enrichments; including new cell types can alter the relative 
strength of each cell type signal.  
Skene et al. utilised the full Karolinska Institute Superset of data, of which the Zeisel 
et al. cortex and hippocampus datasets constitute a subset. This superset has 24 cell 
classes and 149 cell subclasses from diverse regions and cell types of the brain. All 
cells were sequenced in the same manner, using UMI tags as described earlier in this 
thesis so as to allow accurate quantification. The cells were then clustered in the 
same hierarchical clustering method as Zeisel et al., which generated classes and 
subclasses. Skene et al. then identified these using known marker expression, 
histology, or molecular studies
133
. It also contains some embryonic cell types. 
It is key to note that the samples I am using for the EWCE are cortical-like in the 
case of the t(1;11) cells, and are hippocampal and cortical (including most of the 
whole brain except hippocampus) for the mouse samples. Skene et al. are asking a 
broader question relating to many regions of the brain, whereas I have lists of 
differentially expressed genes from the hippocampal region of the brain or brain 
minus hippocampus, or a neuronal cortical like culture. Skene et al. used lists of 
genes associated with major mental illness by GWAS or MAGMA studies as they 
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were seeking in which brain regions and which cells these mutations exerted their 
effects (assuming a cell with high expression of the gene would be affected by the 
mutation). Hits from GWAS or MAGMA are not definitively associated with any 
brain region (indeed, this was what Skene et al. were interested in), so it was 
appropriate for Skene et al. to use datasets from all parts of the brain. In contrast my 
lists of differentially expressed genes are tied to the culture or brain region their 
samples originate from. In this sense it is more sensible to compare them to a similar 
cell dataset if possible. A positive result for a gene list from a culture or a brain 
region highly similar to the region the cells are from is more informative; it means 
that this perturbed gene list from a particular type of culture corresponds to a 
particular cell type. Given that I could not rebuild the Karolinska dataset to remove 
certain brain areas, I was left with three choices for each gene list; whether to 
compare to the KI superset (with or without embryonic cells), to the Zeisel 
hippocampal dataset, or to the Zeisel somatosensory cortex dataset. 
I also investigated whether it would be possible to rebuild a new dataset from the 
datasets indicated in Skene et al.. This would contain the majority of the cell types 
across many brain regions, but not the cells from the hippocampus (contributing both 
to hippocampal-unique classes and common classes), and would therefore be a better 
comparison for the cortical gene lists than the KI superset. However, not all of the 
data is released to the public yet and only the cell profiles, not the individual data for 
each of the thousands of cells used to make those profiles, are available. I had 
considered removing the hippocampal cells from the superset as well, but without the 
individual cell data from all papers, not just Zeisel et al., there is no way to remove 
the contribution of each brain region to the cell profiles or much more importantly 
know whether any of the cell profiles are brain region specific. Of the 149 cell 
subclasses, I do not know how many cells were used to produce each cell subclass, or 
where in the brain these cells were derived from, or whether the subclasses are 
present in all parts of the brain or only some. I therefore did not alter the KI superset 
in removing the hippocampal specific lines. Given that common cell types clustered 
together by group this likely means that they are largely similar across brain regions 
and are not pressing problems. I did remove embryonic cell types from the analysis 
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as these are not relevant to adult cells and the relevant cell types are clearly 
designated; the specificity values for each gene were then recalculated. The results 
for the cortical lists are also highly similar if hippocampal cells are removed (data 
not shown). 
I also argue that two issues are particularly important in considering the appropriate 
comparison. The first concerns risks of false positives, the second risks of false 
negatives. 
 Genes randomly selected from the list of expressed genes in brain region X 
are more likely to be specific to/enriched in brain region X, compared to 
genes randomly selected from the list of expressed genes in all brain regions. 
This is because the list of X-expressed genes is a subset of all expressed 
genes. It is by definition enriched for X-specific genes if they exist. As 
EWCE utilises gene specificity, this means that cell types which are highly 
enriched for these X-specific genes will appear significant. These cell types 
will also by definition be X-specific. As differentially expressed genes 
between sample A and B of region X can only include genes expressed in 
region X, this list of differentially expressed genes therefore will appear 
enriched for genes and cell types specific to X if compared to similar length 
lists drawn from all across the brain. There is therefore an unknown risk of 
false positives in comparing to a larger dataset. A larger dataset al.so requires 
a greater multiple testing correction; therefore only the correct comparison 
should be utilised, as over-comparing will dilute significance due to including 
spurious cell types, while under-comparing will inflate significance.  
 If most cell types are genuinely targeted by the mutation, then it will be 
difficult to assess cell type significance as there is no “non-significant” 
baseline to compare to. One would in this case just say that specific genes in 
general are targeted, but this could be due to other, unknown factors.  
 
As the cortical samples we utilised consisted of large tracts of the mouse brain, a 
comparison to the entire KI superset seemed most appropriate rather than using the 
somatosensory cortex dataset described by Zeisel et al.. I removed embryonic cell 
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types. Although psychiatric illnesses are neurodevelopmental conditions, the 
corresponding cell types are no longer represented in the mouse RNA-Seq profiles as 
they were produced from adult mice. I also used the KI superset, similarly without 
embryonic cell types, to analyse the hippocampal gene lists. However I urge caution 
in interpreting the results due to the issue of p value inflation I raise above. However, 
convergence between this and other studies of the Der1 hippocampus mean that there 
is supporting evidence for what I eventually found, and as the more informative 
comparison it made sense to utilise the larger dataset. I therefore used the KI superset 
without embryonic cell types to analyse the mouse derived gene lists.  
I used the Zeisel et al. cortical profiles to analyse the t(1;11) gene list, as the cells 
have been described as being “foetal cortical” in nature. I considered using the KI 
superset either in its totality, or just utilising embryonic cell types. There are eight 
embryonic-unique cell types in total. They are limited in their scope; there are three 
dopaminergic cell types, three GABAergic cell types, oculomotor and trochlear 
nucleus embryonic neuorns, and red nucleus embryonic neurons. As described 
above, the astrocytes, oligodendrocytes, etc. profiles are generated from all regions 
of the brain and all samples, and it is not possible to separate out the contributions 
from embryonic cell types. It is therefore not possible to create new cell profiles 
using just embryonic cell types for embryonic astrocytes, embryonic 
oligodendrocytes, etc. from the KI superset, although these “embryonic” versions of 
adult cell types surely exist. An embryonic dataset is therefore extremely limited in 
scope. I therefore had to choose between using the entire KI superset or the Zeisel 
cortical dataset. The former gives inaccurate comparisons as the cell types are from 
the whole brain, and only a few are embryonic. The Zeisel dataset is non-embryonic 
but does include a variety of cell types. I opted to use it.  
It is important to recall DISC1’s involvement in a diverse array of processes 
including cellular migration, development, and mitochondrial activity (see 
Introduction). DISC1 immuno-reactive neurons have been found throughout all 
layers of the human cortex, and in rat cortical astrocytes, neurons, oligodendrocytes, 
and microglia
69,268
. Hence, there is a potential for the t(1;11)/Der1 to alter the 
activities of a wide variety of cell types.  
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Figure 81 is taken from Zeisel et al. describing their cell profiles from both 
hippocampal and cortical samples
157
. It shows some of the transcription factor genes 
highly expressed in each of their cell subtypes, as well as some pan-type 
transcription factors. As many of these, including the orthologues of Dlx6, Dlx1, 
Lhx9, Epas1 are differentially expressed in the t(1;11) samples it is likely some of 
these cell types will be highlighted by the analysis. 
 
Figure 81. Figure from Zeisel et al.157. Each cell type is colour coded and subtypes are labelled. Inteneuron=Red, 
Neuron=Blue, Orange/Yellow=Endothelial/Mural, Microglia=Green, Astrocyte/Ependymal=Purple/Dark Green, 
Oligodendrocyte=Pink. Bars indicate how widespread a gene is, with narrow bars being specific to only a few subtypes.  
7.2 Results 
In general I found that the class level identifications closely tracked the subclass 
results in terms of significance. All human derived gene lists were compared against 
the Zeisel cortical dataset. The Der1 cortical and hippocampal mouse data were 
compared against the KI superset minus embryonic samples. In all cases I used genes 
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implicated by DESeq2; those which are differentially expressed at the whole gene 
level with a BaseMean greater than half that of DISC1/Disc1 and an adjusted p 
value<0.05. This is the appropriate list of genes to use as the reference datasets use 
gene level not exon level expression. Genes were used regardless of direction or 
magnitude of fold change, as the goal of EWCE is just to see what cells might have 
transcriptional alterations. All comparisons used 1x10
5 
lists selected from the 
background to build up a background distribution of gene specificity. Bonferroni 
corrections were used for multiple testing. It should be noted in some cases that the 
actual list of altered gene was more enriched for cell types than any of 1x10
5 
lists 
selected from the background. A Monte-Carlo based analysis I developed also 
closely concurred with the significance of all cell types (data not shown); this was 
initially developed as there were issues with utilising the “EWCE” package. These 
issues were eventually overcome. 
7.3 Human iPSC-derived neuron data 
I looked for enrichments of specific genes in both the 8 class level identifications of 
the data described in Zeisel et al.(interneuron, astrocyte/ependymal, etc) and the 41 
subclass level identifications. Given that Skene et al. have used more datasets, their 
class and subclass identifications are different. 
The results of this analysis are displayed in Figure 82. The sample list contained 
1,252 genes. We can see that a variety of cell types have significant enrichment for 
the genes differentially expressed in iPSC-derived neurons carrying the t(1;11). It is 
of course not necessarily the case that these cells actually exist in the iPSC-derived 
culture. Notably, only a single type of pyramidal cell showed significant enrichment. 
This was SS_S1PyrL23. These cells are distinguished by mainly being expressed in 
Layers 2 and 3 of the cortex and for having high staining of the Rasgrf2 gene 
compared to other cells. They lack expression of deeper cell markers such as Synpr2, 
Foxp2, Cplx3, or Rorb. 
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Figure 82. Results of EWCE for list of human iPSC-derived neuron differentially expressed genes in t(1;11) cells 
compared to cortical dataset. Cell subclasses are coloured by class; Red=Astrocyte/Ependymal, Purple=Interneuron, 
Orange=Microglia, Green=Oligodendrocyte, Yeloow=Endothelial/Mural, Blue=Pyramidal Neuron (all classes). The 
dark blue line indicates the threshold for significance , Bonferroni corrected p value<0.05. The light blue line indicates p 
values of <1x10-5 as there were no background lists with as much specificity as the differentially expressed gene list. 
Results above this line cannot be graphed on a log scale as the –log10 of 0 is not defined.  
The changes in Oligodendrocyte expressed genes are also interesting. Zeisel et al. 
hypothesised that the 6 oligodendrocyte subclasses represented different stages in 
oligodendrocyte maturation. Oligo1 does not express the genes associated with 
oligodendrocyte precursor cells, so they hypothesised it is the first post-mitotic state 
for oligodendrocytes. Figure 83 displays the differential expression of the Oligo 
subclasses according to Zeisel et al.. However the significance appears to be driven 
by genes expressed in all oligodendrocyte subclasses, rather than by genes which are 
highly significant in a single cell type. Genes such as these typically have a low SI in 
several subclasses and a high SI in a single class. The top two markers for the 5 
significant subclasses are ATP8B1, GNA12 (Oligo2, SIs 0.2, 0.19), GSTP1, METRN 
(Oligo3, SIs 0.07, 0.08), HGBZ, COL11A2 (Oligo4, SIs 0.21, 0.18), S100B, APOD 
(Oligo5 SIs 0.32, 0.23), CAR2, APOD (Oligo6, SIs 0.18, 0.16). Overall these are low 
scores, and the presence of APOD twice offers the clue that markers driving 
significance are oligodendrocyte-wide as opposed to subclass specific. 
Oligodendrocyte-wide markers which are differentially expressed include DCT 
(SI=0.87), CNP (SI=0.83), GPR37 (SI=0.76), SEMA3D (SI=0.75), SLC44A1 
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(SI=0.75), CAR2 (SI=0.7), APOD (SI=0.68). As can be seen in Figure 83, most of the 
subclass markers show non-zero expression in other Oligodendrocyte cell types too. 
DCT and CNP show similar oligodendrocyte class specificity to classic genes such as 
MBP, MOG, and MOPB, which have SIs in the mid-80s, for the broad 
Oligodendrocyte class but are not differentially expressed.  
 
Figure 83. Adapted from Zeisel et al. 2015 figure 3157. A heatmap of genes showing differential and progressive 
expression across the Oligo1 to Oligo6 classes. Red=high expression, blue=low (scale not given by Zeisel et al.). 
In addition, Astro1 and Astro2 subclasses are noted as having enrichment. These 
subclasses were distinguished by Zeisel et al. by differential expression of a number 
of markers, and also show different localisation, as displayed in Figure 84. 
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Figure 84. Adapted from Zeisel et al. 2015 figure 3157. Left is differential expression of a number of cell markers for 
Astro1 and Astro2. Right shows immunohistochemistry for glial fibrillary acidic protein (red, Astro1) and MFGE8 
(green, Astro2), heavily associated with Astro1 and Astro2 respectively. 
7.3.1 Gene ontology analysis 
I also carried out a gene ontology analysis to see if the genes associated with 
particular cell types highlighted by the EWCE analysis were associated with specific 
functions, components, or processes. I used GOrilla to carry out this analysis. Gene 
lists were retrieved by filtering the list of KI Superset genes for those differentially 
expressed in t(1;11) iPSC-derived neurons. For each significant cell class, the list of 
genes which have their maximum expression in that class were extracted and used 
for GOrilla. The approach has some drawbacks in that some genes contribute to 
multiple cell classes but as they can only have their maximum expression in one line, 
they only appear in one. The analysis is therefore less than optimal. However a flat 
approach of using a certain number of genes will not work due to the differing 
number of specific genes per cell line.  
The concept was to see if the differentially expressed genes known to be highly 
specific to certain cell types converged on any distinctive processes in those cells. 
Although the functions of the cell types are known, it is possible that disturbances 
caused by t(1;11)/Der1 affect only a subset of cell activities. This could lead to 
potential pathways or functions to investigate in future experiments. Hook et al. had 
shown, for example, that catecholamine release appeared to be highly abnormal in 
iPSC-derived neurons of patients with schizophrenia
137
. I hoped to indicate if 
particular pathways in particular cell types might be disturbed. It is beneficial to 
know not only what cell types differentially expressed genes are specific to, but also 
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what activities within those cell types they are involved in. Although the approach is 
inferior to actually culturing those cell types and assumes that the genes are relevant 
solely to those cells they are most specific to, it is informative particularly if 
converges are observed. 
The PyrSS class has three significant Processes including “negative regulation of 
gonadotropin secretion”, “opioid receptor signaling pathway” driven by genes 
INHBA, SIGMAR1, OPRK1, and a single significant related Function “opioid 
receptor activity”. The only significant component is “synapse part” with p value 
3.9x10
-4
 driven by genes KCNIP3, ERC2, IGSF21, CAP2, DDN, WFS1, SLITRK1, 
SIGMAR1. However in all these cases the FDRs are quite high, ranging from 0.74 to 
1, due to the relatively low number of 46 genes. Nevertheless this might indicate 
some kind of opioid related dysfunction in the t(1;11) neurons. There also appear to 
some metabolic dysfunctions in other cell types. The AstrocyteEpendymal class has 
significance for the terms “fatty acid beta-oxidation”, p=1.62x10
-4
, and 
“neurotransmitter metabolic process”, p=7.33x10
-4
, which has genes such as GLDC, 
NQO1, SLC1A3. Oligodendrocytes also appear particularly affected, with 28 Process 
terms significant. 13 of these contain the word “metabolic” and 8 the word 
“biosynthetic”. Oligodendrocytes are of course responsible for myelination of axonal 
sheaths. Although myelination is not a significant GO term it is possible that some of 
the metabolic GO terms relate to dysfunctions either in the biosynthetic process or in 
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7.4 Mouse cortical data 
7.4.1 Mouse cortex Heterozygous 
A number of classes were found significant for enrichment in the list of genes 
differentially expressed in the Der1 heterozygous cortex, as shown in Figure 85. The 
sample list contained 2,112 genes. Given that both Avp and Oxt were found 
differentially expressed, it is no surprise that their corresponding neuron class of 
“Oxytocin and Vasopressin Expressing Neurons” is implicated. Cxcl14, Sema3c, are 
genes highly expressed in the Interneuron class, while the Hypothalamic 
Dopaminergic Neurons class is of particular relevance to schizophrenia and is 
associated with the genes Hap1, Gabrq, Pomc.  
 
Figure 85. Results of EWCE for list of differentially expressed genes in Der1 heterozygous cortex compared to WT 
cortical dataset. The dark blue line indicates the threshold for significance using the KI superset analysis, Bonferroni 
corrected p value<0.05. All of the indicated cell types are also significant if the hippocampal-specific classes are removed 
(except pyramidal CA1 which is removed as a class). The light blue line indicates p values of <1x10-5 as there were no 
background lists with as much specificity as the differentially expressed gene list. Results above this line cannot be 
graphed on a log scale as the –log10 of 0 is not defined. 
The subclass results are displayed in Figure 86.  
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Figure 86. Results of EWCE for list of differentially expressed genes in Der1 heterozygous cortex compared to WT 
cortical dataset at subclass level. The dark blue line indicates the threshold for significance using the KI superset 
analysis, Bonferroni corrected p value<0.05. Note it is higher than in class analysis as there are more cell types to correct 
for. The light blue line indicates p values of <1x10-5 as there were no background lists with as much specificity as the 
differentially expressed gene list. Results above this line cannot be graphed on a log scale as the –log10 of 0 is not 
defined. 
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7.4.1.1 Gene ontology analysis 
I carried out a gene ontology analysis as above on the classes. Some of the results 
were predictable; the “Oxytocin and Vasopressin expressing Neuron” class had 
processes all of relevance to the functions of these proteins and containing both Oxt 
and Avp. Others were more novel. “Hypothalamic dopaminergic neurons” and 
“Striatal Interneurons” had processes linked to the GABAergic signalling pathway 
(two subunits of GABAAR) and butyrate metabolism (only one gene, Acads) 
respectively. It should be noted that due to the low number of genes in the above 
processes, the FDRs are quite high. “Dopaminergic Adult” also has terms of high 
relevance to the cell type, indicating dysfunction of this specialised cell type as well.  
The “AstrocyteEpendymal” class has some differences and some similarities 
compared to the human t(1;11) GO terms of the same class. Many of the terms relate 
to fatty acid metabolism, and transport also emerges as a theme amongst less 
significant GO terms. “Regulation of transport” has p value=1.3x10
-4
 and contains 
the transport genes Slc1a2, Slc9a3rl, Slc38a3, and the gene Slc25a18 is also 
dysregulated. The “PyrSS” class shows a very clear convergence on terms relating to 
protein trafficking and localisation within the cell, with genes such as Dlg4 (related 
to the gene encoding PSD-95) and Bsn (a synaptic release protein) altered. Cacnb3 
and Cacng3 were also altered. 
7.4.2 Mouse cortex Group One 
No cell types were associated with the list of genes differentially expressed between 
mouse homozygous cortical and WT samples. However, as discussed in the 
appropriate chapter, the homozygous cortical Der1 samples separate into two groups. 
I examined the associations with the list of genes differentially expressed in each of 
these groups. The results of the Group One analysis are shown in Figure 87, while 
the results for the Group Two analysis are shown in Figure 89. 
The class level results are shown in Figure 87. The sample list contained 692 genes. 
The strongest signal is coming from the “Medium Spiny Neuron” and “pyramidal 
CA1” classes. A number of interesting genes are differentially expressed and 
associated with the “Medium Spiny Neuron”, including Drd1. Also associated and 
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differentially expressed are a large number of phosphodiesterases associated with 
signal transduction; Pde7b, Pde1b, Pde10a, which range in specificity from 0.45 to 
0.67. Gpr88 and Gpr6 are also seen; the former appears to control Medium Spiny 
Neuron firing, with knockout mice having decreased GABAergic and increased 
glutamatergic signalling efficiency. Interestingly, this knockout mouse had 
differential expression of Rgs4 protein, a possible regulator of synaptic plasticity
282
. 
Rgs4 maximum specificity across the 24 classes is 0.29 in “Pyramidal SS” neurons, 
the second highest is 0.17 in “Medium Spiny Neurons”. It too is differentially 
expressed here. 
 
Figure 87. Results of EWCE for list of differentially expressed genes in Der1 homozygous cortex Group One compared 
to WT cortical dataset. The dark blue line indicates the threshold for significance using KI superset analysis, Bonferroni 
corrected p value<0.05. All of the above cell types are also significant if the hippocampal-specific classes are removed 
(except pyramidal CA1 which is removed as a class). The light blue line indicates p values of <1x10-5 as there were no 
background lists with as much specificity as the differentially expressed gene list. Results above this line cannot be 
graphed on a log scale as the –log10 of 0 is not defined. Note that pyramidal SS is significant. 
Both subclasses of the “medium spiny neuron” class are significant as shown in 
Figure 88, which displays the results of the subclass analysis.  
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Figure 88. Results of EWCE for list of differentially expressed genes in Der1 homozygous cortex Group One compared 
to WT cortical dataset at subclass level. The dark blue line indicates the threshold for significance using the KI superset 
analysis, Bonferroni corrected p value<0.05. Note it is higher as there are more cell types to correct for. The light blue 
line indicates p values of <1x10-5 as there were no background lists with as much specificity as the differentially 
expressed gene list. Results above this line cannot be graphed on a log scale as the –log10 of 0 is not defined. 
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These two subclasses correspond to D1R and D2R, but many of the genes are 
reasonably expressed in both cell subclasses with a few diverging genes like Drd1 
and Adora2a showing preferences for each subclass. The Astro2, CA1Pyr1, 
CA1Pyr2, CA1PyrInt, and CA2Pyr2 subclasses are also significantly enriched. This 
is probably due to similar processes being highlighted between the CA1 pyramidal 
neurons and the SS pyramidal neurons.  
7.4.2.1 Gene ontology analysis 
I carried out a gene ontology analysis as above on the classes. The 
“AstrocyteEpendymal” class has some differences and some similarities compared to 
the human t(1;11) GO terms of the same class. Notably, “Transport” is the top 
significant term at p=5.25x10
-6
 with genes such as Apoe, Sdc4 (syndecan-4, a 
heparan sulfate proteoglycan), and Dbi, a lipid metaboliser which acts on 
Diazepam/Valium. Fatty acid metabolism also appears, with Cpt2, the gene encoding 
carnitine palmitoyltransferase II, differentially expressed. The human homologue is 
also differentially expressed and associated with a similar GO term. The two genes 
Apoe, Agt (angiotensin), both relate to the GO term “cholesterol esterification”. 
Finally, the PyrSS class has many terms driven by potassium and calcium receptor 
subunits (Cacnb4, Kcnb1, Kcns2, Kcna1)., and the ATPases which power them. The 
12
th
 term in this cell subclass is “transport”, p=6.23x10
-4
, which includes not only 
these metal ion transporters but also a kinesin Kif3c and the neurotransmitter 
transporter Slc6a17. The human homologue of this gene is found at dendritic 
spines
283
. PyrSS also includes the Arc gene.  
7.4.3 Mouse cortex Group Two 
The class results are displayed in Figure 89. The sample list contained 2,619 genes. 
Many classes appear significant in both Group One and Group Two. Many of the 
genes driving the Medium Spiny Neuron significance are the same as in Group One, 
namely Adora2a, Gpr88, Scn4b, Nexn, Actn2, Pde10a, Drd1. This observation led 
me to carry out an analysis using just the overlapping genes, which is described later. 
Astrocyte_Ependymal significance is notably due to Gfap, the marker for these cell 
types.  
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Figure 89. Results of EWCE for list of differentially expressed genes in Der1 homozygous cortex Group Two compared 
to WT cortical dataset. The dark blue line indicates the threshold for significance the KI superset analysis., Bonferroni 
corrected p value<0.05. All of the above cell types are also significant if the hippocampal-specific classes are removed, as 
is the class “Striatal Interneruon”, except pyramidal CA1 which is removed as a class. The light blue line indicates p 
values of <1x10-5 as there were no background lists with as much specificity as the differentially expressed gene list. 
Results above this line cannot be graphed on a log scale as the –log10 of 0 is not defined. Striatal Interneuron is 
significant. 
Subclass results are shown in Figure 90. In addition to the subclasses enriched in 
Group One, Group Two also has the Astro1 subclass significantly enriched, along 
with 8 types of oligodendrocyte.  
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Figure 90. Results of EWCE for list of differentially expressed genes in Der1 homozygous cortex Group Two compared 
to WT cortical dataset at subclass level. The dark blue line indicates the threshold for significance using the KI superset 
analysis, Bonferroni corrected p value<0.05. Note it is higher as there are more cell types to correct for. The light blue 
line indicates p values of <1x10-5 as there were no background lists with as much specificity as the differentially 
expressed gene list. Results above this line cannot be graphed on a log scale as the –log10 of 0 is not defined. 
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Significant oligodendrocytes include 6 types of “Mature Oligodendrocyte” and two 
types of “Myelin-forming Oligodendrocyte”. This appears to be due to the classic 
markers Mog, Mobp, with the appearance of the genes Selenoi, Selenop, Selenok as 
well. These selenium related proteins are not well studied, but one paper has shown 
that male mice deficient in Selenop and in another selenium metabolism protein Scly 
show neurodegeneration, apparently due to a failure of GABAergic inhibition 
development
284
. This shows some similarities to the observed differences in 
GABAergic-maturation related genes described elsewhere. As in the Group One 
comparison, the subclasses Astro2, CA1Pyr1, CA1Pyr2, CA1PyrInt, and CA2Pyr2 
subclasses are also significantly enriched along with both “Medium Spiny Neuron” 
subclasses. 
7.4.3.1 Gene ontology analysis 
I carried out a gene ontology analysis as above on the classes. The same classes are 
involved as previously; however, the number of involved genes is far greater and the 
GO terms have correspondingly smaller associated p-values. The terms themselves 
bear similarities in the “AstrocyteEpendymal” class, and many of the genes overlap. 
However, other classes have GO terms diverging from those they have in other 
sample sets. “Striatal Interneuron” has the GO term “response to estradiol” with 
genes Pam, Ramp3, Socs2, a contrast to the related terms in the heterozygous cortex. 
The activation of estradiol receptors appears to be necessary for long-term 
potentiation in striatal interneurons, so despite the low number of associated genes 
this is a highly intersting finding
285
. 
The “PyrCA1” class also has entirely new GO terms, relating to metabolism, 
particularly that of RNA, and gene expression. 116 genes relate to gene expression. 
Two are bromodomain proteins, while the previously mentioned Ntrk3 appears too, 
as does Bbs7 in the RNA metabolism GO term. Camk2a and Dendrin are also 
encoded by differentially expressed genes related to this cell type, and they have 
roles in plasticity.  
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“Oligodendrocytes” appears as a significant class, in agreement with the human 
(t1:11). Unlike there however, its GO terms are highly specific to the function of 
myelination. Dysregulation of Mag (myelin-associated protein), Mbp (myelin basic 
protein), Plp1 (a type of myelin protein) and a claudin Cldn11 associated with 
myelin all point towards a serious defect in the myelinating propetries of these cells. 
7.4.4 Mouse cortex overlapping Group One and Group Two 
This list of genes is those differentially expressed in both groups. As described 
previously, they show an unusual pattern in expression. The sample list contained 
249 genes. The class results are shown in Figure 91, while subclass results are in 
Figure 92. 
 
Figure 91. Results of EWCE for list of differentially expressed genes overlapping between Group One and Group Two 
of homozygous Der1 cortex compared to WT cortical dataset. The dark blue line indicates the threshold for significance 
using the KI superset analysis, Bonferroni corrected p value<0.05. All of the above cell types are also significant if the 
hippocampal-specific classes are removed (except pyramidal CA1 which is removed as a class). The light blue line 
indicates p values of <1x10-5 as there were no background lists with as much specificity as the differentially expressed 
gene list. Results above this line cannot be graphed on a log scale as the –log10 of 0 is not defined. 
In addition to the subclasses enriched in Group One, the list overlapping with Group 
Two also has the Astro1 subclass significantly enriched. As described in the previous 
section, a large number of genes show reasonable expression in both Medium Spiny 
Neuron subclasses, with further genes being primarily expressed in one.  
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Figure 92. Results of EWCE for list of differentially expressed genes in both Der1 homozygous cortex Group One and 
Group Two, when each is separately compared to WT cortical dataset at subclass level. The dark blue line indicates the 
threshold for significance using the KI superset analysis, Bonferroni corrected p value<0.05. The light blue line indicates 
p values of <1x10-5 as there were no background lists with as much specificity as the differentially expressed gene list. 
Results above this line cannot be graphed on a log scale as the –log10 of 0 is not defined. 
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7.4.5 Mouse cortex overlapping Group One, Group Two, and cortex 
heterozygotes 
This list is a subset of the previous; also overlapping with the cortex heterozygous 
list. The sample list contained 120 genes. Class results are in Figure 93, while 
subclass results are in Figure 94. Only one class is significantly enriched in the 
subset of genes differentially expressed in all models; “Astrocytes_ependymal”. 
Genes highly enriched in this class include Apoe, S100a1, Mlc1, Fxyd1, Slc25a18. At 
the subclass level, both subclasses of Astrocyte are significantly associated with the 
gene list, with the aforementioned genes showing good expression in both classes. In 
addition, CA1 pyramidal neurons have emerged as significant, although given that 
the SS neurons are not also altered this may not point to identical pyramidal 
dysfunction across all Der1 groups.  
 
Figure 93. Results of EWCE for list of differentially expressed genes overlapping between Group One and Group Two 
of homozygous Der1 cortex, as well as with heterozygous Der1 cortex compared to WT cortical dataset. The dark blue 
line indicates the threshold for significance the KI superset analysis., Bonferroni corrected p value<0.05. The light blue 
line indicates p values of <1x10-5 as there were no background lists with as much specificity as the differentially 
expressed gene list. Results above this line cannot be graphed on a log scale as the –log10 of 0 is not defined. 
Less subclasses are significant in this analysis; with only Astro1, Astro2, and 
CA1PyrInt appearing significant. This makes Astro1 and Astro2 among the most 
consistent subclasses to have enriched genes overrepresented among differentially 
expressed genes. 
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Figure 94. Results of EWCE for list of differentially expressed genes overlapping between Group One, Group Two, and 
Cortex Heterozygotes when each is compared to WT cortical dataset at subclass level. The dark blue line indicates the 
threshold for significance using the KI superset analysis, Bonferroni corrected p value<0.05. Note it is higher as there 
are more cell types to correct for. The light blue line indicates p values of <1x10-5 as there were no background lists with 
as much specificity as the differentially expressed gene list. Results above this line cannot be graphed on a log scale as 
the –log10 of 0 is not defined. 
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7.5 Mouse hippocampal data 
The number of differentially expressed genes between mouse heterozygous t(1;11) 
carriers and wild type controls is 175. The results of the class analysis are displayed 
in Figure 95.  
 
 
Figure 95. Results of EWCE for list of mouse hippocampal differentially expressed genes compared to KI superset. The 
dark blue line indicates the threshold for significance using the KI superset analysis, Bonferroni corrected p value<0.05. 
The light blue line indicates p values of <1x10-5 as there were no background lists with as much specificity as the 
differentially expressed gene list. Results above this line cannot be graphed on a log scale as the –log10 of 0 is not 
defined. 
The same classes appear to be affected as in the cortex; “Medium Spiny Neurons” 
and pyramidal cells. In addition, “Interneuron” has emerged as a significant class. 
The subclass results are displayed in Figure 96. Only a single subclass, S1PyrL5a, is 
significant.  
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Figure 96. Results of EWCE for list of differentially expressed genes in Der1 heterozygous hippocampus compared to 
WT hippocampal dataset at subclass level. The dark blue line indicates the threshold for significance using the KI 
superset analysis, Bonferroni corrected p value<0.05. Note it is higher as there are more cell types to correct for. The 
light blue line indicates p values of <1x10-5 as there were no background lists with as much specificity as the 
differentially expressed gene list. Results above this line cannot be graphed on a log scale as the –log10 of 0 is not 
defined. 
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7.5.1 Gene ontology analysis 
I carried out a gene ontology analysis as above on the classes. The classes have very 
distinctive and obvious patterns. “Medium Spiny Neuron” related GO terms are all of 
relation to synaptic transmission, although the number of genes involved is low, only 
Syt2 and Unc13c. “PyrSS” has two stronger patterns, each with more related genes. 
The first is related to neuronal apoptosis, driven by Thrb, Scn2a1, Cit, Bok. Cit and 
Thrb arte also related to the second process with multiple GOterms; development. 
These terms are also driven by the genes Sox5, Plxnd1 (a plexin, the interacting 
partner of semaphorins which aid neuronal direction) and Cask. Cask, as a member 
of the superfamily which includes Dlg genes, encodes a MAGUK protein. Cask-null 
mice are embryonic lethal and Cask-deficient neurons appear to have abnormal 
levels of neurexins and neuroligins (important synaptic molecules), although the 
experiment showing this had a relatively small sample size
286
. 
No cell types were associated with the list of genes differentially expressed between 
mouse homozygous hippocampal and WT samples. However, the number of 
differentially expressed genes in this analysis was extremely low, and Der1 status did 
not even register as the first or second component in principal component analysis. 
Therefore, a lack of results is not surprising here. 
7.6 Differentially expressed genes from published papers 
GO term analyses were not possible as neither Wen et al. nor Srikanth et al. provided 
a list of all expressed genes, just lists of differentially expressed genes
132,287
. 
7.6.1 Wen et al. 
Wen et al. looked at iPSC-derived neurons from a family carrying a DISC1 
frameshift mutation
132
. The family is small however, and the frameshift is not 
unambiguously linked with psychiatric illness, as in addition members of the 
pedigree have psychiatric illness but no DISC1 frameshift. A total of 3,697 genes 
were differentially expressed in their study, although they did not use as large a 
number of RNA samples as our study (one control and two mutants, all in triplicate). 
A further description is given in the Introduction. 
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The results of this analysis are displayed in Figure 97. It is clear that genes highly 
associated with a broad range of cells are affected, similar to the mouse cortical 
analysis. In addition, both the Astrocyte subclasses have re-emerged as significant, as 
in the t(1;11) analysis. Three subclasses of the endothelial/mural cell class are also 
implicated; this class is distinguished from other cell groups chiefly by high 
expression of Cldn5. Many cell types are apparently affected. 
 
Figure 97. Results of EWCE for list of differentially expressed genes found by Wen et al.  compared to cortical dataset. 
Cell subclasses are coloured by class; Red=Astrocyte/Ependymal, Purple=Interneuron, Orange=Microglia, 
Green=Oligodendrocyte, Yeloow=Endothelial/Mural, Blue=Pyramidal Neuron (all classes). The dark blue line indicates 
the threshold for significance , Bonferroni corrected p value<0.05. The light blue line indicates p values of <1x10-5. 
7.6.2 Brennand et al. 
The study of Brennand et al. was the first to look at differential expression in iPSC-
derived neurons from psychiatric patients
124
. Lines were established from patients 
with idiopathic schizophrenia, although the sample numbers were small. It utilised a 
microarray approach to look at expression differences and found 596 genes 
differentially expressed at p<0.05 and fold-change >1.3, which I searched for 
association with here. A further description is given in the Introduction. 
The results of this analysis are displayed in Figure 98. As with the t(1;11) samples, 
the list of genes shows enrichment for both Astrocyte types (also significant in my 
analysis), and almost all oligodendrocyte maturation stages. Two Interneuron 
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subclasses are implicated; Int1 and Int14. Both subclasses are characterised by high 
expression of Neuropeptide Y, with Int14 also having high expression of Gda 
compared to other cell types. Gda encodes Cypin, a PSD-95 interactor with 
homology to DPYSL1, a protein related to DPYSL2 and DPYSL3
288
. Int14 also has 
relatively high expression of the chromatin modifiers Tox and Tox3, which are 
differentially expressed. Int1 meanwhile is characterised among the interneuron 
subclasses by the highest expression of Sst, which encodes somatostatin. This cell 
type is highly restricted to the somatosensory cortex. All subclasses of the 
endothelial/mural cell class are also implicated; these are distinguished from other 
cell groups chiefly by high expression of Cldn5. This is not a differentially expressed 
gene however; although genes that are include IFI44, CYYR1, SLC16A9 and LEF1, 
the homologues of which show high expression in both “Vend1” and “Vend2”, as 
well as pericytes in the case of CYYR1. 
 
Figure 98. Results of EWCE for list of differentially expressed genes found by Brennend et al.  compared to cortical 
dataset. Cell subclasses are coloured by class; Red=Astrocyte/Ependymal, Purple=Interneuron, Orange=Microglia, 
Green=Oligodendrocyte, Yeloow=Endothelial/Mural, Blue=Pyramidal Neuron (all classes). The dark blue line indicates 
the threshold for significance, Bonferroni corrected p value<0.05. The light blue line indicates p values of <1x10-5-. 
Differential expression of genes associated with both subclasses of astrocytes is also 
observed; genes contributing to this include Gfap and Aqp4, known astrocytic genes.  
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7.6.3 Srikanth et al.  
Srikanth et al. looked at two different timepoints in the production of neurons 
directly from iPSCs
138
, a protocol that differs from ours which utilises neural 
precursor intermediates. They induced mutations in the iPSC lines prior to neuron 
differentiation, in exon 2 and exon 8 of DISC1. The first mutation should remove all 
DISC1 isoforms while the second is closer in its effect on DISC1 by inducing a 
truncation close to the breakpoint. They also looked at heterozygous and 
homozygous carriers of these mutations. Sx2 and Sx8 refer to the mutations, w/m to 
wild type/mutant status, and 18 or 50 to the timepoints. For example, Sx8wm50 
refers to the heterozygous carriers of the exon 8 truncation at the day 50 stage. I used 
these lists to generate EWCE data. The Sx2mmd50, Sx8mmd50, and Sx8wmd50 
results are displayed in turn. 
7.6.3.1 Sx2mmd50 
The results of this analysis are displayed in Figure 99. This mutation, which would 
presumably have the greatest effect on DISC1 expression, appears to have caused the 
dysregulation of genes highly expressed in a very broad variety of cell types. A total 
of 1,393 genes were dysregulated. Most pyramidal cell subclasses are significant 
along with most interneuron cell subclasses, possibly indicating dysregulation of a 
number of broadly expressed markers for each cell class. 
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Figure 99. Results of EWCE for list of differentially expressed genes found by Srikanth et al.  for the Sx2mmd50 model 
compared to cortical dataset. Cell subclasses are coloured by class; Red=Astrocyte/Ependymal, Purple=Interneuron, 
Orange=Microglia, Green=Oligodendrocyte, Yeloow=Endothelial/Mural, Blue=Pyramidal Neuron (all classes). The 
dark blue line indicates the threshold for significance, Bonferroni corrected p value<0.05. The light blue line indicates p 
values of <1x10-5. 
7.6.3.2 Sx8mmd50 
The results of this analysis are displayed in Figure 100. The effects are quite 
interesting. The list of affected genes, totalling 116 genes, is only highly enriched in 
pyramidal cells, but is enriched in all of these cell subclasses. This is essentially a 
subset of the cell subclasses enriched in the Sx2mmd50 dataset. I looked to see if the 
same genes might be responsible; of the 27 genes differentially expressed in both 
experiments and expressed in the Zeisel dataset; a handful have high expression 
confined to the pyramidal neuron class. These include Neurod2, Neurod6, Kcnip3, 
which have an SI of 0.6 or more for this class. Both of the Neurod genes encode 
bHLH neurogenic transcription factors.  
It is difficult to work out the contribution of these 27 overlapping genes. However, I 
did note that the total SI for the neuronal subclasses of the 114 genes differentially 
expressed in the Sx8mmd50 dataset was 21.2, while the corresponding figure for the 
1,391 genes of the Sx2mmd50 dataset was 189.8. The 27 genes contribute 6.7 in 
each case. This corresponds to 31% of contribution for 23.6% of genes in the 
Sx8mmd50 dataset, and 3.5% of contribution for 1.94% of genes in the Sx2mmd50 
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dataset, which is not particularly strong evidence in favour of these overlapping 
genes being key. 
 
Figure 100. Results of EWCE for list of differentially expressed genes found by Srikanth et al. for the Sx8mmd50 model 
compared to cortical dataset. Cell subclasses are coloured by class; Red=Astrocyte/Ependymal, Purple=Interneuron, 
Orange=Microglia, Green=Oligodendrocyte, Yeloow=Endothelial/Mural, Blue=Pyramidal Neuron (all classes). The 
dark blue line indicates the threshold for significance, Bonferroni corrected p value<0.05. The light blue line indicates p 
values of <1x10-5. 
7.6.3.3 Sx8wmd50 
The results of this analysis are displayed in Figure 101. This final Srikanth gene list 
is generated from a model which has the effect on full length DISC1 closest to that of 
the t(1;11), although it does not result in gene fusion. 487 genes were dysregulated. 
We can see that Astrocyte subclass 1, Oligo subclass 6 (corresponding to mature 
myelinating oligodendrocytes), and two endothelial cell types are among those 
subclasses which are enriched for genes showing differential expression.  
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Figure 101. Results of EWCE for list of differentially expressed genes found by Srikanth et al. for the Sx8wmd50 model 
compared to cortical dataset. Cell subclasses are coloured by class; Red=Astrocyte/Ependymal, Purple=Interneuron, 
Orange=Microglia, Green=Oligodendrocyte, Yeloow=Endothelial/Mural, Blue=Pyramidal Neuron (both classes). The 
dark blue line indicates the threshold for significance, Bonferroni corrected p value<0.05. The light blue line indicates p 
values of <1x10-5. 
7.7 Discussion 
7.7.1 IPSC-derived neuron data 
Comparisons between EWCE data for the t(1;11) neurons and neurons carrying 
DISC1 mutations reveal that many of the cell types implicated by one analysis 
reappear in others. A full overview of the enrichments using the Zeisel et al. cortical 
dataset is given in Table 36 and a view of the overlaps between gene sets for 
enrichment is given in the Appendix. 
 
Table 36. Evaluation of cell types with associated genes significantly enriched among differentially expressed genes in 
each list according to the EWCE analysis using the Zeisel dataset. Classes are as in the Zeisel et al. dataset. 
These cross comparisons reveal that there are substantial overlaps and some 
differences between the cells highlighted by the analyses of each human neuron 
model. The cells that most appear are Astro1, Oligo6, Vsmc (5 occurrences), Oligo2, 
Pyr2/3, Pyr4, (4 occurrences), and several with 3 occurrences including Astro2, 
Choroid, Int1, Int14, and other Pyramidal and Oligodendrocytic cell types. It is 
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worthwhile to note which cells did not appear in any analysis; these are the 
microglial subtypes Mgl2, Pvm1, and Pvm2. The disturbance of genes associated 
with the astrocyte subclasses Astro1 and Astro2 are consistent findings and appear to 
be genuine; indicating possible dysregulation of astrocytic activity in the presumably 
early developmental stage the iPSC-derived neurons represent. As discussed below, 
these also appear in several mouse cortex lists as well, so the disturbances appear to 
be present in both relatively immature human iPSC-neuron models and the mature 
mutant mouse cortex model. It is also compelling that the Srikanth homozygous 
DISC1 mutation at exon 8 has effects which are a subset of those caused by the 
homozygous exon 2 mutation, which should affect all isoforms.  
There are some conclusions to be drawn from the data and it is possible to a limited 
extent to discuss these changes in the context of cortical architecture. It must be 
stressed that as the iPSC-derived cells are highly immature and are in an essentially 
2D culture it is inaccurate to speak of them as having any kind of cortical 
architecture. However I initially found it notable that frequent dysregulation of genes 
associated with Astro1 and Astro2 was found, which Zeisel et al. described as 
astrocytes associated with different sides of the layer I/II cortical boundaries. I also 
noted that the Pyramidal II/III subclass was frequently dysregulated as well, and 
thought this might be a significant co-occurrence. Yet in the Sx8wm50 neuron 
cultures, the Astro1 significance does not concur with a II/III significance. Similarly, 
these two subclasses are not both seen significant in any mouse analysis. 
7.7.2 Mutant mouse data 
In the Der1 mouse cortex the cell classes “astroyctes_ependymal”, “medium spiny 
neuron”, and pyramidal cells are significantly enriched in every gene list. At the 
subclass level, the Astro1, Astro2, CA1Pyr1, CA1Pyr2, CA2Pyr2, and CA1PyrInt 
subclasses are all significant in the heterozygous Der1 comparison. In addition, both 
subclasses of the medium spiny neuron, Astro2, CA1Pyr1, CA1Pyr2, and CA1PyrInt 
subclasses are also significantly enriched in both homozygote groups, as well as the 
list of genes overlapping between both homozygote groups and the heterozygote 
group. We see that the lists appear to converge on the same few cell types across the 
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mouse brain, perhaps indicating a consistent pathological effect of the Der1 in the 
cortex. Astro1 or Astro2 significance does not co-present with layer-specific 
pyramidal dysfunction but only with general pyramidal cells dysfunction at the class 
level, so it does not appear that there has been a layer specific dysfunction as I 
hypothesised in the previous section. 
The hippocampal data shows similarity to the cortical; with the pyramidal classes 
and medium spiny neurons implicated. In contrast the Interneuron class is newly 
significant, while there is no evidence of astrocyte_ependymal significance. 
These results should be discussed in the context of the findings of my colleague, 
Marion Bonneau, who has studied the anatomical morphology of the Der1 cortex and 
hippocampus. Bonneau found that there were no gross changes in hippocampal size 
in heterozygous Der1 mice. There was a trend towards cortical thinness and 
significantly increased lateral ventricle size in the heterozygotes. However, these 
findings were not apparent in an MRI study which used a larger sample size. 
Bonneau also found that there was no difference in the staining of a particular cell 
type, parvalbumin positive interneurons, in the prefrontal cortex of either the 
heterozygous or homozygous Der1 mice. However, there was an overall increase in 
these interneurons in the hippocampus. These cells possibly correspond to the cell 
type Int2 (a hippocampal cell type) or IntPvalb; both of which highly express 
parvalbumin. Neither appeared significant in my mouse hippocampal heterozygous 
analysis; although the class of Interneuron did. The fact that some cell types have 
emerged as significant in the EWCE approach suggests that changes in expression of 
specific markers are both up and down; indicating general dysfunction rather than 
cellular absence. This is in agreement with Bonneau’s data as well. 
7.7.3 Conclusion 
Dysfunction may not affect all cells equally. The persistent significance of 
Astrocytes is highly interesting; Astro1 is significant in every single analysis with the 
exception of the mouse heterozygous Der1 hippocampus and the iPSC-derived 
neuron with two exon8 altered DISC1 alleles. Astro2 is nearly as broadly disturbed. 
Astrocytes release neurotransmitters and have been associated with synapses for 
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some time; it was suggested two decades ago that they should be considered part of a 
“tripartite synapse”
289
. More recently, mouse studies have shown that the release of 
D-serine (an NMDAR co-agonist) by hippocampal astrocytes increases during 
wakefulness, and mice further into wakefulness are more adept at learning contextual 
fear memory. Given the link between NMDAR and learning/memory, the author’s 
conclusion was that astrocytes can modulate neuronal sensitivity to memory 
formation
290
. The release of D-serine was mediated by α7 nicotinic acetylcholine 
receptors. Their disruption here is potentially important in this regard and has 
relevance to the phenotypes of major mental illness. 
The Srikanth cell line with two mutations in Exon2 had particularly broad disruption 
across interneuron and pyramidal cell lines, while many other iPSC-neuron models, 
including our own, had pyramidal disruption. The evidence also suggests that in 
adult life the mouse cortex continues to exhibit some cellular abnormalities. It is 
possible that misplacement of developing cells, indicated by the mouse dysregulation 
of Hox genes including Dlx2, Dlx6, Vax1, Vax2, as well as guidance genes like Ntn5, 
Slit1 and Slit3, could result in a phenotype without gross pathology, which Bonneau 
did not detect, but with subtle wiring and transcriptomic differences. This would 
make sense in the context of psychiatric disease being developmental but is a 
speculative explanation currently. We also saw some emergence of significance in 
the t(1;11) neurons of many oligodendrocyte classes, particularly relating to 
metabolic processes, whereas these did not appear altered at all in the Der1 mouse 
models. This also points towards a developmental role for astrocytes and 
oligodendrocytes in the aetiology of t(1;11) pathology. As a final comment, this 
investigation has not revealed a single “smoking gun” cell type responsible for the 
effects of the t(1;11), or for those of other DISC1/Der1 mutations. This is not entirely 
surprising given DISC1’s expression in a variety of cell types. Genes associated with 
many cell types, particularly many neuronal subclasses, appear to be dysregulated 
and developmental aspects will almost certainly be involved.  
It is highly notable that the mouse cortical gene lists consistently implicated 
pyramidal cells, and in the homozygous Der1 groups only, Medium Spiny Neurons. 
It is these cell groups that were highlighted by Skene et al. in their original analysis 
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using common variation, although they also implicated cortical interneurons (with 
weaker signal), which this analysis did not indicate as clearly. This different signal 
could be due to simply different aetiologies between common disease-mutation and 
our unique mutation. Alternatively developmental timing may be responsible, i.e., we 
are looking at particular cultures and mouse samples, which can only correspond 
(even if roughly so) to a single time point. In contrast, mutations predisposing to 
schizophrenia might exert their effects at a different time point, and indeed the KI 
superset is comprised of datasets of various ages
157,291–293
.  
The GO term analysis offers some clues as to what functions might be disrupted in 
the various cell types, and whether these functions, and the genes driving them, differ 
across models. In the “AstrocyteEpendymal” cell class, we can see that many terms 
bear high similarity between the Der1 heterozygous cortex (CHet) and the Der1 
homozygous cortex Group Two (G2), with the first group (G1) and the human 
t(1;11) neurons (HTN) being more divergent. 23 and 39 genes drive the term 
“carboxylic acid catabolic process” in CHet and G2, respectively, and 15 are 
overlapping. These include Aldoc, Glul, Gldc, and Sardh. Two are also altered in the 
same G1 GO term. These are Acaa2 and Sardh. However, particularly of interest are 
the “Medium Spiny Neuron” and pyramidal classes. In G1 and G2, the GO terms of 
the MSNs are near-identical and gene numbers are large enough that the FDRs are 
quite low. The term “regulation of metal ion transport” has 14 and 13 genes 
associated respectively; 9 of these are identical and include Drd1a, Rgs9, Scn4b, and 
Adora2a. In addition, all 14 genes of G1 are upregulated, while all 13 of G2 are 
downregulated in comparison to the WT. The term “regulation of long term synaptic 





contains the same genes, Ptpn5 Mme, Adora2a, Drd1a. As before, all these genes are 
upregulated in G1 and downregulated in G2. The human homologue of Ptpn5 
encodes STEP, a brain specific phosphatase which acts on both AMPAR and 
NMDAR subunits to oppose synaptic strengthening. It has been proposed that 
abnormally high and abnormally low expression of STEP is harmful. Stimulation of 
α7 receptors by Aβ appears to result in STEP over-activity, and STEP is inactivated 
by antipsychotic agents. Conversely, sufficient expression of STEP appears 
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necessary for stress resilience
294
. STEP’s relevance to synaptic plasticity is obvious 
and the fact that it is disturbed in both homozygotes, albeit in opposite directions, is 
interesting.  
Finally, pyramidal cells were notably disturbed in several models. In the CA1 
pyramidal neuron class, the Chet model displays terms related to cell metabolism and 
basic activities. Although these are vague terms, more specific terms such as 
“negative regulation of cell morphogenesis involved in differentiation” (p=7.91x10
-4
) 
point towards development as being abnormal in these mice. Genes here include 
Slit1, Nrp1, and Sema3e, while another term relating to development is dendrite 
morphogenesis (p=1.68x10
-5
), with genes Chrna7, Nrp1, Camk2a, Slitrk5, Rock2. 
The top 10 Process terms in the G1refer to synaptic activity and ion transport, and 
include some of the same genes such as Chrna7 and Sema3e. In contrast, the G2 and 
hippocampus have diverging changes. The G2 changes revolve around transcription 
factor disruption and fundamental RNA-related activity, while the hippocampus has 
only 3 genes driving its GO terms; Cnih2, Greb1l, Crlf1. The SS changes show a 
similar pattern, although this class is not significant in G2. Chet terms relate to 
protein trafficking and localisation, while the hippocampal terms relate to neuronal 
death, development, and differentiation. The G1 top term is “regulation of 
transmembrane transport”, with 11 genes driving the term including Arc, Cacnb4, 
Rgs4, which have been discussed elsewhere in this thesis, and three potassium 
receptor subunits Kcna1, Kcnb1, Kcns2. Transport evidently emerges as a theme in 
the cortical samples. In addition to widespread pyramidal cell disruption, the facts 
remain that astrocytes have emerged as being implicated in schizophrenia pathology 
by this analysis. We also see clear convergences of our Der1 homozygous model and 
common variation on Medium Spiny Neurons, a cell type of relevance. 
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8.1 Thesis 
This thesis describes the analysis of RNA-Seq data from two models relating to 
psychiatric illness. The first is the iPSC-derived neuronal model of the t(1;11), a 
translocation which segregates with highly increased risk of psychiatric illness in a 
Scottish pedigree. The translocation disrupts three genes, DISC1 and DISC2 on 
chromosome 1, and DISC1FP1 on chromosome 11. Only DISC1 is known to encode 
a protein
66
. The second model is a corresponding mouse model, referred to as Der1 
and described in detail by Malavasi et al. 2018
70
. Creation of the model involved the 
insertion of 150kb of human genetic material 3’ to the t(1;11) chromosome 1 
breakpoint downstream of the analogous location in the mouse Disc1 gene, removing 
98kb in the process
70
. Both models were subjected to RNA sequencing of 
comparable sequencing depth. Neurons carrying the t(1;11), and two brain regions of 
the mouse, were harvested and sequenced. RNA-Seq data were analysed for regional 
effects where appropriate, for differential expression, and some selected 
differentially expressed genes were verified by RT-qPCR. It also describes the 
overlaps seen with studies of interest and overrepresentation of specific GO terms, 
especially those relevant to psychiatric illness. Data from both the iPSC-derived 
neuronal and mouse models were also used in two separate analyses, the first to 
detect whether the relative proportions of cells were altered in the samples, and the 
second to examine if the differentially expressed genes were found associated with 
any particular cell types, and if so, whether these cell associated genes were 
associated with particular functions.  
8.2 DESeq2 and DEXSeq analysis 
The DESeq2 analysis of the human and mouse datasets has confirmed a number of 
interesting changes, while rejecting some hypotheses. Both iPSC-derived neurons 
and Der1 mice displayed the expected effects on DISC1/Disc1 expression, and were 
clearly affected by the translocation/Der1. Over 1,200 genes were found 
differentially expressed in the human neurons, with over 2,000 in the heterozygous 
Der1 mouse cortex, and a significantly lower number of 175 in the hippocampus. 
The effect on the homozygotes was less clear, but they differed from the WT 
samples. The cortex samples showed a surprising splitting into two groups which is 
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discussed in detail in the relevant chapter. It can also be stated that there is no 
evidence for the t(1;11) causing regional expression effects, or for significant 
transcriptional alterations of potential DISC1 interactors. There is ample evidence for 
extensive overlap with analogous experiments utilising iPSC-derived neurons with 
DISC1 mutations, and with genes implicated by studies searching for common 
mutation predisposing to schizophrenia. This was seen in both the human and mouse 
cortex datasets. Potential Disc1 interactors in the mouse were altered at a rate greater 
than expected by chance
73
. 
qPCR results confirmed changes in a number of genes, while also confirming the 
reliability of the human RNA-Seq analysis. The qPCR results in the mouse cortex 
showed a looser relationship between qPCR score and gene counts, suggesting that 
the mouse analysis is less reliable. This apparent imbalance may simply be due to the 
larger variation in total sequencing depth across mouse samples, however. In both 
datasets the changes show a general linear trend between the overall log2fold change 
of the qPCR score and counts between genotypes, so this is reassuring as to the 
validity of the data. The changes in the mouse were also more subtle and rarely 
resulted in the doubling or halving of a gene’s expression. Finally it must be noted 
that PCAs showed that mouse sex was a significant factor in differentiating the 
samples; correlating with the second largest factor after genotype. It is possible that 
this is a factor in non-significance of genes and the appropriate solution would be to 
utilise a larger sample set. As it stands if the samples were split by sex, 4 Hets vs 3 
WTs would not be an adequate sample size for multiple qPCRs. As to the genes 
which were actually confirmed, a number of highly relevant genes were shown to be 
differentially expressed. These findings and their possible relevance are discussed 
below, along with other differentially expressed genes and the gene ontologies 
overrepresented among them. In order to give a full and complete discussion, 
reference is made to the results of the EWCE analysis, a summary of which is given 
in the relevant chapter. This discussion therefore covers i) the altered genes, ii) which 
cells and activities these appear to be related to, and iii) how this might result in 
deleterious phenotypes.  
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Human genes I confirmed by qPCR included BBS1, CALB1, DRD2, GPC1,METRN, 
NTRK2, QKI, with confirmed exon level changes in DPYSL3, NTRK2, and SLC12A2. 
All of these, except for DRD2, were downregulated. Mouse confirmed cortical 
changes included Arc and Avp, both in the heterozygote, both downregulated. 
Summaries of all genes can be found in the relevant sections of Chapters 3 and 4. 
8.3 Deconvolution analysis 
The purpose of the deconvolution analysis, utilising DeconRNASeq developed by 
Gong et  al., was to search for changes in cell specific marker expression indicating 
differences in prevalence of these cell types
135
. Unlike the EWCE analysis of Skene 
et al., this is roughly quantitative and takes account of the direction of gene 
expression changes, and makes the assumption that consistent changes in expression 
of sets of cell specific markers indicate changes in cell proportions. Two separate 
sets of analyses were carried out for the deconvolution analysis for both mouse 
datasets as well as the human dataset. The first utilised the RNA-Seq data of enriched 
profiles described by Zhang et al. and looked at broad class level differences in the 
prevalence of each cell type
203
. The second looked at scRNA-Seq data generated by 
Zeisel et al., and looked at subclass level differences
157
. A third, minor analysis 
involved the use of data generated by Darmanis et al., specifically to give a human to 
human comparison for class level data
295
. In all cases, different numbers of marker 
genes and housekeeping normalising genes were utilised, and these settings were 
verified using pseudosamples. 
The Zhang cortical analysis was characterised by quite high accuracy in the 
deconvolution of pseudosamples, with mean absolute difference in proportion of the 
6 cell types being an average of around 6% between predicted and actual 
proportions. The comparison dataset, Zhang Two, was also highly well predicted and 
these enriched samples were identified as being over 95% of the correct cell type, 
except at high marker numbers which tend to incorporate markers of reduced 
specificity. The cortical samples in the Zhang Two dataset bear high similarity in cell 
proportions, to the proportions found in our sample deconvolutions. The 
hippocampal deconvolution was highly similar, with even better accuracy of 
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pseudosample deconvolution, as were the human Zhang and Darmanis 
deconvolutions. These all also noted that higher marker numbers were suboptimal. 
Overall these are reassuring proofs as to the validity of the deconvolution. There was 
no genotype effect on any cell type in the hippocampal or cortical Der1 samples that 
showed pairwise significance. The human results however bore some significances; 
the Zhang analysis showed a mild but universally significant effect on astrocyte 
proportions (decreased in t(1;11)) which survived multiple testing correction (Sidak-
Bonferroni). Astrocytes had also been shown to be frequently significant in the 
mouse cortical analysis, though never in pairwise comparisons. In contrast, the 
highly variable Darmanis deconvolution had no clear effect.  
To conclude, there are no changes which survived post-hoc significance testing in the 
Der1 mouse samples. However, it is possible that astrocytic proportions or 
transcriptional activity are altered in the human cells. The Group One and Group 
Two of the cortical homozygotes also were more divergent from one another when t-
tests were carried out, indicating greater dysfunction. This ties in with the results of 
the EWCE implicating astrocytes universally, and indicates that the dysfunction 
thereof is due to decreased cell numbers or activity.  
The Zeisel analysis had diverging results. In all cases, confidence in these results 
must be lower, as the comparative dataset deconvolution showed very poor 
prediction, and in any case poor housekeeping expression across the comparative 
Allen dataset means there were few cells of some types to compare to. Mean absolute 
difference for pseudosamples was also worse than in the Zhang analysis; minimums 
of 20% for cortical, 24% for hippocampal, 14% for human. These are, in real terms, 
quite large margins of error. This is to be expected given the larger number of cell 
types. The cortical analyses were highly dependent on whether Der1 homozygous 
cortical samples were split into two groups; this is an indication of the difference of 
these two sample sets, as also shown by the Zhang analysis. Results were also quite 
dependant on deconvolution settings; there were no cell types which displayed 
universal significance according to an ANOVA test, and only one pairwise 
difference between genotypes was ever reported significant (out of a large number). 
The cell type exhibiting the most common agreement on significance was Int10, with 
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a total of two thirds of the deconvolutions regarding it as significant when cortex 
homozygotes were split into two groups. Three variations were used for the cortical 
deconvolution, leaving out or merging certain cell types, and the Der1 sample 
proportions were quite similar regardless of this, with most cell types not changing a 
great deal if the deconvolution settings were the same. In contrast, changing 
deconvolution settings resulted in large changes in overall predicted cellular 
proportions. The hippocampal analysis was characterised by similar variation, 
particularly if the number of normalising housekeeping genes was altered, and no 
cell type displayed universal significance or posthoc testing significance. Int4 and 
Int14 showed the highest degree of support. The human analysis displayed no 
evidence for any cell types being significant.  
To conclude, it would be irresponsible to not be suspicious of the Zeisel 
deconvolution results. The high variation in pseudosample deconvolution and poor 
Allen prediction means they should not be relied upon. In any case, no cell type 
possessed universal significance across the deconvolution settings in any of the three 
analyses. As stated earlier, this poor prediction is an inevitable consequence of large 
numbers of cell types. In this light it is unsurprising that I could not carry out a 
reliable analysis. I do note that the cortical analyses changed drastically when the 
homozygote samples were split into groups or kept together; highlighting the 
divergence between these two groups.  
8.4 EWCE analysis 
The EWCE analysis revealed that differentially expressed genes were associated 
with a variety of cell classes, “AstrocyteEpendymal”, “PyrSS”, “Oligodendrocytes”, 
and “EndothelialMural” being significantly implicated in the human cells. The 
challenge is now to explore and explain the functional relevance of these 
implications. 
Pyramidal cells were significant in most analyses, although the exact GO terms and 
genes implicated tended to differ across the models. The human PyrSS genes were 
few in number and related primarily to gonadotrophin signalling. Those of the 
hippocampal heterozygous Der1 were primarily cell death related. The Der1 mouse 
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het cortex had a number of highly interesting and related genes altered, which in 
many cases converge on calcium influx. In addition to the subunits encoded by 
Cacnb3 and Cacng3, I noticed a co-dysregulation of Chnra7 (down), Chrnb2 (down), 
Lynx1 (up), and Lypd6 (up). There is a wealth of research into the latter two genes, 
which are related to the toxins in snake venoms and function as endogenous 
modulators of nicotinic acetylcholinergic receptors
296
. Lypd6 is highly enriched in 
neuronal tissue, and overexpression enhances nicotine-evoked calcium influx 
through nAChRs, while knockdown decreases this influx
296
. In contrast, knockdown 
of Lynx1 appears to enhance this influx. The authors also suggested that Lynx1 could 
exert a neuroprotective effect by preventing nAChRs-mediated excitotoxicity 
297
 
Lynx1 also controls dendritic spine dynamics; knockdown appears to increase the 
rate of dendritic spine formation and removal
298
, It has been referred to as a 




The nAchRs are described as having quite divergent effects on neuronal activity; 
expression of them in interneurons in cortical layers 2/3 means they have an 
inhibitory effect on pyramidal cells, whereas they appear to have an different role in 
layer 6 as they are expressed directly by the pyramidal cells themselves
300
. This 
appears to be via receptors containing the subunit encoded by Chrnb2, and results in 
the strengthening of glutamatergic synapses. Nicotine can stimulate LTP in L6 
neurons, but not the shallower layers, and the subunit composition of the receptor is 
important too. For example α7 encoded by Chrna7 is not necessary for nicotine-LTP 
in L6
300
. However, it is the case that the Der1 cortical samples and the t(1;11) 
neurons are not distinctly associated with any layer, and it is therefore premature to 
draw conclusions about the effect of disrupted cholinergic transmission on cells, 
given its layer specific effects. It is also the case that differential expression of Lynx1 
and Lypd6 in various cell types may modulate the effects of endogenous 
acetylcholine. One research group found these two “proto-toxins” are expressed in 
parvalbumin positive and somatostatin positive interneurons, respectively, and not 
co-expressed. Mice lacking Chrna7 also show deficits in parvalbumin positive 
interneurons, and that gene is downregulated in the Der1 heterozygous cortex
198
. The 
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Karolinska Institute dataset shows that Lynx1 is broadly and near equally expressed 
in pyramidal cells from multiple layers of the cortex, while Lypd6 is much more 
associated with interneurons (especially Sst
+
 ones). 
However it is highly interesting that Lynx1 is upregulated in the Der1 cortex while 
Chrnb2 is downregulated, implying diminished cholinergic receptor activity. A 
possible outcome from this would be diminished capacity for LTP in the mouse 
heterozygous cortex in the appropriate layers. Is the same situation occurring in the 
mouse heterozygous hippocampus? The pyramidal cells show clear convergences on 
cell death here, and surprisingly both Chrna4 and Lypd6b are upregulated. α4 
(upregulated in the het hippocampus) and β2 (downregulated in the het cortex) 
subunits together form a nicotinic receptor. Unfortunately there is little information 
available on Lypd6b at present, but if it is similar to Lypd6 this is evidence that the 
nicotinic situation is reversed in the hippocampus compared to the cortex. 
Excitotoxicity could be the cause of the dysregulated cell death genes we observe. It 
must be stressed that this is a preliminary theory; there are of course many processes 
at work in neurons, and the dysregulations could be by chance. It must also be noted 
that in each brain region only one of the pair of subunits is dysregulated, but there are 
some interesting convergences on the theme of diminished synaptic activity in the 
cortex from other cell types. 
As mentioned previously, astrocytes are of immense importance to neuronal 
function, and have been designated as part of a “tripartite synapse” by some 
researchers. It has been shown that fluctuations in Ca
2+
 cytosolic concentration alter 
astrocytic activity, and that in vivo elevations of this concentration have been 
observed in response to synaptic release of norepinephrine and glutamate in the 
cortex
301
. Of direct relevance might be the role of astrocytes in clearing 
neurotransmitters, preventing excitotoxicity, and maintaining homeostasis. A number 
of differentially expressed genes which are most highly expressed in the 
“AstrocyteEpendymal” class are related to this very function. Glutamate is a 
particularly potent excitotoxic agent which is removed from the synaptic cleft by 
glutamate transporters EAAT1-4, with the first two being primary involved in this 
function and expressed in astrocytes
302
. SLC1A3, encoding EAAT1, is differentially 
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expressed, as is SLC1A6, encoding EAAT4, although this is described as a neuronal 
gene and correspondingly does not have its maximum expression in 
“AstrocyteEpendymal” cells
302
. Nevertheless downregulation of the gene in neurons 
would have a similar effect of excess synaptic glutamate. A similar scenario is seen 
with glycine, another neurotransmitter. Three of the four genes involved in the 
glycine cleavage/synthesis system are differentially expressed, as is the receptor 
GLRA1. Of the three, GLDC has maximum expression in astrocytes, while the other 
subunits DLD, GCSH, as well as GLRA1 are expressed across a variety of neurons. 
All the genes mentioned above are downregulated in the t(1;11) samples, with the 
exception of GLRA1. The functional implications of these changes would mean 
excess glutamate and glycine; possibly at the “trisynapse” given the role of 
astrocytes in clearing these neurotransmitters here and the fact that most of the genes 
are astrocyte-associated. The imbalance might have the effect of unusual synaptic 
plasticity, as synaptic NMDARs must be activated for both LTP/LTD and NMDAR-
mediated cell death
303
. However, it has been shown that these synaptic NMDARs 
exhibit a preference for D-serine rather than glycine as a co-agonist
303
, and in 
addition that high levels of glycine can stimulate LTD in opposition to LTP
304
. 
Astrocytes themselves do release neurotransmitters, including D-serine and 
glutamate in response to neuronal activity
301
. This has been shown to modulate 
plasticity via NMDARs, and it is the case that impaired clearance of 
neurotransmitters, regardless of neuronal or astrocytic source, could result in aberrant 
plasticity or even cell death. The dysregulation of both the glycine and glutamate 
neurotransmitters is therefore some evidence for aberrant activity of NMDARs. The 
findings of our research group, published as Malavasi et al. 2018, showed evidence 
for potential weaker synaptic activity in Der1 mice; as suggested by total PSD-95 
prevalence being unchanged but its distribution shifted towards less nanodomains per 
PSD-95 cluster
70
. In this context, the human t(1;11) alterations fit perfectly and give 
a potential explanation for this finding; aberrant LTD. The calcium/nicotinergic 
transcriptional alterations seen in the mouse Der1 cortical heterozygote also fit well 
with the phenotypes observed by Malavasi et al.. 
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A second theme in the universally altered “AstrocyteEpendymal” cell set was fatty 
acid and lipid metabolism. Human genes included CPT2, ECI2 (fatty acid oxidisers), 
GPC5, and IMPA2 (lipid phosphatase). Cpt2 was also changed in the mouse 
homozygous G1 group, as was Cpt1a in the mouse heterozygote. Apoe was altered in 
all three mouse groups, although I could not confirm this with qPCR in the mouse 
cortical heterozygote. Myelin is an unusually lipid-heavy construct; 70% of the dry 
weight is composed of lipid. Astrocytes can promote the myelination of neurons in 
oligodendrocyte-neuron culture, and it has been shown that they are a source of the 
lipids needed to form myelin. SCAP, the sterol sensor which activates cholesterol 
and fatty acid related transcription factors in astrocytes, is important for myelination 
formation in mice. Mice with SCAP
-
 oligodendrocytes have a neurological 
phenotype (microcephaly, tremors, increased lethality) and hypomyelination. Mice 
lacking the same protein in astrocytes also displayed microcephaly, hypomyelination, 
and downregulated Mag and Mbp
305
. This has crucial implications for proper 
neuronal functioning. Cholesterol has been shown to have effects on synapse 
formation too. Both glial-derived media containing cholesterol, and cholesterol itself, 
increase electrophysiological activity and synapsin/glutamate receptor staining in 
neurites
306
. It has been suggested that the carrying agent for this cholesterol is Apoe-
positive lipoproteins
307
. More recent papers have shown that increased cholesterol 
elimination boosts dendritic output, which suggests that less cholesterol is better for 
synaptic activity
308
. These authors also reported increased phosphorylation of Trk 
compared to TrkB, although total levels of TrkB (encoded by Ntrk2, homologue 
confirmed differentially expressed in t(1;11) neurons by qPCR) were not reported. 
The authors suggested that this might be related to the distribution of lipids and TrkB 
in the cell membrane
308
. This also suggests that fatty acid metabolism in neurons 
alone, even without accompanying glia, is important. Therefore whether in neurons 
or astrocytes (which should be present in some proportion in our samples) the 
alterations in fatty acid metabolism matter. Given the deficit in lipid metabolism by 
astrocyte-associated genes, and the dysregulation of Apoe in all mouse models 
examined here, one might expect it to be the case that the t(1;11) and Der1 models 
display myelination deficits. It must be noted that as the Apoe changes were not 
significant at qPCR level, the changes are either minor, not genuine, or the small 
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sample size makes discovery difficult. Expression was also not investigated in the 
cortical homozygotes.  
The human cells, as well as the Der1 homozygote cortex Group Two, had the cell 
type “Oligodendrocytes” significantly associated with differentially expressed genes. 
The Der1 cortex Group Two oligodendrocyte genes have a clear association with 
myelination, with Mbp, Mag, and Plpl1 being differentially expressed and associated 
with this term. Similarly, this thesis shows that the human gene QKI, a regulator of 
these crucial myelination genes, is differentially expressed in the t(1;11) cultures
216
. 
There is no evidence of differential proportions of oligodendrocytes as shown by my 
deconvolution analysis. The t(1;11) cultures should not contain a large number of 
oligodendrocytes, but as described earlier in the QKI section of Chapter 3 reasonable 
expression of immature markers is observed. Qk (the QKI homologue) is also 
reasonably expressed across cell types in the Karolinska Institute superset; mostly in 
astrocytes and oligodendrocytes, but with some expression in pyramidal and neural 
progenitor cells. Also dysregulated in the human neurons are NRG1 and ERBB4
70
. 
Interestingly, multiple papers have shown that inadequate signalling of this receptor-
ligand pair results in myelination deficits. NRG1 promotes the survival, migration, 
and proliferation of Schwann cells, while mouse lines with dominant-negative Erbb 
receptors in oligodendrocytes and myelinating cells have thinner neurons, abnormal 
myelination forming, and abnormal expression of myelination proteins including 
Mbp (but not Mag)
309
. The group went on to show these mice had hypersensitivity to 
amphetamine, greater dopamine-induced signalling, and increased dopamine receptor 
expression (type 1 significant, no stated distinction between receptors within this 
type)
310
. Drd1 and Drd2 are both dysregulated in the cortical Der1 homozygotes 
(both up in Group One, down in Group Two), and DRD2 is qPCR confirmed as 
differentially expressed in the t(1;11) neurons. It is, to reiterate, a target of anti-
psychotic medication.  
Relevant to this cell type is the publication of a recent paper examining iPSC-derived 
t(1;11) carrying oligodendrocytes, as well as myelination phenotypes of the Der1 
mice, and members of the Scottish pedigree
311
. They found t(1;11) carriers of the 
pedigree, 8 in total, all with a psychiatric diagnosis, had altered white matter 
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connectivity compared to 13 controls (12 without a diagnosis, one with). The white 
matter tracts connecting grey matter nodes were decreased in strength and in number, 
by a mean of 1.81% and 1.64% respectively. iPSC-derived oligodendrocytes carrying 
the t(1;11) had a lower proportion of KI-67
+
 differentiating cells after three weeks, as 
well as drastically reduced DISC1, expressed at 30% of the WT level. This implies 
erroneous early development; as also suggested in t(1;11) neurons by my findings 
that the differentiation stage expressed genes GPC1, METRN, SLC12A2 (exon level) 
are downregulated. RNA-Seq showed differential expression of 228 genes, with GO 
terms such as “nervous system development” and “myelination” overrepresented. 
Oligodendrocytes were smaller in t(1;11) carrying lines, and the Der1 mouse 
heterozygous cortex showed unusual myelination, with more myelin sheaths and 
shorter myelin internode lengths. The authors also noted that oligodendrocytes have 
been associated with schizophrenia in particular previously
311
. 
To summarise these papers, EWCE findings, and qPCR results; 
i. Other researchers have shown abnormalities of white matter in the t(1;11) 
family, and that the Der1 mouse cortex and t(1;11) carrying oligodendrocytes 
are abnormal. The mice have deficits in myelination, while the cells are 
smaller and appear to differentiate abnormally, apparently earlier. 
ii. Researchers have also shown that myelination deficits result from impaired 
Nrg1/Erbb4 signalling, and the consequences include amphetamine 
sensitization caused by upregulated dopamine receptors. 
iii. Other researchers have shown that astrocytes are a crucial source of fatty 
acids for the synthesis of myelin in oligodendrocytes. 
iv. Astrocytes are also important for the buffering of glutamate, glycine, and 
other neurotransmitters, which aids in synaptic plasticity. They also produce 
cholesterol, carried by Apoe, which can cause TrkB phosphorylation ratio 
changes and also impacts on synaptic plasticity. 
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v. I have demonstrated here the dysregulation of functions relating to these 
factors. Downregulation of QKI (point i, myelination), of 
SLC12A2/GPC1/METRN (point i, development), of NTRK2 (point iv, both 
gene and exon) were proven by qPCR. Notably, Apoe could not be confirmed 
in the mouse, but Arc downregulation may have relevance to synaptic 
plasticity. 
vi. The RNA-Seq implicates astrocyte neurotransmitter homeostasis in both 
mouse and human datasets (point iv), as well as astrocyte fatty acid 
metabolism (point iii, leading to point i and ii). 
vii.  Previously described were the downregulation of ERBB4 and NRG1, with 
the co-occurring upregulation of DRD2 (point ii)
70
.  
These papers, EWCE findings, and qPCR results are summarised in image form in 
Figure 102. 
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Figure 102. Conclusions of discussion. Cell types indicated by EWEC are represented by blue squares. Genes which are 
qPCR verified as differentially expressed in the t(1;11) iPSC-derived neurons are represented by circles; red indicating 
downregulated in t(1;11), green indicating upregulated in t(1;11).  
A logical conclusion can be developed from these findings and the links between 
them. The recent finding that myelin and white matter integrity is altered in 
oligodendrocytes and carriers of the t(1;11) fits cleanly with the convergence of two 
separate pathways on myelin production. The first is ERBB4/NRG1 signalling, 
leading to upregulation of dopamine receptor signalling and impaired myelination, 
while the second is astrocytic malfunction. This not only can alter the supply of fatty 
acids needed to produce myelin but also has effects on synaptic plasticity. There is 
evidence for altered synaptic activity in the Der1 mice and verified qPCR changes in 
related genes in the t(1;11) and Der1 samples. There is therefore a strong case for 
myelination and synaptogenesis being altered by t(1;11)/Der1, likely via one or both 
of the pathways of astrocytic malfunction and ERBB4/NRG1 signalling causing 
hyperdopaminergic signalling. 
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Exactly how myelination and synaptogenesis, and hypomyelination and synaptic 
weakening specifically, are related is difficult to say. However, a review by 
O’Rourke et al. notes that “OPCs are the only glial cell type to receive direct 
synaptic input from neurons…and glutamatergic synaptic signalling can direct the 
local translation of a myelin protein (myelin basic protein) at the site of axon-OPC 
contact in vitro”. There are clearly links between the two processes which enhance 
the communicative aspects of neuronal activity, and the findings of this thesis and 
recent papers point towards these links as potentially being important in major 
mental illness. 
8.5 Future directions 
This thesis has highlighted the disruption of many functions in the t(1;11) neuron 
cultures, and described a plausible dysregulation in the activity or proportion of 
astrocytes or related functions. The high level of overlap between the t(1;11) neuron 
cultures and Der1 mice, especially as regards the EWCE analyses, implies that the 
Der1 mouse accurately models some aspects of the t(;11). As described above, there 
are extensive links between synaptic dysregulation (notably dopaminergic 
hyperfunctioning and ERBB4/NRG1 signalling), myelination, and astrocyte 
homeostasis and metabolic support. Future approaches involving the t(1;11) could be 
biochemical and investigate these disturbed processes, although the relative 
immaturity of the iPSC-derived neurons make this difficult. Responses of the cells to 
dopamine, glutamate, and other neurotransmitters, as well as drugs, would be highly 
interesting and could utilise the Der1 if the t(1;11) neurons are not sufficiently 
mature. Other potential avenues of experimentation could involve the BBS subunits, 
which are important for early cellular migration and division. Dendritic outgrowth is 
also a target for future work. One drawback of the “cells-in-a-dish” approach is the 
difficulty in accessing the cell-specific effects of receptors such as the nAchRs; as 
described above, these have diverging effects in different layers of the cortex.  
Now that an oligodendrocyte t(1;11) model has been made which displays abnormal 
phenotypes, the obvious next move is to examine an astrocytic t(1;11) model. This 
would be of high interest; interactions between t(1;11) astrocytes and other cell types 
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(neurons, oligodendrocytes) could be examined by co-culture and compared to WT 
astrocytes. Indeed, t(1;11) neurons and oligodendrocytes would allow the examining 
of emergent phenotypes only evident when several cell types carry a mutation. In 
nature, all these cells have the t(1;11), and the most accurate insights will come from 
an experimental design that acknowledges this. Astrocytes have already been 
generated from iPSCs with protocols that report near universal expression of 
astrocytic markers and efficient generation
312
. Some of these papers, which mainly 
focus on neurodegenerative diseases, have specifically sought to examine the non-
cell autonomous nature of those diseases. They therefore utilised cell co-cultures, 
examining phenotypes of relevance to neurodegeneration
313
. Could this be extended 
to RNA-Seq? There exist bioinformatics methods to extract the individual RNA-Seq 
profiles of mixed cultures, where each cell type originates from a different species
314
. 
In theory, this could be used to examine the status of each cell type, e.g., t(1;11) 
neurons and Der1 mouse astrocytes cultured together vs t(1;11) neurons and WT 
mouse astrocytes. This would sacrifice some accuracy (as mouse astrocytes are not 
human astrocytes) but would allow RNA-Seq analysis of individual cell types. The 
added advantage is that both of these models already exist, and as this thesis shows, 


























9.1 Exon illustrations in selected qPCR DEXSeq candidates 
Differentially expressed exons which were targeted with primer pairs are highlighted 









Note that two related exons are within the circle. The non-overlapping part of the 






















9.2 Dissociation curves of human qRT-PCR products, showing 
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Process P-value FDR q-value Enrichment Function P-value FDR q-value Enrichment Component P-value FDR q-value Enrichment
cellular metabolic process 5.51E-20 8.45E-16 1.61 binding 3.49E-11 1.58E-07 1.21 intracellular organelle part 4.53E-34 8.79E-31 1.73
macromolecule metabolic process 6.58E-19 5.05E-15 1.7 ubiquitin-like protein binding 2.11E-09 4.76E-06 6.59 intracellular part 7.28E-33 7.05E-30 1.33
metabolic process 6.28E-18 3.21E-14 1.51 organic cyclic compound binding 9.16E-09 1.38E-05 1.44 organelle part 2.26E-31 1.46E-28 1.67
nitrogen compound metabolic process 8.58E-18 3.29E-14 1.61 RNA binding 1.20E-08 1.36E-05 2.19 membrane-bounded organelle 4.95E-29 2.40E-26 1.46
primary metabolic process 2.10E-16 6.44E-13 1.54 heterocyclic compound binding 2.41E-08 2.18E-05 1.43 intracellular membrane-bounded organelle 1.06E-28 4.11E-26 1.5
macromolecule catabolic process 2.28E-16 5.83E-13 3.2 ubiquitin binding 3.33E-08 2.51E-05 6.98 protein-containing complex 7.75E-27 2.50E-24 1.81
organic substance metabolic process 2.76E-15 6.05E-12 1.5 nucleoside phosphate binding 1.30E-07 8.36E-05 1.73 intracellular organelle 4.96E-25 1.37E-22 1.39
cellular macromolecule metabolic process 1.88E-14 3.61E-11 1.72 nucleotide binding 1.30E-07 7.31E-05 1.73 organelle 5.04E-24 1.22E-21 1.37
proteolysis involved in cellular protein catabolic process 2.69E-14 4.59E-11 3.54 catalytic activity 1.57E-07 7.86E-05 1.37 nuclear part 6.27E-22 1.35E-19 1.92
cellular macromolecule catabolic process 9.32E-14 1.43E-10 3.18 small molecule binding 6.79E-07 3.06E-04 1.62 cytoplasmic part 1.15E-20 2.23E-18 1.49
modification-dependent macromolecule catabolic process 1.36E-13 1.90E-10 3.63 ubiquitin-like protein ligase binding 1.07E-06 4.39E-04 3.01 catalytic complex 1.09E-18 1.92E-16 2.7
protein metabolic process 1.69E-13 2.16E-10 1.76 ubiquitin protein ligase binding 1.32E-06 4.98E-04 3.06 cell part 3.05E-18 4.93E-16 1.19
modification-dependent protein catabolic process 2.88E-13 3.40E-10 3.62 protein binding 2.50E-06 8.67E-04 1.23 proteasome accessory complex 5.27E-14 7.85E-12 23.99
ubiquitin-dependent protein catabolic process 4.82E-13 5.28E-10 3.64 modification-dependent protein binding 2.81E-06 9.05E-04 4.21 mitochondrial part 1.66E-13 2.30E-11 2.87
cellular localization 7.50E-13 7.66E-10 2.09 purine ribonucleoside triphosphate binding 3.49E-06 1.05E-03 1.7 mitochondrial protein complex 6.75E-13 8.72E-11 4.73
proteolysis 6.92E-12 6.63E-09 2.48 ribonucleotide binding 5.34E-06 1.51E-03 1.67 mitochondrion 8.14E-13 9.86E-11 2.14
cellular catabolic process 9.71E-12 8.76E-09 2.24 purine ribonucleotide binding 7.39E-06 1.96E-03 1.66 peptidase complex 8.96E-13 1.02E-10 8.29
macromolecule localization 1.51E-11 1.29E-08 2.04 proteasome-activating ATPase activity 7.51E-06 1.88E-03 24.72 nucleoplasm 1.82E-12 1.96E-10 2.02
catabolic process 1.76E-11 1.42E-08 2.12 nucleoside-triphosphatase activity 7.82E-06 1.86E-03 2.04 nucleus 2.25E-12 2.29E-10 1.48
intracellular transport 3.84E-11 2.94E-08 2.31 purine nucleotide binding 9.30E-06 2.10E-03 1.65 proteasome regulatory particle 1.14E-11 1.10E-09 29.66
organonitrogen compound metabolic process 5.26E-11 3.84E-08 1.57 pyrophosphatase activity 1.48E-05 3.17E-03 1.97 organelle membrane 2.10E-11 1.94E-09 2.17
protein localization 1.01E-10 7.04E-08 1.99 hydrolase activity, acting on acid anhydrides 1.61E-05 3.31E-03 1.96 proteasome complex 5.32E-11 4.68E-09 9.12
protein catabolic process 1.37E-10 9.15E-08 3.5 hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides 1.61E-05 3.16E-03 1.96 endopeptidase complex 6.84E-11 5.77E-09 8.97
establishment of protein localization 1.39E-10 8.85E-08 2.23 ubiquitin-specific protease binding 2.29E-05 4.31E-03 13.24 ribonucleoprotein complex 1.06E-10 8.58E-09 2.51
organic substance catabolic process 2.65E-10 1.63E-07 2.15 ATP binding 2.31E-05 4.18E-03 1.71 proteasome regulatory particle, base subcomplex 1.19E-10 9.24E-09 24.72
9.3 Dissociation curves of mouse qRT-PCR products, showing 
a single product in all qPCRs (and blue flat lines in negative 
controls). 
 
9.4 Top 25 GO terms for housekeeping genes chosen in 
deconvolution, by Process, Function, and Component 
9.4.1 Cortex Zhang 
 
9.4.2 Cortex Zeisel 
 
Process P-value FDR q-value Enrichment Function P-value FDR q-value Enrichment Component P-value FDR q-value Enrichment
translation 3.59E-51 5.50E-47 9.44 structural constituent of ribosome 2.19E-47 9.91E-44 12.25 protein-containing complex 1.11E-67 2.16E-64 2.31
peptide biosynthetic process 2.80E-49 2.14E-45 8.93 RNA binding 2.89E-36 6.54E-33 3.9 intracellular organelle part 8.91E-63 8.69E-60 1.98
peptide metabolic process 1.26E-44 6.44E-41 6.98 structural molecule activity 5.66E-27 8.53E-24 4.26 organelle part 1.25E-59 8.16E-57 1.91
amide biosynthetic process 7.68E-43 2.94E-39 7.09 rRNA binding 1.54E-17 1.74E-14 11.06 intracellular part 3.00E-58 1.46E-55 1.41
cellular amide metabolic process 1.71E-36 5.25E-33 5.04 mRNA binding 4.73E-17 4.28E-14 5.39 ribonucleoprotein complex 2.79E-55 1.09E-52 5.18
cellular nitrogen compound biosynthetic process 7.06E-35 1.80E-31 3.71 nucleic acid binding 6.03E-17 4.55E-14 1.92 ribosome 5.02E-54 1.63E-51 12.61
cellular macromolecule biosynthetic process 7.64E-34 1.67E-30 4.17 heterocyclic compound binding 4.86E-14 3.14E-11 1.59 cytoplasmic part 1.01E-49 2.80E-47 1.75
cellular nitrogen compound metabolic process 6.76E-33 1.29E-29 2.42 organic cyclic compound binding 1.35E-13 7.61E-11 1.57 intracellular organelle 6.18E-48 1.51E-45 1.52
macromolecule biosynthetic process 8.26E-33 1.41E-29 3.9 ribonucleoprotein complex binding 1.17E-12 5.88E-10 6.08 organelle 2.71E-45 5.88E-43 1.49
organonitrogen compound biosynthetic process 1.35E-32 2.07E-29 4.11 unfolded protein binding 1.21E-12 5.46E-10 7.6 cytosolic part 1.69E-42 3.29E-40 8.51
cellular metabolic process 2.36E-31 3.29E-28 1.77 protein-containing complex binding 1.24E-12 5.10E-10 2.36 ribosomal subunit 5.78E-42 1.03E-39 9.84
metabolic process 9.57E-29 1.22E-25 1.65 enzyme binding 1.31E-11 4.92E-09 1.86 intracellular membrane-bounded organelle 3.11E-36 5.06E-34 1.55
cellular biosynthetic process 5.82E-25 6.86E-22 2.64 translation factor activity, RNA binding 2.61E-10 9.08E-08 7.52 cell part 1.52E-35 2.29E-33 1.25
macromolecule metabolic process 9.04E-25 9.90E-22 1.8 translation initiation factor activity 3.30E-10 1.07E-07 9.88 membrane-bounded organelle 2.79E-32 3.89E-30 1.48
nitrogen compound metabolic process 2.85E-24 2.92E-21 1.71 threonine-type endopeptidase activity 2.15E-09 6.49E-07 15.3 cytosolic large ribosomal subunit 1.96E-30 2.54E-28 14.73
cellular macromolecule metabolic process 8.23E-24 7.89E-21 1.95 threonine-type peptidase activity 2.15E-09 6.08E-07 15.3 mitochondrial part 4.10E-27 4.99E-25 3.86
cellular process 2.47E-23 2.23E-20 1.3 ubiquitin-like protein ligase binding 3.28E-09 8.73E-07 3.48 intracellular non-membrane-bounded organelle 4.74E-27 5.44E-25 2.23
organic substance biosynthetic process 1.57E-22 1.34E-19 2.48 ubiquitin protein ligase binding 3.87E-09 9.71E-07 3.55 non-membrane-bounded organelle 1.20E-26 1.30E-24 2.21
biosynthetic process 8.40E-22 6.78E-19 2.42 protein tag 3.88E-09 9.24E-07 22.72 inner mitochondrial membrane protein complex 8.28E-26 8.51E-24 10.65
organic substance metabolic process 1.45E-20 1.11E-17 1.58 NADH dehydrogenase (ubiquinone) activity 2.06E-08 4.67E-06 15.04 large ribosomal subunit 3.94E-25 3.84E-23 9.38
cellular protein metabolic process 1.61E-20 1.18E-17 2.14 NADH dehydrogenase (quinone) activity 2.06E-08 4.44E-06 15.04 mitochondrial membrane part 3.99E-24 3.71E-22 7.39
primary metabolic process 1.95E-19 1.36E-16 1.59 electron transfer activity 2.95E-08 6.07E-06 7.03 mitochondrial protein complex 2.59E-23 2.29E-21 6.47
protein metabolic process 5.00E-19 3.33E-16 1.91 large ribosomal subunit rRNA binding 3.66E-08 7.20E-06 23.81 catalytic complex 8.49E-23 7.20E-21 2.88
organonitrogen compound metabolic process 1.58E-17 1.01E-14 1.74 NADH dehydrogenase activity 8.11E-08 1.53E-05 12.98 mitochondrial inner membrane 9.00E-23 7.32E-21 5.09
cellular protein-containing complex assembly 2.33E-17 1.43E-14 3.36 proton transmembrane transporter activity 9.07E-08 1.64E-05 5.1 mitochondrial membrane 1.14E-21 8.88E-20 4.14
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9.4.3 Hippocampus Zhang 
 
9.4.4 Hippocampus Zeisel 
 
9.4.5 t(1;11) neurons Zhang 
 
9.4.6 t(1;11) neurons Zeisel 
 
Process P-value FDR q-value Enrichment Function P-value FDR q-value Enrichment Component P-value FDR q-value Enrichment
cellular metabolic process 4.29E-26 6.57E-22 1.71 binding 3.49E-11 1.58E-07 1.21 intracellular organelle part 4.53E-34 8.79E-31 1.73
macromolecule metabolic process 9.43E-25 7.23E-21 1.82 ubiquitin-like protein binding 2.11E-09 4.76E-06 6.59 intracellular part 7.28E-33 7.05E-30 1.33
nitrogen compound metabolic process 9.06E-24 4.63E-20 1.72 organic cyclic compound binding 9.16E-09 1.38E-05 1.44 organelle part 2.26E-31 1.46E-28 1.67
metabolic process 2.89E-22 1.11E-18 1.58 RNA binding 1.20E-08 1.36E-05 2.19 membrane-bounded organelle 4.95E-29 2.40E-26 1.46
primary metabolic process 9.90E-22 3.03E-18 1.64 heterocyclic compound binding 2.41E-08 2.18E-05 1.43 intracellular membrane-bounded organelle 1.06E-28 4.11E-26 1.5
organic substance metabolic process 3.71E-21 9.47E-18 1.6 ubiquitin binding 3.33E-08 2.51E-05 6.98 protein-containing complex 7.75E-27 2.50E-24 1.81
cellular macromolecule metabolic process 3.34E-18 7.30E-15 1.83 nucleoside phosphate binding 1.30E-07 8.36E-05 1.73 intracellular organelle 4.96E-25 1.37E-22 1.39
protein metabolic process 2.43E-17 4.66E-14 1.88 nucleotide binding 1.30E-07 7.31E-05 1.73 organelle 5.04E-24 1.22E-21 1.37
macromolecule catabolic process 6.09E-17 1.04E-13 3.25 catalytic activity 1.57E-07 7.86E-05 1.37 nuclear part 6.27E-22 1.35E-19 1.92
proteolysis involved in cellular protein catabolic process 6.16E-17 9.44E-14 3.85 small molecule binding 6.79E-07 3.06E-04 1.62 cytoplasmic part 1.15E-20 2.23E-18 1.49
modification-dependent macromolecule catabolic process 6.21E-17 8.65E-14 4.05 ubiquitin-like protein ligase binding 1.07E-06 4.39E-04 3.01 catalytic complex 1.09E-18 1.92E-16 2.7
modification-dependent protein catabolic process 1.33E-16 1.70E-13 4.05 ubiquitin protein ligase binding 1.32E-06 4.98E-04 3.06 cell part 3.05E-18 4.93E-16 1.19
ubiquitin-dependent protein catabolic process 2.17E-16 2.56E-13 4.08 protein binding 2.50E-06 8.67E-04 1.23 proteasome accessory complex 5.27E-14 7.85E-12 23.99
proteolysis 5.06E-16 5.54E-13 2.81 modification-dependent protein binding 2.81E-06 9.05E-04 4.21 mitochondrial part 1.66E-13 2.30E-11 2.87
cellular macromolecule catabolic process 1.55E-15 1.58E-12 3.36 purine ribonucleoside triphosphate binding 3.49E-06 1.05E-03 1.7 mitochondrial protein complex 6.75E-13 8.72E-11 4.73
organonitrogen compound metabolic process 2.75E-15 2.64E-12 1.7 ribonucleotide binding 5.34E-06 1.51E-03 1.67 mitochondrion 8.14E-13 9.86E-11 2.14
cellular localization 7.20E-15 6.49E-12 2.19 purine ribonucleotide binding 7.39E-06 1.96E-03 1.66 peptidase complex 8.96E-13 1.02E-10 8.29
macromolecule localization 1.62E-13 1.38E-10 2.14 proteasome-activating ATPase activity 7.51E-06 1.88E-03 24.72 nucleoplasm 1.82E-12 1.96E-10 2.02
protein catabolic process 4.58E-13 3.69E-10 3.88 nucleoside-triphosphatase activity 7.82E-06 1.86E-03 2.04 nucleus 2.25E-12 2.29E-10 1.48
intracellular transport 6.91E-13 5.29E-10 2.44 purine nucleotide binding 9.30E-06 2.10E-03 1.65 proteasome regulatory particle 1.14E-11 1.10E-09 29.66
cellular protein metabolic process 2.40E-12 1.75E-09 1.86 pyrophosphatase activity 1.48E-05 3.17E-03 1.97 organelle membrane 2.10E-11 1.94E-09 2.17
protein localization 3.14E-12 2.19E-09 2.08 hydrolase activity, acting on acid anhydrides 1.61E-05 3.31E-03 1.96 proteasome complex 5.32E-11 4.68E-09 9.12
proteasomal protein catabolic process 1.48E-11 9.87E-09 4.09 as above, in phosphorus-containing anhydrides 1.61E-05 3.16E-03 1.96 endopeptidase complex 6.84E-11 5.77E-09 8.97
cellular nitrogen compound metabolic process 2.93E-11 1.87E-08 1.76 ubiquitin-specific protease binding 2.29E-05 4.31E-03 13.24 ribonucleoprotein complex 1.06E-10 8.58E-09 2.51
catabolic process 4.59E-11 2.82E-08 2.09 ATP binding 2.31E-05 4.18E-03 1.71 proteasome regulatory particle, base subcomplex 1.19E-10 9.24E-09 24.72
Process P-value FDR q-value Enrichment Function P-value FDR q-value Enrichment Component P-value FDR q-value Enrichment
translation 1.55E-11 2.38E-07 15.09 RNA binding 1.23E-10 5.54E-07 6.32 protein-containing complex 8.90E-11 1.72E-07 2.57
peptide biosynthetic process 2.97E-11 2.28E-07 14.27 mRNA binding 2.64E-08 5.96E-05 12.94 ribonucleoprotein complex 1.07E-10 1.04E-07 6.95
cellular nitrogen compound biosynthetic process 4.20E-11 2.15E-07 6.22 heterocyclic compound binding 4.31E-08 6.48E-05 2.41 ribosome 2.25E-09 1.45E-06 17.16
cellular macromolecule biosynthetic process 4.91E-11 1.88E-07 7.31 nucleic acid binding 4.71E-08 5.31E-05 3.05 myelin sheath 5.16E-08 2.50E-05 15.09
macromolecule biosynthetic process 2.67E-10 8.18E-07 6.55 organic cyclic compound binding 6.48E-08 5.85E-05 2.37 intracellular part 6.16E-08 2.39E-05 1.44
amide biosynthetic process 5.65E-10 1.44E-06 11.05 translation factor activity, RNA binding 7.48E-08 5.63E-05 27.69 intracellular non-membrane-bounded organelle 1.67E-07 5.38E-05 2.98
peptide metabolic process 1.20E-09 2.62E-06 10.34 nucleoside-triphosphatase activity 1.99E-07 1.28E-04 5.84 non-membrane-bounded organelle 1.93E-07 5.36E-05 2.96
cellular biosynthetic process 1.44E-08 2.76E-05 4.13 pyrophosphatase activity 3.88E-07 2.19E-04 5.51 cytoplasmic part 3.73E-07 9.03E-05 1.82
organonitrogen compound biosynthetic process 4.11E-08 7.00E-05 6.03 hydrolase activity, acting on acid anhydrides 4.04E-07 2.03E-04 5.49 intracellular organelle 6.56E-07 1.41E-04 1.56
organic substance biosynthetic process 4.24E-08 6.50E-05 3.88 as above, in phosphorus-containing anhydrides 4.04E-07 1.83E-04 5.49 organelle 1.49E-06 2.90E-04 1.53
cellular nitrogen compound metabolic process 6.45E-08 8.98E-05 3.13 structural constituent of ribosome 4.50E-07 1.85E-04 14.7 intracellular organelle part 6.30E-06 1.11E-03 1.84
biosynthetic process 7.19E-08 9.18E-05 3.76 unfolded protein binding 7.01E-06 2.64E-03 18.66 organelle part 6.38E-06 1.03E-03 1.8
cellular amide metabolic process 9.75E-08 1.15E-04 6.96 purine ribonucleoside triphosphate binding 7.45E-06 2.59E-03 3.43 cytosolic part 1.26E-05 1.88E-03 8.9
nitrogen compound metabolic process 1.88E-06 2.06E-03 2.07 CTP binding 7.97E-06 2.57E-03 350.77 cell part 2.87E-05 3.97E-03 1.26
cellular macromolecule metabolic process 4.91E-06 5.01E-03 2.41 purine ribonucleotide binding 1.21E-05 3.65E-03 3.3 intracellular membrane-bounded organelle 2.87E-05 3.71E-03 1.58
protein localization 1.14E-05 1.09E-02 3.32 purine nucleotide binding 1.32E-05 3.72E-03 3.28 ribosomal subunit 2.99E-05 3.63E-03 9.93
cellular metabolic process 1.21E-05 1.09E-02 1.92 ribonucleotide binding 1.35E-05 3.58E-03 3.27 polysomal ribosome 6.81E-05 7.76E-03 37.58
macromolecule localization 1.33E-05 1.13E-02 3.28 translation elongation factor activity 1.44E-05 3.62E-03 61.9 cytosolic large ribosomal subunit 7.17E-05 7.72E-03 17.99
primary metabolic process 1.34E-05 1.08E-02 1.91 ATPase activity 2.18E-05 5.17E-03 6.73 smooth endoplasmic reticulum 9.28E-05 9.47E-03 33.95
establishment of localization in cell 1.54E-05 1.18E-02 3.67 sulfonylurea receptor binding 2.39E-05 5.39E-03 233.85 membrane-bounded organelle 2.24E-04 2.17E-02 1.47
macromolecule metabolic process 1.67E-05 1.22E-02 2.08 GTP binding 3.39E-05 7.28E-03 7.63 ribonucleoprotein granule 2.64E-04 2.44E-02 8.73
metabolic process 2.17E-05 1.51E-02 1.79 purine ribonucleoside binding 3.74E-05 7.67E-03 7.51 perinuclear region of cytoplasm 2.87E-04 2.53E-02 4.65
cellular protein metabolic process 2.34E-05 1.56E-02 2.72 purine nucleoside binding 4.04E-05 7.92E-03 7.42 mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) 3.54E-04 2.98E-02 70.15
protein metabolic process 2.72E-05 1.74E-02 2.4 ribonucleoside binding 4.11E-05 7.74E-03 7.4 proton-transporting ATP synthase complex, coupling factor F(o) 4.31E-04 3.48E-02 63.78
organonitrogen compound metabolic process 3.29E-05 2.02E-02 2.17 rRNA binding 4.69E-05 8.46E-03 20.04 proteasome regulatory particle, base subcomplex 5.17E-04 4.00E-02 58.46
Process P-value FDR q-value Enrichment Function P-value FDR q-value Enrichment Component P-value FDR q-value Enrichment
regulation of mRNA metabolic process 1.47E-15 2.27E-11 10.09 RNA binding 1.56E-12 7.09E-09 3.44 protein-containing complex 3.83E-16 7.47E-13 2.22
mRNA processing 1.59E-14 1.22E-10 8.32 protein binding 1.01E-09 2.30E-06 1.41 catalytic complex 4.59E-12 4.48E-09 3.92
RNA splicing 7.83E-14 4.02E-10 8.91 threonine-type endopeptidase activity 1.87E-07 2.84E-04 36.88 intracellular organelle part 5.17E-11 3.37E-08 1.57
non-canonical Wnt signaling pathway 3.52E-12 1.35E-08 14.98 threonine-type peptidase activity 1.87E-07 2.13E-04 36.88 proteasome complex 2.08E-10 1.02E-07 22.5
regulation of cellular amino acid metabolic process 7.81E-12 2.40E-08 24.59 heterocyclic compound binding 4.37E-07 3.97E-04 1.69 endopeptidase complex 2.44E-10 9.51E-08 22.13
mRNA metabolic process 6.62E-11 1.70E-07 5.47 organic cyclic compound binding 7.43E-07 5.62E-04 1.67 organelle part 4.19E-10 1.36E-07 1.52
regulation of cellular amine metabolic process 1.18E-10 2.59E-07 18.91 nucleic acid binding 1.42E-06 9.22E-04 1.88 nuclear speck 4.74E-10 1.32E-07 6.8
regulation of transcription from RNA polymerase II promoter in response to stress 1.88E-10 3.61E-07 14.89 cytochrome-c oxidase activity 1.10E-05 6.23E-03 28.1 nucleoplasm 1.10E-09 2.69E-07 2.37
negative regulation of G2/M transition of mitotic cell cycle 2.81E-10 4.81E-07 17.36 oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor 1.10E-05 5.54E-03 28.1 intracellular part 2.73E-09 5.93E-07 1.25
regulation of DNA-templated transcription in response to stress 3.06E-10 4.71E-07 14.23 heme-copper terminal oxidase activity 1.10E-05 4.98E-03 28.1 peptidase complex 3.82E-09 7.45E-07 16.39
regulation of G2/M transition of mitotic cell cycle 4.28E-10 5.98E-07 10.26 oxidoreductase activity, acting on a heme group of donors 1.33E-05 5.51E-03 26.82 nuclear part 3.89E-09 6.91E-07 1.97
regulation of mRNA catabolic process 4.57E-10 5.86E-07 10.2 enzyme binding 9.21E-05 3.49E-02 2.07 ribonucleoprotein complex 8.64E-09 1.41E-06 3.59
Wnt signaling pathway, planar cell polarity pathway 5.59E-10 6.61E-07 16.21 ATPase activity, coupled 1.11E-04 3.89E-02 4.31 cytosol 1.15E-08 1.73E-06 1.92
regulation of hematopoietic stem cell differentiation 6.77E-10 7.45E-07 19.82 proton transmembrane transporter activity 1.44E-04 4.69E-02 7.57 spliceosomal complex 1.38E-08 1.93E-06 9.96
NIK/NF-kappaB signaling 6.77E-10 6.95E-07 19.82 molecular_function 2.46E-04 7.45E-02 1.1 respiratory chain complex 1.63E-08 2.12E-06 17.61
positive regulation of Wnt signaling pathway 9.38E-10 9.02E-07 11 copper chaperone activity 2.71E-04 7.69E-02 73.76 membrane-bounded organelle 2.94E-08 3.59E-06 1.46
Fc receptor signaling pathway 9.38E-10 8.49E-07 11 ATP binding 3.77E-04 1.01E-01 2.24 nuclear body 7.22E-08 8.29E-06 4.1
negative regulation of cell cycle G2/M phase transition 9.53E-10 8.15E-07 15.37 cuprous ion binding 4.49E-04 1.13E-01 59.01 nucleoplasm part 8.89E-08 9.64E-06 3.42
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent 1.15E-09 9.34E-07 18.7 electron transfer activity 5.92E-04 1.41E-01 7.38 catalytic step 2 spliceosome 9.90E-08 1.02E-05 14.05
regulation of cell cycle G2/M phase transition 1.18E-09 9.05E-07 9.45 ATPase activity 6.17E-04 1.40E-01 3.48 intracellular organelle 1.27E-07 1.24E-05 1.43
positive regulation of canonical Wnt signaling pathway 1.37E-09 1.00E-06 12.39 adenyl ribonucleotide binding 6.30E-04 1.36E-01 2.15 proteasome core complex 1.41E-07 1.31E-05 38.82
regulation of transcription from RNA polymerase II promoter in response to hypoxia 1.68E-09 1.18E-06 17.94 mRNA binding 6.30E-04 1.30E-01 3.79 nucleus 2.85E-07 2.53E-05 1.77
antigen processing and presentation of exogenous peptide antigen via MHC class I 1.90E-09 1.27E-06 17.7 nucleotide binding 6.55E-04 1.29E-01 1.94 organelle 4.34E-07 3.68E-05 1.35
Fc-epsilon receptor signaling pathway 1.92E-09 1.23E-06 14.32 nucleoside phosphate binding 6.60E-04 1.25E-01 1.93 intracellular membrane-bounded organelle 4.55E-07 3.70E-05 1.52
regulation of establishment of planar polarity 2.11E-09 1.30E-06 14.18 proteasome-activating ATPase activity 6.71E-04 1.22E-01 49.17 cytochrome complex 5.03E-07 3.93E-05 30.73
Process P-value FDR q-value Enrichment Function P-value FDR q-value Enrichment Component P-value FDR q-valueEnrichment
translational initiation 4.69E-38 7.22E-34 13.48 RNA binding 8.50E-50 3.86E-46 3.6 protein-containing complex 1.19E-53 2.31E-50 2.16
mRNA metabolic process 1.94E-37 1.49E-33 5.36 structural constituent of ribosome 2.66E-29 6.03E-26 10.21 intracellular organelle part 5.14E-45 5.02E-42 1.61
protein targeting to ER 1.87E-33 9.60E-30 14.46 nucleic acid binding 2.09E-19 3.16E-16 1.83 organelle part 7.37E-42 4.80E-39 1.57
establishment of protein localization to endoplasmic reticulum 1.07E-32 4.11E-29 13.89 protein binding 1.69E-17 1.92E-14 1.29 ribonucleoprotein complex 5.02E-35 2.45E-32 3.84
protein localization to endoplasmic reticulum 2.80E-32 8.62E-29 12.99 structural molecule activity 2.39E-16 2.18E-13 3.31 cytoplasmic part 6.54E-34 2.55E-31 1.53
cotranslational protein targeting to membrane 5.00E-31 1.28E-27 14.63 heterocyclic compound binding 3.34E-15 2.53E-12 1.54 intracellular part 1.68E-28 5.46E-26 1.23
SRP-dependent cotranslational protein targeting to membrane 1.27E-30 2.79E-27 15.04 NADH dehydrogenase (ubiquinone) activity 1.26E-14 8.20E-12 15.12 ribosomal subunit 1.77E-28 4.93E-26 9.09
intracellular transport 1.16E-28 2.23E-25 3.13 NADH dehydrogenase (quinone) activity 1.26E-14 7.18E-12 15.12 cytosol 1.82E-28 4.44E-26 1.9
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay 1.51E-28 2.58E-25 12.08 organic cyclic compound binding 1.69E-14 8.52E-12 1.52 cytosolic part 7.03E-26 1.53E-23 7.42
establishment of localization in cell 1.28E-27 1.97E-24 2.88 NADH dehydrogenase activity 2.01E-14 9.11E-12 14.73 catalytic complex 6.43E-25 1.26E-22 3.08
translation 1.52E-27 2.13E-24 8.65 oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor 1.56E-13 6.46E-11 11.78 membrane-bounded organelle 3.10E-24 5.50E-22 1.43
cellular metabolic process 3.04E-27 3.90E-24 1.6 rRNA binding 2.54E-10 9.63E-08 9.09 ribosome 4.24E-23 6.90E-21 11.45
viral transcription 2.50E-26 2.96E-23 11.59 translation initiation factor activity 6.38E-10 2.23E-07 10.69 organelle 5.08E-23 7.63E-21 1.35
cellular macromolecule catabolic process 2.77E-26 3.05E-23 3.98 molecular_function 6.43E-10 2.09E-07 1.09 intracellular organelle 6.00E-22 8.37E-20 1.4
intracellular protein transport 5.09E-26 5.22E-23 3.95 threonine-type endopeptidase activity 6.78E-10 2.05E-07 17.23 extracellular exosome 2.73E-21 3.55E-19 2.42
peptide biosynthetic process 6.31E-26 6.07E-23 7.92 threonine-type peptidase activity 6.78E-10 1.92E-07 17.23 extracellular vesicle 6.24E-21 7.62E-19 2.39
nuclear-transcribed mRNA catabolic process 1.06E-25 9.63E-23 8.37 translation factor activity, RNA binding 7.69E-10 2.05E-07 7.66 extracellular organelle 6.52E-21 7.48E-19 2.39
protein targeting to membrane 1.70E-24 1.45E-21 9.44 mRNA binding 3.19E-09 8.06E-07 3.39 respiratory chain complex 4.05E-20 4.39E-18 13.15
peptide metabolic process 2.34E-24 1.89E-21 6 oxidoreductase activity, acting on NAD(P)H 3.48E-09 8.33E-07 6.38 vesicle 5.35E-20 5.49E-18 2.04
mRNA catabolic process 3.10E-24 2.39E-21 7.7 enzyme binding 9.51E-09 2.16E-06 1.78 intracellular membrane-bounded organelle 1.13E-18 1.10E-16 1.46
viral process 3.77E-24 2.76E-21 4.37 ubiquitin-like protein ligase binding 1.37E-08 2.96E-06 3.54 mitochondrial membrane 4.15E-17 3.86E-15 3.75
symbiont process 3.77E-24 2.63E-21 4.37 ubiquitin protein ligase binding 1.50E-08 3.10E-06 3.63 cytosolic large ribosomal subunit 9.91E-17 8.79E-15 12.99
macromolecule catabolic process 8.22E-24 5.50E-21 3.49 electron transfer activity 4.70E-08 9.29E-06 5.74 mitochondrial inner membrane 1.69E-16 1.44E-14 4.56
metabolic process 1.11E-23 7.14E-21 1.51 protein tag 1.27E-07 2.40E-05 20.89 nuclear part 2.64E-16 2.15E-14 1.67
protein targeting 1.55E-23 9.52E-21 6.04 binding 1.32E-07 2.41E-05 1.12 proteasome complex 3.03E-16 2.37E-14 12.33
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Process P-value FDR q-value Enrichment Function P-value FDR q-value Enrichment Component P-value FDR q-value Enrichment
RNA splicing 8.03E-07 1.24E-02 17.08 RNA binding 1.54E-04 7.00E-01 4.51 intracellular organelle part 6.49E-06 1.27E-02 1.94
mRNA processing 2.09E-06 1.61E-02 14.5 pre-mRNA binding 7.70E-04 1.00E+00 48.33 organelle part 1.11E-05 1.09E-02 1.88
regulation of RNA splicing 7.93E-06 4.07E-02 30.16 intracellular organelle 1.97E-05 1.28E-02 1.82
mRNA metabolic process 2.30E-05 8.87E-02 9.54 catalytic step 2 spliceosome 9.06E-05 4.42E-02 33.66
establishment of Golgi localization 2.97E-05 9.13E-02 235.62 organelle 1.37E-04 5.35E-02 1.64
RNA splicing, via transesterification reactions 9.12E-05 2.34E-01 16.18 nucleoplasm part 4.97E-04 1.62E-01 5.47
 with bulged adenosine as nucleophile nuclear speck 5.29E-04 1.48E-01 10.22
mRNA splicing, via spliceosome 9.12E-05 2.01E-01 16.18 ribonucleoprotein complex 5.91E-04 1.44E-01 5.29
Golgi localization 9.60E-05 1.85E-01 134.64 spliceosomal complex 6.39E-04 1.39E-01 17.35
RNA splicing, via transesterification reactions 9.90E-05 1.69E-01 15.84 nuclear body 7.33E-04 1.43E-01 6.55
establishment of localization in cell 1.10E-04 1.70E-01 4.73 intracellular membrane-bounded organelle 9.19E-04 1.63E-01 1.86
regulation of mRNA splicing, via spliceosome 1.19E-04 1.66E-01 30.73
cellular component assembly 1.75E-04 2.24E-01 3.83
regulation of mRNA metabolic process 2.63E-04 3.12E-01 12.28
negative regulation of RNA splicing 2.65E-04 2.92E-01 81.96
Golgi organization 2.94E-04 3.02E-01 22.62
intracellular transport 3.20E-04 3.07E-01 4.81
regulation of mRNA processing 3.22E-04 2.92E-01 21.92
cellular localization 5.41E-04 4.63E-01 3.77
RNA processing 6.62E-04 5.36E-01 5.18
regulation of viral process 9.23E-04 7.10E-01 15.28
interleukin-12-mediated signaling pathway 9.36E-04 6.86E-01 43.84
Appendix 
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9.5 Full GO Process terms for cell types, as in EWCE analysis. 
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